{
    "5e6157cb1af46fc13000000e_1": [
        {
            "start_logit": 9.9375,
            "end_logit": 10.171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -2.095703125,
            "text": "Ret",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 10.171875,
            "text": "syndrome",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.046875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 10.171875,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": 10.171875,
            "text": "with Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.98046875,
            "text": "Rett syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.171875,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.171875,
            "text": "commonly associated with Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.171875,
            "text": "associated with Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 10.171875,
            "text": "the methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -2.095703125,
            "text": "with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.98046875,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -2.095703125,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -2.095703125,
            "text": "commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -2.095703125,
            "text": "associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -2.095703125,
            "text": "the methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.046875,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.046875,
            "text": "with Rett",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.98046875,
            "text": "t syndrome.",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_2": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.2109375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -2.0234375,
            "text": "Ret",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -2.390625,
            "end_logit": 10.2109375,
            "text": "syndrome",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 10.2109375,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.5625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.99609375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.046875,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1328125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeCP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1640625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeC",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1640625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.171875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.21875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2265625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.234375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.25,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.25,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.265625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -7.9453125,
            "text": "syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeCP2 on",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -7.99609375,
            "text": "syndrome (RS) is a debilitating neurological disorder",
            "probability": 0.0
        },
        {
            "start_logit": -2.390625,
            "end_logit": -8.046875,
            "text": "syndrome (",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_3": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.21875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.349609375,
            "end_logit": 10.21875,
            "text": "syndrome",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -2.1328125,
            "text": "Ret",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 10.21875,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 10.21875,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 10.21875,
            "text": "t syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.3359375,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.75,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.03125,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.21875,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.140625,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.21875,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.21875,
            "text": "cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.21875,
            "text": "gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.21875,
            "text": "Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.21875,
            "text": "MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 10.21875,
            "text": "the MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.3828125,
            "text": "Rett syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -6.16796875,
            "end_logit": -2.1328125,
            "text": "disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -2.1328125,
            "text": "neurodevelopmental disorder Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_4": [
        {
            "start_logit": 9.953125,
            "end_logit": 10.21875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -2.064453125,
            "text": "Ret",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -2.380859375,
            "end_logit": 10.21875,
            "text": "syndrome",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 10.21875,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.40625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.703125,
            "text": "Rett syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1015625,
            "text": "Rett syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1171875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1484375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1953125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.2265625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.25,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.25,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.25,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.296875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.3515625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.390625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeC",
            "probability": 0.0
        },
        {
            "start_logit": -2.380859375,
            "end_logit": -7.703125,
            "text": "syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -2.380859375,
            "end_logit": -8.1015625,
            "text": "syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": -2.380859375,
            "end_logit": -8.1171875,
            "text": "syndrome is a severe neurodevelopmental disorder",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_5": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.109375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.12109375,
            "text": "Ret",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -2.609375,
            "end_logit": 10.109375,
            "text": "syndrome",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 10.109375,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.25390625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.76171875,
            "text": "Rett syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.109375,
            "text": "cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.09375,
            "text": "Rett syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3359375,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.109375,
            "text": "gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.4453125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.109375,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.109375,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 10.109375,
            "text": "the MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -2.12109375,
            "text": "cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": -7.76171875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -2.12109375,
            "text": "gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": -8.09375,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -2.12109375,
            "text": "Mutations in the MeCP2 gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -2.12109375,
            "text": "MeCP2 gene cause Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_6": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.25,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.2890625,
            "end_logit": 10.25,
            "text": "syndrome",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -2.025390625,
            "text": "Ret",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 10.25,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.7109375,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.86328125,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.9921875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MECP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0546875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MEC",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0546875,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0625,
            "text": "Rett syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.078125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1953125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.203125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.203125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.21875,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.234375,
            "text": "Rett syndrome (RTT) is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.234375,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2578125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_7": [
        {
            "start_logit": 9.984375,
            "end_logit": 10.25,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -1.98046875,
            "text": "Ret",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -2.283203125,
            "end_logit": 10.25,
            "text": "syndrome",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.31640625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.25,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.86328125,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.91796875,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.9375,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.078125,
            "text": "Rett syndrome (RTT) is associated with",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.109375,
            "text": "Rett syndrome (RTT) is associated with mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1171875,
            "text": "Rett syndrome (RTT) is associated with mutations in",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.171875,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.171875,
            "text": "Rett syndrome (RTT) is associated with mutations in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.203125,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeC",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.203125,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.21875,
            "text": "Rett syndrome (RTT) is associated",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.2265625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.2421875,
            "text": "Rett syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.296875,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_8": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.109375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.12109375,
            "text": "Ret",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -2.609375,
            "end_logit": 10.109375,
            "text": "syndrome",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 10.109375,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.25390625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.76171875,
            "text": "Rett syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.109375,
            "text": "cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.09375,
            "text": "Rett syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3359375,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.109375,
            "text": "gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.4453125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.109375,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.109375,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 10.109375,
            "text": "the MeCP2 gene cause Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -2.12109375,
            "text": "cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": -7.76171875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -2.12109375,
            "text": "gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": -8.09375,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -2.12109375,
            "text": "Mutations in the MeCP2 gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -2.12109375,
            "text": "MeCP2 gene cause Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_9": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.15625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -2.142578125,
            "text": "Ret",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 10.15625,
            "text": "syndrome",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -5.94921875,
            "end_logit": 10.15625,
            "text": "in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.19140625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 10.15625,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.15625,
            "text": "severity in Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.1875,
            "text": "Rett syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.15625,
            "text": "disease severity in Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.15625,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.15625,
            "text": "associated with disease severity in Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -2.142578125,
            "text": "in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -2.142578125,
            "text": "severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -2.142578125,
            "text": "disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -2.142578125,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.50390625,
            "end_logit": -8.1875,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": -2.142578125,
            "text": "associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -7.19140625,
            "text": "in Rett",
            "probability": 0.0
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -8.1875,
            "text": "in Rett syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.19140625,
            "text": "t",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_10": [
        {
            "start_logit": 9.9375,
            "end_logit": 10.234375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": 10.234375,
            "text": "syndrome",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.9375,
            "end_logit": -2.091796875,
            "text": "Ret",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 10.234375,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.52734375,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.77734375,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.8046875,
            "text": "Rett syndrome (RTT), the second",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.93359375,
            "text": "Rett syndrome (RTT), the",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -7.94140625,
            "text": "Rett syndrome (RTT), the second most",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.0,
            "text": "Rett syndrome (RTT), the second most common cause of mental retardation in females, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.0,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.0078125,
            "text": "Rett syndrome (RTT), the second most common",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.0703125,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.078125,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -7.77734375,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -7.8046875,
            "text": "syndrome (RTT), the second",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -7.93359375,
            "text": "syndrome (RTT), the",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -7.94140625,
            "text": "syndrome (RTT), the second most",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -8.0,
            "text": "syndrome (RTT), the second most common cause of mental retardation in females, has",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -8.0,
            "text": "syndrome (RTT",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_11": [
        {
            "start_logit": 9.953125,
            "end_logit": 10.2109375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -2.06640625,
            "text": "Ret",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 10.2109375,
            "text": "syndrome",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 10.2109375,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.7734375,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.80859375,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.94140625,
            "text": "Rett syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.98046875,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0078125,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0390625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0390625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2), which",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2)",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1015625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.109375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1171875,
            "text": "Rett syndrome (RTT) is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1171875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.140625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_12": [
        {
            "start_logit": 9.984375,
            "end_logit": 10.265625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.251953125,
            "end_logit": 10.265625,
            "text": "syndrome",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.984375,
            "end_logit": -1.9833984375,
            "text": "Ret",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 10.265625,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.4765625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.859375,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.9375,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.0,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.046875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.0625,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1015625,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.109375,
            "text": "Rett syndrome (RTT) is caused by",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.125,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MEC",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.125,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2)",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RTT) is caused",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RTT) is caused by mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1484375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1640625,
            "text": "Rett syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1796875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_13": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.2265625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -2.326171875,
            "end_logit": 10.2265625,
            "text": "syndrome",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.12890625,
            "text": "Ret",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 10.2265625,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 10.2265625,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 10.2265625,
            "text": "t syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.5,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.5703125,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.8828125,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.9765625,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.2265625,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.15625,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2578125,
            "text": "Rett syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.2265625,
            "text": "cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.2265625,
            "text": "Mutations in MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 10.2265625,
            "text": "MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.2265625,
            "text": "in MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -6.18359375,
            "end_logit": -2.12890625,
            "text": "disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -2.12890625,
            "text": "neurodevelopmental disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.326171875,
            "end_logit": -7.5703125,
            "text": "syndrome (",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_14": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.1953125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -2.00390625,
            "text": "Ret",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.41796875,
            "end_logit": 10.1953125,
            "text": "syndrome",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.109375,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 10.1953125,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.984375,
            "text": "Rett syndrome ,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.1953125,
            "text": "of Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.015625,
            "text": "Rett syndrome , an autism spectrum disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.125,
            "text": "Rett syndrome , an autism spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.1875,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.2109375,
            "text": "Rett syndrome , an",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.2734375,
            "text": "Rett syndrome , an autism",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.1953125,
            "text": "methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.703125,
            "end_logit": 10.1953125,
            "text": "gene encoding the methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -2.00390625,
            "text": "of Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.41796875,
            "end_logit": -7.984375,
            "text": "syndrome ,",
            "probability": 0.0
        },
        {
            "start_logit": -2.41796875,
            "end_logit": -8.015625,
            "text": "syndrome , an autism spectrum disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": -2.41796875,
            "end_logit": -8.125,
            "text": "syndrome , an autism spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -2.41796875,
            "end_logit": -8.1875,
            "text": "syndrome , an autism spectrum disorder mainly affecting",
            "probability": 0.0
        },
        {
            "start_logit": -2.41796875,
            "end_logit": -8.2109375,
            "text": "syndrome , an",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_15": [
        {
            "start_logit": 10.0078125,
            "end_logit": 10.28125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -1.9189453125,
            "text": "Ret",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -2.23046875,
            "end_logit": 10.28125,
            "text": "syndrome",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 10.28125,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -7.5703125,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -7.8046875,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -7.96484375,
            "text": "Rett syndrome ( RTT ) is",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.046875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.0546875,
            "text": "Rett syndrome ( RTT",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.0625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.09375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.1328125,
            "text": "Rett syndrome ( RT",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.15625,
            "text": "Rett syndrome ( RTT )",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.1875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the transcriptional repressor methyl-CpG",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.203125,
            "text": "Rett syndrome ( RTT ) is a",
            "probability": 0.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -7.8046875,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -7.96484375,
            "text": "syndrome ( RTT ) is",
            "probability": 0.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -8.046875,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 0.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -8.0546875,
            "text": "syndrome ( RTT",
            "probability": 0.0
        },
        {
            "start_logit": -2.23046875,
            "end_logit": -8.0625,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_16": [
        {
            "start_logit": 9.9921875,
            "end_logit": 10.2265625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -1.9697265625,
            "text": "Ret",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -2.33984375,
            "end_logit": 10.2265625,
            "text": "syndrome",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 10.2265625,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.59375,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.7578125,
            "text": "Rett syndrome (RTT) is an X",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.796875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.81640625,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.90625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.90625,
            "text": "Rett syndrome (RTT) is an X-linked",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -7.99609375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.0078125,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.09375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.109375,
            "text": "Rett syndrome (RTT) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.125,
            "text": "Rett syndrome (RTT) is an X-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.140625,
            "text": "Rett syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.15625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.1640625,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.171875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeC",
            "probability": 0.0
        },
        {
            "start_logit": 9.9921875,
            "end_logit": -8.203125,
            "text": "Rett syndrome (RTT) is an",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_17": [
        {
            "start_logit": 9.9453125,
            "end_logit": 10.1640625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -2.087890625,
            "text": "Ret",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.46875,
            "end_logit": 10.1640625,
            "text": "syndrome",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 10.1640625,
            "text": "as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 10.1640625,
            "text": "known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 10.1640625,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.5546875,
            "text": "Rett syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 10.1640625,
            "text": "disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.66015625,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 10.1640625,
            "text": "a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -8.0859375,
            "text": "Rett syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.1640625,
            "text": "methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.1640625,
            "text": "neurodevelopmental disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.1640625,
            "text": "delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.1640625,
            "text": "factor methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -6.51953125,
            "end_logit": -2.087890625,
            "text": "as Ret",
            "probability": 0.0
        },
        {
            "start_logit": -6.73046875,
            "end_logit": -2.087890625,
            "text": "known as Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -2.087890625,
            "text": "disorder known as Ret",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -7.5546875,
            "text": "syndrome (",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_18": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.1796875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -2.142578125,
            "text": "Ret",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -2.46875,
            "end_logit": 10.1796875,
            "text": "syndrome",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 10.1796875,
            "text": "t syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.546875,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.73046875,
            "text": "Rett syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.015625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2 (",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.1171875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.1328125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.15625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.15625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.1796875,
            "text": "Rett syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.1875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2109375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2109375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.21875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2578125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2578125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -7.73046875,
            "text": "syndrome is",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_19": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.1875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.134765625,
            "text": "Ret",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -2.451171875,
            "end_logit": 10.1875,
            "text": "syndrome",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 10.1875,
            "text": "t syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.35546875,
            "text": "Rett",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.9921875,
            "text": "Rett syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1171875,
            "text": "Rett syndrome is a monogenic disease due",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.140625,
            "text": "Rett syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2421875,
            "text": "Rett syndrome is a monogenic disease due to",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.296875,
            "text": "Rett syndrome is a monogenic disease due to de",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3046875,
            "text": "Rett syndrome is a monogenic",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3203125,
            "text": "Rett syndrome is a monogenic disease due to de novo",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.328125,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3515625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3671875,
            "text": "Rett syndrome is a mono",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3828125,
            "text": "Rett syndrome is a monogenic disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.390625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3984375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.40625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDK",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_1": [
        {
            "start_logit": 9.015625,
            "end_logit": 10.015625,
            "text": "apoE2 isoform",
            "probability": 1.0
        },
        {
            "start_logit": -0.50732421875,
            "end_logit": 10.015625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": -2.4375,
            "end_logit": 10.015625,
            "text": "isoform",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -2.861328125,
            "text": "apoE",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.40625,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 10.015625,
            "text": "common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.89453125,
            "text": "apoE2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 10.015625,
            "text": "2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 10.015625,
            "text": "the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.921875,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.015625,
            "text": "and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.015625,
            "text": ", and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.16796875,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.015625,
            "text": "relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.015625,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.015625,
            "text": "to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.54296875,
            "text": "apoE2 isoform is encoded by the R158",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.71875,
            "text": "apoE2 isoform is encoded by the R1",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.94921875,
            "text": "apoE2 isoform is",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -8.03125,
            "text": "apoE2 isoform is encoded by",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_2": [
        {
            "start_logit": 9.015625,
            "end_logit": 10.015625,
            "text": "apoE2 isoform",
            "probability": 1.0
        },
        {
            "start_logit": -0.50732421875,
            "end_logit": 10.015625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": -2.4375,
            "end_logit": 10.015625,
            "text": "isoform",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -2.861328125,
            "text": "apoE",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.40625,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 10.015625,
            "text": "common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.89453125,
            "text": "apoE2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 10.015625,
            "text": "2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 10.015625,
            "text": "the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.921875,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.015625,
            "text": "and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.015625,
            "text": ", and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.16796875,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.015625,
            "text": "relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.015625,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.015625,
            "text": "to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.54296875,
            "text": "apoE2 isoform is encoded by the R158",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.71875,
            "text": "apoE2 isoform is encoded by the R1",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.94921875,
            "text": "apoE2 isoform is",
            "probability": 0.0
        },
        {
            "start_logit": 9.015625,
            "end_logit": -8.03125,
            "text": "apoE2 isoform is encoded by",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_1": [
        {
            "start_logit": 7.99609375,
            "end_logit": 7.70703125,
            "text": "SERCA",
            "probability": 1.0
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.3671875,
            "text": "SERCA)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.70703125,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.70703125,
            "text": "(SERCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -6.3671875,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -6.66796875,
            "text": "sarcoplasmic reticulum (SR) calcium pump (",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.02734375,
            "text": "sarcoplasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.04296875,
            "text": "sarcoplasmic reticulum (SR) calcium pump",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.33984375,
            "text": "sarcoplasmic reticulum (",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.41015625,
            "text": "sarcoplasmic reticulum (SR",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.47265625,
            "text": "sarcoplasmic reticulum (SR) calcium",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -7.5390625,
            "text": "sarcoplasmic reticulum (SR)",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -6.3671875,
            "text": "(SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -8.3125,
            "text": "sarcoplasmic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -6.66796875,
            "text": "(",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_2": [
        {
            "start_logit": 6.9921875,
            "end_logit": 9.3359375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 1.0
        },
        {
            "start_logit": -2.869140625,
            "end_logit": 9.3359375,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": -3.1875,
            "end_logit": 9.3359375,
            "text": "ATPase",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -5.703125,
            "end_logit": 9.3359375,
            "text": "Ca(2+)-ATPase",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -3.548828125,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -5.0,
            "text": "sarc",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.3359375,
            "text": "+)-ATPase",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.3359375,
            "text": "(2+)-ATPase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.3359375,
            "text": "reticulum Ca(2+)-ATPase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.3359375,
            "text": ")-ATPase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 9.3359375,
            "text": "-ATPase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 9.3359375,
            "text": "o/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.3359375,
            "text": "endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.3359375,
            "text": "2+)-ATPase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 9.3359375,
            "text": "/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -6.1796875,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -7.91796875,
            "text": "sarco/endoplasmic reticulum Ca(2+)-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -8.0078125,
            "text": "sarco/",
            "probability": 0.0
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -8.015625,
            "text": "sarco/endoplasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -8.0234375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_3": [
        {
            "start_logit": 7.90234375,
            "end_logit": 5.5390625,
            "text": "SERCA",
            "probability": 0.81982421875
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 4.01953125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 0.18017578125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -5.88671875,
            "text": "SERCA,",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.58984375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.70703125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.828125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.95703125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.9609375,
            "text": "SERCA, an endoplasmic reticulum",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.96875,
            "text": "SERCA, an",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.078125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.078125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.0859375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.09375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.1484375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.1640625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.1796875,
            "text": "SERCA, an endoplasmic reticulum (ER",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.1953125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -8.203125,
            "text": "SERCA, an endoplasmic reticulum (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 4.01953125,
            "text": ".",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 4.01953125,
            "text": "ER lumen.",
            "probability": 5.960464477539063e-08
        }
    ],
    "54db62a3034aea571d000001_4": [
        {
            "start_logit": 7.0078125,
            "end_logit": 3.58203125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -3.763671875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.0006403923034667969
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -3.958984375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 0.0005269050598144531
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -4.98046875,
            "text": "Sarcoplasmic",
            "probability": 0.00019073486328125
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -6.80859375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.55859375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.60546875,
            "text": "Sarcoplasmic reticulum Ca(",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.62890625,
            "text": "Sarcoplasmic reticulum Ca(2",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.6328125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.7109375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.71484375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.77734375,
            "text": "Sarcoplasmic reticulum Ca",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -7.81640625,
            "text": "Sarcoplasmic reticulum",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -8.109375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -8.1171875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -8.140625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 7.0078125,
            "end_logit": -8.140625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 3.58203125,
            "text": "ATPase",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 3.58203125,
            "text": "Ca(2+)-ATPase",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 3.58203125,
            "text": "-ATPase",
            "probability": 3.5762786865234375e-07
        }
    ],
    "54db62a3034aea571d000001_5": [
        {
            "start_logit": 3.0703125,
            "end_logit": 0.86767578125,
            "text": "SERCA",
            "probability": 0.6201171875
        },
        {
            "start_logit": 3.0703125,
            "end_logit": 0.28662109375,
            "text": "SERCA enzymes).",
            "probability": 0.347412109375
        },
        {
            "start_logit": -0.61328125,
            "end_logit": 0.86767578125,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 0.01558685302734375
        },
        {
            "start_logit": -0.61328125,
            "end_logit": 0.28662109375,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0087127685546875
        },
        {
            "start_logit": 3.0703125,
            "end_logit": -4.109375,
            "text": "SERCA enzymes",
            "probability": 0.004276275634765625
        },
        {
            "start_logit": -2.6875,
            "end_logit": 0.86767578125,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 0.0019588470458984375
        },
        {
            "start_logit": -2.6875,
            "end_logit": 0.28662109375,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0010986328125
        },
        {
            "start_logit": 3.0703125,
            "end_logit": -6.3515625,
            "text": "SERCA enzymes)",
            "probability": 0.0004546642303466797
        },
        {
            "start_logit": -0.61328125,
            "end_logit": -4.109375,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes",
            "probability": 0.00010794401168823242
        },
        {
            "start_logit": -0.61328125,
            "end_logit": -4.3203125,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases",
            "probability": 8.672475814819336e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 0.86767578125,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 0.28662109375,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": -2.6875,
            "end_logit": -4.109375,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes",
            "probability": 1.3470649719238281e-05
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 0.86767578125,
            "text": "(SERCA",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 0.86767578125,
            "text": "actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": -0.61328125,
            "end_logit": -6.3515625,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes)",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": -2.6875,
            "end_logit": -4.3203125,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 0.28662109375,
            "text": ".",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -8.15625,
            "end_logit": 0.86767578125,
            "text": "endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -8.28125,
            "end_logit": 0.86767578125,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 7.271766662597656e-06
        }
    ],
    "54db62a3034aea571d000001_6": [
        {
            "start_logit": 6.21484375,
            "end_logit": 6.7578125,
            "text": "SERCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": 6.7578125,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 0.0002493858337402344
        },
        {
            "start_logit": 6.21484375,
            "end_logit": -6.1171875,
            "text": "SERCA)",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.7578125,
            "text": "(SERCA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 6.7578125,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -6.1171875,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -6.54296875,
            "text": "sarco(endo)plasmic reticulum calcium pump",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.328125,
            "text": "sarco(endo)plasmic reticulum calcium pump (",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.44140625,
            "text": "sarco(endo)plasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.46484375,
            "text": "sarco(endo)plasm",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.68359375,
            "text": "sarco(",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.73046875,
            "text": "sarco(endo)plasmic reticulum calcium",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.7421875,
            "text": "sarco(endo)plasmic",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.796875,
            "text": "sarco(endo",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.828125,
            "text": "sarco",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -7.99609375,
            "text": "sarco(endo)",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -6.1171875,
            "text": "(SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -6.1171875,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -6.54296875,
            "text": "o(endo)plasmic reticulum calcium pump",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.328125,
            "text": "(",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_7": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.8359375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": 1.5849609375,
            "text": "SERCA",
            "probability": 0.0002613067626953125
        },
        {
            "start_logit": -1.5595703125,
            "end_logit": 9.8359375,
            "text": ".",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -5.9765625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -6.71875,
            "text": "SERCA is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.03515625,
            "text": "SERCA is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.0390625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 9.8359375,
            "text": "pumps free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.21484375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 9.8359375,
            "text": "of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.875,
            "end_logit": 9.8359375,
            "text": "P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.38671875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 9.8359375,
            "text": "stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 9.8359375,
            "text": "family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.8359375,
            "text": "ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.8359375,
            "text": "free cytosolic calcium into intracellular stores.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.4765625,
            "text": "SERCA is a membrane protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.8359375,
            "text": "and pumps free cytosolic calcium into intracellular stores.",
            "probability": 0.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.5078125,
            "text": "SERCA is a membrane protein that belongs to the family of P",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 9.8359375,
            "text": "intracellular stores.",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_8": [
        {
            "start_logit": 9.6328125,
            "end_logit": 9.8359375,
            "text": "SERCA2a",
            "probability": 1.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -2.533203125,
            "text": "SERCA",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -2.900390625,
            "end_logit": 9.8359375,
            "text": "2a",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -5.3671875,
            "text": "SERCA2a isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -5.76953125,
            "text": "SERCA2a isoform in the heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 9.8359375,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.8359375,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.4765625,
            "text": "SERCA2a isoform in the heart.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 9.8359375,
            "text": "the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.8359375,
            "text": "Three different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.8359375,
            "text": "SERCA is mainly represented by the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.8359375,
            "text": "different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.8359375,
            "text": "-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.8359375,
            "text": "mainly represented by the SERCA2a",
            "probability": 0.0
        },
        {
            "start_logit": -2.900390625,
            "end_logit": -5.3671875,
            "text": "2a isoform",
            "probability": 0.0
        },
        {
            "start_logit": -2.900390625,
            "end_logit": -5.76953125,
            "text": "2a isoform in the heart",
            "probability": 0.0
        },
        {
            "start_logit": -6.65234375,
            "end_logit": -2.533203125,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -2.533203125,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA",
            "probability": 0.0
        },
        {
            "start_logit": -2.900390625,
            "end_logit": -7.4765625,
            "text": "2a isoform in the heart.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -2.533203125,
            "text": "the SERCA",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_9": [
        {
            "start_logit": 8.4140625,
            "end_logit": 0.30859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase",
            "probability": 0.97265625
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -4.21484375,
            "text": "The",
            "probability": 0.01059722900390625
        },
        {
            "start_logit": -3.68359375,
            "end_logit": 6.86328125,
            "text": ".",
            "probability": 0.0038204193115234375
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -5.49609375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is",
            "probability": 0.002941131591796875
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -5.8828125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA",
            "probability": 0.0019969940185546875
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -6.30859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA)",
            "probability": 0.0013055801391601562
        },
        {
            "start_logit": -5.01171875,
            "end_logit": 6.86328125,
            "text": "SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0010128021240234375
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -6.7265625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against",
            "probability": 0.0008597373962402344
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -6.9140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive",
            "probability": 0.0007128715515136719
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -6.9765625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump",
            "probability": 0.0006694793701171875
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.1640625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (",
            "probability": 0.0005550384521484375
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.33203125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from",
            "probability": 0.00046896934509277344
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.33984375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to",
            "probability": 0.00046563148498535156
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.40234375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol",
            "probability": 0.0004372596740722656
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.51171875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a",
            "probability": 0.00039196014404296875
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.5234375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the",
            "probability": 0.00038743019104003906
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.55859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the",
            "probability": 0.00037407875061035156
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.86328125,
            "text": "pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 9.34600830078125e-05
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.86328125,
            "text": "a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 9.059906005859375e-05
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.86328125,
            "text": "(SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 8.779764175415039e-05
        }
    ],
    "550739cf3b8a5dc045000002_1": [
        {
            "start_logit": 6.87109375,
            "end_logit": 6.03125,
            "text": "AAUAAA hexamer",
            "probability": 0.99609375
        },
        {
            "start_logit": 6.87109375,
            "end_logit": 0.457275390625,
            "text": "AAUAAA",
            "probability": 0.003765106201171875
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.171875,
            "text": "AAUAAA hexa",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.23828125,
            "text": "AA",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -5.484375,
            "end_logit": 6.03125,
            "text": "mer",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -7.39453125,
            "text": "AAUA",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.03125,
            "text": "hexamer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.03125,
            "text": "UAAA hexamer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.03125,
            "text": "The most canonical AAUAAA hexamer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.03125,
            "text": "canonical AAUAAA hexamer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 6.03125,
            "text": "most canonical AAUAAA hexamer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 6.03125,
            "text": "AA hexamer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 0.457275390625,
            "text": "UAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 0.457275390625,
            "text": "The most canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 0.457275390625,
            "text": "canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 0.457275390625,
            "text": "most canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 0.457275390625,
            "text": "AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.171875,
            "text": "hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -6.171875,
            "text": "UAAA hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -6.171875,
            "text": "The most canonical AAUAAA hexa",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_2": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.78125,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": -4.3984375,
            "end_logit": 8.78125,
            "text": "AA",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -4.796875,
            "text": "AA",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.78125,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.78125,
            "text": "UAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.046875,
            "text": "AAUA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.78125,
            "text": "signal AAUAAA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -4.796875,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -4.796875,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.046875,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -7.046875,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.86328125,
            "text": "polyadenylation",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.046875,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.95703125,
            "text": "polyadenylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.09375,
            "text": "polyaden",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.95703125,
            "text": "signal",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_3": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.78125,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": -4.3984375,
            "end_logit": 8.78125,
            "text": "AA",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -4.796875,
            "text": "AA",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.78125,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.78125,
            "text": "UAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.046875,
            "text": "AAUA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.78125,
            "text": "signal AAUAAA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -4.796875,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -4.796875,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.046875,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -7.046875,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.86328125,
            "text": "polyadenylation",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.046875,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.95703125,
            "text": "polyadenylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -8.09375,
            "text": "polyaden",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.95703125,
            "text": "signal",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_4": [
        {
            "start_logit": 9.5859375,
            "end_logit": 9.4453125,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -2.787109375,
            "text": "AA",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -3.6015625,
            "end_logit": 9.4453125,
            "text": "AA",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -5.58203125,
            "text": "AAUAAA) nearby the 3' end",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -5.8203125,
            "text": "AAUAAA) nearby the 3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -6.828125,
            "text": "AAUA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.07421875,
            "text": "AAUAAA) nearby the 3'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.25,
            "text": "AAUAAA) nearby the 3' end of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.484375,
            "text": "AAUAAA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.4453125,
            "text": "UAAA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.58203125,
            "text": "AAUAAA) nearby the 3' end of pre",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.73828125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.0390625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.0390625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.4453125,
            "text": "A polyadenylation signal (AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.046875,
            "text": "AAUAAA) nearby the 3' end of pre-",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.078125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.1015625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis.",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.4453125,
            "text": "polyadenylation signal (AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.4453125,
            "text": "(AAUAAA",
            "probability": 0.0
        }
    ],
    "5e764647c6a8763d23000016_1": [
        {
            "start_logit": -3.50390625,
            "end_logit": 4.21875,
            "text": "CVD 103-HgR",
            "probability": 0.8203125
        },
        {
            "start_logit": -5.8671875,
            "end_logit": 4.21875,
            "text": "HgR",
            "probability": 0.07720947265625
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 4.21875,
            "text": "The oral live cholera vaccine CVD 103-HgR",
            "probability": 0.0305938720703125
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 4.21875,
            "text": "R",
            "probability": 0.0266876220703125
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 4.21875,
            "text": "-HgR",
            "probability": 0.0213623046875
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 4.21875,
            "text": "103-HgR",
            "probability": 0.01812744140625
        },
        {
            "start_logit": -2.33984375,
            "end_logit": -2.103515625,
            "text": "1993",
            "probability": 0.004711151123046875
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -2.103515625,
            "text": "launched 1993",
            "probability": 0.00030350685119628906
        },
        {
            "start_logit": -5.9296875,
            "end_logit": -2.103515625,
            "text": "Orochol, Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 0.00012993812561035156
        },
        {
            "start_logit": -6.546875,
            "end_logit": -2.103515625,
            "text": "Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 7.069110870361328e-05
        },
        {
            "start_logit": -3.50390625,
            "end_logit": -5.3203125,
            "text": "CVD 103-HgR (Orochol, Mutachol)",
            "probability": 5.8591365814208984e-05
        },
        {
            "start_logit": -2.33984375,
            "end_logit": -6.50390625,
            "text": "1993, Switzerland) the ideal cholera vaccine: single-dose, protective efficacy of 80",
            "probability": 5.7697296142578125e-05
        },
        {
            "start_logit": -2.33984375,
            "end_logit": -6.6484375,
            "text": "1993, Switzerland",
            "probability": 5.0127506256103516e-05
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -2.103515625,
            "text": "R (Orochol, Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 4.780292510986328e-05
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -2.103515625,
            "text": "(Orochol, Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 4.029273986816406e-05
        },
        {
            "start_logit": -2.33984375,
            "end_logit": -7.24609375,
            "text": "1993, Switzerland) the ideal cholera vaccine: single-dose, protective efficacy of 80-100%",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": -7.609375,
            "end_logit": -2.103515625,
            "text": "achol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": -2.33984375,
            "end_logit": -7.53125,
            "text": "1993, Switzerland) the ideal cholera vaccine: single-dose, protective efficacy of 80-100",
            "probability": 2.0563602447509766e-05
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -2.103515625,
            "text": "time (launched 1993",
            "probability": 1.9609928131103516e-05
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -2.103515625,
            "text": "first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 1.811981201171875e-05
        }
    ],
    "5319a7d2b166e2b806000029_1": [
        {
            "start_logit": 5.84765625,
            "end_logit": -2.046875,
            "text": "CHIP)",
            "probability": 0.45263671875
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -2.568359375,
            "text": "CHIP) can",
            "probability": 0.268798828125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -2.712890625,
            "text": "CHIP",
            "probability": 0.2325439453125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -5.59375,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and",
            "probability": 0.01303863525390625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -5.59765625,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90",
            "probability": 0.01299285888671875
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -6.828125,
            "text": "CHIP) can remod",
            "probability": 0.003795623779296875
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -6.921875,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor (AhR",
            "probability": 0.00345611572265625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.2265625,
            "text": "CHIP) can remodel mature aryl hydrocarbon",
            "probability": 0.0025482177734375
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.2265625,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both",
            "probability": 0.0025482177734375
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.234375,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor",
            "probability": 0.0025272369384765625
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.2421875,
            "text": "CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes",
            "probability": 0.00251007080078125
        },
        {
            "start_logit": 5.84765625,
            "end_logit": -7.25,
            "text": "CHIP) can remodel",
            "probability": 0.002490997314453125
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -2.046875,
            "text": "hsc70-interacting protein (CHIP)",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -2.568359375,
            "text": "hsc70-interacting protein (CHIP) can",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -2.046875,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP)",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -2.712890625,
            "text": "hsc70-interacting protein (CHIP",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -2.568359375,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP) can",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -2.712890625,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -2.046875,
            "text": "(CHIP)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -2.046875,
            "text": "of hsc70-interacting protein (CHIP)",
            "probability": 4.76837158203125e-07
        }
    ],
    "5313058de3eabad02100000e_1": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.09375,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -1.7197265625,
            "text": "lumbosacral",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -2.0859375,
            "end_logit": 10.09375,
            "text": "vertebrae",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -6.15625,
            "end_logit": 10.09375,
            "text": "transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -6.6640625,
            "text": "lumbosacral transitional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 10.09375,
            "text": "in lumbosacral transitional vertebrae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.328125,
            "end_logit": 10.09375,
            "text": "lumbago in lumbosacral transitional vertebrae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 10.09375,
            "text": "form of lumbago in lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.09375,
            "text": "a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.046875,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.21875,
            "text": "lumbosacral transitional vertebrae, is",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.09375,
            "text": "Bertolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.09375,
            "text": "tolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.09375,
            "text": "of lumbago in lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3359375,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.34375,
            "text": "lumbosacral transitional vertebrae,",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -1.7197265625,
            "text": "in lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -1.7197265625,
            "text": "lumbago in lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -1.7197265625,
            "text": "form of lumbago in lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -1.7197265625,
            "text": "a form of lumbago in lumbosacral",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_2": [
        {
            "start_logit": 8.34375,
            "end_logit": 8.5546875,
            "text": "lumbosacral",
            "probability": 1.0
        },
        {
            "start_logit": 8.34375,
            "end_logit": -7.8125,
            "text": "lumbosacral anomalies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.34375,
            "end_logit": -8.2890625,
            "text": "lumbosacral anomalies and often have severe sciatica",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.34375,
            "end_logit": -8.2890625,
            "text": "lumbosacral anomalies and often have severe sciatica.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.34375,
            "end_logit": -8.3125,
            "text": "lumbosacral anomalies and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.5546875,
            "text": "characteristic lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 8.5546875,
            "text": "Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.5546875,
            "text": "with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.5546875,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.65625,
            "end_logit": 8.5546875,
            "text": "tolotti's syndrome have characteristic lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.8125,
            "text": "anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.2890625,
            "text": "anomalies and often have severe sciatica",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.2890625,
            "text": "anomalies and often have severe sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.3125,
            "text": "anomalies and",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -7.8125,
            "text": "characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -7.8125,
            "text": "Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -7.8125,
            "text": "with Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -7.8125,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -7.8125,
            "text": "tolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -8.2890625,
            "text": "characteristic lumbosacral anomalies and often have severe sciatica",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_3": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.1796875,
            "text": "lumbosacral junction",
            "probability": 1.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -1.9443359375,
            "text": "lumbosacral",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -2.369140625,
            "end_logit": 10.1796875,
            "text": "junction",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.1015625,
            "text": "lumbosacral junction pseudarticulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.52734375,
            "text": "lumbosacral junction pseud",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.1796875,
            "text": "Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1796875,
            "text": "unilateral lumbosacral junction",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.1796875,
            "text": "sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3359375,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome):",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.1796875,
            "text": "symptomatic unilateral lumbosacral junction",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.359375,
            "text": "lumbosacral junction pseudartic",
            "probability": 0.0
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -6.1015625,
            "text": "junction pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -7.52734375,
            "text": "junction pseud",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -1.9443359375,
            "text": "Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -1.9443359375,
            "text": "unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -1.9443359375,
            "text": "sensory ablation as a treatment for symptomatic unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -1.9443359375,
            "text": "symptomatic unilateral lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -8.3359375,
            "text": "junction pseudarticulation (Bertolotti's syndrome):",
            "probability": 0.0
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -8.359375,
            "text": "junction pseudartic",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -6.1015625,
            "text": "pseudarticulation",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_4": [
        {
            "start_logit": 6.50390625,
            "end_logit": 8.078125,
            "text": "fifth lumbar vertebra",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.73388671875,
            "end_logit": 8.078125,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": -3.798828125,
            "end_logit": 8.078125,
            "text": "vertebra",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": -5.9375,
            "end_logit": 8.078125,
            "text": "the fifth lumbar vertebra",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 8.078125,
            "text": "lumbar vertebra",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -5.0859375,
            "text": "fifth lumbar",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -5.453125,
            "text": "fifth",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.078125,
            "text": "transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 8.078125,
            "text": "of the fifth lumbar vertebra",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.078125,
            "text": "variation of the fifth lumbar vertebra",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.25,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.73388671875,
            "end_logit": -0.09112548828125,
            "text": "Lumbosacral transitional vertebra",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.56640625,
            "text": "fifth lumbar vertebra in which an enlarged transverse process",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.79296875,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.86328125,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.921875,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.9453125,
            "text": "fifth lumbar vertebra in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.1015625,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum or ilium.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.140625,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -8.1484375,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5313058de3eabad02100000e_5": [
        {
            "start_logit": 5.94140625,
            "end_logit": 6.87890625,
            "text": "lumbosacral vertebrae",
            "probability": 0.986328125
        },
        {
            "start_logit": 1.6630859375,
            "end_logit": 6.87890625,
            "text": "Transitional lumbosacral vertebrae",
            "probability": 0.013641357421875
        },
        {
            "start_logit": -4.41015625,
            "end_logit": 6.87890625,
            "text": "vertebrae",
            "probability": 3.153085708618164e-05
        },
        {
            "start_logit": 5.94140625,
            "end_logit": -5.76171875,
            "text": "lumbosacral",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.94140625,
            "end_logit": -8.09375,
            "text": "lumbosacral vertebrae and low back pain:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.94140625,
            "end_logit": -8.3359375,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.94140625,
            "end_logit": -8.390625,
            "text": "lumbosacral vertebrae and low back pain",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.6630859375,
            "end_logit": -5.76171875,
            "text": "Transitional lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.6630859375,
            "end_logit": -8.09375,
            "text": "Transitional lumbosacral vertebrae and low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": 1.6630859375,
            "end_logit": -8.3359375,
            "text": "Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": 1.6630859375,
            "end_logit": -8.390625,
            "text": "Transitional lumbosacral vertebrae and low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -8.09375,
            "text": "vertebrae and low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -8.3359375,
            "text": "vertebrae and low back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": -4.41015625,
            "end_logit": -8.390625,
            "text": "vertebrae and low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -8.09375,
            "text": "low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -8.3359375,
            "text": "low back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -8.390625,
            "text": "low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -8.09375,
            "text": "back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -8.3359375,
            "text": "back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -8.390625,
            "text": "back pain",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_6": [
        {
            "start_logit": 9.890625,
            "end_logit": 10.4609375,
            "text": "facet joint",
            "probability": 1.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": 10.4609375,
            "text": "joint",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 9.890625,
            "end_logit": -2.052734375,
            "text": "facet",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 9.890625,
            "end_logit": -5.640625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 10.4609375,
            "text": "the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.2890625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.6328125,
            "text": "facet joint contralateral",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.4609375,
            "text": "Case report of surgically treated mechanical low back pain from the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.4609375,
            "text": "from the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.4609375,
            "text": "pain from the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.4609375,
            "text": "surgically treated mechanical low back pain from the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.4609375,
            "text": "mechanical low back pain from the facet joint",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.3046875,
            "text": "facet joint contralateral to",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.3671875,
            "text": "facet joint contralateral to a",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.375,
            "text": "facet joint contralateral to a unilateral",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -5.640625,
            "text": "joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -7.2890625,
            "text": "joint contralateral to a unilateral anomalous lumbosacral articulation",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -7.6328125,
            "text": "joint contralateral",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -2.052734375,
            "text": "the facet",
            "probability": 0.0
        },
        {
            "start_logit": -1.6103515625,
            "end_logit": -8.3046875,
            "text": "joint contralateral to",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_7": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.21875,
            "text": "facet joint",
            "probability": 1.0
        },
        {
            "start_logit": 0.63671875,
            "end_logit": 9.21875,
            "text": "L6-S1 facet joint",
            "probability": 0.0001767873764038086
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -2.96484375,
            "text": "facet",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -3.341796875,
            "end_logit": 9.21875,
            "text": "joint",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.0859375,
            "text": "facet joint contralateral to an anomalous lumbosacral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 9.21875,
            "text": "S1 facet joint",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.2421875,
            "text": "facet joint contralateral to an anomalous lumbosacral articulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.21875,
            "text": "-S1 facet joint",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.54296875,
            "text": "facet joint contralateral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.58203125,
            "text": "facet joint contralateral to an anomalous lumbosacral articulation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 9.21875,
            "text": "symptomatic L6-S1 facet joint",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.63671875,
            "end_logit": 0.806640625,
            "text": "L6-S1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.21875,
            "text": "Repeated fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -8.2734375,
            "text": "facet joint contralateral to",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.21875,
            "text": "fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.21875,
            "text": "a symptomatic L6-S1 facet joint",
            "probability": 0.0
        },
        {
            "start_logit": 0.63671875,
            "end_logit": -2.96484375,
            "text": "L6-S1 facet",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 0.806640625,
            "text": "S1",
            "probability": 0.0
        },
        {
            "start_logit": 0.63671875,
            "end_logit": -7.0859375,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 0.806640625,
            "text": "-S1",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_8": [
        {
            "start_logit": 10.0625,
            "end_logit": 10.3515625,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": 10.3515625,
            "text": "vertebrae",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 10.0625,
            "end_logit": -1.3984375,
            "text": "lumbosacral",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 10.3515625,
            "text": "transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.0625,
            "end_logit": -6.78515625,
            "text": "lumbosacral transitional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 10.3515625,
            "text": "with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 10.3515625,
            "text": "back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -7.5,
            "text": "lumbosacral transitional vertebrae.",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.3515625,
            "text": "association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.3515625,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.3515625,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.3515625,
            "text": "lotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.3515625,
            "text": "pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.3515625,
            "text": "ti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.3515625,
            "text": "syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -1.3984375,
            "text": "with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -1.3984375,
            "text": "back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -1.6591796875,
            "end_logit": -7.5,
            "text": "vertebrae.",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -1.3984375,
            "text": "association of back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -1.3984375,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_1": [
        {
            "start_logit": 9.9140625,
            "end_logit": 10.3125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 10.3125,
            "text": "DB",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -2.111328125,
            "text": "mpM",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -5.7890625,
            "text": "mpMoRFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 10.3125,
            "text": "oRFsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 10.3125,
            "text": "FsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -7.625,
            "text": "mpMoR",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.1171875,
            "text": "mpMoRFsDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.1875,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.1953125,
            "text": "mpMoRFsDB:",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.234375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.2421875,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.25,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.2890625,
            "text": "mpMoRFsDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.296875,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -8.1171875,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -8.1875,
            "text": "DB: a database of molecular recognition features in membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -8.1953125,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -8.234375,
            "text": "DB: a database of molecular recognition features in membrane",
            "probability": 0.0
        },
        {
            "start_logit": -2.1015625,
            "end_logit": -8.2421875,
            "text": "DB: a database of molecular recognition features in",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_2": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.359375,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -2.00390625,
            "end_logit": 10.359375,
            "text": "DB",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.068359375,
            "text": "mpM",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -5.875,
            "text": "mpMoRFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 10.359375,
            "text": "oRFsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 10.359375,
            "text": "FsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.21875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.41015625,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.5,
            "text": "mpMoRFsDB provides valuable information related to disorder",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.828125,
            "text": "mpMoRFsDB provides",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.84765625,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.85546875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.90234375,
            "text": "mpMoR",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.9375,
            "text": "mpMoRFsDB provides valuable information related to disorder-based",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.96875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.0546875,
            "text": "mpMoRFsDB provides valuable information related to disorder-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1328125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2578125,
            "text": "mpMoRFsDB provides valuable information related",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.265625,
            "text": "mpMoRFsDB provides valuable",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2734375,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_3": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.3203125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": 10.3203125,
            "text": "DB",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.05859375,
            "text": "mpM",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -5.95703125,
            "text": "mpMoRFs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 10.3203125,
            "text": "oRFsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 10.3203125,
            "text": "FsDB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.75,
            "text": "mpMoR",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1796875,
            "text": "mpMoRFsDB: a database",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2265625,
            "text": "mpMoRFsDB:",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2890625,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3046875,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.328125,
            "text": "mpMoRFsDB: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.34375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.34375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3515625,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.390625,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -8.1796875,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -8.2265625,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -8.2890625,
            "text": "DB: a database of molecular recognition features in",
            "probability": 0.0
        },
        {
            "start_logit": -2.083984375,
            "end_logit": -8.3046875,
            "text": "DB: a database of molecular recognition features",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_1": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.9609375,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -2.76171875,
            "end_logit": 9.9609375,
            "text": "imaging",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -3.744140625,
            "end_logit": 9.9609375,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.078125,
            "end_logit": -3.6953125,
            "text": "magnetic",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 9.9609375,
            "text": "of magnetic resonance imaging",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.234375,
            "text": "magnetic resonance",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.9609375,
            "text": "approach of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.9609375,
            "text": "resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.734375,
            "end_logit": 9.9609375,
            "text": "was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 9.9609375,
            "text": "diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.9609375,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.9609375,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.44140625,
            "text": "magnetic resonance imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.9609375,
            "text": "a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.9609375,
            "text": "report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.9609375,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.9609375,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -3.744140625,
            "end_logit": -3.6953125,
            "text": "novel approach of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -3.744140625,
            "end_logit": -6.234375,
            "text": "novel approach of magnetic resonance",
            "probability": 0.0
        },
        {
            "start_logit": -2.76171875,
            "end_logit": -7.44140625,
            "text": "imaging and",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_2": [
        {
            "start_logit": 9.4609375,
            "end_logit": 10.171875,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -2.3828125,
            "end_logit": 10.171875,
            "text": "imaging",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -3.025390625,
            "text": "magnetic",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 10.171875,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 10.171875,
            "text": "of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.171875,
            "text": "approach of magnetic resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.79296875,
            "text": "magnetic resonance",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 10.171875,
            "text": "resonance imaging",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 10.171875,
            "text": "was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 10.171875,
            "text": "diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.171875,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": 10.171875,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.171875,
            "text": "report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.171875,
            "text": "a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.171875,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.171875,
            "text": "we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.171875,
            "text": "that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.171875,
            "text": ", we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.8671875,
            "text": "magnetic resonance imaging and",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -8.3046875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_1": [
        {
            "start_logit": 9.875,
            "end_logit": 10.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.189453125,
            "text": "tra",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -2.482421875,
            "end_logit": 10.1640625,
            "text": "R",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 10.1640625,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -6.9140625,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.9453125,
            "text": "traseR: an R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.953125,
            "text": "traseR: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0703125,
            "text": "traseR:",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.203125,
            "text": "traseR: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2109375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2109375,
            "text": "traseR: an R package for performing trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2109375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "traseR: an R",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "traseR: an R package for performing trait-associated SNP",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2734375,
            "text": "traseR: an",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -7.9453125,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -7.953125,
            "text": "R: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -8.0703125,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -8.203125,
            "text": "R: an R package for performing trait-",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_2": [
        {
            "start_logit": 9.84375,
            "end_logit": 9.9375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.265625,
            "text": "tra",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.93359375,
            "end_logit": 9.9375,
            "text": "R",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.05859375,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.9375,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.9375,
            "text": "present traseR",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.8359375,
            "text": "traseR,",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.9921875,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0703125,
            "text": "traseR, an easy-to-use",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.109375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.21875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.25,
            "text": "traseR, an easy-to-use R Bioconductor package that performs",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_3": [
        {
            "start_logit": 9.875,
            "end_logit": 9.921875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.208984375,
            "text": "tra",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -2.958984375,
            "end_logit": 9.921875,
            "text": "R",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.921875,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.14453125,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 9.921875,
            "text": "present traseR",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.84765625,
            "text": "traseR,",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.96875,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0,
            "text": "traseR, an easy-to-use",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0546875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1640625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.171875,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "traseR, an",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "traseR, an easy-to-use R",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_4": [
        {
            "start_logit": 9.84375,
            "end_logit": 9.9375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.26953125,
            "text": "tra",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.9296875,
            "end_logit": 9.9375,
            "text": "R",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.06640625,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.9375,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.9375,
            "text": "present traseR",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.87109375,
            "text": "traseR,",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0703125,
            "text": "traseR, an easy-to-use",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1796875,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2734375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_5": [
        {
            "start_logit": 9.90625,
            "end_logit": 10.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -2.10546875,
            "text": "tra",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.46875,
            "end_logit": 10.1640625,
            "text": "R",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 10.1640625,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.90625,
            "end_logit": -6.98828125,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.015625,
            "text": "traseR: an R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.0234375,
            "text": "traseR: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.1796875,
            "text": "traseR:",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.2578125,
            "text": "traseR: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.2734375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R package for performing trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.015625,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.0234375,
            "text": "R: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.1796875,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.2578125,
            "text": "R: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.2734375,
            "text": "R: an R package for performing trait-associated SNP enrichment",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.28125,
            "text": "R: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.28125,
            "text": "R: an R package for performing trait",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_6": [
        {
            "start_logit": 9.90625,
            "end_logit": 10.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -2.10546875,
            "text": "tra",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.46875,
            "end_logit": 10.1640625,
            "text": "R",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 10.1640625,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.90625,
            "end_logit": -6.98828125,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.015625,
            "text": "traseR: an R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.0234375,
            "text": "traseR: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.1796875,
            "text": "traseR:",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.2578125,
            "text": "traseR: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.2734375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R package for performing trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.28125,
            "text": "traseR: an R",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.015625,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.0234375,
            "text": "R: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.1796875,
            "text": "R:",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.2578125,
            "text": "R: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.2734375,
            "text": "R: an R package for performing trait-associated SNP enrichment",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.28125,
            "text": "R: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 0.0
        },
        {
            "start_logit": -2.46875,
            "end_logit": -8.28125,
            "text": "R: an R package for performing trait",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_7": [
        {
            "start_logit": 9.84375,
            "end_logit": 9.9375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.26953125,
            "text": "tra",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.9296875,
            "end_logit": 9.9375,
            "text": "R",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.06640625,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.9375,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.9375,
            "text": "present traseR",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.87109375,
            "text": "traseR,",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0,
            "text": "traseR, an easy-to-use R Bioconductor package that",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0703125,
            "text": "traseR, an easy-to-use",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1796875,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1875,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2109375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2265625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2578125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.265625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2734375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_8": [
        {
            "start_logit": 9.953125,
            "end_logit": 10.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -1.9716796875,
            "text": "tra",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 10.1640625,
            "text": "R",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 10.1640625,
            "text": "seR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.953125,
            "end_logit": -6.9765625,
            "text": "trase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.859375,
            "text": "traseR R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.921875,
            "text": "traseR R",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.93359375,
            "text": "traseR R package preloaded with up-to",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0078125,
            "text": "traseR R package preloaded with up-to-date collection of trait",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0234375,
            "text": "traseR R package preloaded with up-to-",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.046875,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.046875,
            "text": "traseR R package preload",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0859375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.109375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1171875,
            "text": "traseR R package preloaded with up-to-date collection of trait-",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.15625,
            "text": "traseR R package preloaded with up-",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1640625,
            "text": "The traseR",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.859375,
            "text": "R R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.921875,
            "text": "R R",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.93359375,
            "text": "R R package preloaded with up-to",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_1": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.2890625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": 10.2890625,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.431640625,
            "text": "GBs",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 10.2890625,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -6.98046875,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0390625,
            "text": "GBshape: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.125,
            "text": "GBshape: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.140625,
            "text": "GBshape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1640625,
            "text": "GBshape: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.171875,
            "text": "GBshape:",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.203125,
            "text": "GBshape: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2265625,
            "text": "GBshape: a",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.25,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.0390625,
            "text": "e: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.125,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.140625,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.1640625,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.171875,
            "text": "e:",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_2": [
        {
            "start_logit": 9.734375,
            "end_logit": 10.0546875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": 10.0546875,
            "text": "e",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.4453125,
            "text": "GBs",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 10.0546875,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.58984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.0546875,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.671875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.73046875,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.8671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.875,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.87890625,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.91796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.93359375,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.0546875,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.98046875,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0390625,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0546875,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0703125,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_3": [
        {
            "start_logit": 9.8203125,
            "end_logit": 10.3125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": 10.3125,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.328125,
            "text": "GBs",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 10.3125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.16015625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.140625,
            "text": "GBshape: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.1953125,
            "text": "GBshape:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.2109375,
            "text": "GBshape: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.265625,
            "text": "GBshape: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.28125,
            "text": "GBshape: a genome",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.328125,
            "text": "GBshape: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.140625,
            "text": "e: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.1953125,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.2109375,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.21875,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.21875,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.265625,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.28125,
            "text": "e: a genome",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_4": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.3046875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": 10.3046875,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.375,
            "text": "GBs",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.078125,
            "end_logit": 10.3046875,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.51171875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.8984375,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1640625,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.265625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.8984375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1640625,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.265625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_5": [
        {
            "start_logit": 9.8203125,
            "end_logit": 10.203125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.203125,
            "text": "e",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.2890625,
            "text": "GBs",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 10.203125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.234375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.48046875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 10.203125,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.66015625,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.71875,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.78125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7890625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7890625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.890625,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.203125,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.94140625,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.953125,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.95703125,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.203125,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_6": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.3046875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": 10.3046875,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.375,
            "text": "GBs",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.078125,
            "end_logit": 10.3046875,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.51171875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.8984375,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1640625,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.265625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.8984375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1640625,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.265625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_7": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.3046875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": 10.3046875,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.375,
            "text": "GBs",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.078125,
            "end_logit": 10.3046875,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.51171875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.8984375,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1640625,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.265625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.8984375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1640625,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.1953125,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.265625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -8.2890625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to download quantitative values of DNA shape features as a",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_8": [
        {
            "start_logit": 9.8203125,
            "end_logit": 10.3125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": 10.3125,
            "text": "e",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.328125,
            "text": "GBs",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 10.3125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.16015625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.140625,
            "text": "GBshape: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.1953125,
            "text": "GBshape:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.2109375,
            "text": "GBshape: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.21875,
            "text": "GBshape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.265625,
            "text": "GBshape: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.28125,
            "text": "GBshape: a genome",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.328125,
            "text": "GBshape: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.140625,
            "text": "e: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.1953125,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.2109375,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.21875,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.21875,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.265625,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.158203125,
            "end_logit": -8.28125,
            "text": "e: a genome",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_9": [
        {
            "start_logit": 9.8203125,
            "end_logit": 10.203125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.203125,
            "text": "e",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.2890625,
            "text": "GBs",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 10.203125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.234375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.48046875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 10.203125,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.66015625,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.71875,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.78125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7890625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7890625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.890625,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.203125,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.94140625,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.953125,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.95703125,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.203125,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_1": [
        {
            "start_logit": 8.828125,
            "end_logit": 9.34375,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": -3.068359375,
            "end_logit": 9.34375,
            "text": "patch",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -3.65625,
            "text": "epidural",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -4.25390625,
            "text": "epidural blood patch.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.34375,
            "text": "blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.34375,
            "text": "she was treated for CSF leak using an epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.34375,
            "text": "CSF leak using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.34375,
            "text": "was treated for CSF leak using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 9.34375,
            "text": "treated for CSF leak using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 9.34375,
            "text": "an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.578125,
            "text": "epidural blood",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.34375,
            "text": "using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.34375,
            "text": "leak using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.34375,
            "text": "for CSF leak using an epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.068359375,
            "end_logit": -4.25390625,
            "text": "patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -3.65625,
            "text": "she was treated for CSF leak using an epidural",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -4.25390625,
            "text": "blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -3.65625,
            "text": "CSF leak using an epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -3.65625,
            "text": "was treated for CSF leak using an epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -4.25390625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_2": [
        {
            "start_logit": 8.921875,
            "end_logit": 9.515625,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": -3.349609375,
            "end_logit": 9.515625,
            "text": "patch",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 8.921875,
            "end_logit": -3.4140625,
            "text": "epidural",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.28125,
            "end_logit": 9.515625,
            "text": "invasive measures with epidural blood patch",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 9.515625,
            "text": "blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.37890625,
            "text": "epidural blood patch providing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.015625,
            "end_logit": 9.515625,
            "text": "measures with epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.6328125,
            "text": "epidural blood patch providing the cornerstone of the invasive measures",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.84765625,
            "text": "epidural blood patch providing the cornerstone of",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.859375,
            "text": "epidural blood patch providing the cornerstone",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.875,
            "text": "epidural blood patch providing the",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.515625,
            "text": "with epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.0859375,
            "text": "epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.25,
            "text": "epidural blood patch providing the cornerstone of the",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -3.4140625,
            "text": "invasive measures with epidural",
            "probability": 0.0
        },
        {
            "start_logit": -3.349609375,
            "end_logit": -7.37890625,
            "text": "patch providing",
            "probability": 0.0
        },
        {
            "start_logit": -3.349609375,
            "end_logit": -7.6328125,
            "text": "patch providing the cornerstone of the invasive measures",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -6.875,
            "text": "invasive measures",
            "probability": 0.0
        },
        {
            "start_logit": -3.349609375,
            "end_logit": -7.84765625,
            "text": "patch providing the cornerstone of",
            "probability": 0.0
        },
        {
            "start_logit": -3.349609375,
            "end_logit": -7.859375,
            "text": "patch providing the cornerstone",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_3": [
        {
            "start_logit": 9.8125,
            "end_logit": 10.1875,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": 10.1875,
            "text": "patch",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -2.17578125,
            "text": "epidural",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 10.1875,
            "text": "blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 10.1875,
            "text": ", epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.01171875,
            "text": "epidural blood",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.07421875,
            "text": "epidural blood patch should",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 10.1875,
            "text": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 10.1875,
            "text": "puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.1875,
            "text": "needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.1875,
            "text": "age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.1875,
            "text": "high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1875,
            "text": "gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.1875,
            "text": "postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.1875,
            "text": ", age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1875,
            "text": "large-gauge needle puncture, epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.15625,
            "text": "epidural blood patch should be",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.21875,
            "text": "epidural blood patch should be performed",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -7.07421875,
            "text": "patch should",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -2.17578125,
            "text": ", epidural",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_4": [
        {
            "start_logit": 9.0859375,
            "end_logit": 7.8984375,
            "text": "acupuncture",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.296875,
            "text": "acupuncture rather",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.95703125,
            "text": "acupuncture rather than an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.95703125,
            "text": "acupuncture rather than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.9609375,
            "text": "acupuncture rather than an epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -8.1796875,
            "text": "acupuncture rather than an epidural blood patch.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -8.203125,
            "text": "acupuncture rather than an epidural blood",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -8.2890625,
            "text": "acupuncture rather than an epidural",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 7.8984375,
            "text": "using acupuncture",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0,
            "end_logit": 7.8984375,
            "text": "Both parturients were successfully managed using acupuncture",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 7.8984375,
            "text": "parturients were successfully managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 7.8984375,
            "text": "managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 7.8984375,
            "text": "successfully managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 7.8984375,
            "text": "ients were successfully managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 7.8984375,
            "text": "urients were successfully managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 7.8984375,
            "text": "were successfully managed using acupuncture",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.296875,
            "text": "using acupuncture rather",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.296875,
            "text": "Both parturients were successfully managed using acupuncture rather",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.296875,
            "text": "parturients were successfully managed using acupuncture rather",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -7.296875,
            "text": "managed using acupuncture rather",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_5": [
        {
            "start_logit": 3.833984375,
            "end_logit": 5.98046875,
            "text": "epidural blood patch",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.64453125,
            "end_logit": 5.98046875,
            "text": "LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.0005655288696289062
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 5.98046875,
            "text": "shunt placement alleviated by an epidural blood patch",
            "probability": 0.00010710954666137695
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 5.98046875,
            "text": "patch",
            "probability": 7.134675979614258e-05
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 5.98046875,
            "text": "blood patch",
            "probability": 5.340576171875e-05
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 5.98046875,
            "text": "a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": 3.833984375,
            "end_logit": -4.66015625,
            "text": "epidural blood patch.",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 5.98046875,
            "text": "case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 5.98046875,
            "text": "after LP shunt placement alleviated by an epidural blood patch",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 5.98046875,
            "text": "In this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 5.98046875,
            "text": "an epidural blood patch",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 5.98046875,
            "text": "low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 5.98046875,
            "text": "this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 5.98046875,
            "text": "17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 5.98046875,
            "text": "by an epidural blood patch",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 5.98046875,
            "text": "girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -8.140625,
            "end_logit": 5.98046875,
            "text": ", a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -8.203125,
            "end_logit": 5.98046875,
            "text": "placement alleviated by an epidural blood patch",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 3.833984375,
            "end_logit": -7.3359375,
            "text": "epidural",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 3.833984375,
            "end_logit": -8.3203125,
            "text": "epidural blood",
            "probability": 5.960464477539062e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_6": [
        {
            "start_logit": 9.6953125,
            "end_logit": 10.0859375,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": -2.43359375,
            "end_logit": 10.0859375,
            "text": "patch",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -2.076171875,
            "text": "epidural",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -5.7890625,
            "text": "epidural blood",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 10.0859375,
            "text": "blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.0859375,
            "text": ") epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 10.0859375,
            "text": "patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 10.0859375,
            "text": "be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": 10.0859375,
            "text": "should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": 10.0859375,
            "text": "early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0859375,
            "text": "within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.0859375,
            "text": "), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.0859375,
            "text": "offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.0859375,
            "text": "(within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.0859375,
            "text": "puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.0859375,
            "text": "of dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.0859375,
            "text": "dural puncture) epidural blood patch",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -2.076171875,
            "text": ") epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -2.076171875,
            "text": "patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -2.076171875,
            "text": "be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_1": [
        {
            "start_logit": 9.6953125,
            "end_logit": 9.765625,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -2.576171875,
            "text": "DSM",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -3.078125,
            "end_logit": 9.765625,
            "text": "NC",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.15625,
            "text": "DSMNC: a database",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.2265625,
            "text": "DSMNC:",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.265625,
            "text": "DSMNC: a",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.296875,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.3125,
            "text": "DSMNC: a database of",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.34375,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.3671875,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -8.390625,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.15625,
            "text": "NC: a database",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.2265625,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.265625,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.296875,
            "text": "NC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.3125,
            "text": "NC: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.34375,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.3671875,
            "text": "NC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -8.390625,
            "text": "NC: a database of somatic mutations in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -8.15625,
            "text": "a database",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_2": [
        {
            "start_logit": 9.8828125,
            "end_logit": 9.4375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -1.72265625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -1.875,
            "text": "DSM",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -2.732421875,
            "end_logit": 9.4375,
            "text": "NC",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.41796875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.015625,
            "end_logit": 9.4375,
            "text": "established DSMNC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.58203125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.732421875,
            "end_logit": -1.72265625,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -4.62109375,
            "end_logit": -1.72265625,
            "text": "http://dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -3.296875,
            "end_logit": -3.90625,
            "text": "\u223c",
            "probability": 0.0
        },
        {
            "start_logit": -3.296875,
            "end_logit": -4.2421875,
            "text": "\u223c0.8",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -1.72265625,
            "text": "cn",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -1.72265625,
            "text": "established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -1.875,
            "text": "established DSM",
            "probability": 0.0
        },
        {
            "start_logit": -3.296875,
            "end_logit": -5.7421875,
            "text": "\u223c0.8 million",
            "probability": 0.0
        },
        {
            "start_logit": -3.296875,
            "end_logit": -5.77734375,
            "text": "\u223c0",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -1.72265625,
            "text": "dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -1.72265625,
            "text": "big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -1.72265625,
            "text": "/dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.72265625,
            "text": ".big.ac.cn",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_3": [
        {
            "start_logit": 9.734375,
            "end_logit": 9.7734375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.43359375,
            "text": "DSM",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -3.009765625,
            "end_logit": 9.7734375,
            "text": "NC",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -4.6171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.5390625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.78515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 9.7734375,
            "text": "established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.85546875,
            "text": "DSMNC:",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.90625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.99609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.09375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/),",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.203125,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.234375,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.7734375,
            "text": "Here, we established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.7734375,
            "text": "we established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.7734375,
            "text": ", we established DSMNC",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_4": [
        {
            "start_logit": 9.671875,
            "end_logit": 9.734375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -2.583984375,
            "text": "DSM",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -3.08984375,
            "end_logit": 9.734375,
            "text": "NC",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.671875,
            "end_logit": -7.8203125,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -7.88671875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.03125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.09375,
            "text": "DSMNC:",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.109375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.140625,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.171875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.1796875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin,",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.1796875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur in",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.1953125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.2265625,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.234375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct",
            "probability": 0.0
        },
        {
            "start_logit": -3.08984375,
            "end_logit": -7.8203125,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -3.08984375,
            "end_logit": -7.88671875,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 0.0
        },
        {
            "start_logit": -3.08984375,
            "end_logit": -8.03125,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin",
            "probability": 0.0
        },
        {
            "start_logit": -3.08984375,
            "end_logit": -8.09375,
            "text": "NC:",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_5": [
        {
            "start_logit": 9.734375,
            "end_logit": 9.7734375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.43359375,
            "text": "DSM",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -3.009765625,
            "end_logit": 9.7734375,
            "text": "NC",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -4.6171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.5390625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.78515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 9.7734375,
            "text": "established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.85546875,
            "text": "DSMNC:",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.90625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.99609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.09375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/),",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.203125,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/), which",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.234375,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.7734375,
            "text": "Here, we established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.7734375,
            "text": "we established DSMNC",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.7734375,
            "text": ", we established DSMNC",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_1": [
        {
            "start_logit": 8.5546875,
            "end_logit": 7.8515625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -4.09375,
            "text": "Epstein",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -5.0703125,
            "text": "Epstein-Barr virus (EBV",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -5.31640625,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.1875,
            "end_logit": 7.8515625,
            "text": "virus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.49609375,
            "text": "Epstein-Barr",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.59375,
            "text": "Epstein-Barr virus (EBV) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.59765625,
            "text": "Epstein-Barr virus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.8125,
            "text": "Epstein-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 7.8515625,
            "text": "Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 7.8515625,
            "text": "-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.1875,
            "end_logit": -5.0703125,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -4.1875,
            "end_logit": -5.31640625,
            "text": "EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -5.1875,
            "end_logit": -5.0703125,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -5.1875,
            "end_logit": -5.31640625,
            "text": "virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -4.1875,
            "end_logit": -7.59375,
            "text": "EBV) is",
            "probability": 0.0
        },
        {
            "start_logit": -5.1875,
            "end_logit": -7.59375,
            "text": "virus (EBV) is",
            "probability": 0.0
        },
        {
            "start_logit": -5.1875,
            "end_logit": -7.59765625,
            "text": "virus (",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -5.0703125,
            "text": "Barr virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -5.0703125,
            "text": "-Barr virus (EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_2": [
        {
            "start_logit": 8.1328125,
            "end_logit": 7.72265625,
            "text": "cytomegalovirus",
            "probability": 1.0
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -5.91796875,
            "text": "cytomegalovirus (CMV",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 7.72265625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.89453125,
            "text": "cytomegalovirus (CMV)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -8.0625,
            "text": "cytomegalovirus (CMV) IgM and IgG were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 7.72265625,
            "text": "her cytomegalovirus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 7.72265625,
            "text": "negative; however, interestingly her cytomegalovirus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 7.72265625,
            "text": "the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -5.91796875,
            "text": "CMV",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -5.54296875,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -5.54296875,
            "text": "Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -7.89453125,
            "text": "CMV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -6.23046875,
            "text": "positive",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -8.0625,
            "text": "CMV) IgM and IgG were",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": -5.54296875,
            "text": "a positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -5.54296875,
            "text": "the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -5.54296875,
            "text": "result. Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -5.91796875,
            "text": "(CMV",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -5.91796875,
            "text": "her cytomegalovirus (CMV",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -5.91796875,
            "text": "negative; however, interestingly her cytomegalovirus (CMV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_3": [
        {
            "start_logit": 9.25,
            "end_logit": 6.54296875,
            "text": "Epstein-Barr virus",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.25,
            "end_logit": 0.06610107421875,
            "text": "Epstein-Barr virus infection",
            "probability": 0.0015239715576171875
        },
        {
            "start_logit": 9.25,
            "end_logit": -3.431640625,
            "text": "Epstein",
            "probability": 4.6372413635253906e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.1953125,
            "text": "Epstein-Barr",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -8.0234375,
            "text": "Epstein-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.69921875,
            "end_logit": 6.54296875,
            "text": "virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.54296875,
            "text": "to Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.54296875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.54296875,
            "text": "Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 6.54296875,
            "text": "splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 6.54296875,
            "text": "secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 6.54296875,
            "text": "taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 6.54296875,
            "text": "was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 6.54296875,
            "text": "-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 6.54296875,
            "text": "urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 6.54296875,
            "text": "He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -5.69921875,
            "end_logit": 0.06610107421875,
            "text": "virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 0.06610107421875,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 0.06610107421875,
            "text": "to Epstein-Barr virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 0.06610107421875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_4": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.140625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -2.650390625,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -3.494140625,
            "text": "Epstein",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 9.140625,
            "text": "virus",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.0859375,
            "text": "Epstein-Barr virus (EBV",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.34375,
            "text": "Epstein-Barr",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.22265625,
            "text": "Epstein-Barr virus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 9.140625,
            "text": "Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 9.140625,
            "text": "Infection with Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 9.140625,
            "text": "-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 9.140625,
            "text": "with Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.63671875,
            "end_logit": -2.650390625,
            "text": "EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -3.865234375,
            "end_logit": -2.650390625,
            "text": "virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -2.63671875,
            "end_logit": -4.0859375,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -3.865234375,
            "end_logit": -4.0859375,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.63671875,
            "end_logit": -6.9921875,
            "text": "EBV) is almost ubiquitous in humans and generally occurs at two ages: infantile, which is usually asymptomatic and associated with poorer socioeconomic conditions, and adolescent",
            "probability": 0.0
        },
        {
            "start_logit": -4.74609375,
            "end_logit": -5.4453125,
            "text": "adolescent, which causes infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -2.650390625,
            "text": "Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -2.650390625,
            "text": "(EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -2.650390625,
            "text": "Infection with Epstein-Barr virus (EBV)",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_5": [
        {
            "start_logit": 9.828125,
            "end_logit": 10.1171875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -2.49609375,
            "end_logit": 10.1171875,
            "text": "virus",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.828125,
            "end_logit": -2.318359375,
            "text": "Epstein",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.828125,
            "end_logit": -6.625,
            "text": "Epstein-Barr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 10.1171875,
            "text": "Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.1171875,
            "text": "-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.5078125,
            "text": "Epstein-Barr virus viral load (EBV-VL",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.58203125,
            "text": "Epstein-Barr virus viral load (EBV",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.67578125,
            "text": "Epstein-Barr virus viral load",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 10.1171875,
            "text": "measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.8359375,
            "text": "Epstein-Barr virus viral",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.97265625,
            "text": "Epstein-Barr virus viral load (EBV-VL)",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.1171875,
            "text": "evaluated diagnostic methods were real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.1171875,
            "text": "The evaluated diagnostic methods were real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.1171875,
            "text": "different assays [measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -8.078125,
            "text": "Epstein-Barr virus viral load (EBV-",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.1171875,
            "text": "real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.1171875,
            "text": "of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.1171875,
            "text": "assays [measurement of Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -8.1484375,
            "text": "Epstein-",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_6": [
        {
            "start_logit": 9.6328125,
            "end_logit": 10.125,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -2.439453125,
            "end_logit": 10.125,
            "text": "virus",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -2.6953125,
            "text": "Epstein",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -6.28515625,
            "text": "Epstein-Barr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.890625,
            "end_logit": 10.125,
            "text": "Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.125,
            "text": "-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.72265625,
            "text": "Epstein-Barr virus-related infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.125,
            "text": ", and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.96875,
            "text": "Epstein-",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.125,
            "text": "peripheral smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.125,
            "text": "smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.125,
            "text": "the peripheral smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.125,
            "text": "positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.125,
            "text": "The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.125,
            "text": "and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.109375,
            "text": "Epstein-Barr virus-",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.1796875,
            "text": "Epstein-Barr virus-related infectious mononucleosis was",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.25,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.2734375,
            "text": "Epstein-Barr virus-related infectious mononucle",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.28125,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the most likely",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_7": [
        {
            "start_logit": 5.5390625,
            "end_logit": 6.91796875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": 6.91796875,
            "text": "virus",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 2.318359375,
            "end_logit": -0.951171875,
            "text": "Cytomegalovirus",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -4.875,
            "text": "Epstein-Barr virus (EBV",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 6.91796875,
            "text": "against Epstein-Barr virus",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.91796875,
            "text": "viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -6.5234375,
            "text": "Epstein",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.91796875,
            "text": "Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.91796875,
            "text": "both viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -6.609375,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.91796875,
            "text": "Barr virus",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 6.91796875,
            "text": "subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.24609375,
            "text": "Epstein-Barr",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.71875,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.80859375,
            "text": "Epstein-Barr virus (EBV) by",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.89453125,
            "text": "Epstein-Barr virus (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.90625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -7.953125,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -8.0,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.5390625,
            "end_logit": -8.078125,
            "text": "Epstein-Barr virus (EBV) by the Monospot",
            "probability": 2.980232238769531e-07
        }
    ],
    "5a690487b750ff445500001f_8": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.21875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -2.34375,
            "end_logit": 10.21875,
            "text": "virus",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.23046875,
            "text": "Epstein",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -5.9140625,
            "text": "Epstein-Barr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 10.21875,
            "text": "for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 10.21875,
            "text": "Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 10.21875,
            "text": "-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 10.21875,
            "text": ", but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 10.21875,
            "text": "he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 10.21875,
            "text": "but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.921875,
            "text": "Epstein-",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.21875,
            "text": "had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.21875,
            "text": "a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.9921875,
            "text": "Epstein-Barr virus.",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.21875,
            "text": "septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.21875,
            "text": "positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.21875,
            "text": "His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.21875,
            "text": "G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.21875,
            "text": "negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -2.23046875,
            "text": "for Epstein",
            "probability": 0.0
        }
    ],
    "5c89623bf9c2ba6b28000004_1": [
        {
            "start_logit": -5.2890625,
            "end_logit": 1.650390625,
            "text": "(c.19G>A, p.Val7Met",
            "probability": 0.332275390625
        },
        {
            "start_logit": -5.4140625,
            "end_logit": 1.650390625,
            "text": "Val7Met",
            "probability": 0.293212890625
        },
        {
            "start_logit": -6.59375,
            "end_logit": 1.650390625,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0899658203125
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 1.650390625,
            "text": "novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.07757568359375
        },
        {
            "start_logit": -7.171875,
            "end_logit": 1.650390625,
            "text": "mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.050445556640625
        },
        {
            "start_logit": -7.328125,
            "end_logit": 1.650390625,
            "text": "missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.04315185546875
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 1.650390625,
            "text": "c.19G>A, p.Val7Met",
            "probability": 0.032318115234375
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 1.650390625,
            "text": "Met",
            "probability": 0.028533935546875
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 1.650390625,
            "text": "sequence analysis of the gene and a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.02679443359375
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 1.650390625,
            "text": "gene and a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0257720947265625
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -7.02734375,
            "text": "(c.19G>A, p.Val7Met)",
            "probability": 5.692243576049805e-05
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -7.02734375,
            "text": "Val7Met)",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -6.59375,
            "end_logit": -5.96484375,
            "text": "a novel homozygous missense mutation",
            "probability": 4.4345855712890625e-05
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -5.96484375,
            "text": "novel homozygous missense mutation",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -7.421875,
            "text": "(c.19G>A, p.Val7",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -7.421875,
            "text": "Val7",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -7.6328125,
            "text": "(c.19G>A, p.Val7Met) of CFL2",
            "probability": 3.0934810638427734e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -7.671875,
            "text": "(c.19G",
            "probability": 2.9742717742919922e-05
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -7.6328125,
            "text": "Val7Met) of CFL2",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": -7.78125,
            "text": "(c.19G>A, p.Val7Met) of CFL2 was identified in",
            "probability": 2.6702880859375e-05
        }
    ],
    "56c85ed65795f9a73e000012_1": [
        {
            "start_logit": 6.76953125,
            "end_logit": -0.10125732421875,
            "text": "inhibits",
            "probability": 0.9697265625
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -4.12109375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.0174102783203125
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -5.0390625,
            "text": "inhibits TCR",
            "probability": 0.006954193115234375
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.38671875,
            "text": "inhibits TCR-",
            "probability": 0.0006647109985351562
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.4453125,
            "text": "inhibits TCR-mediated",
            "probability": 0.0006270408630371094
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.73046875,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.00047135353088378906
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.74609375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell",
            "probability": 0.0004642009735107422
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.75390625,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 0.00046062469482421875
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.81640625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 0.0004324913024902344
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.859375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation,",
            "probability": 0.0004146099090576172
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.95703125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.00037598609924316406
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -7.97265625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-",
            "probability": 0.000370025634765625
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.03125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 0.0003490447998046875
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.0390625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and",
            "probability": 0.0003464221954345703
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.0703125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production,",
            "probability": 0.000335693359375
        },
        {
            "start_logit": 6.76953125,
            "end_logit": -8.1171875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T",
            "probability": 0.00032019615173339844
        },
        {
            "start_logit": -6.984375,
            "end_logit": -0.10125732421875,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -0.10125732421875,
            "text": "we show that dasatinib inhibits",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": -0.10125732421875,
            "text": ", we show that dasatinib inhibits",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -0.10125732421875,
            "text": "dasatinib inhibits",
            "probability": 4.172325134277344e-07
        }
    ],
    "56c85ed65795f9a73e000012_2": [
        {
            "start_logit": 6.109375,
            "end_logit": -0.01068115234375,
            "text": "inhibits",
            "probability": 0.9716796875
        },
        {
            "start_logit": 6.109375,
            "end_logit": -3.76953125,
            "text": "inhibits TCR",
            "probability": 0.0226593017578125
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.36328125,
            "text": "inhibits TCR-",
            "probability": 0.0006237030029296875
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.4453125,
            "text": "inhibits TCR-mediated",
            "probability": 0.0005745887756347656
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.55859375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell",
            "probability": 0.0005125999450683594
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.64453125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 0.0004703998565673828
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.7109375,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.00044035911560058594
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.8125,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 0.00039768218994140625
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.828125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 0.0003917217254638672
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.828125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.0003917217254638672
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.84765625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-",
            "probability": 0.0003840923309326172
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.8515625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation,",
            "probability": 0.00038242340087890625
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.86328125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T",
            "probability": 0.0003781318664550781
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.95703125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses",
            "probability": 0.00034427642822265625
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.98828125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and",
            "probability": 0.00033354759216308594
        },
        {
            "start_logit": 6.109375,
            "end_logit": -7.9921875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production,",
            "probability": 0.0003323554992675781
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -0.01068115234375,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -0.01068115234375,
            "text": "we show that dasatinib inhibits",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": -0.01068115234375,
            "text": ", we show that dasatinib inhibits",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -0.01068115234375,
            "text": "show that dasatinib inhibits",
            "probability": 7.748603820800781e-07
        }
    ],
    "56c85ed65795f9a73e000012_3": [
        {
            "start_logit": -0.97412109375,
            "end_logit": 0.900390625,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 0.94384765625
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -2.291015625,
            "text": "protein tyrosine kinase",
            "probability": 0.038787841796875
        },
        {
            "start_logit": -6.328125,
            "end_logit": 0.900390625,
            "text": "small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.00445556640625
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 0.900390625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.00372314453125
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 0.900390625,
            "text": "inhibitor",
            "probability": 0.0014247894287109375
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 0.900390625,
            "text": "molecule protein tyrosine kinase inhibitor",
            "probability": 0.0013275146484375
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 0.900390625,
            "text": "tyrosine kinase inhibitor",
            "probability": 0.0012874603271484375
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -6.09765625,
            "text": "protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.0008640289306640625
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 0.900390625,
            "text": "a small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.0008182525634765625
        },
        {
            "start_logit": -8.328125,
            "end_logit": 0.900390625,
            "text": "atinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.0006031990051269531
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 0.900390625,
            "text": "kinase inhibitor",
            "probability": 0.0005803108215332031
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 0.900390625,
            "text": "-molecule protein tyrosine kinase inhibitor",
            "probability": 0.0005364418029785156
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.1875,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.00028824806213378906
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.234375,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 0.00027489662170410156
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.32421875,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.0002524852752685547
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.52734375,
            "text": "protein tyrosine",
            "probability": 0.00020599365234375
        },
        {
            "start_logit": -6.328125,
            "end_logit": -2.291015625,
            "text": "small-molecule protein tyrosine kinase",
            "probability": 0.00018322467803955078
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.72265625,
            "text": "protein tyrosine kinase inhibitor, inhibits T",
            "probability": 0.00016939640045166016
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -2.291015625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.0001518726348876953
        },
        {
            "start_logit": -0.97412109375,
            "end_logit": -7.94921875,
            "text": "protein tyrosine kinase inhibitor, inhibits T-",
            "probability": 0.00013506412506103516
        }
    ],
    "56c85ed65795f9a73e000012_4": [
        {
            "start_logit": 4.65625,
            "end_logit": -0.75146484375,
            "text": "inhibits",
            "probability": 0.984375
        },
        {
            "start_logit": 4.65625,
            "end_logit": -5.58984375,
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 0.00782012939453125
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.125,
            "text": "inhibits T-cell",
            "probability": 0.0016775131225585938
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.21875,
            "text": "inhibits T-cell activation and",
            "probability": 0.0015277862548828125
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.5703125,
            "text": "inhibits T",
            "probability": 0.0010738372802734375
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.6484375,
            "text": "inhibits T-cell activation",
            "probability": 0.0009937286376953125
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.6875,
            "text": "inhibits T-cell activation and proliferation",
            "probability": 0.0009560585021972656
        },
        {
            "start_logit": 4.65625,
            "end_logit": -7.7734375,
            "text": "inhibits T-",
            "probability": 0.0008769035339355469
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -0.75146484375,
            "text": "protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.0004093647003173828
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -2.25390625,
            "text": "protein tyrosine kinase",
            "probability": 9.101629257202148e-05
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -3.244140625,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -0.75146484375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -6.78125,
            "end_logit": -0.75146484375,
            "text": "small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -2.25390625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -0.75146484375,
            "text": "tyrosine kinase inhibitor, inhibits",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.78125,
            "end_logit": -0.75146484375,
            "text": "molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -0.75146484375,
            "text": "inhibitor, inhibits",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -3.12890625,
            "end_logit": -5.58984375,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -8.125,
            "end_logit": -0.75146484375,
            "text": "a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -0.75146484375,
            "text": ", inhibits",
            "probability": 2.682209014892578e-06
        }
    ],
    "56c85ed65795f9a73e000012_5": [
        {
            "start_logit": 8.421875,
            "end_logit": 8.6171875,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.421875,
            "end_logit": 1.62890625,
            "text": "inhibits",
            "probability": 0.0009250640869140625
        },
        {
            "start_logit": -0.20458984375,
            "end_logit": 8.6171875,
            "text": "CD4+CD25+ regulatory T cells",
            "probability": 0.00018084049224853516
        },
        {
            "start_logit": 8.421875,
            "end_logit": -3.197265625,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -4.08203125,
            "end_logit": 8.6171875,
            "text": "cells",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 8.6171875,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 8.6171875,
            "text": "T cells",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.6171875,
            "text": "regulatory T cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.3984375,
            "text": "inhibits the proliferation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.6171875,
            "text": "+CD25+ regulatory T cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.48828125,
            "text": "inhibits the proliferation and function of CD4+CD25+",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.53125,
            "text": "inhibits the proliferation and function of CD4+CD25",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.58984375,
            "text": "inhibits the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.6171875,
            "text": "of CD4+CD25+ regulatory T cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.68359375,
            "text": "inhibits the proliferation and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.6171875,
            "text": "CD25+ regulatory T cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.96484375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.984375,
            "text": "inhibits the proliferation and function of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.984375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.421875,
            "end_logit": -8.0703125,
            "text": "inhibits the proliferation and function of CD4+",
            "probability": 5.960464477539063e-08
        }
    ],
    "58f4b25e70f9fc6f0f000011_1": [
        {
            "start_logit": 3.068359375,
            "end_logit": 2.125,
            "text": "Liver",
            "probability": 0.9658203125
        },
        {
            "start_logit": -0.359375,
            "end_logit": 2.125,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 0.03131103515625
        },
        {
            "start_logit": -3.18359375,
            "end_logit": 2.125,
            "text": "10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 0.001857757568359375
        },
        {
            "start_logit": -0.359375,
            "end_logit": -3.044921875,
            "text": "transplant of 10",
            "probability": 0.00017762184143066406
        },
        {
            "start_logit": -0.359375,
            "end_logit": -3.314453125,
            "text": "transplant",
            "probability": 0.0001361370086669922
        },
        {
            "start_logit": 3.068359375,
            "end_logit": -7.03125,
            "text": "Liver Injury",
            "probability": 0.00010198354721069336
        },
        {
            "start_logit": 3.068359375,
            "end_logit": -7.578125,
            "text": "Liver Injury Network",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 2.125,
            "text": "higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -0.359375,
            "end_logit": -5.35546875,
            "text": "transplant of 10%",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -7.921875,
            "end_logit": 2.125,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -0.359375,
            "end_logit": -5.4609375,
            "text": "transplant of 10% or higher",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 2.125,
            "text": "prospective U.S. Drug-Induced Liver",
            "probability": 1.4901161193847656e-05
        },
        {
            "start_logit": -8.125,
            "end_logit": 2.125,
            "text": "been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -8.15625,
            "end_logit": 2.125,
            "text": "ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -8.15625,
            "end_logit": 2.125,
            "text": "registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 2.125,
            "text": "Drug-Induced Liver",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 2.125,
            "text": "need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": -3.18359375,
            "end_logit": -3.044921875,
            "text": "10",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": -0.359375,
            "end_logit": -7.03125,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -0.359375,
            "end_logit": -7.2421875,
            "text": "transplant of 10% or",
            "probability": 2.6226043701171875e-06
        }
    ],
    "58f4b25e70f9fc6f0f000011_2": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.21875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.03515625,
            "text": "liver injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.703125,
            "text": "liver injury patterns were found",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.7421875,
            "text": "liver injury patterns",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.91015625,
            "text": "liver injury patterns were found to affect potential severity as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -8.1875,
            "text": "liver injury patterns were found to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -8.2265625,
            "text": "liver injury patterns were found to affect potential severity as measured by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -8.234375,
            "text": "liver injury patterns were found to affect potential severity as measured",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -8.3515625,
            "text": "liver injury patterns were found to affect",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.578125,
            "end_logit": -8.3671875,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy's Law criteria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.21875,
            "text": "No additional alleles outside those associated with liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.21875,
            "text": "with liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -7.03515625,
            "text": "No additional alleles outside those associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.03515625,
            "text": "with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.703125,
            "text": "were found",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -7.91015625,
            "text": "severity as",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -7.703125,
            "text": "No additional alleles outside those associated with liver injury patterns were found",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -7.703125,
            "text": "found",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -7.7421875,
            "text": "No additional alleles outside those associated with liver injury patterns",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.703125,
            "text": "with liver injury patterns were found",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_3": [
        {
            "start_logit": 8.0859375,
            "end_logit": 7.73046875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.73046875,
            "text": "15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.75390625,
            "text": "liver aminotransferase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.9140625,
            "text": "liver aminotransferase levels above the upper limit",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 7.73046875,
            "text": "sample.We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 7.73046875,
            "text": ",353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.73046875,
            "text": "3 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.73046875,
            "text": "We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1875,
            "end_logit": 7.73046875,
            "text": ", liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -6.5546875,
            "text": "15",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.51171875,
            "text": "severity of",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.53125,
            "text": "severity of DILI based",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.6953125,
            "text": "severity of DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin,",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.73046875,
            "text": "severity",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -6.5546875,
            "text": "sample.We conducted a retrospective cohort study of 15",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.8671875,
            "text": "severity of DILI",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.875,
            "text": "severity of DILI based on",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.90625,
            "text": "severity of DILI based on levels of alanine aminotransferase or aspartate aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.93359375,
            "text": "severity of DILI based on levels of alanine aminotransferase or aspartate aminotransferase and",
            "probability": 0.0
        },
        {
            "start_logit": -6.51171875,
            "end_logit": -7.94921875,
            "text": "severity of DILI based on levels of alanine aminotransferase or aspartate aminotransferase and total bilirubin, and validated the model in",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_4": [
        {
            "start_logit": 8.703125,
            "end_logit": 7.546875,
            "text": "Liver",
            "probability": 1.0
        },
        {
            "start_logit": 8.703125,
            "end_logit": -4.1953125,
            "text": "Liver Failure",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 7.546875,
            "text": "Risk of Acute Liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.71875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.90234375,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.0546875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.546875,
            "text": "Acute Liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.296875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.3125,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -4.1953125,
            "text": "Risk of Acute Liver Failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -4.1953125,
            "text": "Acute Liver Failure",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.71875,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.90234375,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -7.9609375,
            "text": "Risk of",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -8.0546875,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -7.71875,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -8.296875,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -8.3125,
            "text": "Risk of Acute Liver Failure in Patients With Drug-",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -7.90234375,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -8.0546875,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_5": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1171875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.1171875,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.1171875,
            "text": "drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.96484375,
            "text": "liver injury",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.046875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.1171875,
            "text": "hepatocellular drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.078125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.2109375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.2265625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.234375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.234375,
            "text": "liver injury (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.265625,
            "text": "liver injury (DILI) with jaundice indicates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.265625,
            "text": "liver injury (DILI) with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.28125,
            "text": "liver injury (DILI)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.1171875,
            "text": "that hepatocellular drug-induced liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.3203125,
            "text": "liver injury (DILI) with jaundice indicates a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.3359375,
            "text": "liver injury (DILI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.1171875,
            "text": "Law, which states that hepatocellular drug-induced liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.3671875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.3671875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 5.960464477539063e-08
        }
    ],
    "58f4b25e70f9fc6f0f000011_6": [
        {
            "start_logit": 7.84765625,
            "end_logit": 7.81640625,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -5.99609375,
            "text": "liver injury",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.81640625,
            "text": "drug-induced liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.81640625,
            "text": "identify drug-induced liver",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 7.81640625,
            "text": "Hy's law is a method used to identify drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.046875,
            "text": "liver injury (DILI)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.81640625,
            "text": "method used to identify drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.81640625,
            "text": "to identify drug-induced liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.25,
            "text": "liver injury (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.84765625,
            "end_logit": -8.3125,
            "text": "liver injury (DILI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 7.81640625,
            "text": "law is a method used to identify drug-induced liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 7.81640625,
            "text": "s law is a method used to identify drug-induced liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 7.81640625,
            "text": "'s law is a method used to identify drug-induced liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -5.99609375,
            "text": "drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -5.99609375,
            "text": "identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -5.99609375,
            "text": "Hy's law is a method used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -5.99609375,
            "text": "method used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -5.99609375,
            "text": "to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -5.99609375,
            "text": "law is a method used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -5.99609375,
            "text": "s law is a method used to identify drug-induced liver injury",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_7": [
        {
            "start_logit": 8.5234375,
            "end_logit": 8.3203125,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.046875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.1328125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.171875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.1796875,
            "text": "liver injury",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.1796875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.1953125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.21875,
            "text": "liver injury is identified in clinical trials by ALT>",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.2265625,
            "text": "liver injury is identified in clinical trials by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.25,
            "text": "liver injury is identified in clinical trials by ALT>3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.2578125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.3203125,
            "text": "severe liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.3203125,
            "text": "Potential severe liver",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": -6.78125,
            "text": "FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -6.78125,
            "text": "US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -6.78125,
            "text": "the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -6.78125,
            "text": ", and termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -6.78125,
            "text": "termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -6.78125,
            "text": "'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -6.78125,
            "text": "N, and termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_8": [
        {
            "start_logit": 8.375,
            "end_logit": 8.2109375,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.60546875,
            "text": "liver injury",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.6640625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.2109375,
            "text": "Severe liver",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.80859375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.8125,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.8359375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.8359375,
            "text": "liver injury is identified by the liver chemistry threshold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.875,
            "text": "liver injury is identified by the liver chemistry",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.87890625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.890625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.8984375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.90625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.9609375,
            "text": "liver injury is identified by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.984375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.0546875,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -6.11328125,
            "text": "the Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -6.11328125,
            "text": "Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -6.11328125,
            "text": "termed Hy's law by the Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -6.11328125,
            "text": "and bilirubin>2\u00d7 ULN, termed Hy's law by the Food and Drug Administration",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_1": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.8671875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": 8.8671875,
            "text": "DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.8671875,
            "text": ", dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.8671875,
            "text": "ACs i.e., dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.8671875,
            "text": "FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.8671875,
            "text": "idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.8671875,
            "text": "Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.8671875,
            "text": "., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.8671875,
            "text": "been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.8671875,
            "text": "one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.8671875,
            "text": "the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.8671875,
            "text": "rucizumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.8671875,
            "text": "izumab for one of the DOACs i.e., dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.890625,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -6.41796875,
            "text": "DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -7.890625,
            "text": "DOACs i.e., dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -8.1953125,
            "text": "DOACs i",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -8.2109375,
            "text": "DOACs i.e",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -6.41796875,
            "text": "ACs",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -6.41796875,
            "text": "FDA), idarucizumab for one of the DOACs",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_2": [
        {
            "start_logit": 9.15625,
            "end_logit": 9.2890625,
            "text": "vitamin K antagonists",
            "probability": 1.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -0.92578125,
            "text": "vitamin K",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 9.15625,
            "end_logit": -3.4140625,
            "text": "vitamin",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -3.70703125,
            "end_logit": 9.2890625,
            "text": "antagonists",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 9.2890625,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.2890625,
            "text": "to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.2890625,
            "text": "oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 9.2890625,
            "text": "dabigatran may be preferred to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 9.2890625,
            "text": "New oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.2890625,
            "text": "K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 9.2890625,
            "text": ", or dabigatran may be preferred to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.109375,
            "end_logit": 9.2890625,
            "text": "rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.0625,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 9.2890625,
            "text": "may be preferred to vitamin K antagonists",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.2890625,
            "text": "preferred to vitamin K antagonists",
            "probability": 0.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.1171875,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such",
            "probability": 0.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.171875,
            "text": "vitamin K antagonists in",
            "probability": 0.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.1875,
            "text": "vitamin K antagonists in patients without cancer or renal failure",
            "probability": 0.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.203125,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of",
            "probability": 0.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.21875,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_3": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.9296875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.9296875,
            "text": "Idarucizumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.9296875,
            "text": "immediate, complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.9296875,
            "text": "of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.9296875,
            "text": "complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.9296875,
            "text": "rucizumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.9296875,
            "text": "reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.7890625,
            "text": "dabigatran anticoagulant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.9296875,
            "text": "izumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.9296875,
            "text": "sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.9296875,
            "text": ", complete and sustained reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.92578125,
            "text": "dabigatran anticoagulant activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.2578125,
            "text": "dabigatran anticoagulant activity, and was safe and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.2890625,
            "text": "dabigatran anticoagulant activity, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.359375,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.375,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.390625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.390625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.3984375,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.40625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired volunteers",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_4": [
        {
            "start_logit": 8.46875,
            "end_logit": 8.65625,
            "text": "Dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 8.46875,
            "end_logit": -6.91796875,
            "text": "Dabigatran Anticoagulant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.65625,
            "text": "Reversal of Dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.65625,
            "text": "of Dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.46875,
            "end_logit": -7.9609375,
            "text": "Dabigatran Anticoagulant Activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.65625,
            "text": "Mediated Reversal of Dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.171875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.171875,
            "text": "Dabigatran Anticoagulant Activity in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.296875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.65625,
            "text": "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.359375,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.390625,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.3984375,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.4140625,
            "text": "Dabigatran Anticoagulant Activity in a Randomized,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.421875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -6.91796875,
            "text": "Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.91796875,
            "text": "Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -6.91796875,
            "text": "of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -6.91796875,
            "text": "Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.9609375,
            "text": "Anticoagulant Activity",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_5": [
        {
            "start_logit": 8.015625,
            "end_logit": 9.0078125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.0078125,
            "text": "reversal of dabigatran",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.0078125,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 9.0078125,
            "text": "drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.0078125,
            "text": "We also discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.0078125,
            "text": "also discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.0078125,
            "text": "discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.0078125,
            "text": "nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.0078125,
            "text": "reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -7.78515625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.0078125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.046875,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.0703125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.203125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.2265625,
            "text": "dabigatran and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.328125,
            "text": "dabigatran and two agents, andexanet and ciraparanta",
            "probability": 0.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.34375,
            "text": "dabigatran and two agents, andexanet",
            "probability": 0.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.34375,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixaban, and",
            "probability": 0.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.3515625,
            "text": "dabigatran and two agents, andexanet and",
            "probability": 0.0
        },
        {
            "start_logit": 8.015625,
            "end_logit": -8.3515625,
            "text": "dabigatran and two agents, andexane",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_6": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.9375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 8.9375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.9375,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 8.9375,
            "text": "urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.9375,
            "text": "Idarucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.9375,
            "text": "effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.9375,
            "text": "approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 8.9375,
            "text": "is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.9375,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.9375,
            "text": "rucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.9375,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.9375,
            "text": "izumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.9375,
            "text": "the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.9375,
            "text": "targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.21875,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -8.1015625,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -8.1328125,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -8.21875,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.3203125,
            "end_logit": -8.3359375,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -8.21875,
            "text": "of dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_7": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.8125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -5.8515625,
            "end_logit": 8.8125,
            "text": "bleeding associated with dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.8125,
            "text": "with dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.8125,
            "text": "associated with dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.8125,
            "text": "initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.8125,
            "text": "CONCLUSIONS: The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.8125,
            "text": "The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.8125,
            "text": "definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.8125,
            "text": "data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.8125,
            "text": "idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.8125,
            "text": "treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.8125,
            "text": "of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.8125,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.8125,
            "text": "rucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.8125,
            "text": "izumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.2265625,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -8.2265625,
            "text": "bleeding associated with dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -8.265625,
            "text": "bleeding associated with",
            "probability": 0.0
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -8.4375,
            "text": "bleeding associated",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -8.2265625,
            "text": "with dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_8": [
        {
            "start_logit": 7.96484375,
            "end_logit": 9.0859375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 9.0859375,
            "text": "anticoagulant activity of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.0859375,
            "text": "completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 9.0859375,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 9.0859375,
            "text": "The administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 9.0859375,
            "text": "promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.0859375,
            "text": "administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.0859375,
            "text": "intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.296875,
            "end_logit": 9.0859375,
            "text": "izumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.0859375,
            "text": "reversed the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.0859375,
            "text": "the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.5703125,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from 92",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.609375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.93359375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.94921875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.0234375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.09375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.1015625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.125,
            "text": "dabigatran as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -8.15625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_9": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.8828125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.8828125,
            "text": "binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.76953125,
            "text": "dabigatran with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.8828125,
            "text": "that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.8828125,
            "text": "fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.8828125,
            "text": "antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.8828125,
            "text": "Idarucizumab, a monoclonal antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.94921875,
            "text": "dabigatran with high affinity, is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.8828125,
            "text": "monoclonal antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.0,
            "text": "dabigatran with high",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.8828125,
            "text": "rucizumab, a monoclonal antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.0625,
            "text": "dabigatran with high affinity, is in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.09375,
            "text": "dabigatran with high affinity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.15625,
            "text": "dabigatran with high affinity, is in development",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.1875,
            "text": "dabigatran with high affinity, is in development as a specific antidote for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.1953125,
            "text": "dabigatran with high affinity, is in development as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.203125,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.28125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.34375,
            "text": "dabigatran with high affinity,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.40625,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_10": [
        {
            "start_logit": 8.4453125,
            "end_logit": 8.71875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.71875,
            "text": "antidote to dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.71875,
            "text": "to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.71875,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.71875,
            "text": "specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -8.0234375,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.71875,
            "text": "randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.71875,
            "text": "a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.71875,
            "text": "study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.71875,
            "text": "the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.71875,
            "text": "investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.71875,
            "text": "healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.71875,
            "text": "in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.71875,
            "text": "safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.71875,
            "text": "idarucizumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.71875,
            "text": ", a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.71875,
            "text": "izumab, a specific antidote to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -8.0234375,
            "text": "antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -8.1796875,
            "text": "antidote",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -8.0234375,
            "text": "to dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_11": [
        {
            "start_logit": 8.03125,
            "end_logit": 9.0703125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": 9.0703125,
            "text": "anticoagulant activity of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 9.0703125,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 9.0703125,
            "text": "To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.0703125,
            "text": "reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.0703125,
            "text": "humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.0703125,
            "text": "the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.0703125,
            "text": "specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.0703125,
            "text": "fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.0703125,
            "text": "evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.0703125,
            "text": "a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.2734375,
            "text": "dabigatran and",
            "probability": 0.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.3359375,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties",
            "probability": 0.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.3984375,
            "text": "dabigatran and to review the pharmacology,",
            "probability": 0.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.421875,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and",
            "probability": 0.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.4296875,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -6.75,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -7.60546875,
            "text": "anticoagulant activity",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -8.2734375,
            "text": "anticoagulant activity of dabigatran and",
            "probability": 0.0
        },
        {
            "start_logit": -6.21875,
            "end_logit": -8.3359375,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_12": [
        {
            "start_logit": 10.1484375,
            "end_logit": 9.84375,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -1.3603515625,
            "text": "Dabigatran",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.94921875,
            "end_logit": 9.84375,
            "text": "te",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -6.7890625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.51171875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.55078125,
            "text": "Dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.63671875,
            "text": "Dabigatran etexila",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.84375,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.88671875,
            "text": "Dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.0390625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.0390625,
            "text": "Dabigatran etexilate is",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.84375,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.84375,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.28125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.3046875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.3203125,
            "text": "Dabigatran etexilate is an",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.4453125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 0.0
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -6.7890625,
            "text": "te is an oral thrombin",
            "probability": 0.0
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -7.51171875,
            "text": "te is an oral thrombin inhibitor",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_13": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.8984375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.8984375,
            "text": "to dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.8984375,
            "text": "ICH related to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.8984375,
            "text": "In ICH related to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "dabigatran, anticoagulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.8984375,
            "text": "related to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7890625,
            "text": "dabigatran, anticoagulation can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.203125,
            "text": "dabigatran, anticoagulation can be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.234375,
            "text": "dabigatran, anticoagulation can be rapidly reversed with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.25,
            "text": "dabigatran, anticoagulation can be rapidly reversed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.40625,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.4296875,
            "text": "dabigatran, anticoagulation can be rapidly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.53125,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -7.7890625,
            "text": "anticoagulation can",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.53125,
            "text": "to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -8.203125,
            "text": "anticoagulation can be",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.7890625,
            "text": "to dabigatran, anticoagulation can",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -8.234375,
            "text": "anticoagulation can be rapidly reversed with",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -8.25,
            "text": "anticoagulation can be rapidly reversed",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.53125,
            "text": "ICH related to dabigatran, anticoagulation",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_14": [
        {
            "start_logit": 10.234375,
            "end_logit": 10.265625,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -1.224609375,
            "text": "dabigatran",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": -2.248046875,
            "end_logit": 10.265625,
            "text": "te",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 10.234375,
            "end_logit": -6.80078125,
            "text": "dabigatran etexila",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 10.265625,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": 10.265625,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -7.53125,
            "text": "dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -7.53125,
            "text": "dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 10.265625,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.265625,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.265625,
            "text": "reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -8.3984375,
            "text": "dabigatran etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.265625,
            "text": "for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.265625,
            "text": "rucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.265625,
            "text": "izumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -1.224609375,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -1.224609375,
            "text": "reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -1.224609375,
            "text": "for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -1.224609375,
            "text": "rucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -1.224609375,
            "text": "izumab is a reversal agent for dabigatran",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_15": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.9296875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.9296875,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.9296875,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.9296875,
            "text": "anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.9296875,
            "text": "completely reversed the anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.9296875,
            "text": "rucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.9296875,
            "text": "izumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.9296875,
            "text": "the anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.9296875,
            "text": "reversed the anticoagulant effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.9296875,
            "text": "effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.0234375,
            "text": "dabigatran within",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.25,
            "text": "dabigatran within minutes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.0234375,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -8.0234375,
            "text": "of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.0546875,
            "text": "Idarucizumab completely reversed the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.0703125,
            "text": "Idarucizumab completely reversed the anticoagulant effect",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.0234375,
            "text": "anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.0546875,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.0703125,
            "text": "anticoagulant effect",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -8.25,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_16": [
        {
            "start_logit": 10.1484375,
            "end_logit": 9.84375,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -1.3603515625,
            "text": "Dabigatran",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -2.94921875,
            "end_logit": 9.84375,
            "text": "te",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -6.7890625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.51171875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.55078125,
            "text": "Dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.63671875,
            "text": "Dabigatran etexila",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.84375,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -7.88671875,
            "text": "Dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.0390625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.0390625,
            "text": "Dabigatran etexilate is",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.84375,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.84375,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.28125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.3046875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.3203125,
            "text": "Dabigatran etexilate is an",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.4453125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 0.0
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -6.7890625,
            "text": "te is an oral thrombin",
            "probability": 0.0
        },
        {
            "start_logit": -2.94921875,
            "end_logit": -7.51171875,
            "text": "te is an oral thrombin inhibitor",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_17": [
        {
            "start_logit": 10.234375,
            "end_logit": 10.21875,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -1.2265625,
            "text": "dabigatran",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -2.345703125,
            "end_logit": 10.21875,
            "text": "te",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 10.234375,
            "end_logit": -6.90234375,
            "text": "dabigatran etexila",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 10.21875,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -7.546875,
            "text": "dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 10.21875,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -7.65625,
            "text": "dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 10.21875,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.21875,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.234375,
            "end_logit": -8.3359375,
            "text": "dabigatran etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.21875,
            "text": "reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.21875,
            "text": "for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.21875,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 10.21875,
            "text": "rucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -1.2265625,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -1.2265625,
            "text": "reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -1.2265625,
            "text": "for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": -1.2265625,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": -1.2265625,
            "text": "rucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_18": [
        {
            "start_logit": 8.078125,
            "end_logit": 9.0546875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.0546875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.0546875,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.0546875,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.0546875,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.0546875,
            "text": "rucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.0546875,
            "text": "effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.0546875,
            "text": "izumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 9.0546875,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.0546875,
            "text": "humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.671875,
            "end_logit": 9.0546875,
            "text": "antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.671875,
            "end_logit": 9.0546875,
            "text": "monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.125,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.9921875,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -8.109375,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -8.125,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -8.125,
            "text": "of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": -7.9921875,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -7.9921875,
            "text": "reversal of the anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": -8.109375,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_19": [
        {
            "start_logit": 8.3515625,
            "end_logit": 8.8671875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.8671875,
            "text": "to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.8671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.8671875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.8671875,
            "text": "izumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.8671875,
            "text": "targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.3671875,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90625,
            "end_logit": -8.3671875,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -8.3671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.2265625,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.25,
            "text": "Idarucizumab is a monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.2890625,
            "text": "Idarucizumab is",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3046875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3203125,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3359375,
            "text": "Idarucizumab is a monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3828125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3828125,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -8.2265625,
            "text": "rucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -8.25,
            "text": "rucizumab is a monoclonal",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_20": [
        {
            "start_logit": 8.3515625,
            "end_logit": 8.8671875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.8671875,
            "text": "to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.8671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.8671875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.8671875,
            "text": "izumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.8671875,
            "text": "targeted to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.3671875,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90625,
            "end_logit": -8.3671875,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -8.3671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.2265625,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.25,
            "text": "Idarucizumab is a monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.2890625,
            "text": "Idarucizumab is",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3046875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3203125,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3359375,
            "text": "Idarucizumab is a monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3828125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.3828125,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -8.2265625,
            "text": "rucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -8.25,
            "text": "rucizumab is a monoclonal",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_21": [
        {
            "start_logit": 10.15625,
            "end_logit": 10.171875,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -1.4638671875,
            "text": "dabigatran",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -2.41015625,
            "end_logit": 10.171875,
            "text": "te",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 10.15625,
            "end_logit": -6.9296875,
            "text": "dabigatran etexila",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 10.171875,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.3671875,
            "text": "dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.171875,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.171875,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.71484375,
            "text": "dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 10.171875,
            "text": "directly binds dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.171875,
            "text": "binds dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.1875,
            "text": "dabigatran etexilate and",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.265625,
            "text": "dabigatran etexilate and neutralizes its activity.",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.3046875,
            "text": "dabigatran etexilate and neutralizes",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.171875,
            "text": "Idarucizumab, a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.3671875,
            "text": "dabigatran etexilate and neutralizes its activity",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.3984375,
            "text": "dabigatran etexilate and neutralizes its",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.4296875,
            "text": "dabigatran etexilate and neutral",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.171875,
            "text": "antibody fragment, directly binds dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.171875,
            "text": "rucizumab, a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_22": [
        {
            "start_logit": 8.359375,
            "end_logit": 8.859375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.859375,
            "text": "binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.859375,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -7.84375,
            "text": "dabigatran with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.578125,
            "end_logit": 8.859375,
            "text": "rucizumab is an antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.859375,
            "text": "fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.09375,
            "text": "dabigatran with high",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.1328125,
            "text": "dabigatran with high affinity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 8.859375,
            "text": "izumab is an antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 8.859375,
            "text": "antibody fragment that binds dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.203125,
            "text": "dabigatran with high affinity.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": -7.84375,
            "text": "binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.84375,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -8.09375,
            "text": "binds dabigatran with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -8.1328125,
            "text": "binds dabigatran with high affinity",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -8.203125,
            "text": "binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.09375,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -8.1328125,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high affinity",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": -7.84375,
            "text": "rucizumab is an antibody fragment that binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -7.84375,
            "text": "fragment that binds dabigatran with",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_23": [
        {
            "start_logit": 10.4375,
            "end_logit": 9.9921875,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -0.387451171875,
            "text": "dabigatran",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -2.6640625,
            "end_logit": 9.9921875,
            "text": "te",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 10.4375,
            "end_logit": -7.4375,
            "text": "dabigatran etexila",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -7.4453125,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -7.51953125,
            "text": "dabigatran et",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -7.76171875,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.9921875,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 9.9921875,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.015625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.0234375,
            "text": "dabigatran etex",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.9921875,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.1171875,
            "text": "dabigatran etexilate using",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.296875,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions.",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.34375,
            "text": "dabigatran etexilate using idarucizumab was",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.3671875,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with",
            "probability": 0.0
        },
        {
            "start_logit": 10.4375,
            "end_logit": -8.375,
            "text": "dabigatran etexilate using idarucizumab was safe and",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.9921875,
            "text": "CONCLUSION Reversal of dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.9921875,
            "text": "Reversal of dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 9.9921875,
            "text": "of dabigatran etexilate",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_24": [
        {
            "start_logit": 8.453125,
            "end_logit": 8.75,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.75,
            "text": "to dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.75,
            "text": "specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.75,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -8.1796875,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.75,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.75,
            "text": "binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.75,
            "text": "rucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.75,
            "text": "only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.75,
            "text": "izumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.75,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.75,
            "text": "is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.75,
            "text": "humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 8.75,
            "text": ", monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.671875,
            "end_logit": 8.75,
            "text": "it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6875,
            "end_logit": 8.75,
            "text": "the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6875,
            "end_logit": 8.75,
            "text": "antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": -8.1796875,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -8.1796875,
            "text": "specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.1796875,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_25": [
        {
            "start_logit": 8.1328125,
            "end_logit": 8.9765625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.375,
            "end_logit": 8.9765625,
            "text": "In 2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.9765625,
            "text": "2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.9765625,
            "text": "anticoagulant effects of dabigatran",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.9765625,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.9765625,
            "text": "rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 8.9765625,
            "text": "was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.9765625,
            "text": "reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.9765625,
            "text": "minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.9765625,
            "text": "effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.9765625,
            "text": "izumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.9765625,
            "text": "approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.9765625,
            "text": "the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.9765625,
            "text": "humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.9765625,
            "text": ") reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.9765625,
            "text": "of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.9765625,
            "text": ", the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.9765625,
            "text": "rucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -8.0859375,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.375,
            "end_logit": -7.17578125,
            "text": "In 2015",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_26": [
        {
            "start_logit": 8.03125,
            "end_logit": 9.0703125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 9.0703125,
            "text": ", dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 9.0703125,
            "text": "direct thrombin inhibitor, dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.0703125,
            "text": "thrombin inhibitor, dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.0703125,
            "text": "reverse the direct thrombin inhibitor, dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.0703125,
            "text": "the direct thrombin inhibitor, dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.0703125,
            "text": "inhibitor, dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.296875,
            "end_logit": 9.0703125,
            "text": "Idarucizumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.0703125,
            "text": "antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.1328125,
            "text": "dabigatran, which was recently approved for use",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.171875,
            "text": "dabigatran, which was recently approved for use in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.1796875,
            "text": "dabigatran, which was recently approved for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.2421875,
            "text": "dabigatran, which was recently approved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.2734375,
            "text": "dabigatran, which",
            "probability": 0.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.3515625,
            "text": "dabigatran, which was",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -6.7734375,
            "text": "direct thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.11328125,
            "text": "direct thrombin",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.7734375,
            "text": "thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -6.26171875,
            "end_logit": -8.1328125,
            "text": ", dabigatran, which was recently approved for use",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.11328125,
            "text": "thrombin",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_27": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.8671875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.8671875,
            "text": "targeting dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.8671875,
            "text": "antibody fragment targeting dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.8671875,
            "text": "fragment targeting dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.8671875,
            "text": "Idarucizumab, an antibody fragment targeting dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.21875,
            "text": "dabigatran, is the first specific antidote for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.2890625,
            "text": "dabigatran, is the first specific antidote",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3046875,
            "text": "dabigatran,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3203125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.328125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3359375,
            "text": "dabigatran, is the first specific antidote for a NOAC to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.34375,
            "text": "dabigatran, is the first",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3671875,
            "text": "dabigatran, is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.390625,
            "text": "dabigatran, is the first specific antid",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3984375,
            "text": "dabigatran, is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3984375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.40625,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.40625,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.4296875,
            "text": "dabigatran, is the first specific",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.453125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_28": [
        {
            "start_logit": 8.453125,
            "end_logit": 8.6953125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.890625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.6953125,
            "text": "Idarucizumab neutralised plasma concentrations of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -8.15625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.6953125,
            "text": "rucizumab neutralised plasma concentrations of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.6953125,
            "text": "izumab neutralised plasma concentrations of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -8.234375,
            "text": "dabigatran, and reversed the effects of the drug on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.6953125,
            "text": "of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.6953125,
            "text": "neutralised plasma concentrations of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -8.296875,
            "text": "dabigatran, and reversed the effects of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -8.3046875,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.890625,
            "text": "effects of the drug on coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -7.890625,
            "text": "coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -8.15625,
            "text": "effects of the drug on coagulation variables",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.890625,
            "text": ", and reversed the effects of the drug on coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": -7.890625,
            "text": "and reversed the effects of the drug on coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": -7.890625,
            "text": "drug on coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.890625,
            "text": "Idarucizumab neutralised plasma concentrations of dabigatran, and reversed the effects of the drug on coagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -8.234375,
            "text": "effects of the drug on",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -8.15625,
            "text": "coagulation variables",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_29": [
        {
            "start_logit": 8.1328125,
            "end_logit": 8.984375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.984375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.984375,
            "text": "Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.984375,
            "text": "reverse the anticoagulant effects of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 8.984375,
            "text": "of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.984375,
            "text": "to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.984375,
            "text": "developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.984375,
            "text": "fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.984375,
            "text": "antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.984375,
            "text": "rucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.984375,
            "text": "was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.984375,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.984375,
            "text": "effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.984375,
            "text": "izumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.984375,
            "text": ", was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.77734375,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.05859375,
            "end_logit": -7.65625,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.05859375,
            "end_logit": -7.77734375,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.05859375,
            "end_logit": -7.79296875,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.05859375,
            "end_logit": -8.03125,
            "text": "anticoagulant effects of",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_30": [
        {
            "start_logit": 8.375,
            "end_logit": 8.7265625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.2109375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.375,
            "end_logit": -7.7578125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 8.7265625,
            "text": "of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.7265625,
            "text": "Idarucizumab also reversed the effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.7265625,
            "text": "effects of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.15625,
            "text": "dabigatran and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.1875,
            "text": "dabigatran and, unlike PCCs, was not associated with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.2109375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.21875,
            "text": "dabigatran and, unlike PCCs, was not associated with over-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.28125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.2890625,
            "text": "dabigatran and, unlike PCCs, was not associated with over",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.421875,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.484375,
            "text": "dabigatran and, unlike PCCs, was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.5,
            "text": "dabigatran and, unlike PCCs,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.2109375,
            "text": "thrombin generation",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -7.2109375,
            "text": ", unlike PCCs, was not associated with over-correction of thrombin generation",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.7578125,
            "text": "thrombin generation.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.2109375,
            "text": "PCCs, was not associated with over-correction of thrombin generation",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -7.2109375,
            "text": "correction of thrombin generation",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_31": [
        {
            "start_logit": 9.984375,
            "end_logit": 9.4765625,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -1.3955078125,
            "text": "Dabigatran",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -3.267578125,
            "end_logit": 9.4765625,
            "text": "te",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.984375,
            "end_logit": -6.98046875,
            "text": "Dabigatran et",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.05078125,
            "text": "Dabigatran etexila",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.734375,
            "text": "Dabigatran etexilate (DE) dose-dependently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.78515625,
            "text": "Dabigatran etex",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.8359375,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.8828125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.4765625,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.98046875,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.99609375,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1015625,
            "text": "Dabigatran etexilate (DE) dose",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.109375,
            "text": "Dabigatran etexilate (DE)",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1328125,
            "text": "Dabigatran etexilate (",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.2421875,
            "text": "Dabigatran etexilate (DE) dose-",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.28125,
            "text": "Dabigatran etexilate (DE",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.296875,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.3046875,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.3203125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_32": [
        {
            "start_logit": 8.328125,
            "end_logit": 8.734375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.734375,
            "end_logit": 8.734375,
            "text": "article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.734375,
            "text": "this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.734375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 8.734375,
            "text": "effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0625,
            "end_logit": 8.734375,
            "text": "of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.734375,
            "text": "we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.734375,
            "text": "reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.734375,
            "text": ", we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.734375,
            "text": "discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.734375,
            "text": "the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.734375,
            "text": "evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.734375,
            "text": "izumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.734375,
            "text": "idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.734375,
            "text": "efficacy for reversing effect of dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.328125,
            "end_logit": -8.390625,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.734375,
            "end_logit": -8.375,
            "text": "article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for",
            "probability": 0.0
        },
        {
            "start_logit": -6.734375,
            "end_logit": -8.390625,
            "text": "article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.734375,
            "end_logit": -8.390625,
            "text": "article, we discuss the evidence addressing",
            "probability": 0.0
        },
        {
            "start_logit": -6.734375,
            "end_logit": -8.3984375,
            "text": "article, we discuss the evidence addressing idarucizumab safety,",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_33": [
        {
            "start_logit": 8.5703125,
            "end_logit": 8.578125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.578125,
            "text": "for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.140625,
            "end_logit": 8.578125,
            "text": "reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.578125,
            "text": "potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.578125,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.578125,
            "text": "The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5703125,
            "end_logit": -8.359375,
            "text": "dabigatran.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.578125,
            "text": "agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.578125,
            "text": "This was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.578125,
            "text": "Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.578125,
            "text": "was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.578125,
            "text": "the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.578125,
            "text": "izumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.578125,
            "text": "idarucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.578125,
            "text": "rucizumab, a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 8.578125,
            "text": "a potential reversal agent for dabigatran",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -8.359375,
            "text": "for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -7.8359375,
            "text": "recent The Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -7.8359375,
            "text": "The Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -7.8359375,
            "text": "This was until the recent The Food and Drug Administration",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_1": [
        {
            "start_logit": 10.171875,
            "end_logit": 10.3359375,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -1.1337890625,
            "text": "lectin",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -1.9013671875,
            "end_logit": 10.3359375,
            "text": "pathway",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 10.3359375,
            "text": "complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.171875,
            "end_logit": -6.54296875,
            "text": "lectin complement",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 10.3359375,
            "text": "the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 10.3359375,
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 10.3359375,
            "text": "study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 10.3359375,
            "text": "association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.3359375,
            "text": "part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.3359375,
            "text": "aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.3359375,
            "text": "whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.3359375,
            "text": "of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.3359375,
            "text": "ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.3359375,
            "text": "an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.3515625,
            "text": "lectin complement pathway and SLE.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -1.1337890625,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.1337890625,
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -1.1337890625,
            "text": "study aims to investigate whether an association exists between the ficolins that are part of the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -1.1337890625,
            "text": "association exists between the ficolins that are part of the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_2": [
        {
            "start_logit": 10.0703125,
            "end_logit": 10.375,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -1.5009765625,
            "text": "lectin",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -1.8232421875,
            "end_logit": 10.375,
            "text": "pathway",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 10.375,
            "text": "complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 10.375,
            "text": "the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -6.96875,
            "text": "lectin complement",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.90625,
            "text": "lectin complement pathway (",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.375,
            "text": "To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.375,
            "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.375,
            "text": "of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.375,
            "text": "initiator of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.1796875,
            "text": "lectin complement pathway (LCP",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.375,
            "text": "assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.375,
            "text": "involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.3515625,
            "text": "lectin complement pathway (LC",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.359375,
            "text": "lectin complement pathway (LCP), in",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.3984375,
            "text": "lectin complement pathway (LCP),",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -1.5009765625,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -1.5009765625,
            "text": "To assess the involvement of ficolin-3, the main initiator of the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -1.8232421875,
            "end_logit": -7.90625,
            "text": "pathway (",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_3": [
        {
            "start_logit": 9.984375,
            "end_logit": 10.0546875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -1.626953125,
            "text": "lectin",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -2.201171875,
            "end_logit": 10.0546875,
            "text": "pathway",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 9.984375,
            "end_logit": -5.27734375,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 10.0546875,
            "text": "complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.109375,
            "text": "lectin complement pathway activation",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.203125,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.25,
            "text": "lectin complement pathway activation in",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.328125,
            "text": "lectin complement pathway activation in patients with",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.0546875,
            "text": "Ficolin-3-mediated lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.390625,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.0546875,
            "text": "mediated lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -1.626953125,
            "text": "Ficolin-3-mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -1.626953125,
            "text": "mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.109375,
            "text": "pathway activation",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.203125,
            "text": "pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.25,
            "text": "pathway activation in",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.328125,
            "text": "pathway activation in patients with",
            "probability": 0.0
        },
        {
            "start_logit": -2.201171875,
            "end_logit": -8.390625,
            "text": "pathway activation in patients with subarachnoid hemorrhage",
            "probability": 0.0
        },
        {
            "start_logit": -7.01953125,
            "end_logit": -5.27734375,
            "text": "complement",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_4": [
        {
            "start_logit": 9.8203125,
            "end_logit": 9.1328125,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -1.6484375,
            "text": "lectin",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -3.083984375,
            "end_logit": 9.1328125,
            "text": "pathway",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -5.703125,
            "text": "lectin complement",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.6015625,
            "text": "lectin complement pathway initiator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.1328125,
            "text": "complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7421875,
            "text": "lectin complement pathway initiators",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.8671875,
            "text": "lectin complement pathway initiators.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.1328125,
            "text": "the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.1328125,
            "text": "among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.1328125,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.1328125,
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.1328125,
            "text": "high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.1328125,
            "text": ", Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.1328125,
            "text": "Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.1328125,
            "text": "has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.1328125,
            "text": "collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.1328125,
            "text": "only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.1328125,
            "text": "is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 9.1328125,
            "text": "3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_5": [
        {
            "start_logit": 9.96875,
            "end_logit": 9.890625,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -1.5859375,
            "text": "lectin",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -2.599609375,
            "end_logit": 9.890625,
            "text": "pathway",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -5.2890625,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.7578125,
            "end_logit": 9.890625,
            "text": "the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.890625,
            "text": "complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.49609375,
            "text": "lectin complement pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.890625,
            "text": "in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.890625,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.890625,
            "text": "molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.890625,
            "text": "Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.890625,
            "text": "kata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.890625,
            "text": "antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 9.890625,
            "text": "pattern recognition molecule in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -5.7578125,
            "end_logit": -1.5859375,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -1.5859375,
            "text": "in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -1.5859375,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -1.5859375,
            "text": "molecule in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -2.599609375,
            "end_logit": -7.49609375,
            "text": "pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -1.5859375,
            "text": "Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_6": [
        {
            "start_logit": 10.09375,
            "end_logit": 10.3515625,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -1.41796875,
            "text": "lectin",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -1.87890625,
            "end_logit": 10.3515625,
            "text": "pathway",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -5.51953125,
            "end_logit": 10.3515625,
            "text": "complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 10.3515625,
            "text": "the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.09375,
            "end_logit": -6.8125,
            "text": "lectin complement",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.09375,
            "end_logit": -7.59765625,
            "text": "lectin complement pathway and",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.3515625,
            "text": "in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.046875,
            "text": "lectin complement pathway and form complexes with serine proteases named",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.109375,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.125,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.1484375,
            "text": "lectin complement pathway and form complexes with serine proteases",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.1640625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins. MASP",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.171875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1,",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.1796875,
            "text": "lectin complement pathway and form",
            "probability": 0.0
        },
        {
            "start_logit": 10.09375,
            "end_logit": -8.1875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 10.3515625,
            "text": "recognition molecules in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.3515625,
            "text": "molecules in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -8.703125,
            "end_logit": 10.3515625,
            "text": "3 are recognition molecules in the lectin complement pathway",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -1.41796875,
            "text": "the lectin",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_1": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.3515625,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": 10.3515625,
            "text": "c",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.9658203125,
            "text": "Deep",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -6.4609375,
            "text": "DeepLo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 10.3515625,
            "text": "Loc",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.1015625,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.1640625,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3203125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.1015625,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.1640625,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3203125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3359375,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3359375,
            "text": "c: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.4609375,
            "text": "Lo",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.1015625,
            "text": "Loc: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.1640625,
            "text": "Loc: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.3203125,
            "text": "Loc: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.3359375,
            "text": "Loc: prediction of protein subcellular localization using deep",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_2": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.3515625,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": 10.3515625,
            "text": "c",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.9658203125,
            "text": "Deep",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -6.4609375,
            "text": "DeepLo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 10.3515625,
            "text": "Loc",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.1015625,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.1640625,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3203125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.1015625,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.1640625,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3203125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3359375,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": -2.04296875,
            "end_logit": -8.3359375,
            "text": "c: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.4609375,
            "text": "Lo",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.1015625,
            "text": "Loc: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.1640625,
            "text": "Loc: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.3203125,
            "text": "Loc: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -8.3359375,
            "text": "Loc: prediction of protein subcellular localization using deep",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_1": [
        {
            "start_logit": 9.671875,
            "end_logit": 10.046875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": 10.046875,
            "text": "17A",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.671875,
            "end_logit": -2.697265625,
            "text": "interleukin",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 9.671875,
            "end_logit": -6.84375,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.046875,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.046875,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.046875,
            "text": "fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.046875,
            "text": "ab is a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.203125,
            "text": "interleukin-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.046875,
            "text": "Secukinumab is a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.046875,
            "text": "human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.046875,
            "text": "inumab is a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.046875,
            "text": "ukinumab is a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.046875,
            "text": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.046875,
            "text": "a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.671875,
            "end_logit": -8.3515625,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": -8.203125,
            "text": "17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": -8.3515625,
            "text": "17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -2.697265625,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.697265625,
            "text": "fully human anti-interleukin",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_2": [
        {
            "start_logit": 9.5703125,
            "end_logit": 10.0234375,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.708984375,
            "end_logit": 10.0234375,
            "text": "17A",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -2.8984375,
            "text": "interleukin",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -6.72265625,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 10.0234375,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.0234375,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.0234375,
            "text": "fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.86328125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.0234375,
            "text": "human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0234375,
            "text": "ab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.0234375,
            "text": "a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.0234375,
            "text": "inumab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.0234375,
            "text": "Secukinumab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.0234375,
            "text": "ukinumab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.1171875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.2421875,
            "text": "interleukin-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.28125,
            "text": "interleukin-17A monoclonal antibody, demonstrated",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.296875,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3828125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.40625,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_3": [
        {
            "start_logit": 9.6640625,
            "end_logit": 10.0625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": 10.0625,
            "text": "17A",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -2.70703125,
            "text": "interleukin",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -6.62109375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -6.83203125,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 10.0625,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.0625,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.0625,
            "text": "fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.0625,
            "text": "human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.0625,
            "text": "ab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0625,
            "text": "a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.0625,
            "text": "We evaluated secukinumab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.25,
            "text": "interleukin-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.34375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.3515625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.3515625,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.359375,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.4296875,
            "text": "interleukin-17A monoclonal antibody, in patients",
            "probability": 0.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": -6.62109375,
            "text": "17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": -8.25,
            "text": "17A monoclonal",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_4": [
        {
            "start_logit": 9.609375,
            "end_logit": 10.046875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.658203125,
            "end_logit": 10.046875,
            "text": "17A",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -2.818359375,
            "text": "interleukin",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -6.94921875,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.14453125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.046875,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.046875,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.046875,
            "text": "Anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.1875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis:",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.203125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.28125,
            "text": "interleukin-17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.3046875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.3125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.328125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised,",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.3359375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.34375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind,",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.359375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo",
            "probability": 0.0
        },
        {
            "start_logit": -2.658203125,
            "end_logit": -7.14453125,
            "text": "17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis",
            "probability": 0.0
        },
        {
            "start_logit": -2.658203125,
            "end_logit": -8.1875,
            "text": "17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis:",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_5": [
        {
            "start_logit": 9.7421875,
            "end_logit": 10.0625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.646484375,
            "end_logit": 10.0625,
            "text": "17A",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -2.55859375,
            "text": "interleukin",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -6.86328125,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 10.0625,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": 10.0625,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.0625,
            "text": "fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.0625,
            "text": "human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.0625,
            "text": "anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.0625,
            "text": "ab, a fully human anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.1875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.1953125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.2265625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.25,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.25,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind,",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.265625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.3125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.34375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis:",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.3515625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.390625,
            "text": "interleukin-17A monoclonal",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_6": [
        {
            "start_logit": 9.5703125,
            "end_logit": 9.90625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.931640625,
            "end_logit": 9.90625,
            "text": "17A",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -2.876953125,
            "text": "interleukin",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.1640625,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 9.90625,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.90625,
            "text": "targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.90625,
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.90625,
            "text": "To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.90625,
            "text": "different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.90625,
            "text": "human monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.90625,
            "text": "PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.90625,
            "text": "monoclonal antibody for targeted interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.375,
            "text": "interleukin-17A blockade",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3828125,
            "text": "interleukin-17A blockade, in",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -2.876953125,
            "text": "targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.876953125,
            "text": "fully human monoclonal antibody for targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -2.876953125,
            "text": "To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -2.931640625,
            "end_logit": -8.375,
            "text": "17A blockade",
            "probability": 0.0
        },
        {
            "start_logit": -2.931640625,
            "end_logit": -8.3828125,
            "text": "17A blockade, in",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -2.876953125,
            "text": "different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_7": [
        {
            "start_logit": 9.5703125,
            "end_logit": 9.96875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": 9.96875,
            "text": "17A",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -2.89453125,
            "text": "interleukin",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -7.12890625,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 9.96875,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.25,
            "text": "interleukin-17A-",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.296875,
            "text": "interleukin-17A-blocking",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3046875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3203125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.359375,
            "text": "interleukin-17A-blocking antibody secukinumab does",
            "probability": 0.0
        },
        {
            "start_logit": 9.5703125,
            "end_logit": -8.3671875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.15625,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.25,
            "text": "17A-",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.296875,
            "text": "17A-blocking",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.3046875,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.3125,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.3203125,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label,",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.3203125,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-",
            "probability": 0.0
        },
        {
            "start_logit": -2.833984375,
            "end_logit": -8.359375,
            "text": "17A-blocking antibody secukinumab does",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_8": [
        {
            "start_logit": 9.609375,
            "end_logit": 10.0625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -2.603515625,
            "end_logit": 10.0625,
            "text": "17A",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -2.779296875,
            "text": "interleukin",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.1328125,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 10.0625,
            "text": "-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.0625,
            "text": "influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.79296875,
            "text": "interleukin-17A (",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -7.828125,
            "text": "interleukin-17A (IL-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.0625,
            "text": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.0625,
            "text": "-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.0625,
            "text": "objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.0625,
            "text": "meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.0625,
            "text": "healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0625,
            "text": "subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0625,
            "text": "efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.0625,
            "text": "to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.0625,
            "text": "vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.1328125,
            "text": "interleukin-17A (IL-17A)",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.1796875,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) sec",
            "probability": 0.0
        },
        {
            "start_logit": 9.609375,
            "end_logit": -8.1875,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_1": [
        {
            "start_logit": 9.59375,
            "end_logit": 10.1953125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.1953125,
            "text": "disease",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -2.642578125,
            "text": "Alzheimer",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -6.36328125,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 10.1953125,
            "text": "'s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 10.1953125,
            "text": "paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 10.1953125,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 10.1953125,
            "text": "this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 10.1953125,
            "text": "the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.53515625,
            "text": "Alzheimer'",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 10.1953125,
            "text": "novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.1953125,
            "text": "presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.1953125,
            "text": "abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.1953125,
            "text": "in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.1953125,
            "text": "The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1953125,
            "text": "new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1953125,
            "text": "cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.1953125,
            "text": "approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.1953125,
            "text": "of the Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.015625,
            "text": "Alzheimer's disease mouse",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_2": [
        {
            "start_logit": 5.796875,
            "end_logit": 6.78515625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 6.78515625,
            "text": "disease",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 5.796875,
            "end_logit": -4.921875,
            "text": "Alzheimer's disease (AD",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 5.796875,
            "end_logit": -5.86328125,
            "text": "Alzheimer's disease (AD)",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.78515625,
            "text": "of Alzheimer's disease",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 5.796875,
            "end_logit": -6.48046875,
            "text": "Alzheimer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.78515625,
            "text": "'s disease",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -3.4140625,
            "end_logit": -4.921875,
            "text": "AD",
            "probability": 0.0
        },
        {
            "start_logit": -3.4140625,
            "end_logit": -5.86328125,
            "text": "AD)",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -4.640625,
            "text": "34%",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -4.90625,
            "text": "34",
            "probability": 0.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": -4.921875,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": -5.86328125,
            "text": "disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -4.921875,
            "text": "(AD",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -7.33203125,
            "text": "34% in the basal dendrites",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -4.921875,
            "text": "of Alzheimer's disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -7.5390625,
            "text": "34% in the basal dendrites proximal",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -4.640625,
            "text": "spines was reduced by 34%",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -4.921875,
            "text": "'s disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -4.640625,
            "text": "reduced by 34%",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_3": [
        {
            "start_logit": 9.0234375,
            "end_logit": 10.0546875,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": 10.0546875,
            "text": "disease",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -3.572265625,
            "text": "Alzheimer",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 10.0546875,
            "text": "onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 10.0546875,
            "text": "'s disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 10.0546875,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 10.0546875,
            "text": "with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.69140625,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 10.0546875,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0546875,
            "text": "early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.0546875,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.0546875,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.0546875,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.0546875,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.0546875,
            "text": "Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.0546875,
            "text": "-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0546875,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.0546875,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.0546875,
            "text": "in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.66796875,
            "text": "Alzheimer'",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_4": [
        {
            "start_logit": 8.5234375,
            "end_logit": 8.609375,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -7.796875,
            "text": "AD in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 8.609375,
            "text": "for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.0859375,
            "text": "AD in 3 out",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.609375,
            "text": "1 family, this mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.609375,
            "text": "mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.609375,
            "text": "responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.609375,
            "text": ", this mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.609375,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.609375,
            "text": "family, this mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.2890625,
            "text": "AD in 3 out of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.3046875,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far. Two subjects of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.328125,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.3359375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.3359375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.3515625,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far. Two",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -8.3671875,
            "text": "AD in 3 out of 7 siblings and it is also present in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.609375,
            "text": "was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.609375,
            "text": "this mutation was responsible for AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.796875,
            "text": "for AD in",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_5": [
        {
            "start_logit": 8.6640625,
            "end_logit": 8.4296875,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.109375,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.125,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.1484375,
            "text": "AD patient is extracellular amyloid plaques formed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.4296875,
            "text": "an AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.4296875,
            "text": "of an AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.6171875,
            "text": "(APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -6.6171875,
            "text": "LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -6.6171875,
            "text": "APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -7.09765625,
            "text": "of AD.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -6.6171875,
            "text": "the \"London\" mutation (APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -6.6171875,
            "text": "facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -7.7265625,
            "text": "(APP(LON)",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.09765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -7.7265625,
            "text": "LON)",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -7.09765625,
            "text": "early-onset familial form (<60 years old) of AD.",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -7.953125,
            "text": "(APP",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -7.96875,
            "text": "(APP(",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -7.09765625,
            "text": "the early-onset familial form (<60 years old) of AD.",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -7.09765625,
            "text": "AD.",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_6": [
        {
            "start_logit": 8.390625,
            "end_logit": 8.1875,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.1875,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1875,
            "text": "this study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.1875,
            "text": "may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.1875,
            "text": "to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 8.1875,
            "text": "in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.1875,
            "text": "be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.1875,
            "text": "studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.1875,
            "text": "both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.1875,
            "text": "vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.1875,
            "text": "in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.1875,
            "text": "vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -7.96875,
            "text": "study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -8.203125,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -8.2109375,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.96875,
            "text": "this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.203125,
            "text": "this study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.2109375,
            "text": "this study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.96875,
            "text": "may",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -7.95703125,
            "text": "identified in",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_7": [
        {
            "start_logit": 8.5,
            "end_logit": 9.9296875,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.927734375,
            "end_logit": 9.9296875,
            "text": "disease",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 8.5,
            "end_logit": -4.1875,
            "text": "Alzheimer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.9296875,
            "text": "'s disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.9296875,
            "text": "familial Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.9296875,
            "text": "to familial Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.9296875,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5,
            "end_logit": -6.71484375,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.9296875,
            "text": "variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.9296875,
            "text": "related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 9.9296875,
            "text": "Here, we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.9296875,
            "text": "amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.9296875,
            "text": "type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.9296875,
            "text": "APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.9296875,
            "text": ", we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.9296875,
            "text": ") variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.9296875,
            "text": "we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.68359375,
            "text": "Alzheimer's disease using",
            "probability": 0.0
        },
        {
            "start_logit": 8.5,
            "end_logit": -7.7734375,
            "text": "Alzheimer'",
            "probability": 0.0
        },
        {
            "start_logit": 8.5,
            "end_logit": -8.046875,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_8": [
        {
            "start_logit": 8.734375,
            "end_logit": 9.9375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.888671875,
            "end_logit": 9.9375,
            "text": "disease",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -3.927734375,
            "text": "Alzheimer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.9375,
            "text": "'s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.9375,
            "text": "with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -6.421875,
            "text": "Alzheimer's disease (V642I",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -6.6953125,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 9.9375,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 9.9375,
            "text": "associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.9375,
            "text": "mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.15234375,
            "text": "Alzheimer's disease (V64",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.9375,
            "text": "Transgenic mice over-expressing a mutated form of the human amyloid precursor protein (APP, 695 isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.26171875,
            "text": "Alzheimer's disease (V642",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.9375,
            "text": "a mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.9375,
            "text": "isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 9.9375,
            "text": "human amyloid precursor protein (APP, 695 isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.56640625,
            "text": "Alzheimer'",
            "probability": 0.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.98828125,
            "text": "Alzheimer's disease (V642I, so-called London mutation,",
            "probability": 0.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.9921875,
            "text": "Alzheimer's disease (V642I,",
            "probability": 0.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -7.99609375,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_9": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.8515625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 9.8515625,
            "text": "disease",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -3.578125,
            "text": "Alzheimer",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.8515625,
            "text": "'s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98046875,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 9.8515625,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.8515625,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.54296875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.72265625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.73828125,
            "text": "Alzheimer'",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.8515625,
            "text": "of Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.921875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.93359375,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.0390625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.2578125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.28125,
            "text": "Alzheimer's disease genes: the amyloid",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.296875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.359375,
            "text": "Alzheimer's disease genes",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_10": [
        {
            "start_logit": 9.0,
            "end_logit": 8.96875,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 9.0,
            "end_logit": -3.38671875,
            "text": "Alzheimer",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -4.09375,
            "end_logit": 8.96875,
            "text": "disease",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.953125,
            "text": "Alzheimers disease (AD",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.8359375,
            "text": "Alzheimers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.93359375,
            "text": "Alzheimers disease (AD)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.96875,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.875,
            "text": "Alzheimers disease (AD).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.95703125,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -8.0859375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -8.09375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -8.09375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -8.1328125,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.96875,
            "text": "of Alzheimers disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -4.953125,
            "text": "AD",
            "probability": 0.0
        },
        {
            "start_logit": -4.09375,
            "end_logit": -4.953125,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -6.62109375,
            "text": "AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -6.93359375,
            "text": "AD)",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -7.3203125,
            "text": "AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -7.5,
            "text": "AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val71",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_11": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.6640625,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": -3.2890625,
            "end_logit": 9.6640625,
            "text": "disease",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -3.673828125,
            "text": "Alzheimer",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -4.921875,
            "text": "Alzheimers",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.6640625,
            "text": "onset Alzheimers disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.6640625,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.6640625,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.6640625,
            "text": "with early-onset Alzheimers disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.6640625,
            "text": "early-onset Alzheimers disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.6640625,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.6640625,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.6640625,
            "text": "families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 9.6640625,
            "text": "two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.6640625,
            "text": "Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.6640625,
            "text": "-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.6640625,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.6640625,
            "text": "shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 9.6640625,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -3.673828125,
            "text": "onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -3.673828125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_12": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.8515625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 9.8515625,
            "text": "disease",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -3.578125,
            "text": "Alzheimer",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.8515625,
            "text": "'s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98046875,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 9.8515625,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.8515625,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.54296875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.72265625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.73828125,
            "text": "Alzheimer'",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.8515625,
            "text": "of Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.921875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.93359375,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.0390625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.2578125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.28125,
            "text": "Alzheimer's disease genes: the amyloid",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.296875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -8.359375,
            "text": "Alzheimer's disease genes",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_13": [
        {
            "start_logit": 9.0234375,
            "end_logit": 10.0546875,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": 10.0546875,
            "text": "disease",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -3.572265625,
            "text": "Alzheimer",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 10.0546875,
            "text": "onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 10.0546875,
            "text": "'s disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 10.0546875,
            "text": "s disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 10.0546875,
            "text": "with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.69140625,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 10.0546875,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0546875,
            "text": "early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.0546875,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.0546875,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.0546875,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.0546875,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.0546875,
            "text": "Italian families with early-onset Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.0546875,
            "text": "-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0546875,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.0546875,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.0546875,
            "text": "in two Italian families with early-onset Alzheimer's disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.66796875,
            "text": "Alzheimer'",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_1": [
        {
            "start_logit": 5.08984375,
            "end_logit": 0.150146484375,
            "text": "multiple origins.",
            "probability": 0.90478515625
        },
        {
            "start_logit": 5.08984375,
            "end_logit": -2.197265625,
            "text": "multiple",
            "probability": 0.08660888671875
        },
        {
            "start_logit": 5.08984375,
            "end_logit": -4.71875,
            "text": "multiple origins",
            "probability": 0.006961822509765625
        },
        {
            "start_logit": -1.40625,
            "end_logit": 0.150146484375,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0013704299926757812
        },
        {
            "start_logit": -1.40625,
            "end_logit": -2.197265625,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 0.00013053417205810547
        },
        {
            "start_logit": -1.40625,
            "end_logit": -3.361328125,
            "text": "single",
            "probability": 4.106760025024414e-05
        },
        {
            "start_logit": -5.828125,
            "end_logit": 0.150146484375,
            "text": ", whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": -1.40625,
            "end_logit": -4.71875,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 0.150146484375,
            "text": "whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -6.703125,
            "end_logit": 0.150146484375,
            "text": ".",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 0.150146484375,
            "text": "Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 0.150146484375,
            "text": "from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 0.150146484375,
            "text": "most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 0.150146484375,
            "text": "using multiple origins.",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 0.150146484375,
            "text": "archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -1.40625,
            "end_logit": -6.0234375,
            "text": "single origins",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 0.150146484375,
            "text": "replicate using multiple origins.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 0.150146484375,
            "text": "replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 0.150146484375,
            "text": "eukaryotes replicate using multiple origins.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -8.0,
            "end_logit": 0.150146484375,
            "text": "archaea and all eukaryotes replicate using multiple origins.",
            "probability": 1.9073486328125e-06
        }
    ],
    "52fe58f82059c6d71c00007a_2": [
        {
            "start_logit": 9.2578125,
            "end_logit": -0.0076904296875,
            "text": "multiple",
            "probability": 0.97509765625
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -4.30859375,
            "text": "multiple DNA replication origins",
            "probability": 0.01322174072265625
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.3828125,
            "text": "multiple DNA replication origins are",
            "probability": 0.0045166015625
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.078125,
            "text": "multiple DNA replication",
            "probability": 0.0022525787353515625
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.78515625,
            "text": "multiple DNA replication origins are a",
            "probability": 0.0011110305786132812
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.86328125,
            "text": "multiple DNA",
            "probability": 0.0010280609130859375
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2890625,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 0.00067138671875
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.5390625,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes",
            "probability": 0.000522613525390625
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.546875,
            "text": "multiple DNA replication origins are a hallmark",
            "probability": 0.0005183219909667969
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.6796875,
            "text": "multiple DNA replication origins are a hallmark of",
            "probability": 0.00045418739318847656
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.80859375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some Archaea",
            "probability": 0.0003991127014160156
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -8.0234375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 0.00032210350036621094
        },
        {
            "start_logit": -8.390625,
            "end_logit": -4.30859375,
            "text": "DNA replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -5.3828125,
            "text": "DNA replication origins are",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -6.078125,
            "text": "DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -6.78515625,
            "text": "DNA replication origins are a",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -6.86328125,
            "text": "DNA",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -7.2890625,
            "text": "Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -7.2890625,
            "text": "DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -7.5390625,
            "text": "Eukaryotes",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_3": [
        {
            "start_logit": 9.65625,
            "end_logit": 2.46875,
            "text": "Multiple orc/cdc6-associated replication origins",
            "probability": 0.63330078125
        },
        {
            "start_logit": 9.65625,
            "end_logit": 1.8876953125,
            "text": "Multiple orc/cdc6-associated replication origins were",
            "probability": 0.355224609375
        },
        {
            "start_logit": 9.65625,
            "end_logit": -1.6611328125,
            "text": "Multiple",
            "probability": 0.01019287109375
        },
        {
            "start_logit": 9.65625,
            "end_logit": -5.61328125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted",
            "probability": 0.0001964569091796875
        },
        {
            "start_logit": 9.65625,
            "end_logit": -5.90234375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal genome",
            "probability": 0.00014603137969970703
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.08984375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all",
            "probability": 0.00012099742889404297
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.1171875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in",
            "probability": 0.00011819601058959961
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.171875,
            "text": "Multiple orc/cdc6",
            "probability": 0.0001119375228881836
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.7109375,
            "text": "Multiple orc/cdc6-",
            "probability": 6.532669067382812e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.9140625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaea",
            "probability": 5.328655242919922e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.96484375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed halo",
            "probability": 5.048513412475586e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -6.984375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarch",
            "probability": 4.965066909790039e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal",
            "probability": 4.667043685913086e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.08984375,
            "text": "Multiple orc/cdc",
            "probability": 4.45246696472168e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.3828125,
            "text": "Multiple orc/cdc6-associated",
            "probability": 3.337860107421875e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.38671875,
            "text": "Multiple orc/",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.41796875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.42578125,
            "text": "Multiple orc",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 2.46875,
            "text": "origins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 1.8876953125,
            "text": "were",
            "probability": 5.960464477539063e-08
        }
    ],
    "52fe58f82059c6d71c00007a_4": [
        {
            "start_logit": 5.203125,
            "end_logit": -2.896484375,
            "text": "multiple replication origins",
            "probability": 0.70703125
        },
        {
            "start_logit": 5.203125,
            "end_logit": -4.09765625,
            "text": "multiple",
            "probability": 0.212646484375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.19921875,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.0260009765625
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.5859375,
            "text": "multiple replication origins serve",
            "probability": 0.017669677734375
        },
        {
            "start_logit": -3.5390625,
            "end_logit": 1.6953125,
            "text": "Sulfolobus chromosome implies",
            "probability": 0.01116943359375
        },
        {
            "start_logit": 5.203125,
            "end_logit": -7.3125,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for",
            "probability": 0.0085601806640625
        },
        {
            "start_logit": 5.203125,
            "end_logit": -7.31640625,
            "text": "multiple replication",
            "probability": 0.00849151611328125
        },
        {
            "start_logit": 5.203125,
            "end_logit": -7.546875,
            "text": "multiple replication origins serve purposes other than simply shortening the time required",
            "probability": 0.006771087646484375
        },
        {
            "start_logit": -7.09375,
            "end_logit": 1.6953125,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies",
            "probability": 0.0003192424774169922
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 1.6953125,
            "text": "the Sulfolobus chromosome implies",
            "probability": 0.00031185150146484375
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 1.6953125,
            "text": "chromosome implies",
            "probability": 0.0002796649932861328
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 1.6953125,
            "text": "strong replication-biased structuring of the Sulfolobus chromosome implies",
            "probability": 0.0002505779266357422
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 1.6953125,
            "text": "implies",
            "probability": 0.00022101402282714844
        },
        {
            "start_logit": -8.09375,
            "end_logit": 1.6953125,
            "text": "replication-biased structuring of the Sulfolobus chromosome implies",
            "probability": 0.00011742115020751953
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -2.896484375,
            "text": "Sulfolobus chromosome implies that the multiple replication origins",
            "probability": 0.00011295080184936523
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -4.09765625,
            "text": "Sulfolobus chromosome implies that the multiple",
            "probability": 3.3915042877197266e-05
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -6.19921875,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -6.34765625,
            "text": "Sulfolobus",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.09375,
            "end_logit": -2.896484375,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple replication origins",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -2.896484375,
            "text": "the Sulfolobus chromosome implies that the multiple replication origins",
            "probability": 3.159046173095703e-06
        }
    ],
    "52fe58f82059c6d71c00007a_5": [
        {
            "start_logit": 4.63671875,
            "end_logit": 0.5361328125,
            "text": "multiple replication origin",
            "probability": 0.966796875
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -3.154296875,
            "text": "multiple replication origin paradigm",
            "probability": 0.0241546630859375
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -5.75,
            "text": "multiple replication origin paradigm has also been demonstrated",
            "probability": 0.0018014907836914062
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -5.8515625,
            "text": "multiple replication origin paradigm has also been demonstrated within",
            "probability": 0.001628875732421875
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -5.97265625,
            "text": "multiple",
            "probability": 0.00144195556640625
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -6.58984375,
            "text": "multiple replication origin paradigm has",
            "probability": 0.0007781982421875
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -6.76171875,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.0006551742553710938
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -6.9609375,
            "text": "multiple replication",
            "probability": 0.0005369186401367188
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.4375,
            "text": "multiple replication origin paradigm has also been",
            "probability": 0.0003333091735839844
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.5390625,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain",
            "probability": 0.0002999305725097656
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.58203125,
            "text": "multiple replication origin paradigm has also been demonstrated within the",
            "probability": 0.0002884864807128906
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.6328125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of",
            "probability": 0.0002732276916503906
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.703125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal",
            "probability": 0.00025653839111328125
        },
        {
            "start_logit": 4.63671875,
            "end_logit": -7.7421875,
            "text": "multiple replication origin paradigm has also",
            "probability": 0.0002448558807373047
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 0.5361328125,
            "text": "the multiple replication origin",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": -7.8125,
            "end_logit": 0.5361328125,
            "text": "origin",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -5.7265625,
            "end_logit": -3.154296875,
            "text": "the multiple replication origin paradigm",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -3.154296875,
            "text": "paradigm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": -3.154296875,
            "text": "origin paradigm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.7265625,
            "end_logit": -5.75,
            "text": "the multiple replication origin paradigm has also been demonstrated",
            "probability": 5.960464477539063e-08
        }
    ],
    "52fe58f82059c6d71c00007a_6": [
        {
            "start_logit": 7.6953125,
            "end_logit": -1.154296875,
            "text": "multiple",
            "probability": 0.94189453125
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -4.5859375,
            "text": "multiple chromosome replication",
            "probability": 0.0305328369140625
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -6.02734375,
            "text": "multiple chromosome replication origins",
            "probability": 0.007221221923828125
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -6.41796875,
            "text": "multiple chromosome",
            "probability": 0.004886627197265625
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.59375,
            "text": "multiple chromosome replication origins in",
            "probability": 0.0015077590942382812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.65625,
            "text": "multiple chromosome replication origins in Sulfolobus",
            "probability": 0.0014162063598632812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.69921875,
            "text": "multiple chromosome replication origins in Sulfolobus species has",
            "probability": 0.0013561248779296875
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.734375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic",
            "probability": 0.0013093948364257812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.8203125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added",
            "probability": 0.001201629638671875
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.859375,
            "text": "multiple chromosome replication origins in Sulfolobu",
            "probability": 0.001155853271484375
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.86328125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait",
            "probability": 0.00115203857421875
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.8671875,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another",
            "probability": 0.0011472702026367188
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.984375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet",
            "probability": 0.0010194778442382812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -8.0,
            "text": "multiple chromosome replication origins in Sulfolobus species",
            "probability": 0.0010042190551757812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -8.015625,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait to",
            "probability": 0.0009889602661132812
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -8.0390625,
            "text": "multiple chromosome replication origins in Sulfolo",
            "probability": 0.0009655952453613281
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -8.0546875,
            "text": "multiple chromosome replication origins in Sulfo",
            "probability": 0.0009503364562988281
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -4.5859375,
            "text": "chromosome replication",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -6.02734375,
            "text": "chromosome replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -6.41796875,
            "text": "chromosome",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_7": [
        {
            "start_logit": 9.2265625,
            "end_logit": 5.3359375,
            "text": "multiple replication origins",
            "probability": 0.82177734375
        },
        {
            "start_logit": 9.2265625,
            "end_logit": 3.80078125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.177734375
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -2.01953125,
            "text": "multiple",
            "probability": 0.0005249977111816406
        },
        {
            "start_logit": 1.6533203125,
            "end_logit": 3.80078125,
            "text": "Sulfolobus solfataricus",
            "probability": 9.08970832824707e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.57421875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve method",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.89453125,
            "text": "multiple replication",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.9453125,
            "text": "multiple replication origins of",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.171875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.296875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.4453125,
            "text": "multiple replication origins of the archaeon Sulfolobus sol",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.65234375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfa",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.65625,
            "text": "multiple replication origins of the archaeon Sulfolobus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.76953125,
            "text": "multiple replication origins of the",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.7734375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.8359375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.859375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.921875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataric",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.94921875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfata",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.94921875,
            "text": "multiple replication origins of the archae",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 5.3359375,
            "text": "origins",
            "probability": 2.384185791015625e-07
        }
    ],
    "52fe58f82059c6d71c00007a_8": [
        {
            "start_logit": 8.78125,
            "end_logit": 1.146484375,
            "text": "multiple replication origins",
            "probability": 0.88671875
        },
        {
            "start_logit": 8.78125,
            "end_logit": -0.94287109375,
            "text": "multiple",
            "probability": 0.10968017578125
        },
        {
            "start_logit": 8.78125,
            "end_logit": -5.53125,
            "text": "multiple replication origins have",
            "probability": 0.0011138916015625
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.04296875,
            "text": "multiple replication origins have been observed",
            "probability": 0.000667572021484375
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.0546875,
            "text": "multiple replication origins have been observed in",
            "probability": 0.00024271011352539062
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.09375,
            "text": "multiple replication origins have been",
            "probability": 0.0002334117889404297
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.109375,
            "text": "multiple replication",
            "probability": 0.00022971630096435547
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.41015625,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.00016939640045166016
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.45703125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known",
            "probability": 0.00016164779663085938
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.53125,
            "text": "multiple replication origins have been observed in archaea,",
            "probability": 0.0001506805419921875
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.80078125,
            "text": "multiple replication origins have been observed in archaea",
            "probability": 0.00011467933654785156
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.83203125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about",
            "probability": 0.00011116266250610352
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.94140625,
            "text": "multiple replication origins have been observed in archaea, considerably",
            "probability": 9.959936141967773e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -8.03125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their",
            "probability": 9.143352508544922e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -8.0625,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes",
            "probability": 8.863210678100586e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -8.078125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary",
            "probability": 8.726119995117188e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 1.146484375,
            "text": "While multiple replication origins",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 1.146484375,
            "text": "origins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.97265625,
            "end_logit": -0.94287109375,
            "text": "While multiple",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 1.146484375,
            "text": "replication origins",
            "probability": 5.960464477539063e-08
        }
    ],
    "52fe58f82059c6d71c00007a_9": [
        {
            "start_logit": 8.5859375,
            "end_logit": 2.560546875,
            "text": "multiple orc/cdc6-associated replication origins",
            "probability": 0.97265625
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -1.48828125,
            "text": "multiple",
            "probability": 0.016937255859375
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -2.0390625,
            "text": "multiple orc/cdc6-associated replication origins in",
            "probability": 0.00975799560546875
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.6875,
            "text": "multiple orc/cdc6-",
            "probability": 9.34600830078125e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.69140625,
            "text": "multiple orc/cdc6",
            "probability": 9.34600830078125e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.79296875,
            "text": "multiple orc/cdc6-associated replication origins in halo",
            "probability": 8.374452590942383e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.96484375,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaea",
            "probability": 7.051229476928711e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.9765625,
            "text": "multiple orc/cdc6-associated replication origins in haloarch",
            "probability": 7.003545761108398e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.078125,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 6.324052810668945e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.15234375,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal",
            "probability": 5.84721565246582e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.43359375,
            "text": "multiple orc/cdc",
            "probability": 4.416704177856445e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.55078125,
            "text": "multiple orc/",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.58984375,
            "text": "multiple orc",
            "probability": 3.7789344787597656e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.7109375,
            "text": "multiple orc/cdc6-associated",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.984375,
            "text": "multiple or",
            "probability": 2.5570392608642578e-05
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -8.015625,
            "text": "multiple orc/cdc6-associated replication",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 2.560546875,
            "text": "origins",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 2.560546875,
            "text": "replication origins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 2.560546875,
            "text": "orc/cdc6-associated replication origins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 2.560546875,
            "text": "associated replication origins",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe31317a43ad31278000044_1": [
        {
            "start_logit": 5.3203125,
            "end_logit": 4.2109375,
            "text": "pro-inflammatory cytokines",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.4765625,
            "end_logit": 4.2109375,
            "text": "cytokines",
            "probability": 0.0004105567932128906
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -3.638671875,
            "text": "pro-inflammatory cytokines (IL-1\u03b2",
            "probability": 0.0003886222839355469
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -4.69921875,
            "text": "pro",
            "probability": 0.0001354217529296875
        },
        {
            "start_logit": -3.794921875,
            "end_logit": 4.2109375,
            "text": "adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 0.00010967254638671875
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -6.26171875,
            "text": "pro-inflammatory",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -7.734375,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6 and IL-8",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -7.91796875,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6 and IL-8).",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.0390625,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.046875,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6 and IL",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.0546875,
            "text": "pro-",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.078125,
            "text": "pro-inflammatory cytokines (",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.078125,
            "text": "pro-inflammatory cytokines (IL-",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 5.3203125,
            "end_logit": -8.140625,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 4.2109375,
            "text": "of pro-inflammatory cytokines",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 4.2109375,
            "text": "inflammatory cytokines",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 4.2109375,
            "text": "We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 4.2109375,
            "text": "human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 4.2109375,
            "text": "obesity and expression of pro-inflammatory cytokines",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -8.21875,
            "end_logit": 4.2109375,
            "text": "relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.3113021850585938e-06
        }
    ],
    "5fe31317a43ad31278000044_2": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.7734375,
            "text": "IL-1\u03b2",
            "probability": 0.9970703125
        },
        {
            "start_logit": 3.466796875,
            "end_logit": 9.7734375,
            "text": "adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.002529144287109375
        },
        {
            "start_logit": -3.134765625,
            "end_logit": 9.7734375,
            "text": "1\u03b2",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -2.931640625,
            "text": "IL",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 3.466796875,
            "end_logit": 0.8486328125,
            "text": "adipose tissue",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.8203125,
            "end_logit": 9.7734375,
            "text": "Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 9.7734375,
            "text": "the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.7734375,
            "text": "data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.7734375,
            "text": "local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.7734375,
            "text": "tissue inflammation, specifically for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.296875,
            "text": "IL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 9.7734375,
            "text": "inflammation, specifically for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 9.7734375,
            "text": "for IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.7734375,
            "text": "-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": 9.7734375,
            "text": ", the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.7734375,
            "text": "both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.7734375,
            "text": "MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.89453125,
            "text": "IL-1\u03b2 and",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.7734375,
            "text": "show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.7734375,
            "text": "human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_3": [
        {
            "start_logit": 2.8046875,
            "end_logit": 5.76953125,
            "text": "TNF\u03b1",
            "probability": 0.92236328125
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": 5.76953125,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.076904296875
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 5.76953125,
            "text": "of TNF\u03b1",
            "probability": 8.863210678100586e-05
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.76953125,
            "text": "production of TNF\u03b1",
            "probability": 6.848573684692383e-05
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 5.76953125,
            "text": "kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 4.601478576660156e-05
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 5.76953125,
            "text": "the production of TNF\u03b1",
            "probability": 1.9788742065429688e-05
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 5.76953125,
            "text": "drives the production of TNF\u03b1",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": -8.359375,
            "end_logit": 5.76953125,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -8.390625,
            "end_logit": 5.76953125,
            "text": "Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.2576580047607422e-05
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 5.76953125,
            "text": "is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": 2.8046875,
            "end_logit": -6.390625,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 2.8046875,
            "end_logit": -6.484375,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -4.4296875,
            "text": "tumor progression locus 2",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 2.8046875,
            "end_logit": -7.546875,
            "text": "TNF\u03b1, IL",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 2.8046875,
            "end_logit": -7.75,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -5.78515625,
            "text": "tumor progression",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -6.04296875,
            "text": "tumor progression locus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -6.69921875,
            "text": "tumor progression locus 2 (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -7.24609375,
            "text": "tumor progression locus 2 (Tp",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.32275390625,
            "end_logit": -7.40234375,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe31317a43ad31278000044_4": [
        {
            "start_logit": 2.505859375,
            "end_logit": 6.02734375,
            "text": "TNF\u03b1",
            "probability": 0.9404296875
        },
        {
            "start_logit": -0.261962890625,
            "end_logit": 6.02734375,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.059173583984375
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 6.02734375,
            "text": "of TNF\u03b1",
            "probability": 0.00016367435455322266
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 6.02734375,
            "text": "production of TNF\u03b1",
            "probability": 0.00012946128845214844
        },
        {
            "start_logit": -7.140625,
            "end_logit": 6.02734375,
            "text": "kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 6.115436553955078e-05
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.02734375,
            "text": "the production of TNF\u03b1",
            "probability": 3.0279159545898438e-05
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.02734375,
            "text": "drives the production of TNF\u03b1",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -8.265625,
            "end_logit": 6.02734375,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -8.34375,
            "end_logit": 6.02734375,
            "text": "Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -8.40625,
            "end_logit": 6.02734375,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": -8.4375,
            "end_logit": 6.02734375,
            "text": "is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 2.505859375,
            "end_logit": -5.74609375,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 2.505859375,
            "end_logit": -6.50390625,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 2.505859375,
            "end_logit": -6.671875,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 2.505859375,
            "end_logit": -7.55078125,
            "text": "TNF\u03b1, IL",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -0.261962890625,
            "end_logit": -4.9296875,
            "text": "tumor progression locus 2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 2.505859375,
            "end_logit": -7.79296875,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -0.261962890625,
            "end_logit": -5.98046875,
            "text": "tumor progression",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.261962890625,
            "end_logit": -6.1953125,
            "text": "tumor progression locus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.261962890625,
            "end_logit": -6.7890625,
            "text": "tumor progression locus 2 (",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe31317a43ad31278000044_5": [
        {
            "start_logit": 8.7109375,
            "end_logit": 9.28125,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": 9.28125,
            "text": "1\u03b2",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -4.1015625,
            "text": "IL",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.890625,
            "end_logit": 9.28125,
            "text": "-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.328125,
            "text": "IL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.69140625,
            "text": "IL-1\u03b2 reporter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.28125,
            "text": "induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.28125,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.75390625,
            "text": "IL-1\u03b2 reporter activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.28125,
            "text": "(tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.28125,
            "text": "AR agonist-induced IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": -7.69140625,
            "text": "1\u03b2 reporter",
            "probability": 0.0
        },
        {
            "start_logit": -3.87109375,
            "end_logit": -7.75390625,
            "text": "1\u03b2 reporter activity",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -4.1015625,
            "text": "induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -4.1015625,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -4.1015625,
            "text": "(tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -4.1015625,
            "text": "AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.328125,
            "text": "-",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.69140625,
            "text": "-1\u03b2 reporter",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.328125,
            "text": "induced IL-",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_6": [
        {
            "start_logit": 6.2421875,
            "end_logit": 7.4765625,
            "text": "TNF -\u03b1",
            "probability": 1.0
        },
        {
            "start_logit": -3.828125,
            "end_logit": 7.4765625,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 4.2319297790527344e-05
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 7.4765625,
            "text": "\u03b1",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -4.1953125,
            "text": "TNF",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -4.62109375,
            "text": "TNF -\u03b1, in human adipose tissue",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.4765625,
            "text": "Additionally, high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.4765625,
            "text": "high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 7.4765625,
            "text": "not TNF -\u03b1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.4765625,
            "text": ", but not TNF -\u03b1",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.4765625,
            "text": "8, but not TNF -\u03b1",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.4765625,
            "text": "but not TNF -\u03b1",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 7.4765625,
            "text": "of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 7.4765625,
            "text": "1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -6.9140625,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.4765625,
            "text": ", high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -7.42578125,
            "text": "TNF -\u03b1, in human adipose tissue were",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -7.6328125,
            "text": "TNF -\u03b1, in human adipose",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -7.92578125,
            "text": "TNF -",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -7.94140625,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher expression",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.2421875,
            "end_logit": -7.99609375,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher expression of MAP3K8.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe31317a43ad31278000044_7": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.7734375,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -3.06640625,
            "end_logit": 9.7734375,
            "text": "1\u03b2",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -2.888671875,
            "text": "IL",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -4.21484375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 9.7734375,
            "text": "-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.7734375,
            "text": "yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.7734375,
            "text": "of IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.734375,
            "end_logit": 9.7734375,
            "text": ", yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.7734375,
            "text": "lower mRNA expression levels of IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.56640625,
            "text": "IL-1\u03b2, IL-6 and CXCL1",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.63671875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.7734375,
            "text": "displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.76953125,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.7734375,
            "text": "mRNA expression levels of IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.83984375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.8671875,
            "text": "IL-",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.875,
            "text": "IL-1\u03b2,",
            "probability": 0.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.93359375,
            "text": "IL-1\u03b2, IL-6 and CXCL",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 9.7734375,
            "text": "Mice lacking MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.7734375,
            "text": "MAP3K8 had similar bodyweight gain as WT mice, yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_1": [
        {
            "start_logit": 5.85546875,
            "end_logit": 4.32421875,
            "text": "SARS-CoV",
            "probability": 0.9990234375
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -3.1171875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antiviral",
            "probability": 0.0005860328674316406
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -3.21484375,
            "text": "SARS-CoV-2",
            "probability": 0.0005311965942382812
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -6.15625,
            "text": "SARS",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -6.171875,
            "text": "SARS-",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -6.9609375,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -7.02734375,
            "text": "SARS-CoV-",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -7.07421875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -7.890625,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -8.0390625,
            "text": "SARS-CoV-2.",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 5.85546875,
            "end_logit": -8.2421875,
            "text": "SARS-CoV-2. There are reports about the uses of",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 4.32421875,
            "text": "CoV",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 4.32421875,
            "text": "against SARS-CoV",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 4.32421875,
            "text": ". In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 4.32421875,
            "text": "era, there has been a race for drugs to be effective against SARS-CoV",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.890625,
            "end_logit": 4.32421875,
            "text": "effective against SARS-CoV",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 4.32421875,
            "text": "the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 4.32421875,
            "text": "In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 4.32421875,
            "text": "COVID-19 era, there has been a race for drugs to be effective against SARS-CoV",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 4.32421875,
            "text": "race for drugs to be effective against SARS-CoV",
            "probability": 7.748603820800781e-07
        }
    ],
    "621ebb733a8413c65300005c_2": [
        {
            "start_logit": 9.578125,
            "end_logit": 10.1640625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.36328125,
            "end_logit": 10.1640625,
            "text": "19",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.708984375,
            "text": "COV",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.58984375,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 10.1640625,
            "text": "treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.80859375,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 10.1640625,
            "text": "ID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 10.1640625,
            "text": "repurposed drugs advocated to treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 10.1640625,
            "text": "to treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 10.1640625,
            "text": "key repurposed drugs advocated to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 10.1640625,
            "text": "-19",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.69921875,
            "text": "COVID-19 (",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.046875,
            "text": "COVID-19 (lopin",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0625,
            "text": "COVID-19 (lopinavir, ritonavir",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0859375,
            "text": "COVID-19 (lopinavir",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.125,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1328125,
            "text": "COVID-19 (lopinavir,",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1484375,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1640625,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and fav",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.234375,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir),",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_3": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.96875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.71875,
            "end_logit": 9.96875,
            "text": "19",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -2.92578125,
            "text": "COV",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.0,
            "end_logit": 9.96875,
            "text": "treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -6.546875,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -6.84765625,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -6.86328125,
            "text": "COVID-19 patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.96875,
            "text": "To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 9.96875,
            "text": "to treat COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 9.96875,
            "text": "ID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.96875,
            "text": "idol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.96875,
            "text": "-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.96875,
            "text": ") to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.96875,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.96875,
            "text": "Arbidol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.96875,
            "text": "favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.96875,
            "text": "iravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.96875,
            "text": "vir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -2.71875,
            "end_logit": -6.86328125,
            "text": "19 patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -2.92578125,
            "text": "treat COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_4": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.8125,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.015625,
            "end_logit": 9.8125,
            "text": "19",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -3.19921875,
            "text": "COV",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.63671875,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.83203125,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.8125,
            "text": "ID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.8125,
            "text": "possible COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.5234375,
            "text": "COVID-19 treatments",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.8125,
            "text": "considered possible COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.8125,
            "text": "-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.8125,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.8125,
            "text": "are considered possible COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -3.015625,
            "end_logit": -7.5234375,
            "text": "19 treatments",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -3.19921875,
            "text": "possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -3.19921875,
            "text": "considered possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -3.19921875,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -3.19921875,
            "text": "are considered possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -6.63671875,
            "text": "ID-",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.63671875,
            "text": "possible COVID-",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -6.83203125,
            "text": "ID",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_5": [
        {
            "start_logit": 8.265625,
            "end_logit": 9.40625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.6640625,
            "end_logit": 9.40625,
            "text": "19",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 8.265625,
            "end_logit": -4.51953125,
            "text": "COV",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 9.40625,
            "text": "treatment of COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.40625,
            "text": "Favipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.40625,
            "text": "ID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.40625,
            "text": "of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.671875,
            "text": "COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.8828125,
            "text": "COVID-19 in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.40625,
            "text": "been used for treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.05078125,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.40625,
            "text": "-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.40625,
            "text": "for treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.40625,
            "text": "has been used for treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.40625,
            "text": "used for treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.890625,
            "text": "COVID-19 in many countries.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.921875,
            "text": "COVID-19 in many",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -8.0,
            "text": "COVID-19 in many countries",
            "probability": 0.0
        },
        {
            "start_logit": -3.6640625,
            "end_logit": -6.8828125,
            "text": "19 in",
            "probability": 0.0
        },
        {
            "start_logit": -6.2421875,
            "end_logit": -4.51953125,
            "text": "treatment of COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_6": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.3671875,
            "text": "COVID-19 infection",
            "probability": 1.0
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": 10.3671875,
            "text": "infection",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -1.9111328125,
            "text": "COV",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -5.56640625,
            "text": "COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 10.3671875,
            "text": "severe COVID-19 infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.3671875,
            "text": "ID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.43359375,
            "text": "COVID-",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 10.3671875,
            "text": "19 infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 10.3671875,
            "text": "-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 10.3671875,
            "text": "To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 10.3671875,
            "text": "treating patients with severe COVID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.609375,
            "text": "COVID-19 infection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 10.3671875,
            "text": "with severe COVID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.73046875,
            "text": "COVID",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.3671875,
            "text": "patients with severe COVID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.3671875,
            "text": "vir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.7890625,
            "end_logit": -1.9111328125,
            "text": "severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -1.9912109375,
            "end_logit": -7.609375,
            "text": "infection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -1.9111328125,
            "text": "To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -1.9111328125,
            "text": "treating patients with severe COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_7": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.65625,
            "text": "COVID-19 infections",
            "probability": 1.0
        },
        {
            "start_logit": -3.15234375,
            "end_logit": 9.65625,
            "text": "severe COVID-19 infections",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -3.1953125,
            "end_logit": 9.65625,
            "text": "infections",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -3.015625,
            "text": "COV",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -4.1796875,
            "text": "COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.65625,
            "text": "ID-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.203125,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.65625,
            "text": "with severe COVID-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.33984375,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 9.65625,
            "text": "patients with severe COVID-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 9.65625,
            "text": "in patients with severe COVID-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.015625,
            "end_logit": 9.65625,
            "text": "-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.65625,
            "text": "Favipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 9.65625,
            "text": "19 infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.65625,
            "text": "ipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0
        },
        {
            "start_logit": -3.15234375,
            "end_logit": -3.015625,
            "text": "severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -3.15234375,
            "end_logit": -4.1796875,
            "text": "severe COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -3.15234375,
            "end_logit": -7.203125,
            "text": "severe COVID-",
            "probability": 0.0
        },
        {
            "start_logit": -3.15234375,
            "end_logit": -7.33984375,
            "text": "severe COVID",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -3.015625,
            "text": "with severe COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_8": [
        {
            "start_logit": 8.5859375,
            "end_logit": 9.40625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.662109375,
            "end_logit": 9.40625,
            "text": "19",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -4.23046875,
            "text": "COV",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.390625,
            "end_logit": 9.40625,
            "text": "treatment of COVID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.40625,
            "text": "of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -6.6171875,
            "text": "COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.40625,
            "text": "ID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 9.40625,
            "text": "the treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.17578125,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 9.40625,
            "text": "in the treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5859375,
            "end_logit": -7.32421875,
            "text": "COVID-19.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 9.40625,
            "text": "Molnupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.40625,
            "text": "-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.390625,
            "end_logit": -4.23046875,
            "text": "treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -3.662109375,
            "end_logit": -7.32421875,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -4.23046875,
            "text": "of COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -4.23046875,
            "text": "the treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -4.23046875,
            "text": "in the treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -4.23046875,
            "text": "Molnupiravir/Favipiravir in the treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.390625,
            "end_logit": -6.6171875,
            "text": "treatment of COVID-",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_9": [
        {
            "start_logit": 9.578125,
            "end_logit": 8.65625,
            "text": "influenza infections",
            "probability": 1.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -1.748046875,
            "text": "influenza",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.087890625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -3.802734375,
            "end_logit": 8.65625,
            "text": "infections",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.16796875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.25,
            "text": "influenza infections, has been suggested to be effective against SARS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.2890625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.515625,
            "text": "influenza infections, has been suggested to be effective against SARS-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.78125,
            "text": "influenza infections, has been suggested",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.8125,
            "text": "influenza infections, has been suggested to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.875,
            "text": "influenza infections,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.96484375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.984375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0078125,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.015625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0234375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.03125,
            "text": "influenza infections, has been suggested to be effective against",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.09375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.65625,
            "text": "emerging influenza infections",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_10": [
        {
            "start_logit": 8.390625,
            "end_logit": 9.0234375,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -4.140625,
            "end_logit": 9.0234375,
            "text": "19",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -4.41015625,
            "text": "COV",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 8.390625,
            "end_logit": -6.30859375,
            "text": "COVID-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -6.796875,
            "text": "COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.0234375,
            "text": "Comparing ICU admission rates of mild/moderate COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.0234375,
            "text": "moderate COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 9.0234375,
            "text": "ID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.25,
            "text": "COVID-19 patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.0234375,
            "text": "mild/moderate COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.125,
            "end_logit": 9.0234375,
            "text": "ICU admission rates of mild/moderate COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.77734375,
            "text": "COVID-19 patients treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.0234375,
            "text": "-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -7.984375,
            "text": "COVID-19 patients treated with hydroxychloroquine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.1171875,
            "text": "COVID-19 patients treated with hydroxychlor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.1640625,
            "text": "COVID-19 patients treated with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.2109375,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychlor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.2421875,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.2734375,
            "text": "COVID-19 patients treated with hydroxychloroquine,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.390625,
            "end_logit": -8.296875,
            "text": "COVID-19 patients treated with hydroxych",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_11": [
        {
            "start_logit": 8.8671875,
            "end_logit": 0.51806640625,
            "text": "influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 0.9658203125
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -2.98046875,
            "text": "influenza",
            "probability": 0.029296875
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -5.921875,
            "text": "influenza A/California/04/2009 (H1N1) virus",
            "probability": 0.0015459060668945312
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.57421875,
            "text": "influenza A",
            "probability": 0.0008053779602050781
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.8359375,
            "text": "influenza A/California/04/2009 (H1N1",
            "probability": 0.0006198883056640625
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.53125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in",
            "probability": 0.00030922889709472656
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.71484375,
            "text": "influenza A/California/04/2009",
            "probability": 0.0002562999725341797
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.796875,
            "text": "influenza A/California",
            "probability": 0.00023698806762695312
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.828125,
            "text": "influenza A/",
            "probability": 0.00022971630096435547
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.9921875,
            "text": "influenza A/California/04",
            "probability": 0.00019502639770507812
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.046875,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice",
            "probability": 0.00018465518951416016
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.1171875,
            "text": "influenza A/California/",
            "probability": 0.00017213821411132812
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.21875,
            "text": "influenza A/California/04/",
            "probability": 0.00015544891357421875
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.2578125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice.",
            "probability": 0.0001494884490966797
        },
        {
            "start_logit": -6.328125,
            "end_logit": 0.51806640625,
            "text": "pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 0.51806640625,
            "text": "treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 0.51806640625,
            "text": "infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 0.51806640625,
            "text": ") virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 0.51806640625,
            "text": "(H1N1) virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.109375,
            "end_logit": 0.51806640625,
            "text": "of pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_12": [
        {
            "start_logit": 9.4765625,
            "end_logit": 9.796875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.07421875,
            "end_logit": 9.796875,
            "text": "19",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -2.953125,
            "text": "COV",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.796875,
            "text": "with COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -6.80859375,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.03515625,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.796875,
            "text": "ID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.38671875,
            "text": "COVID-19.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 9.796875,
            "text": "treating patients with COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.796875,
            "text": "patients with COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.796875,
            "text": "-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.796875,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 9.796875,
            "text": "Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -2.953125,
            "text": "with COV",
            "probability": 0.0
        },
        {
            "start_logit": -3.07421875,
            "end_logit": -7.38671875,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -2.953125,
            "text": "treating patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -2.953125,
            "text": "patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -2.953125,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": -2.953125,
            "text": "Favipiravir possesses high utility for treating patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -6.80859375,
            "text": "with COVID-",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_13": [
        {
            "start_logit": 9.40625,
            "end_logit": 4.36328125,
            "text": "influenza viruses",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.40625,
            "end_logit": -2.0625,
            "text": "influenza",
            "probability": 0.0016231536865234375
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.86328125,
            "text": "influenza viruses,",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.95703125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.078125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1328125,
            "text": "influenza viruses, including A(H1N1",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1484375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9)",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.15625,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1953125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1)",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.203125,
            "text": "influenza viruses, including",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.203125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.234375,
            "text": "influenza viruses, including A(H1N1)pdm09",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 4.36328125,
            "text": "viruses",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 4.36328125,
            "text": "of influenza viruses",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 4.36328125,
            "text": "Favipiravir is active against a broad range of influenza viruses",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 4.36328125,
            "text": "broad range of influenza viruses",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 4.36328125,
            "text": "ipiravir is active against a broad range of influenza viruses",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 4.36328125,
            "text": "against a broad range of influenza viruses",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_14": [
        {
            "start_logit": 9.8984375,
            "end_logit": 9.9765625,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.017578125,
            "text": "influenza",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -2.744140625,
            "end_logit": 9.9765625,
            "text": "infections",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -6.0,
            "text": "influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 9.9765625,
            "text": "treatment of influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.9765625,
            "text": "virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.47265625,
            "text": "influenza virus infections and",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.9765625,
            "text": "of influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 9.9765625,
            "text": "Favipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.88671875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.95703125,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.9765625,
            "text": "the treatment of influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0703125,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.09375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1328125,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1328125,
            "text": "influenza virus infections and has shown",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.171875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.9765625,
            "text": "ipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1796875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.2265625,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_15": [
        {
            "start_logit": 5.57421875,
            "end_logit": 6.1640625,
            "text": "COVID-19",
            "probability": 0.51171875
        },
        {
            "start_logit": 5.375,
            "end_logit": 6.1640625,
            "text": "antiviral drug, is being used for COVID-19",
            "probability": 0.421142578125
        },
        {
            "start_logit": 5.375,
            "end_logit": 4.32421875,
            "text": "antiviral",
            "probability": 0.067138671875
        },
        {
            "start_logit": -6.34375,
            "end_logit": 6.1640625,
            "text": "19",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 5.57421875,
            "end_logit": -6.60546875,
            "text": "COV",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.57421875,
            "end_logit": -6.6171875,
            "text": "COVID-",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.60546875,
            "text": "antiviral drug, is being used for COV",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.6171875,
            "text": "antiviral drug, is being used for COVID-",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.1640625,
            "text": "Favipiravir, an antiviral drug, is being used for COVID-19",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.57421875,
            "end_logit": -6.91796875,
            "text": "COVID-19 treatment",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.91796875,
            "text": "antiviral drug, is being used for COVID-19 treatment",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.57421875,
            "end_logit": -7.1953125,
            "text": "COVID",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.1640625,
            "text": "ID-19",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.1953125,
            "text": "antiviral drug, is being used for COVID",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.57421875,
            "end_logit": -7.4296875,
            "text": "COVID-19 treatment,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.1640625,
            "text": "an antiviral drug, is being used for COVID-19",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.4296875,
            "text": "antiviral drug, is being used for COVID-19 treatment,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 6.1640625,
            "text": "being used for COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 6.1640625,
            "text": "for COVID-19",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 6.1640625,
            "text": "is being used for COVID-19",
            "probability": 4.172325134277344e-07
        }
    ],
    "621ebb733a8413c65300005c_16": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.296875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.4375,
            "text": "influenza in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.81640625,
            "text": "influenza in Japan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.296875,
            "text": "pandemic influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.0390625,
            "text": "influenza in Japan in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.0859375,
            "text": "influenza in Japan in 2014",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.15625,
            "text": "influenza in Japan in 2014 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.1640625,
            "text": "influenza in Japan in 2014 and has shown",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.1875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.1875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.203125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.296875,
            "text": "was approved for new and reemerging pandemic influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2578125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2578125,
            "text": "influenza in Japan in 2014 and has shown potent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2578125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2578125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.28125,
            "text": "influenza in Japan in 2014 and has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.296875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.3046875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.296875,
            "text": "new and reemerging pandemic influenza",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_17": [
        {
            "start_logit": 7.9921875,
            "end_logit": 6.6953125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.0546875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -6.5,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.1953125,
            "text": "influenza and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.65625,
            "text": "influenza and Ebola,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.7890625,
            "text": "influenza and Ebola, which has shown",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.91015625,
            "text": "influenza and Ebola, which has",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.91796875,
            "text": "influenza and Ebola, which",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.921875,
            "text": "influenza and Ebola, which has shown some promise in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.94140625,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.95703125,
            "text": "influenza and Ebola, which has shown some promise",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.98828125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.99609375,
            "text": "influenza and Ebola, which has shown some promise in early trials",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -8.078125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 6.6953125,
            "text": "Favipiravir is an antiviral previously indicated for influenza",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -8.109375,
            "text": "influenza and Ebola, which has shown some",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -8.1171875,
            "text": "influenza and Ebola",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.6953125,
            "text": "for influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.6953125,
            "text": "antiviral previously indicated for influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 6.6953125,
            "text": "previously indicated for influenza",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_18": [
        {
            "start_logit": 9.7421875,
            "end_logit": 10.2265625,
            "text": "Ebola virus infection",
            "probability": 1.0
        },
        {
            "start_logit": -2.076171875,
            "end_logit": 10.2265625,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -2.3125,
            "end_logit": 10.2265625,
            "text": "infection",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -2.4296875,
            "text": "Ebola",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 10.2265625,
            "text": "been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 10.2265625,
            "text": "virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 10.2265625,
            "text": "treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.15625,
            "text": "Ebola virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 10.2265625,
            "text": "antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 10.2265625,
            "text": "now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": 10.2265625,
            "text": "treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 10.2265625,
            "text": "mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 10.2265625,
            "text": "demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 10.2265625,
            "text": "of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 10.2265625,
            "text": "has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 10.2265625,
            "text": "novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.2265625,
            "text": "was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 10.2265625,
            "text": "in treating Ebola virus infection",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.1953125,
            "text": "Ebola virus infection.",
            "probability": 0.0
        },
        {
            "start_logit": -2.076171875,
            "end_logit": -2.4296875,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_19": [
        {
            "start_logit": 10.078125,
            "end_logit": 9.6484375,
            "text": "influenza virus",
            "probability": 1.0
        },
        {
            "start_logit": 1.8515625,
            "end_logit": 9.6484375,
            "text": "infections with the influenza virus",
            "probability": 0.0002696514129638672
        },
        {
            "start_logit": 10.078125,
            "end_logit": -1.59375,
            "text": "influenza",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -3.166015625,
            "end_logit": 9.6484375,
            "text": "virus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 9.6484375,
            "text": "treatment of infections with the influenza virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.078125,
            "end_logit": -7.66015625,
            "text": "influenza virus] inhibits in vitro murine norovirus replication",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.078125,
            "end_logit": -7.734375,
            "text": "influenza virus]",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -7.75,
            "text": "influenza virus] inhibits in vitro murine norovirus",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -7.80859375,
            "text": "influenza virus] inhibits in vitro murine norovirus replication.",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.6484375,
            "text": "of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.0546875,
            "text": "influenza virus] inhibits",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.265625,
            "text": "influenza virus] inhibits in vitro",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 9.6484375,
            "text": "the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": 9.6484375,
            "text": "with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 9.6484375,
            "text": "drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 9.6484375,
            "text": "for the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.6484375,
            "text": "demonstrate that Favipiravir [T-705, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.6484375,
            "text": ", a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.6484375,
            "text": "5, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.6484375,
            "text": "clinical development for the treatment of infections with the influenza virus",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_20": [
        {
            "start_logit": 7.75,
            "end_logit": 9.578125,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -3.384765625,
            "end_logit": 9.578125,
            "text": "19",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 9.578125,
            "text": "with COVID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -5.0703125,
            "text": "COV",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.578125,
            "text": "patients with COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.578125,
            "text": "ID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 9.578125,
            "text": "treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 9.578125,
            "text": "-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.578125,
            "text": "The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.578125,
            "text": "combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.578125,
            "text": "for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.578125,
            "text": "Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.578125,
            "text": "Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.578125,
            "text": "option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.65234375,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0390625,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.73046875,
            "end_logit": -5.0703125,
            "text": "with COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -5.0703125,
            "text": "patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -5.0703125,
            "text": "treatment option for patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -5.0703125,
            "text": "The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_21": [
        {
            "start_logit": 9.59375,
            "end_logit": 9.8203125,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -2.775390625,
            "text": "COV",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -3.044921875,
            "end_logit": 9.8203125,
            "text": "19",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -6.5234375,
            "text": "COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.59375,
            "end_logit": -6.91015625,
            "text": "COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.8203125,
            "text": "for COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.8203125,
            "text": "ID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.734375,
            "end_logit": 9.8203125,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.609375,
            "text": "COVID-19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 9.8203125,
            "text": "safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.8203125,
            "text": "option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.8203125,
            "text": "therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.8203125,
            "text": "-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.8203125,
            "text": "Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.8203125,
            "text": "Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.171875,
            "text": "COVID-19. Recent",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.8203125,
            "text": "iravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.8203125,
            "text": ", Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.8203125,
            "text": "ipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.8203125,
            "text": "a safer therapeutic option for COVID-19",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_22": [
        {
            "start_logit": 8.0703125,
            "end_logit": 8.6640625,
            "text": "Covid-19",
            "probability": 1.0
        },
        {
            "start_logit": -4.54296875,
            "end_logit": 8.6640625,
            "text": "19",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -4.8203125,
            "text": "Cov",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 8.6640625,
            "text": "Management of Covid-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -6.56640625,
            "text": "Covid-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.6640625,
            "text": "of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.09375,
            "text": "Covid-19:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.6640625,
            "text": "id-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.1953125,
            "text": "Covid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.6640625,
            "text": "Hydroxychloroquine for Management of Covid-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.6640625,
            "text": "Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.6640625,
            "text": "-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.6640625,
            "text": "Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.6640625,
            "text": "for Management of Covid-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.6640625,
            "text": "vir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.6640625,
            "text": "Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -8.0234375,
            "text": "Covid-19: A Retrospective Study.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -8.21875,
            "text": "Covid-19: A Retrospective",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.54296875,
            "end_logit": -7.09375,
            "text": "19:",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -4.8203125,
            "text": "Management of Cov",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_23": [
        {
            "start_logit": 8.5390625,
            "end_logit": 8.1953125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.91796875,
            "text": "influenza inf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.1953125,
            "text": "of influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.1953125,
            "text": "treatment of influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -8.3515625,
            "text": "influenza infec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.1953125,
            "text": "antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.1953125,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.1953125,
            "text": "Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.1953125,
            "text": "the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.1953125,
            "text": "are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.1953125,
            "text": "for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.1953125,
            "text": "eltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 8.1953125,
            "text": "amivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.91796875,
            "text": "of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -6.91796875,
            "text": "treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -6.91796875,
            "text": "antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -6.91796875,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -6.91796875,
            "text": "Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -6.91796875,
            "text": "the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -6.91796875,
            "text": "are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_24": [
        {
            "start_logit": 8.4921875,
            "end_logit": 9.109375,
            "text": "coronavirus disease 2019",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.4921875,
            "end_logit": 2.3125,
            "text": "coronavirus disease",
            "probability": 0.001125335693359375
        },
        {
            "start_logit": -3.05078125,
            "end_logit": 9.109375,
            "text": "2019",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -4.2265625,
            "text": "coronavirus",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.109375,
            "text": "managing coronavirus disease 2019",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 9.109375,
            "text": "disease 2019",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.109375,
            "text": "Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.671875,
            "text": "coronavirus disease 2019 (COVID",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.109375,
            "text": "promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.109375,
            "text": "IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.109375,
            "text": "OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.109375,
            "text": "for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.109375,
            "text": "vir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.109375,
            "text": "ipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.109375,
            "text": ": Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.94921875,
            "text": "coronavirus disease 2019 (COVID-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.9765625,
            "text": "coronavirus disease 2019 (COVID-19",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -8.0703125,
            "text": "coronavirus disease 2019 (COVID-19)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -8.140625,
            "text": "coronavirus disease 2019 (COV",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 2.3125,
            "text": "managing coronavirus disease",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_25": [
        {
            "start_logit": 8.796875,
            "end_logit": 8.171875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.171875,
            "text": "severe influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.61328125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.71875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.796875,
            "end_logit": -7.97265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.0,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.0859375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.1484375,
            "text": "influenza,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.1796875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.203125,
            "text": "influenza, the next pandemic influenza strain, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.2109375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.25,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.2578125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.796875,
            "end_logit": -8.3125,
            "text": "influenza, the next pandemic influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.171875,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -7.61328125,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -7.71875,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -7.97265625,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -8.0,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections for",
            "probability": 0.0
        },
        {
            "start_logit": -6.47265625,
            "end_logit": -8.0859375,
            "text": "severe influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_26": [
        {
            "start_logit": 9.890625,
            "end_logit": 9.5546875,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -1.9638671875,
            "text": "influenza",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": -3.29296875,
            "end_logit": 9.5546875,
            "text": "infections",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 9.5546875,
            "text": "pandemic influenza virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.890625,
            "end_logit": -6.16015625,
            "text": "influenza virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.5546875,
            "text": "treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.5546875,
            "text": "virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.5546875,
            "text": "antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.890625,
            "text": "influenza virus infections.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.5546875,
            "text": "Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.5546875,
            "text": "to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.5546875,
            "text": "2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.5546875,
            "text": "has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 9.5546875,
            "text": "been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.5546875,
            "text": "also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.5546875,
            "text": "drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.5546875,
            "text": "an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.5546875,
            "text": ", is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.5546875,
            "text": "approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 0.0
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -1.9638671875,
            "text": "pandemic influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_27": [
        {
            "start_logit": 8.65625,
            "end_logit": 8.0546875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.0546875,
            "text": "emerging influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.50390625,
            "text": "influenza strains",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.765625,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.84375,
            "text": "influenza strains;",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.859375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.96484375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.1015625,
            "text": "influenza strains; and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.1953125,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.2109375,
            "text": "influenza strains; and several phase 2 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.2578125,
            "text": "influenza strains; and several phase 2 and 3 clinical",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.2734375,
            "text": "influenza strains; and several phase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.2890625,
            "text": "influenza strains; and several phase 2 and 3",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.3046875,
            "text": "influenza strains; and several phase 2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.3125,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.0546875,
            "text": "antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.0546875,
            "text": "purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.0546875,
            "text": "Favipiravir (T-705) is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.0546875,
            "text": "Japan against emerging influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.0546875,
            "text": "a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_28": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.03125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.67578125,
            "text": "influenza and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.921875,
            "text": "influenza and many other RNA viral diseases for which there are no approved",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.03125,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.98046875,
            "text": "influenza and many other RNA viral diseases for which there are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.140625,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.1484375,
            "text": "influenza and many other RNA viral diseases for which there are no",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.265625,
            "text": "influenza and many other RNA viral diseases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.3125,
            "text": "influenza and many other RNA viral diseases for which there",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.03125,
            "text": "for influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.03125,
            "text": "favipiravir is a promising drug candidate for influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.03125,
            "text": "drug candidate for influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.67578125,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza and",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.87890625,
            "text": "antiviral activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.921875,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza and many other RNA viral diseases for which there are no approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.98046875,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza and many other RNA viral diseases for which there are",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.99609375,
            "text": "antiviral",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.921875,
            "text": "viral diseases for which there are no approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.98046875,
            "text": "viral diseases for which there are",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -8.1171875,
            "text": "antiviral activity, favipiravir is a promising drug candidate",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_1": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.140625,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.11328125,
            "text": "Noncon",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.501953125,
            "end_logit": 10.140625,
            "text": "Epilepticus",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 10.140625,
            "text": "Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 10.140625,
            "text": "vulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 10.140625,
            "text": "With Nonconvulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.140625,
            "text": "Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 10.140625,
            "text": "ulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.68359375,
            "text": "Nonconvulsive Status",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.765625,
            "text": "Nonconvulsive",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.91796875,
            "text": "Nonconvulsive Status Epilepticus by",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.98828125,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria.",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.140625,
            "text": "Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1171875,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1328125,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 10.140625,
            "text": "Patients With Nonconvulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.171875,
            "text": "Nonconv",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.140625,
            "text": "the Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.296875,
            "text": "Nonconvulsive Status Epilepticus by Using",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.3359375,
            "text": "Nonconvulsive Status Epilepticus by Using Salz",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_2": [
        {
            "start_logit": 7.83984375,
            "end_logit": 9.6171875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -3.033203125,
            "end_logit": 9.6171875,
            "text": "epilepticus",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 9.6171875,
            "text": "with nonconvulsive status epilepticus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -4.82421875,
            "text": "noncon",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.6171875,
            "text": "the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.6171875,
            "text": "vulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 9.6171875,
            "text": "Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 9.6171875,
            "text": "patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 9.6171875,
            "text": "SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 9.6171875,
            "text": "status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 9.6171875,
            "text": "We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 9.6171875,
            "text": "aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.6171875,
            "text": "assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.6171875,
            "text": "prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.6171875,
            "text": "Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.6171875,
            "text": "determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.6171875,
            "text": "critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -7.77734375,
            "text": "nonconvulsive",
            "probability": 0.0
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -8.03125,
            "text": "nonconvulsive status epilepticus (",
            "probability": 0.0
        },
        {
            "start_logit": 7.83984375,
            "end_logit": -8.0703125,
            "text": "nonconvulsive status epilepticus (NCSE).",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_3": [
        {
            "start_logit": 9.953125,
            "end_logit": 10.109375,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -1.8974609375,
            "text": "Noncon",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -2.521484375,
            "end_logit": 10.109375,
            "text": "Epilepticus",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 10.109375,
            "text": "Status Epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.7265625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.73046875,
            "text": "Nonconvulsive Status",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.109375,
            "text": "ulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -7.96875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0078125,
            "text": "Nonconv",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.0390625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.046875,
            "text": "Nonconvulsive Status Epilepticus:",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1484375,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.109375,
            "text": "vulsive Status Epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1953125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.203125,
            "text": "Nonconvulsive",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.2421875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.328125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.328125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -7.7265625,
            "text": "Epilepticus: Validating the Salzburg Criteria Against",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -7.96875,
            "text": "Epilepticus: Validating the Salzburg Criteria Against an",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_4": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.96875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.279296875,
            "text": "noncon",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.66015625,
            "end_logit": 9.96875,
            "text": "epilepticus",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 9.96875,
            "text": "vulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.96875,
            "text": "status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.96875,
            "text": "for nonconvulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.96875,
            "text": "ulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.96875,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9375,
            "end_logit": 9.96875,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.84375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.96875,
            "text": "the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.96875,
            "text": "diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "nonconvulsive status epilepticus (",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.15625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive status",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.2109375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.21875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.2421875,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_5": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.96875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.279296875,
            "text": "noncon",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.66015625,
            "end_logit": 9.96875,
            "text": "epilepticus",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 9.96875,
            "text": "vulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.96875,
            "text": "status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.96875,
            "text": "for nonconvulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.96875,
            "text": "ulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.96875,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9375,
            "end_logit": 9.96875,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.84375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.96875,
            "text": "the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.96875,
            "text": "diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "nonconvulsive status epilepticus (",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.15625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "nonconvulsive status",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.2109375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.21875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.2421875,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 0.0
        }
    ],
    "623e02e0f0baec9a1b000005_1": [
        {
            "start_logit": 7.80859375,
            "end_logit": 5.98828125,
            "text": "ER retention sequence",
            "probability": 1.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -3.837890625,
            "text": "ER",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -4.34375,
            "text": "ER retention sequence (",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.31640625,
            "text": "ER retention sequence (KDEL)",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.3984375,
            "text": "ER retention",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.70703125,
            "end_logit": 5.98828125,
            "text": "sequence",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.57421875,
            "text": "ER retention sequence (KDEL",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.1484375,
            "text": "ER retention sequence (KD",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 5.98828125,
            "text": "retention sequence",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -4.34375,
            "text": "sequence (",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -4.34375,
            "text": "retention sequence (",
            "probability": 0.0
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -7.31640625,
            "text": "sequence (KDEL)",
            "probability": 0.0
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -7.57421875,
            "text": "sequence (KDEL",
            "probability": 0.0
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -8.1484375,
            "text": "sequence (KD",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -7.31640625,
            "text": "KDEL)",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -7.57421875,
            "text": "KDEL",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -8.1484375,
            "text": "KD",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.31640625,
            "text": "retention sequence (KDEL)",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.3984375,
            "text": "retention",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.57421875,
            "text": "retention sequence (KDEL",
            "probability": 0.0
        }
    ],
    "53617eeb7d100faa0900000a_1": [
        {
            "start_logit": 5.90625,
            "end_logit": 5.41015625,
            "text": "Anorexia Athletica",
            "probability": 0.97998046875
        },
        {
            "start_logit": 5.90625,
            "end_logit": 1.447265625,
            "text": "Anorexia Athletica.",
            "probability": 0.0186614990234375
        },
        {
            "start_logit": -1.076171875,
            "end_logit": 5.41015625,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 0.0009150505065917969
        },
        {
            "start_logit": -1.076171875,
            "end_logit": 1.447265625,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 1.7404556274414062e-05
        },
        {
            "start_logit": -5.5,
            "end_logit": 5.41015625,
            "text": "Athletica",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": 5.90625,
            "end_logit": -6.41796875,
            "text": "Anorexia",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 5.90625,
            "end_logit": -6.62890625,
            "text": "Anorexia Athletic",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 5.41015625,
            "text": "a",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 5.41015625,
            "text": "developing Anorexia Athletica",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 5.41015625,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 5.41015625,
            "text": "prone to developing Anorexia Athletica",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 5.41015625,
            "text": "to developing Anorexia Athletica",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 5.41015625,
            "text": "RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 5.41015625,
            "text": "unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 5.41015625,
            "text": ") constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 5.41015625,
            "text": "are prone to developing Anorexia Athletica",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.5,
            "end_logit": 1.447265625,
            "text": "Athletica.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 1.447265625,
            "text": "a.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 1.447265625,
            "text": "developing Anorexia Athletica.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 1.447265625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "53617eeb7d100faa0900000a_2": [
        {
            "start_logit": 5.0390625,
            "end_logit": 5.46875,
            "text": "anorexia athletica",
            "probability": 1.0
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -4.26953125,
            "text": "anorexia athletica (AA",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": -6.8125,
            "end_logit": 5.46875,
            "text": "a",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.4375,
            "text": "anorexia athletic",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 5.46875,
            "text": "athletica",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -7.0234375,
            "text": "anorexia athletica (",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -7.07421875,
            "text": "anorexia",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 5.46875,
            "text": "with anorexia athletica",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -8.1875,
            "end_logit": 5.46875,
            "text": "We studied 13 female juvenile elite gymnasts with anorexia athletica",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 5.46875,
            "text": "elite gymnasts with anorexia athletica",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -8.484375,
            "end_logit": 5.46875,
            "text": "13 female juvenile elite gymnasts with anorexia athletica",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.515625,
            "end_logit": 5.46875,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.515625,
            "end_logit": 5.46875,
            "text": "juvenile elite gymnasts with anorexia athletica",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 5.46875,
            "text": "female juvenile elite gymnasts with anorexia athletica",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 5.46875,
            "text": "gymnasts with anorexia athletica",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 5.46875,
            "text": "ts with anorexia athletica",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.8125,
            "end_logit": -4.26953125,
            "text": "a (AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -4.26953125,
            "text": "athletica (AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -4.26953125,
            "text": "AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -4.26953125,
            "text": "with anorexia athletica (AA",
            "probability": 0.0
        }
    ],
    "5c900b9eecadf2e73f000004_1": [
        {
            "start_logit": 9.984375,
            "end_logit": 10.2265625,
            "text": "Alnylam Pharmaceuticals",
            "probability": 1.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -1.8505859375,
            "text": "Al",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -2.18359375,
            "end_logit": 10.2265625,
            "text": "Pharmaceuticals",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 9.984375,
            "end_logit": -5.484375,
            "text": "Alnylam",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.18359375,
            "text": "Alnyl",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 10.2265625,
            "text": "nylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.359375,
            "text": "Alnylam Pharmaceuticals;",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 10.2265625,
            "text": "am Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 10.2265625,
            "text": "ylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.2265625,
            "text": "by Alnylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.828125,
            "text": "Aln",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -7.98828125,
            "text": "Alnylam Pharmaceuticals; it was recently approved in",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.2265625,
            "text": "developed by Alnylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.2265625,
            "text": "Patisiran has been developed by Alnylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.15625,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.15625,
            "text": "Alnylam Pharmaceuticals; it was recently approved",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1640625,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR)",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.1640625,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.2265625,
            "text": "been developed by Alnylam Pharmaceuticals",
            "probability": 0.0
        },
        {
            "start_logit": 9.984375,
            "end_logit": -8.21875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_1": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.0859375,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.244140625,
            "text": "Enhancer",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -2.546875,
            "end_logit": 10.0859375,
            "text": "Sharing",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.37109375,
            "text": "Enhancer Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.78125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2734375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.28125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.328125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.328125,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.3359375,
            "text": "Enhancer Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -7.37109375,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -7.78125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -8.2734375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -8.28125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -8.328125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -8.328125,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -8.3359375,
            "text": "Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -7.37109375,
            "text": "Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -7.78125,
            "text": "Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -7.78125,
            "text": "Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_2": [
        {
            "start_logit": 10.0234375,
            "end_logit": 10.203125,
            "text": "enhancer sharing",
            "probability": 1.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -1.69921875,
            "text": "enhancer",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -2.130859375,
            "end_logit": 10.203125,
            "text": "sharing",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -6.77734375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.42578125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.203125,
            "text": "We propose that enhancer sharing",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.203125,
            "text": "that enhancer sharing",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.97265625,
            "text": "enhancer sharing is commonplace",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.9921875,
            "text": "enhancer sharing is",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.9921875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation.",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.09375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.1171875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.1953125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.2109375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.2109375,
            "text": "enhancer sharing is commonplace among",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.2265625,
            "text": "enhancer sharing is common",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.2265625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.203125,
            "text": "propose that enhancer sharing",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.28125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.3046875,
            "text": "enhancer sharing is commonplace among eukaryotes, and",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_3": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.1328125,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.9296875,
            "text": "Enhancer",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -2.45703125,
            "end_logit": 10.1328125,
            "text": "Sharing",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.7578125,
            "text": "Enhancer Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.9375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.265625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3671875,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3671875,
            "text": "Enhancer Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -7.7578125,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -7.9375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -8.265625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -8.3125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -8.3671875,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -2.45703125,
            "end_logit": -8.3671875,
            "text": "Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -7.7578125,
            "text": "Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -7.9375,
            "text": "Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -7.9375,
            "text": "Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": -7.9375,
            "text": "of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -8.265625,
            "text": "Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        }
    ],
    "5c8973f3d558e5f232000007_1": [
        {
            "start_logit": 9.484375,
            "end_logit": 9.984375,
            "text": "Alipogene tiparvovec",
            "probability": 1.0
        },
        {
            "start_logit": -2.681640625,
            "end_logit": 9.984375,
            "text": "c",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 9.484375,
            "end_logit": -2.736328125,
            "text": "Ali",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 9.484375,
            "end_logit": -5.66015625,
            "text": "Alipogene tiparvovec (Glybera",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 9.984375,
            "text": "tiparvovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 9.984375,
            "text": "pogene tiparvovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -6.6171875,
            "text": "Alipogene tiparvovec (Glybera\u00ae)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.984375,
            "text": "vec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.984375,
            "text": "vovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.984375,
            "text": "arvovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -6.859375,
            "text": "Alipogene tiparvovec (Glybera\u00ae",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.984375,
            "text": "gene tiparvovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.03125,
            "text": "Alipogene tiparvove",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.26171875,
            "text": "Alipogene tiparvovec (Glyber",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.51171875,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the first gene therapy",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.64453125,
            "text": "Alipogene tiparvo",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.65234375,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.70703125,
            "text": "Alipogene",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.8125,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the first gene therapy to",
            "probability": 0.0
        },
        {
            "start_logit": -2.681640625,
            "end_logit": -5.66015625,
            "text": "c (Glybera",
            "probability": 0.0
        }
    ],
    "5c929094ecadf2e73f000019_1": [
        {
            "start_logit": 6.2109375,
            "end_logit": 1.99609375,
            "text": "activation",
            "probability": 0.9892578125
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -2.611328125,
            "text": "activation of retrotransposons.",
            "probability": 0.00992584228515625
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -5.16015625,
            "text": "activation of retrotransposons",
            "probability": 0.0007748603820800781
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -6.9140625,
            "text": "activation of",
            "probability": 0.0001341104507446289
        },
        {
            "start_logit": 6.2109375,
            "end_logit": -7.375,
            "text": "activation of retrotransp",
            "probability": 8.45789909362793e-05
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 1.99609375,
            "text": "changes in chromatin composition that can lead to the activation",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -3.43359375,
            "end_logit": -0.4541015625,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -6.953125,
            "end_logit": 1.99609375,
            "text": "lead to the activation",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 1.99609375,
            "text": "can lead to the activation",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 1.99609375,
            "text": ". These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 1.99609375,
            "text": "centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 1.99609375,
            "text": "the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 1.99609375,
            "text": "loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 1.99609375,
            "text": "and changes in chromatin composition that can lead to the activation",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 1.99609375,
            "text": "These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 1.99609375,
            "text": "distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": -0.4541015625,
            "text": "dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": -0.4541015625,
            "text": ".",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -0.4541015625,
            "text": "genome accessibility and their transcriptional program.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -0.4541015625,
            "text": "chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_1": [
        {
            "start_logit": -0.7607421875,
            "end_logit": 8.515625,
            "text": "Disease activity score in 28 joints",
            "probability": 0.896484375
        },
        {
            "start_logit": -3.130859375,
            "end_logit": 8.515625,
            "text": "joints",
            "probability": 0.083740234375
        },
        {
            "start_logit": -4.625,
            "end_logit": 8.515625,
            "text": "28 joints",
            "probability": 0.018829345703125
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.515625,
            "text": "in 28 joints",
            "probability": 0.0006008148193359375
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -4.50390625,
            "text": "Disease activity score in 28 joints (",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -6.82421875,
            "text": "Disease activity score in 28 joints (DAS28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.130859375,
            "end_logit": -4.50390625,
            "text": "joints (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.04296875,
            "text": "Disease activity score in 28 joints (DAS28)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.1015625,
            "text": "Disease activity score",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.25,
            "text": "Disease activity score in 28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.41796875,
            "text": "Disease activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.45703125,
            "text": "Disease activity score in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.484375,
            "text": "Disease activity score in 28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.7607421875,
            "end_logit": -7.92578125,
            "text": "Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.625,
            "end_logit": -4.50390625,
            "text": "28 joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.130859375,
            "end_logit": -6.82421875,
            "text": "joints (DAS28",
            "probability": 0.0
        },
        {
            "start_logit": -3.130859375,
            "end_logit": -7.04296875,
            "text": "joints (DAS28)",
            "probability": 0.0
        },
        {
            "start_logit": -3.130859375,
            "end_logit": -7.25,
            "text": "joints (DAS",
            "probability": 0.0
        },
        {
            "start_logit": -4.625,
            "end_logit": -6.82421875,
            "text": "28 joints (DAS28",
            "probability": 0.0
        },
        {
            "start_logit": -4.625,
            "end_logit": -7.04296875,
            "text": "28 joints (DAS28)",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_2": [
        {
            "start_logit": -1.6083984375,
            "end_logit": 6.55078125,
            "text": "28 joints",
            "probability": 0.90869140625
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 6.55078125,
            "text": "joints",
            "probability": 0.081298828125
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 6.55078125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.003459930419921875
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.55078125,
            "text": "present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0021991729736328125
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.55078125,
            "text": "study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0017070770263671875
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.55078125,
            "text": "in 28 joints",
            "probability": 0.001377105712890625
        },
        {
            "start_logit": -8.296875,
            "end_logit": 6.55078125,
            "text": "questionnaire designed specifically for the present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.001132965087890625
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -6.73828125,
            "text": "28",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -7.10546875,
            "text": "28 joints [DAS28",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -7.46484375,
            "text": "28 joints [",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -7.50390625,
            "text": "28 joints [DAS28]",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -7.875,
            "text": "28 joints [DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -8.140625,
            "text": "28 joints [DAS28]) and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.6083984375,
            "end_logit": -8.1953125,
            "text": "28 joints [DAS28])",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.10546875,
            "text": "joints [DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.46484375,
            "text": "joints [",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.50390625,
            "text": "joints [DAS28]",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.875,
            "text": "joints [DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.140625,
            "text": "joints [DAS28]) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.1953125,
            "text": "joints [DAS28])",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_3": [
        {
            "start_logit": 3.005859375,
            "end_logit": 8.96875,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.998046875
        },
        {
            "start_logit": -3.265625,
            "end_logit": 8.96875,
            "text": "Joints",
            "probability": 0.0018815994262695312
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 8.96875,
            "text": "28 Joints",
            "probability": 0.00019073486328125
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.96875,
            "text": "in 28 Joints",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.96875,
            "text": "Activity Score in 28 Joints",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.96875,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.96875,
            "text": "Score in 28 Joints",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -3.236328125,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -6.37109375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.03125,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.1171875,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.23046875,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.28125,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.3984375,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.47265625,
            "text": "Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.67578125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.71484375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.74609375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.74609375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.005859375,
            "end_logit": -7.8203125,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_4": [
        {
            "start_logit": -4.28515625,
            "end_logit": 6.9765625,
            "text": "joints",
            "probability": 0.4638671875
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 6.9765625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.29931640625
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 6.9765625,
            "text": "28 joints",
            "probability": 0.0841064453125
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 6.9765625,
            "text": "a Disease Activity Score in 28 joints",
            "probability": 0.037200927734375
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 6.9765625,
            "text": "rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.03631591796875
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.9765625,
            "text": "active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.01305389404296875
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.9765625,
            "text": "in patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.01294708251953125
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.9765625,
            "text": "patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.0121612548828125
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.9765625,
            "text": "American College of Rheumatology guidelines, in patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.010528564453125
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.9765625,
            "text": "RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.01044464111328125
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 6.9765625,
            "text": "defined by a Disease Activity Score in 28 joints",
            "probability": 0.01036834716796875
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.9765625,
            "text": "in 28 joints",
            "probability": 0.00997161865234375
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -6.2578125,
            "text": "joints (DAS28) score greater",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -6.26171875,
            "text": "joints (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -6.46875,
            "text": "joints (DAS28",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -6.2578125,
            "text": "Disease Activity Score in 28 joints (DAS28) score greater",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -6.26171875,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.72265625,
            "end_logit": -6.46875,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.28515625,
            "end_logit": -7.24609375,
            "text": "joints (DAS28) score greater tha",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -6.2578125,
            "text": "greater",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_5": [
        {
            "start_logit": -0.9150390625,
            "end_logit": 8.421875,
            "text": "28 joints",
            "probability": 0.9111328125
        },
        {
            "start_logit": -3.69140625,
            "end_logit": 8.421875,
            "text": "joints",
            "probability": 0.056671142578125
        },
        {
            "start_logit": -4.50390625,
            "end_logit": 8.421875,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.025146484375
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 8.421875,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.00421905517578125
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.421875,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.0011005401611328125
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.421875,
            "text": "on 28 joints",
            "probability": 0.000774383544921875
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.421875,
            "text": "based on 28 joints",
            "probability": 0.0007104873657226562
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -4.8515625,
            "text": "28 joints (",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.46875,
            "text": "28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.4765625,
            "text": "28 joints (DAS28) has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.53125,
            "text": "28 joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.61328125,
            "text": "28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.69140625,
            "end_logit": -4.8515625,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.7265625,
            "text": "28 joints (DAS28) has been increasingly used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.875,
            "text": "28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.91796875,
            "text": "28 joints (DAS28) has been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -7.9765625,
            "text": "28 joints (DAS28) has been increasingly used in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -8.0,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -8.0078125,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.9150390625,
            "end_logit": -8.1171875,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arthr",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_6": [
        {
            "start_logit": -1.310546875,
            "end_logit": 8.484375,
            "text": "28 joints",
            "probability": 0.85546875
        },
        {
            "start_logit": -3.697265625,
            "end_logit": 8.484375,
            "text": "joints",
            "probability": 0.07891845703125
        },
        {
            "start_logit": -4.0546875,
            "end_logit": 8.484375,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.055145263671875
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 8.484375,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.00676727294921875
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.484375,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.0016069412231445312
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.484375,
            "text": "based on 28 joints",
            "probability": 0.0010585784912109375
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.484375,
            "text": "on 28 joints",
            "probability": 0.001033782958984375
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -4.765625,
            "text": "28 joints (",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -3.697265625,
            "end_logit": -4.765625,
            "text": "joints (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.41796875,
            "text": "28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.0546875,
            "end_logit": -4.765625,
            "text": "Disease Activity Score based on 28 joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.52734375,
            "text": "28 joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.58203125,
            "text": "28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.59765625,
            "text": "28 joints (DAS28) has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.703125,
            "text": "28 joints (DAS28) has been widely used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.97265625,
            "text": "28 joints (DAS28) has been widely used in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.98828125,
            "text": "28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -7.9921875,
            "text": "28 joints (DAS28) has been widely used in clinical practice",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -8.09375,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research studies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.310546875,
            "end_logit": -8.09375,
            "text": "28 joints (DAS28) has been",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_7": [
        {
            "start_logit": 1.1025390625,
            "end_logit": 8.9765625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.98193359375
        },
        {
            "start_logit": -3.220703125,
            "end_logit": 8.9765625,
            "text": "joints",
            "probability": 0.01305389404296875
        },
        {
            "start_logit": -4.390625,
            "end_logit": 8.9765625,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.0040435791015625
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 8.9765625,
            "text": "28 joints",
            "probability": 0.000995635986328125
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.9765625,
            "text": "in 28 joints",
            "probability": 0.0001310110092163086
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.9765625,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.00010693073272705078
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.9765625,
            "text": "Activity Score in 28 joints",
            "probability": 7.528066635131836e-05
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -2.927734375,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -4.546875,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -6.9765625,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.220703125,
            "end_logit": -2.927734375,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.3671875,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.39453125,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.44921875,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.47265625,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.5703125,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.78125,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.953125,
            "text": "Disease Activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -7.9921875,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1025390625,
            "end_logit": -8.0859375,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_8": [
        {
            "start_logit": 2.126953125,
            "end_logit": 3.048828125,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.994140625
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -3.083984375,
            "text": "joint synovitis",
            "probability": 0.0021572113037109375
        },
        {
            "start_logit": -4.21875,
            "end_logit": 3.048828125,
            "text": "better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00174713134765625
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 3.048828125,
            "text": "joints",
            "probability": 0.0005207061767578125
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -5.09765625,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (DAS28",
            "probability": 0.0002875328063964844
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 3.048828125,
            "text": "the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00015151500701904297
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 3.048828125,
            "text": "28 joints",
            "probability": 0.00012362003326416016
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 3.048828125,
            "text": "reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00011348724365234375
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 3.048828125,
            "text": "component Disease Activity Score in 28 joints",
            "probability": 9.40561294555664e-05
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 3.048828125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 9.119510650634766e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -6.3984375,
            "text": "joint",
            "probability": 7.796287536621094e-05
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 3.048828125,
            "text": "synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 7.796287536621094e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -7.01953125,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (",
            "probability": 4.2438507080078125e-05
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 3.048828125,
            "text": ", the 2-component Disease Activity Score in 28 joints",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 3.048828125,
            "text": "reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 3.921985626220703e-05
        },
        {
            "start_logit": -8.0625,
            "end_logit": 3.048828125,
            "text": "2-component Disease Activity Score in 28 joints",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -7.41015625,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (DAS28)",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -7.55859375,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in",
            "probability": 2.4557113647460938e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -7.65625,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (DAS",
            "probability": 2.2351741790771484e-05
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -7.74609375,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28",
            "probability": 2.0325183868408203e-05
        }
    ],
    "5fe3130da43ad3127800003f_9": [
        {
            "start_logit": -1.0224609375,
            "end_logit": 9.2421875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.81640625
        },
        {
            "start_logit": -2.736328125,
            "end_logit": 9.2421875,
            "text": "joints",
            "probability": 0.1475830078125
        },
        {
            "start_logit": -4.609375,
            "end_logit": 9.2421875,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.0226287841796875
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 9.2421875,
            "text": "28 joints",
            "probability": 0.01111602783203125
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.2421875,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0011053085327148438
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.2421875,
            "text": "in 28 joints",
            "probability": 0.0007443428039550781
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -3.818359375,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -2.736328125,
            "end_logit": -3.818359375,
            "text": "joints (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.37109375,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.609375,
            "end_logit": -3.818359375,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.41796875,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.43359375,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.44140625,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.48828125,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.4921875,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.5078125,
            "text": "Disease Activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -7.80859375,
            "text": "Disease Activity Score in 28 joints (DAS28) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -8.0234375,
            "text": "Disease Activity Score in 28 joints (DAS28) is a key measure in clinical practice",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -8.0625,
            "text": "Disease Activity Score in 28 joints (DAS28) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0224609375,
            "end_logit": -8.1171875,
            "text": "Disease Activity Score in 28 joints (DAS28) is a key measure in",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_10": [
        {
            "start_logit": 2.421875,
            "end_logit": 9.3515625,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.9951171875
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 9.3515625,
            "text": "Joints",
            "probability": 0.004535675048828125
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 9.3515625,
            "text": "28 Joints",
            "probability": 0.0003063678741455078
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 9.3515625,
            "text": "in 28 Joints",
            "probability": 3.516674041748047e-05
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.3515625,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.3515625,
            "text": "Activity Score in 28 Joints",
            "probability": 2.0503997802734375e-05
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.3515625,
            "text": "Score in 28 Joints",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": 2.421875,
            "end_logit": -3.154296875,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 2.421875,
            "end_logit": -6.03125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.1015625,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.19140625,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.21484375,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.32421875,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.51953125,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.5234375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.54296875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.578125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.609375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.640625,
            "text": "Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.421875,
            "end_logit": -7.77734375,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_11": [
        {
            "start_logit": 1.1103515625,
            "end_logit": 3.1015625,
            "text": "rheumatoid arthritis",
            "probability": 0.9990234375
        },
        {
            "start_logit": -7.390625,
            "end_logit": 3.1015625,
            "text": "arthritis",
            "probability": 0.00020325183868408203
        },
        {
            "start_logit": -8.078125,
            "end_logit": 3.1015625,
            "text": "RAPID3) for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 0.00010216236114501953
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 3.1015625,
            "text": "with rheumatoid arthritis",
            "probability": 0.00010138750076293945
        },
        {
            "start_logit": -8.171875,
            "end_logit": 3.1015625,
            "text": "in patients with rheumatoid arthritis",
            "probability": 9.304285049438477e-05
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 3.1015625,
            "text": "patients with rheumatoid arthritis",
            "probability": 8.952617645263672e-05
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 3.1015625,
            "text": "assessing disease activity in patients with rheumatoid arthritis",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 3.1015625,
            "text": "measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -0.72021484375,
            "text": "28 joints",
            "probability": 5.3882598876953125e-05
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -0.72021484375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 1.1103515625,
            "end_logit": -8.0703125,
            "text": "rheumatoid arthritis at",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -4.0078125,
            "end_logit": -2.982421875,
            "text": "ESR",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -0.72021484375,
            "text": "joints",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -2.982421875,
            "text": "28 joints with ESR",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -0.72021484375,
            "text": "Comparison of Disease Activity Score in 28 joints",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -0.72021484375,
            "text": "in 28 joints",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -2.982421875,
            "text": "Disease Activity Score in 28 joints with ESR",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.5390625,
            "end_logit": -2.982421875,
            "text": "joints with ESR",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.125,
            "end_logit": -2.982421875,
            "text": "with ESR",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -2.982421875,
            "text": "Comparison of Disease Activity Score in 28 joints with ESR",
            "probability": 2.980232238769531e-07
        }
    ],
    "5fe3130da43ad3127800003f_12": [
        {
            "start_logit": -5.44921875,
            "end_logit": 4.6640625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.3818359375
        },
        {
            "start_logit": -5.75,
            "end_logit": 4.6640625,
            "text": "joints",
            "probability": 0.28271484375
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 4.6640625,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.1182861328125
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 4.6640625,
            "text": "28 joints",
            "probability": 0.10943603515625
        },
        {
            "start_logit": -8.09375,
            "end_logit": 4.6640625,
            "text": "Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.027130126953125
        },
        {
            "start_logit": -8.265625,
            "end_logit": 4.6640625,
            "text": ", Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0228424072265625
        },
        {
            "start_logit": -8.421875,
            "end_logit": 4.6640625,
            "text": ", and the Disease Activity Score in 28 joints",
            "probability": 0.0195465087890625
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 4.6640625,
            "text": "and the Disease Activity Score in 28 joints",
            "probability": 0.0193939208984375
        },
        {
            "start_logit": -8.453125,
            "end_logit": 4.6640625,
            "text": "Simplified Disease Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0189361572265625
        },
        {
            "start_logit": -4.60546875,
            "end_logit": -4.13671875,
            "text": "DAS28",
            "probability": 0.00013375282287597656
        },
        {
            "start_logit": -5.44921875,
            "end_logit": -4.13671875,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 5.7697296142578125e-05
        },
        {
            "start_logit": -5.75,
            "end_logit": -4.13671875,
            "text": "joints (DAS28",
            "probability": 4.225969314575195e-05
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -4.13671875,
            "text": "the Disease Activity Score in 28 joints (DAS28",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": -6.69921875,
            "end_logit": -4.13671875,
            "text": "28 joints (DAS28",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -5.44921875,
            "end_logit": -6.06640625,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -5.75,
            "end_logit": -6.06640625,
            "text": "joints (",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -4.60546875,
            "end_logit": -7.2578125,
            "text": "DAS",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": -8.09375,
            "end_logit": -4.13671875,
            "text": "Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints (DAS28",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -4.60546875,
            "end_logit": -7.63671875,
            "text": "DAS28) were",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -4.60546875,
            "end_logit": -7.75390625,
            "text": "DAS28) were calculated using data from tocilizumab trials in patients with RA",
            "probability": 3.5762786865234375e-06
        }
    ],
    "5fe3130da43ad3127800003f_13": [
        {
            "start_logit": 5.609375,
            "end_logit": 9.4453125,
            "text": "Disease activity score in 28 joints",
            "probability": 1.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": 9.4453125,
            "text": "joints",
            "probability": 0.0002868175506591797
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 9.4453125,
            "text": "28 joints",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.4453125,
            "text": "in 28 joints",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.609375,
            "end_logit": -4.453125,
            "text": "Disease activity score in 28 joints (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.609375,
            "end_logit": -5.734375,
            "text": "Disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.0625,
            "text": "Disease activity score in 28 joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.18359375,
            "text": "Disease activity score in 28 joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.35546875,
            "text": "Disease activity score in 28 joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.52734375,
            "text": "Disease activity score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.5625,
            "text": "Disease activity score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.5859375,
            "text": "Disease activity score in 28 joints (DAS28)-remission",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.67578125,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.7421875,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.74609375,
            "text": "Disease activity score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.84375,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.89453125,
            "text": "Disease activity",
            "probability": 0.0
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.89453125,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumat",
            "probability": 0.0
        },
        {
            "start_logit": 5.609375,
            "end_logit": -7.8984375,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among",
            "probability": 0.0
        },
        {
            "start_logit": -2.546875,
            "end_logit": -4.453125,
            "text": "joints (",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_14": [
        {
            "start_logit": -1.19140625,
            "end_logit": 6.8671875,
            "text": "C-reactive protein",
            "probability": 0.86474609375
        },
        {
            "start_logit": -3.486328125,
            "end_logit": 6.8671875,
            "text": "joints with C-reactive protein",
            "probability": 0.087158203125
        },
        {
            "start_logit": -4.59375,
            "end_logit": 6.8671875,
            "text": "28 joints with C-reactive protein",
            "probability": 0.0287933349609375
        },
        {
            "start_logit": -5.84765625,
            "end_logit": 6.8671875,
            "text": "protein",
            "probability": 0.00821685791015625
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 6.8671875,
            "text": "with C-reactive protein",
            "probability": 0.007457733154296875
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.8671875,
            "text": "biological disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.0011615753173828125
        },
        {
            "start_logit": -8.1875,
            "end_logit": 6.8671875,
            "text": "disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.0007920265197753906
        },
        {
            "start_logit": -8.28125,
            "end_logit": 6.8671875,
            "text": "to biological disease-modifying anti-rheumatic drugs (bDMARDs) and in low or moderate Disease Activity Score of 28 joints with C-reactive protein",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 6.8671875,
            "text": "-reactive protein",
            "probability": 0.0006313323974609375
        },
        {
            "start_logit": -3.486328125,
            "end_logit": -3.068359375,
            "text": "joints",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -5.8203125,
            "text": "C-reactive protein (DAS)28",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -6.17578125,
            "text": "C-reactive protein (DAS)28-CRP",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -4.59375,
            "end_logit": -3.068359375,
            "text": "28 joints",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -7.57421875,
            "text": "C-reactive protein (DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -7.81640625,
            "text": "C-reactive",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -7.83203125,
            "text": "C-reactive protein (DAS)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -8.1015625,
            "text": "C-reactive protein (DAS)28-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -8.1015625,
            "text": "C-reactive protein (DAS)28-CRP)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.486328125,
            "end_logit": -5.8203125,
            "text": "joints with C-reactive protein (DAS)28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.19140625,
            "end_logit": -8.2109375,
            "text": "C-",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_15": [
        {
            "start_logit": 1.541015625,
            "end_logit": 9.328125,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.98828125
        },
        {
            "start_logit": -3.025390625,
            "end_logit": 9.328125,
            "text": "Joints",
            "probability": 0.01031494140625
        },
        {
            "start_logit": -5.4296875,
            "end_logit": 9.328125,
            "text": "28 Joints",
            "probability": 0.0009298324584960938
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 9.328125,
            "text": "in 28 Joints",
            "probability": 8.255243301391602e-05
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.328125,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 5.167722702026367e-05
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.328125,
            "text": "Activity Score in 28 Joints",
            "probability": 4.780292510986328e-05
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -3.443359375,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -5.515625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.1484375,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.1796875,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.25,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.43359375,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.49609375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.54296875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.54296875,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.578125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.6328125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.76171875,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -7.88671875,
            "text": "Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.541015625,
            "end_logit": -8.0078125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_16": [
        {
            "start_logit": -0.08868408203125,
            "end_logit": 9.421875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.9052734375
        },
        {
            "start_logit": -2.62109375,
            "end_logit": 9.421875,
            "text": "joints",
            "probability": 0.07171630859375
        },
        {
            "start_logit": -3.986328125,
            "end_logit": 9.421875,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.0183563232421875
        },
        {
            "start_logit": -5.578125,
            "end_logit": 9.421875,
            "text": "28 joints",
            "probability": 0.00373077392578125
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.421875,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.00048351287841796875
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 9.421875,
            "text": "in 28 joints",
            "probability": 0.0003509521484375
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.421875,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.00017583370208740234
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -3.814453125,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -2.62109375,
            "end_logit": -3.814453125,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.328125,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.3828125,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.40234375,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.43359375,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.515625,
            "text": "Disease Activity Score in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.53515625,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.66796875,
            "text": "Disease Activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.986328125,
            "end_logit": -3.814453125,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.8671875,
            "text": "Disease Activity Score in 28 joints (DAS28) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -7.953125,
            "text": "Disease Activity Score in 28 joints (DAS28) is a key measure in clinical practice",
            "probability": 0.0
        },
        {
            "start_logit": -0.08868408203125,
            "end_logit": -8.0859375,
            "text": "Disease Activity Score in 28 joints (DAS28) is a",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_17": [
        {
            "start_logit": -4.26171875,
            "end_logit": 8.046875,
            "text": "joints",
            "probability": 0.37548828125
        },
        {
            "start_logit": -4.35546875,
            "end_logit": 8.046875,
            "text": "28 joints",
            "probability": 0.341796875
        },
        {
            "start_logit": -4.91796875,
            "end_logit": 8.046875,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.1947021484375
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 8.046875,
            "text": "The Disease Activity Score including 28 joints",
            "probability": 0.06756591796875
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.046875,
            "text": "OBJECTIVE: The Disease Activity Score including 28 joints",
            "probability": 0.01068878173828125
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.046875,
            "text": "including 28 joints",
            "probability": 0.01007843017578125
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -4.59765625,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -4.59765625,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -5.6953125,
            "text": "joints (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -5.6953125,
            "text": "28 joints (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.91796875,
            "end_logit": -5.6953125,
            "text": "Disease Activity Score including 28 joints (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -6.921875,
            "text": "joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6015625,
            "end_logit": -4.59765625,
            "text": "rheumatoid arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -6.921875,
            "text": "28 joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -7.1015625,
            "text": "joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.35546875,
            "end_logit": -7.1015625,
            "text": "28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.9765625,
            "end_logit": -5.6953125,
            "text": "The Disease Activity Score including 28 joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -7.47265625,
            "text": "joints (DAS28) and the Clinical Disease Activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -4.59765625,
            "text": "DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.26171875,
            "end_logit": -7.53125,
            "text": "joints (DAS",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_18": [
        {
            "start_logit": -1.0859375,
            "end_logit": 8.25,
            "text": "28 joints",
            "probability": 0.89892578125
        },
        {
            "start_logit": -3.7890625,
            "end_logit": 8.25,
            "text": "joints",
            "probability": 0.06024169921875
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 8.25,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.03076171875
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 8.25,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.00637054443359375
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.25,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.0013885498046875
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.25,
            "text": "on 28 joints",
            "probability": 0.0009250640869140625
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.25,
            "text": "based on 28 joints",
            "probability": 0.000865936279296875
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -4.8046875,
            "text": "28 joints (",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -6.2890625,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.44921875,
            "text": "28 joints (DAS28) has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -4.8046875,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.5234375,
            "text": "28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.67578125,
            "text": "28 joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.69921875,
            "text": "28 joints (DAS28) has been increasingly used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.70703125,
            "text": "28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.8359375,
            "text": "28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.875,
            "text": "28 joints (DAS28) has been increasingly used in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.94921875,
            "text": "28 joints (DAS28) has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.98828125,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.99609375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_19": [
        {
            "start_logit": -0.14453125,
            "end_logit": 7.921875,
            "text": "28 joints",
            "probability": 0.97607421875
        },
        {
            "start_logit": -4.09375,
            "end_logit": 7.921875,
            "text": "joints",
            "probability": 0.0188140869140625
        },
        {
            "start_logit": -6.671875,
            "end_logit": 7.921875,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.0014276504516601562
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 7.921875,
            "text": "including 28 joints",
            "probability": 0.0010042190551757812
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.921875,
            "text": "rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0006489753723144531
        },
        {
            "start_logit": -7.890625,
            "end_logit": 7.921875,
            "text": "the Disease Activity Score including 28 joints",
            "probability": 0.0004222393035888672
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.921875,
            "text": "Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0003273487091064453
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.921875,
            "text": "congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0002713203430175781
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.921875,
            "text": "daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0002713203430175781
        },
        {
            "start_logit": -8.421875,
            "end_logit": 7.921875,
            "text": "reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0002472400665283203
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.04296875,
            "text": "28 joints (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.4765625,
            "text": "28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.59765625,
            "text": "28 joints (DAS28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.69921875,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.765625,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.86328125,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.8671875,
            "text": "28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -7.9453125,
            "text": "28 joints (DAS28)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.14453125,
            "end_logit": -8.1640625,
            "text": "28 joints (DAS28) compared with the Clinical Disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.09375,
            "end_logit": -7.04296875,
            "text": "joints (",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_20": [
        {
            "start_logit": -0.6142578125,
            "end_logit": 3.134765625,
            "text": "erythrocyte sedimentation rate",
            "probability": 0.91748046875
        },
        {
            "start_logit": -3.609375,
            "end_logit": 3.134765625,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.04595947265625
        },
        {
            "start_logit": -4.43359375,
            "end_logit": 3.134765625,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0201416015625
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 3.134765625,
            "text": "28 joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0033092498779296875
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 3.134765625,
            "text": "joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0027446746826171875
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 3.134765625,
            "text": "calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0022754669189453125
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 3.134765625,
            "text": "Disease Activity Score in 28 joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0015878677368164062
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 3.134765625,
            "text": "with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.001434326171875
        },
        {
            "start_logit": -7.4375,
            "end_logit": 3.134765625,
            "text": "(DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0009975433349609375
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 3.134765625,
            "text": "CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0007352828979492188
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 3.134765625,
            "text": "rate",
            "probability": 0.0006194114685058594
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 3.134765625,
            "text": "of erythrocyte sedimentation rate",
            "probability": 0.0006146430969238281
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 3.134765625,
            "text": "is used instead of erythrocyte sedimentation rate",
            "probability": 0.0005817413330078125
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 3.134765625,
            "text": "OBJECTIVES: Disease Activity Score in 28 joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.0005216598510742188
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 3.134765625,
            "text": "used instead of erythrocyte sedimentation rate",
            "probability": 0.0004901885986328125
        },
        {
            "start_logit": -0.6142578125,
            "end_logit": -4.4453125,
            "text": "erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.00046944618225097656
        },
        {
            "start_logit": -0.6142578125,
            "end_logit": -7.1953125,
            "text": "erythrocyte sedimentation rate (DAS28",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -3.609375,
            "end_logit": -4.4453125,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -0.6142578125,
            "end_logit": -7.62109375,
            "text": "erythrocyte sedimentation",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -3.609375,
            "end_logit": -4.64453125,
            "text": "C-reactive protein",
            "probability": 1.9371509552001953e-05
        }
    ],
    "5fe3130da43ad3127800003f_21": [
        {
            "start_logit": 2.0078125,
            "end_logit": 7.84375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.99609375
        },
        {
            "start_logit": -3.689453125,
            "end_logit": 7.84375,
            "text": "joints",
            "probability": 0.0033473968505859375
        },
        {
            "start_logit": -5.17578125,
            "end_logit": 7.84375,
            "text": "28 joints",
            "probability": 0.0007562637329101562
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.84375,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 5.894899368286133e-05
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.84375,
            "text": "OBJECTIVE: To optimize use of the Disease Activity Score in 28 joints",
            "probability": 5.412101745605469e-05
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.84375,
            "text": "To optimize use of the Disease Activity Score in 28 joints",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 7.84375,
            "text": "in 28 joints",
            "probability": 4.595518112182617e-05
        },
        {
            "start_logit": -8.1875,
            "end_logit": 7.84375,
            "text": "optimize use of the Disease Activity Score in 28 joints",
            "probability": 3.725290298461914e-05
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -4.6484375,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -6.80859375,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.0390625,
            "text": "Disease Activity Score in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.12890625,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.234375,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.3671875,
            "text": "Disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.4140625,
            "text": "Disease Activity Score",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.53125,
            "text": "Disease Activity Score in 28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test\" of forefeet",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.65625,
            "text": "Disease Activity Score in 28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.68359375,
            "text": "Disease Activity Score in 28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.6953125,
            "text": "Disease Activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.0078125,
            "end_logit": -7.7109375,
            "text": "Disease Activity Score in 28 joints (DAS28) in early rheumatoid arthritis (RA) by adding the \"squeeze test",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5710a592cf1c32585100002a_1": [
        {
            "start_logit": 5.96484375,
            "end_logit": 8.578125,
            "text": "bicarbonate/CO2",
            "probability": 0.93115234375
        },
        {
            "start_logit": 3.357421875,
            "end_logit": 8.578125,
            "text": "CO2",
            "probability": 0.06854248046875
        },
        {
            "start_logit": 5.96484375,
            "end_logit": 1.2080078125,
            "text": "bicarbonate",
            "probability": 0.0005831718444824219
        },
        {
            "start_logit": -4.91015625,
            "end_logit": 8.578125,
            "text": "elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.578125,
            "text": "Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -5.06640625,
            "text": "bicarbonate/CO2 concentrations,",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.578125,
            "text": "to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.578125,
            "text": "and bicarbonate/CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.578125,
            "text": "temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.578125,
            "text": ", Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 8.578125,
            "text": "Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.578125,
            "text": "responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.578125,
            "text": "infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.578125,
            "text": "host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -6.65625,
            "text": "bicarbonate/CO2 concentrations",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -6.953125,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -7.0625,
            "text": "bicarbonate/CO2 concentrations, with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -7.48828125,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.96484375,
            "end_logit": -7.63671875,
            "text": "bicarbonate/CO2 concentrations, with increased",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.357421875,
            "end_logit": -5.06640625,
            "text": "CO2 concentrations,",
            "probability": 5.960464477539063e-08
        }
    ],
    "5710a592cf1c32585100002a_2": [
        {
            "start_logit": 10.2265625,
            "end_logit": 10.7265625,
            "text": "CO(2) /bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": 10.7265625,
            "text": "bicarbonate",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -1.0869140625,
            "text": "CO",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 10.7265625,
            "text": "/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 10.7265625,
            "text": "(2) /bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.56640625,
            "text": "CO(2) /bicarbonate exhibited",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.5859375,
            "text": "CO(2",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 10.7265625,
            "text": ") /bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.71484375,
            "text": "CO(",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.7265625,
            "text": "2) /bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.80859375,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.81640625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.7265625,
            "text": "cultures grown with elevated CO(2) /bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.2265625,
            "end_logit": -7.9140625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.7265625,
            "text": "elevated CO(2) /bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": -7.4375,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate, suggesting",
            "probability": 0.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": -7.56640625,
            "text": "bicarbonate exhibited",
            "probability": 0.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": -7.80859375,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to",
            "probability": 0.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": -7.81640625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and",
            "probability": 0.0
        },
        {
            "start_logit": -0.6728515625,
            "end_logit": -7.9140625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_3": [
        {
            "start_logit": 8.03125,
            "end_logit": 9.1015625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.1015625,
            "text": "by CO2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.1015625,
            "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.1015625,
            "text": "Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.578125,
            "end_logit": 9.1015625,
            "text": "major Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.1015625,
            "text": "triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 9.1015625,
            "text": "virulence genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 9.1015625,
            "text": "genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 9.1015625,
            "text": "the major Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.90234375,
            "text": "CO2, a signal mimicking the host environment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.0078125,
            "text": "CO2, a signal mimicking",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.0234375,
            "text": "CO2,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.0390625,
            "text": "CO2, a signal mimicking the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.0546875,
            "text": "CO2, a signal mimicking the host environment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.0546875,
            "text": "CO2, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.1796875,
            "text": "CO2, a signal mimicking the host",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.21875,
            "text": "CO2, a signal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.90234375,
            "text": "by CO2, a signal mimicking the host environment",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -8.0078125,
            "text": "by CO2, a signal mimicking",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -8.0234375,
            "text": "by CO2,",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_4": [
        {
            "start_logit": 7.89453125,
            "end_logit": 9.140625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 9.140625,
            "text": "of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.140625,
            "text": "presence of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.140625,
            "text": "in presence of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.140625,
            "text": "vitro in presence of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.140625,
            "text": "Furthermore, in vitro in presence of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.140625,
            "text": "in vitro in presence of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.140625,
            "text": ", in vitro in presence of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.94140625,
            "text": "CO2 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.984375,
            "text": "CO2 and in vivo, AtxA is part of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.0390625,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.0546875,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.078125,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.15625,
            "text": "CO2 and in vivo, AtxA is part",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.1875,
            "text": "CO2 and in vivo, AtxA is part of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.1953125,
            "text": "CO2 and in vivo, AtxA is part of the sap and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.2734375,
            "text": "CO2 and in vivo, AtxA is part of the sap and ea",
            "probability": 0.0
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.296875,
            "text": "CO2 and in vivo, AtxA is part of the sap",
            "probability": 0.0
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.3203125,
            "text": "CO2 and in",
            "probability": 0.0
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -8.3984375,
            "text": "CO2 and in vivo",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_5": [
        {
            "start_logit": 10.15625,
            "end_logit": 10.484375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": 10.484375,
            "text": "bicarbonate",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 10.15625,
            "end_logit": -1.1630859375,
            "text": "CO2",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 10.484375,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 10.484375,
            "text": "not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.046875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 10.484375,
            "text": "/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.5625,
            "text": "CO2/bicarbonate,",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.83984375,
            "text": "CO2/bicarbonate, affects",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.91015625,
            "text": "CO2/bicarbonate, affects AtxA synthesis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.0234375,
            "text": "CO2/bicarbonate, affects At",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.046875,
            "text": "CO2/bicarbonate, affects AtxA",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 10.484375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.484375,
            "text": "toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.125,
            "text": "CO2/",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.484375,
            "text": "Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.484375,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.484375,
            "text": "in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.484375,
            "text": "anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -1.1630859375,
            "text": "temperature, not CO2",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_6": [
        {
            "start_logit": 8.0703125,
            "end_logit": 9.5625,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": 9.5625,
            "text": "elevated CO2/bicarbonate",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -2.58203125,
            "end_logit": 9.5625,
            "text": "bicarbonate",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -4.0546875,
            "text": "CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 9.5625,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -4.80078125,
            "text": "CO2/bicarbonate and temperature",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -5.5,
            "text": "CO2/bicarbonate and temperature.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.5625,
            "text": "enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 9.5625,
            "text": "the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 9.5625,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 9.5625,
            "text": "signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.5625,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.5625,
            "text": "two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 9.5625,
            "text": ") is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.5625,
            "text": "by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.5625,
            "text": ", expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.2109375,
            "text": "CO2/bicarbonate and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -4.0546875,
            "text": "elevated CO2",
            "probability": 0.0
        },
        {
            "start_logit": -2.107421875,
            "end_logit": -4.80078125,
            "text": "elevated CO2/bicarbonate and temperature",
            "probability": 0.0
        },
        {
            "start_logit": -2.58203125,
            "end_logit": -4.80078125,
            "text": "bicarbonate and temperature",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_7": [
        {
            "start_logit": 10.15625,
            "end_logit": 10.5234375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -1.3251953125,
            "end_logit": 10.5234375,
            "text": "bicarbonate",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 10.15625,
            "end_logit": -1.2099609375,
            "text": "CO2",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": 10.15625,
            "end_logit": -2.705078125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 10.15625,
            "end_logit": -6.43359375,
            "text": "CO2/bicarbonate levels.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 10.5234375,
            "text": "/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.4140625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.41796875,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 10.5234375,
            "text": "Our data indicate that atxA expression is not influenced by CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.57421875,
            "text": "CO2/bicarbonate levels",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.65625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.67578125,
            "text": "CO2/bicarbonate levels. However, the steady-state",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.7265625,
            "text": "CO2/bicarbonate levels. However, the steady-state level",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.5234375,
            "text": "data indicate that atxA expression is not influenced by CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.5234375,
            "text": "by CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -0.5341796875,
            "end_logit": -2.705078125,
            "text": "five",
            "probability": 0.0
        },
        {
            "start_logit": -1.3251953125,
            "end_logit": -2.705078125,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 0.0
        },
        {
            "start_logit": -0.5341796875,
            "end_logit": -4.859375,
            "text": "five- to sixfold higher",
            "probability": 0.0
        },
        {
            "start_logit": -0.5341796875,
            "end_logit": -5.52734375,
            "text": "five- to sixfold",
            "probability": 0.0
        },
        {
            "start_logit": -0.5341796875,
            "end_logit": -6.9375,
            "text": "five- to sixfold higher than that observed",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_8": [
        {
            "start_logit": 3.46875,
            "end_logit": 8.890625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.890625,
            "text": "transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.890625,
            "text": "all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.890625,
            "text": "which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.890625,
            "text": "three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.890625,
            "text": "genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.890625,
            "text": ", CO2",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.890625,
            "text": "signal, CO2",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.890625,
            "text": "on, in which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -6.5625,
            "text": "transcription of all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.5625,
            "text": "The Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription of all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -6.8671875,
            "text": "transcription",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -7.0390625,
            "text": "transcription of all three genes is activated",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -7.04296875,
            "text": "transcription of all three genes is",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.5625,
            "text": "all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -7.15625,
            "text": "transcription of all three genes is activated in trans by the same regulatory gene, atxA",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.8671875,
            "text": "The Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon, in which transcription",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -6.5625,
            "text": "viewed as a regulon, in which transcription of all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -7.28515625,
            "text": "transcription of all",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.5625,
            "text": "be viewed as a regulon, in which transcription of all three genes",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_9": [
        {
            "start_logit": 2.158203125,
            "end_logit": 8.9765625,
            "text": "CO2",
            "probability": 0.9990234375
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 8.9765625,
            "text": "elevated CO2",
            "probability": 0.0009288787841796875
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -2.07421875,
            "text": "toxin",
            "probability": 0.0001195073127746582
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -2.853515625,
            "text": "toxin gene regulator",
            "probability": 5.513429641723633e-05
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.9765625,
            "text": "Comparison of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 3.3915042877197266e-05
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.9765625,
            "text": "growth in elevated CO2",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.9765625,
            "text": "non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.9765625,
            "text": "synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.9765625,
            "text": "in elevated CO2",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.9765625,
            "text": "by growth in elevated CO2",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.9765625,
            "text": "toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.9765625,
            "text": "that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.9765625,
            "text": "resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 8.9765625,
            "text": "protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": 2.158203125,
            "end_logit": -2.07421875,
            "text": "CO2 and the toxin",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 2.158203125,
            "end_logit": -2.853515625,
            "text": "CO2 and the toxin gene regulator",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -6.91015625,
            "text": "toxin gene regulator, atxA.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -7.1171875,
            "text": "toxin gene",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -7.55859375,
            "text": "toxin gene regulator,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.1796875,
            "end_logit": -7.94921875,
            "text": "toxin gene regulator, atxA",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5710a592cf1c32585100002a_10": [
        {
            "start_logit": 9.328125,
            "end_logit": 8.9296875,
            "text": "acpA",
            "probability": 0.74755859375
        },
        {
            "start_logit": 9.328125,
            "end_logit": 7.8046875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.24267578125
        },
        {
            "start_logit": 6.12890625,
            "end_logit": 7.8046875,
            "text": "bicarbonate",
            "probability": 0.01001739501953125
        },
        {
            "start_logit": 9.328125,
            "end_logit": -3.2265625,
            "text": "acp",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 8.9296875,
            "text": "A",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 7.8046875,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.8984375,
            "text": "acpA, and activation appeared to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.90234375,
            "text": "acpA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9765625,
            "text": "acpA, and activation appeared to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -8.078125,
            "text": "acpA, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.9296875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 8.9296875,
            "text": "and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.9296875,
            "text": "both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.9296875,
            "text": "activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.8046875,
            "text": "by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.8046875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8046875,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.8046875,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.8046875,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_11": [
        {
            "start_logit": 8.09375,
            "end_logit": 9.0546875,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 9.0546875,
            "text": "to CO2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 9.0546875,
            "text": "respond to CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.0546875,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.0546875,
            "text": "genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.4296875,
            "text": "CO2 through",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.0546875,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.0546875,
            "text": "anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.0546875,
            "text": "that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.78515625,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.828125,
            "text": "CO2 through an AtxA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -8.0078125,
            "text": "CO2 through an AtxA-dependent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -8.03125,
            "text": "CO2 through an AtxA-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.09375,
            "end_logit": -8.2734375,
            "text": "CO2 through an At",
            "probability": 0.0
        },
        {
            "start_logit": 8.09375,
            "end_logit": -8.2890625,
            "text": "CO2 through an",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -7.4296875,
            "text": "to CO2 through",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -7.78515625,
            "text": "to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -7.828125,
            "text": "to CO2 through an AtxA",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -8.0078125,
            "text": "to CO2 through an AtxA-dependent",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": -8.03125,
            "text": "to CO2 through an AtxA-",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_12": [
        {
            "start_logit": 9.328125,
            "end_logit": 8.9296875,
            "text": "acpA",
            "probability": 0.74755859375
        },
        {
            "start_logit": 9.328125,
            "end_logit": 7.8046875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.24267578125
        },
        {
            "start_logit": 6.12890625,
            "end_logit": 7.8046875,
            "text": "bicarbonate",
            "probability": 0.01001739501953125
        },
        {
            "start_logit": 9.328125,
            "end_logit": -3.2265625,
            "text": "acp",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 8.9296875,
            "text": "A",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 7.8046875,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.8984375,
            "text": "acpA, and activation appeared to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.90234375,
            "text": "acpA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9765625,
            "text": "acpA, and activation appeared to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -8.078125,
            "text": "acpA, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.9296875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 8.9296875,
            "text": "and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.9296875,
            "text": "both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.9296875,
            "text": "activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.8046875,
            "text": "by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.8046875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8046875,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.8046875,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.8046875,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_13": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.9609375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.9609375,
            "text": "to CO2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.9609375,
            "text": "respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.9609375,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.546875,
            "text": "CO2 through",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.9609375,
            "text": "genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.9609375,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.9609375,
            "text": "anthracis genes that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 8.9609375,
            "text": "that respond to CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.953125,
            "text": "CO2 through an AtxA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.09375,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.109375,
            "text": "CO2 through an AtxA-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.1171875,
            "text": "CO2 through an AtxA-dependent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.25,
            "text": "CO2 through an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.2578125,
            "text": "CO2 through an At",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -8.3984375,
            "text": "CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -7.546875,
            "text": "to CO2 through",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -7.953125,
            "text": "to CO2 through an AtxA",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -8.09375,
            "text": "to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -8.109375,
            "text": "to CO2 through an AtxA-",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_14": [
        {
            "start_logit": 7.828125,
            "end_logit": 9.1484375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.1484375,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 9.1484375,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 9.1484375,
            "text": "enhanced during growth under elevated levels of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.1484375,
            "text": "the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.1484375,
            "text": "of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.1484375,
            "text": "B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.1484375,
            "text": "elevated levels of CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.09375,
            "text": "CO2.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.1484375,
            "text": "during growth under elevated levels of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.1484375,
            "text": "by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.1484375,
            "text": "growth under elevated levels of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 9.1484375,
            "text": "levels of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.1484375,
            "text": "under elevated levels of CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -6.59765625,
            "text": "toxin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -7.09375,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -6.59765625,
            "text": "Expression of the toxin",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -7.5390625,
            "text": "toxin genes by B. anthracis is",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -7.58203125,
            "text": "toxin genes",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -7.5859375,
            "text": "toxin genes by B. anthracis",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_15": [
        {
            "start_logit": 7.71875,
            "end_logit": 9.2265625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.2265625,
            "text": "This CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -6.70703125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.03515625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.30859375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.5859375,
            "text": "CO2 effect is observed only in the presence of another pXO1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.59375,
            "text": "CO2 effect is observed only in the presence of another pX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.6015625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.765625,
            "text": "CO2 effect is observed only in the presence of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.8203125,
            "text": "CO2 effect",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.83203125,
            "text": "CO2 effect is observed only in the presence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.84375,
            "text": "CO2 effect is observed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.84765625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.859375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.90234375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.91015625,
            "text": "CO2 effect is observed only",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.97265625,
            "text": "CO2 effect is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.9765625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.71875,
            "end_logit": -8.0,
            "text": "CO2 effect is observed only in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.890625,
            "end_logit": -6.70703125,
            "text": "anthrax toxin synthesis.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_16": [
        {
            "start_logit": 7.7578125,
            "end_logit": 9.328125,
            "text": "CO2",
            "probability": 0.994140625
        },
        {
            "start_logit": 2.6875,
            "end_logit": 9.328125,
            "text": "5% CO2",
            "probability": 0.006195068359375
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.328125,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.328125,
            "text": "in 5% CO2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 9.328125,
            "text": "% CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.328125,
            "text": "in cells grown in 5% CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 9.328125,
            "text": "cells grown in 5% CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.328125,
            "text": "transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.328125,
            "text": "atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.328125,
            "text": "xA does not appear to differ in cells grown in 5% CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.328125,
            "text": "grown in 5% CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.328125,
            "text": "not appear to differ in cells grown in 5% CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.328125,
            "text": "differ in cells grown in 5% CO2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.26171875,
            "text": "CO2 compared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.84375,
            "text": "CO2 compared with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.2734375,
            "text": "CO2 compared with cells grown in",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.28125,
            "text": "CO2 compared with cells grown",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.28125,
            "text": "CO2 compared with cells grown in air",
            "probability": 0.0
        },
        {
            "start_logit": 2.6875,
            "end_logit": -4.71875,
            "text": "5",
            "probability": 0.0
        },
        {
            "start_logit": 2.6875,
            "end_logit": -7.26171875,
            "text": "5% CO2 compared",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_17": [
        {
            "start_logit": 8.0234375,
            "end_logit": 8.8125,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -4.49609375,
            "end_logit": 8.8125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -4.1015625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of 70",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -5.61328125,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -5.7109375,
            "text": "bicarbonate.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 8.8125,
            "text": "by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.37890625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.5390625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of 70 bp",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.8125,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.7890625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.8125,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.86328125,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.9765625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.8125,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.8125,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.8125,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.8125,
            "text": "stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.8125,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.8125,
            "text": "and activation appeared to be stimulated by bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.39453125,
            "text": "bicarbonate. Deletion analysis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_18": [
        {
            "start_logit": 6.83203125,
            "end_logit": 9.234375,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 9.234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.234375,
            "text": "by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.234375,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.234375,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 9.234375,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 9.234375,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.234375,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 9.234375,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 9.234375,
            "text": "and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -4.7734375,
            "text": "acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -4.7734375,
            "text": "both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -4.7734375,
            "text": "activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -4.7734375,
            "text": "atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -4.7734375,
            "text": "upstream of the translation-initiation codon of capB. Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -4.7734375,
            "text": "and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -6.921875,
            "text": "designated P1 and P2, located at positions 731",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.125,
            "text": "designated P1 and P2, located at positions 73",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.26171875,
            "text": "designated P1 and P2, located at positions 731 bp and 625 bp, respectively, upstream of the translation-initiation codon of capB. Transcription initiated",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -6.921875,
            "text": "located at positions 731",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_19": [
        {
            "start_logit": 9.328125,
            "end_logit": 8.9296875,
            "text": "acpA",
            "probability": 0.74755859375
        },
        {
            "start_logit": 9.328125,
            "end_logit": 7.8046875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.24267578125
        },
        {
            "start_logit": 6.12890625,
            "end_logit": 7.8046875,
            "text": "bicarbonate",
            "probability": 0.01001739501953125
        },
        {
            "start_logit": 9.328125,
            "end_logit": -3.2265625,
            "text": "acp",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 8.9296875,
            "text": "A",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -4.05078125,
            "end_logit": 7.8046875,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.8984375,
            "text": "acpA, and activation appeared to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.90234375,
            "text": "acpA,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -7.9765625,
            "text": "acpA, and activation appeared to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.328125,
            "end_logit": -8.078125,
            "text": "acpA, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.9296875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 8.9296875,
            "text": "and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.9296875,
            "text": "both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.9296875,
            "text": "activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.8046875,
            "text": "by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.8046875,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 7.8046875,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 7.8046875,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.8046875,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_20": [
        {
            "start_logit": 10.15625,
            "end_logit": 10.484375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": 10.484375,
            "text": "bicarbonate",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 10.15625,
            "end_logit": -1.1630859375,
            "text": "CO2",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 10.484375,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 10.484375,
            "text": "not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.046875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 10.484375,
            "text": "/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.5625,
            "text": "CO2/bicarbonate,",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.83984375,
            "text": "CO2/bicarbonate, affects",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -7.91015625,
            "text": "CO2/bicarbonate, affects AtxA synthesis",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.0234375,
            "text": "CO2/bicarbonate, affects At",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.046875,
            "text": "CO2/bicarbonate, affects AtxA",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 10.484375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.484375,
            "text": "toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": 10.15625,
            "end_logit": -8.125,
            "text": "CO2/",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.484375,
            "text": "Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.484375,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.484375,
            "text": "in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 10.484375,
            "text": "anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -1.1630859375,
            "text": "temperature, not CO2",
            "probability": 0.0
        }
    ],
    "5a87ea1861bb38fb2400000d_1": [
        {
            "start_logit": 8.921875,
            "end_logit": 5.1640625,
            "text": "circularized oligodeoxynucleotides",
            "probability": 1.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -3.732421875,
            "text": "circular",
            "probability": 0.0001366138458251953
        },
        {
            "start_logit": 8.921875,
            "end_logit": -4.35546875,
            "text": "circularized oligodeoxynucleotides (",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.921875,
            "end_logit": -5.7890625,
            "text": "circularized oligodeoxynucleotides (coligos",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.23828125,
            "text": "circularized oligodeoxynucleotides (coligos)",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.87890625,
            "text": "circularized oligodeoxynucleotides (coligo",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.98828125,
            "text": "circularized oligodeoxynucle",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.03125,
            "text": "circularized oligodeoxynucleotides (coli",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.234375,
            "text": "circularized oligodeox",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.51953125,
            "text": "circularized",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.421875,
            "end_logit": 5.1640625,
            "text": "otides",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 5.1640625,
            "text": "oligodeoxynucleotides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 5.1640625,
            "text": "ynucleotides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 5.1640625,
            "text": "ized oligodeoxynucleotides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.421875,
            "end_logit": -4.35546875,
            "text": "otides (",
            "probability": 0.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": -5.7890625,
            "text": "otides (coligos",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -4.35546875,
            "text": "oligodeoxynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -4.35546875,
            "text": "ynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -4.35546875,
            "text": "ized oligodeoxynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -6.421875,
            "end_logit": -6.23828125,
            "text": "otides (coligos)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_1": [
        {
            "start_logit": 9.6796875,
            "end_logit": 9.9453125,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": 9.9453125,
            "text": "cardiomyopathy",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -2.6015625,
            "text": "hypertrophic",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.6328125,
            "text": "hypertrophic cardiomyopathy (30",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.296875,
            "text": "hypertrophic cardiomyopathy (30 %",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.4140625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.828125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.96484375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.97265625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.0234375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.03125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.0546875,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.09375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.1328125,
            "text": "hypertrophic cardiomyopathy (30 %)",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.140625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.171875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by",
            "probability": 0.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -8.203125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis",
            "probability": 0.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": -6.6328125,
            "text": "cardiomyopathy (30",
            "probability": 0.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": -7.296875,
            "text": "cardiomyopathy (30 %",
            "probability": 0.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": -7.4140625,
            "text": "cardiomyopathy (30 %), followed by coronary artery anomalies",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_2": [
        {
            "start_logit": 9.2109375,
            "end_logit": 8.5703125,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -2.482421875,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -3.4375,
            "text": "hypertrophic",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -4.4296875,
            "end_logit": 8.5703125,
            "text": "cardiomyopathy",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.08984375,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.11328125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.73046875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.73046875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.828125,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.9765625,
            "text": "hypertrophic cardiomyopathy (HCM),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.984375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.9921875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -8.046875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -8.0625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -8.078125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -8.1328125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.5703125,
            "text": ", hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.5703125,
            "text": "The most common cause of this, hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.5703125,
            "text": "this, hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": -4.4296875,
            "end_logit": -2.482421875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_3": [
        {
            "start_logit": 8.4140625,
            "end_logit": 8.53125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -4.390625,
            "end_logit": 8.53125,
            "text": "cardiomyopathy",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -4.39453125,
            "text": "Hypertrophic",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -5.27734375,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -5.66015625,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.07421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.5703125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -7.94140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.0859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.1875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.2265625,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.2421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.25,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4140625,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.390625,
            "end_logit": -5.27734375,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -4.390625,
            "end_logit": -5.66015625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_4": [
        {
            "start_logit": 9.0625,
            "end_logit": 8.6953125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -3.6484375,
            "text": "Hypertrophic",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -4.31640625,
            "end_logit": 8.6953125,
            "text": "cardiomyopathy",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.140625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.4453125,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.21484375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.81640625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.8984375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.90234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.97265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.0078125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.203125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.2421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.25,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.2734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death",
            "probability": 5.960464477539063e-08
        }
    ],
    "530cf4e0c8a0b4a00c000006_5": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.90625,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -3.53515625,
            "text": "Hypertrophic",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -4.078125,
            "end_logit": 8.90625,
            "text": "cardiomyopathy",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.67578125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.9609375,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.66015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.98046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.078125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.09375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.1015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.1796875,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.203125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.2578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.359375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.078125,
            "end_logit": -5.67578125,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -4.078125,
            "end_logit": -5.9609375,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -5.23046875,
            "end_logit": -5.67578125,
            "text": "HCM",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_6": [
        {
            "start_logit": 9.734375,
            "end_logit": 10.0078125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": 10.0078125,
            "text": "cardiomyopathy",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.53515625,
            "text": "Hypertrophic",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.9296875,
            "text": "Hypertrophic cardiomyopathy is regarded as",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.984375,
            "text": "Hypertrophic cardiomyopathy is regarded as the",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.015625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.015625,
            "text": "Hypertrophic cardiomyopathy is regarded",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.046875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1484375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.2421875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.328125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young",
            "probability": 0.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": -7.9296875,
            "text": "cardiomyopathy is regarded as",
            "probability": 0.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": -7.984375,
            "text": "cardiomyopathy is regarded as the",
            "probability": 0.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": -8.015625,
            "text": "cardiomyopathy is regarded as the most common",
            "probability": 0.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": -8.015625,
            "text": "cardiomyopathy is regarded",
            "probability": 0.0
        },
        {
            "start_logit": -2.7109375,
            "end_logit": -8.046875,
            "text": "cardiomyopathy is regarded as the most common cause",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_7": [
        {
            "start_logit": 9.7890625,
            "end_logit": 10.046875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": 10.046875,
            "text": "cardiomyopathy",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -2.388671875,
            "text": "hypertrophic",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.046875,
            "text": "is hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.3046875,
            "text": "hypertrophic cardiomyopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.046875,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.046875,
            "text": "in athletes is hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 10.046875,
            "text": "athletes is hypertrophic cardiomyopathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -2.388671875,
            "text": "is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -2.583984375,
            "end_logit": -8.3046875,
            "text": "cardiomyopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -2.388671875,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": -2.388671875,
            "text": "in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -2.388671875,
            "text": "athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.3046875,
            "text": "is hypertrophic cardiomyopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -8.3046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.2109375,
            "text": "The most common",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.25,
            "text": "The most",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.265625,
            "text": "The most common cause",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.265625,
            "text": "The most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.265625,
            "text": "The",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_8": [
        {
            "start_logit": 7.82421875,
            "end_logit": 3.220703125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 0.97314453125
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -0.410888671875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 0.0257415771484375
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -4.9375,
            "text": "Hypertrophic",
            "probability": 0.0002791881561279297
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -5.8203125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 0.00011461973190307617
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.0859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 3.230571746826172e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.828125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.94140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.0,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.1171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.1171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.2109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.21875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.25,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.2578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac",
            "probability": 1.0013580322265625e-05
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.2734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.28125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -8.3125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of sudden cardiac",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 3.220703125,
            "text": "cardiomyopathy",
            "probability": 1.7881393432617188e-07
        }
    ],
    "530cf4e0c8a0b4a00c000006_9": [
        {
            "start_logit": 7.8828125,
            "end_logit": 8.1796875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -4.81640625,
            "end_logit": 8.1796875,
            "text": "cardiomyopathy",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -4.90625,
            "text": "hypertrophic",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 8.1796875,
            "text": "disorder hypertrophic cardiomyopathy",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -6.16015625,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -6.52734375,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.1796875,
            "text": "competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.1796875,
            "text": "inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -7.9140625,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.1796875,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.1796875,
            "text": ", is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.1796875,
            "text": "individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -8.0546875,
            "text": "hypertrophic cardiomyopathy (HCM).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.1796875,
            "text": "including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.1796875,
            "text": "the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.1796875,
            "text": "athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.1796875,
            "text": ", including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -4.90625,
            "text": "disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -4.81640625,
            "end_logit": -6.16015625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -4.81640625,
            "end_logit": -6.52734375,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_10": [
        {
            "start_logit": 9.5859375,
            "end_logit": 9.5078125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -2.775390625,
            "text": "Hypertrophic",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -3.400390625,
            "end_logit": 9.5078125,
            "text": "cardiomyopathy",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -5.83203125,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -6.14453125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.69140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.71484375,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.03125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.03125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.1171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.2265625,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes.",
            "probability": 0.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -8.2734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the",
            "probability": 0.0
        },
        {
            "start_logit": -3.400390625,
            "end_logit": -5.83203125,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -3.400390625,
            "end_logit": -6.14453125,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -3.400390625,
            "end_logit": -7.69140625,
            "text": "cardiomyopathy (HCM) is the",
            "probability": 0.0
        },
        {
            "start_logit": -3.400390625,
            "end_logit": -7.71484375,
            "text": "cardiomyopathy (HCM) is",
            "probability": 0.0
        },
        {
            "start_logit": -3.400390625,
            "end_logit": -7.984375,
            "text": "cardiomyopathy (HCM) is the most common",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_11": [
        {
            "start_logit": 9.875,
            "end_logit": 10.046875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.21484375,
            "text": "Hypertrophic",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.630859375,
            "end_logit": 10.046875,
            "text": "cardiomyopathy",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.87890625,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.95703125,
            "text": "Hypertrophic cardiomyopathy (HC)",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0234375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0390625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0859375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.09375,
            "text": "Hypertrophic cardiomyopathy (HC) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1171875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.140625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1796875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication to",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication to continued participation",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2578125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication to continued",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.28125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.296875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3046875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac",
            "probability": 0.0
        },
        {
            "start_logit": -2.630859375,
            "end_logit": -7.87890625,
            "text": "cardiomyopathy (",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_1": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.171875,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.16015625,
            "text": "multiple",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -2.435546875,
            "end_logit": 10.171875,
            "text": "sclerosis",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.171875,
            "text": "for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0,
            "text": "multiple sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.2890625,
            "text": "multiple sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.171875,
            "text": "Diagnostic performance of central vein sign for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.34375,
            "text": "multiple sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.390625,
            "text": "multiple sclerosis with a simplified three-",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -2.16015625,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.0,
            "text": "sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.2890625,
            "text": "sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -2.16015625,
            "text": "Diagnostic performance of central vein sign for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.34375,
            "text": "sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.390625,
            "text": "sclerosis with a simplified three-",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.0,
            "text": "for multiple sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.2890625,
            "text": "for multiple sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.34375,
            "text": "for multiple sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.390625,
            "text": "for multiple sclerosis with a simplified three-",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.0,
            "text": "Diagnostic performance of central vein sign for multiple sclerosis with",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_2": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.046875,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -2.111328125,
            "text": "multiple",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -2.67578125,
            "end_logit": 10.046875,
            "text": "sclerosis",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.046875,
            "text": "for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.0859375,
            "text": "multiple sclerosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.046875,
            "text": "* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.046875,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.046875,
            "text": "FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.046875,
            "text": "CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.046875,
            "text": "\"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.046875,
            "text": "AIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.046875,
            "text": "central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 10.046875,
            "text": "Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.046875,
            "text": "MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -2.111328125,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -2.111328125,
            "text": "* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.111328125,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -2.111328125,
            "text": "FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.111328125,
            "text": "CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -2.111328125,
            "text": "\"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_3": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.1015625,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.28125,
            "text": "Multiple",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -2.548828125,
            "end_logit": 10.1015625,
            "text": "Sclerosis",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.34765625,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.421875,
            "text": "Multiple Sclerosis from central nervous system inflammatory vascul",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 10.1015625,
            "text": "Central vein sign differentiates Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.9375,
            "text": "Multiple Sclerosis from central nervous system",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.98046875,
            "text": "Multiple Sclerosis from",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0234375,
            "text": "Multiple Sclerosis from central nervous system inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.0546875,
            "text": "Multiple Sclerosis from central nervous",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.171875,
            "text": "Multiple Sclerosis from central",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1015625,
            "text": "s Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2734375,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -7.34765625,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -7.421875,
            "text": "Sclerosis from central nervous system inflammatory vascul",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -2.28125,
            "text": "Central vein sign differentiates Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -7.9375,
            "text": "Sclerosis from central nervous system",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -7.98046875,
            "text": "Sclerosis from",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -8.0234375,
            "text": "Sclerosis from central nervous system inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": -2.548828125,
            "end_logit": -8.0546875,
            "text": "Sclerosis from central nervous",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_4": [
        {
            "start_logit": 9.40625,
            "end_logit": 9.609375,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -2.921875,
            "text": "multiple",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -3.291015625,
            "end_logit": 9.609375,
            "text": "sclerosis",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.609375,
            "text": "between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 9.609375,
            "text": "distinguish between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.953125,
            "end_logit": 9.609375,
            "text": "to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.8203125,
            "text": "multiple sclerosis (MS) and neuromyelitis optica",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.609375,
            "text": "To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -7.95703125,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.609375,
            "text": "OBJECTIVE: To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 9.609375,
            "text": "central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.046875,
            "text": "multiple sclerosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.09375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.609375,
            "text": "the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.1484375,
            "text": "multiple sclerosis (MS) and neuromyelitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.2109375,
            "text": "multiple sclerosis (MS) and neuromyelitis optic",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.25,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.2578125,
            "text": "multiple sclerosis (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.609375,
            "text": "assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -8.296875,
            "text": "multiple sclerosis (MS",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_5": [
        {
            "start_logit": 9.90625,
            "end_logit": 10.15625,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -2.1328125,
            "text": "Multiple",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.466796875,
            "end_logit": 10.15625,
            "text": "Sclerosis",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 10.15625,
            "text": "in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.15625,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.15625,
            "text": "Imaging Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.15625,
            "text": "Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 10.15625,
            "text": "Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.90625,
            "end_logit": -8.3046875,
            "text": "Multiple Sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.15625,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.15625,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -2.1328125,
            "text": "in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -2.1328125,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -2.1328125,
            "text": "Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -2.1328125,
            "text": "Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -2.1328125,
            "text": "Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -2.1328125,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -2.1328125,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.466796875,
            "end_logit": -8.3046875,
            "text": "Sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -8.3046875,
            "text": "in Multiple Sclerosis.",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_6": [
        {
            "start_logit": 9.9375,
            "end_logit": 10.1328125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -2.056640625,
            "text": "multiple",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -2.505859375,
            "end_logit": 10.1328125,
            "text": "sclerosis",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.921875,
            "end_logit": 10.1328125,
            "text": "between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.0234375,
            "text": "multiple sclerosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.09375,
            "text": "multiple sclerosis (MS) and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.140625,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.1953125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.1328125,
            "text": "Importance  The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.1328125,
            "text": "central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.25,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.265625,
            "text": "multiple sclerosis (MS) and not MS,",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.1328125,
            "text": "The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.2734375,
            "text": "multiple sclerosis (MS) and not MS, mainly based",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.2734375,
            "text": "multiple sclerosis (MS)",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.1328125,
            "text": "distinguishing between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.1328125,
            "text": "imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -2.056640625,
            "text": "between multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": -2.056640625,
            "text": "Importance  The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -2.056640625,
            "text": "central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_7": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.1953125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.96875,
            "text": "multiple",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.1953125,
            "text": "sclerosis",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 10.1953125,
            "text": "for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.1953125,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.1953125,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1953125,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.1953125,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "multiple sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.1953125,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.1953125,
            "text": "biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -1.96875,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -1.96875,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -1.96875,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -1.96875,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -1.96875,
            "text": "promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -1.96875,
            "text": "diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": -1.96875,
            "text": "biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": -8.3359375,
            "text": "sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -8.3359375,
            "text": "for multiple sclerosis.",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_8": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.1953125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.96875,
            "text": "multiple",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.1953125,
            "text": "sclerosis",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 10.1953125,
            "text": "for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.1953125,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.1953125,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1953125,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.1953125,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "multiple sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.1953125,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.1953125,
            "text": "biomarker for multiple sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -1.96875,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -1.96875,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -1.96875,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -1.96875,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -1.96875,
            "text": "promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -1.96875,
            "text": "diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": -1.96875,
            "text": "biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": -8.3359375,
            "text": "sclerosis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -8.3359375,
            "text": "for multiple sclerosis.",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_9": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.2578125,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": 10.2578125,
            "text": "Sclerosis",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.169921875,
            "text": "Multiple",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.81640625,
            "text": "Multiple Sclerosis Lesions",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.2578125,
            "text": "in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.2578125,
            "text": "The Central Vein Sign in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.046875,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0703125,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0859375,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1015625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1328125,
            "text": "Multiple Sclerosis Lesions Is",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.15625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.2578125,
            "text": "Central Vein Sign in Multiple Sclerosis",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -7.81640625,
            "text": "Sclerosis Lesions",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -8.046875,
            "text": "Sclerosis Lesions Is Present Irrespective",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -8.0625,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -8.0703125,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -8.0859375,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -8.1015625,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at",
            "probability": 0.0
        }
    ],
    "5c8fe7cb0101eac87000000c_1": [
        {
            "start_logit": 6.65234375,
            "end_logit": 1.9931640625,
            "text": "Runt related factor-2",
            "probability": 0.6884765625
        },
        {
            "start_logit": 6.65234375,
            "end_logit": 1.173828125,
            "text": "Runt related factor-2 (",
            "probability": 0.30322265625
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -3.02734375,
            "text": "Runt related factor-2 (Runx2)",
            "probability": 0.0045318603515625
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -3.4296875,
            "text": "Runt related factor-2 (Runx2",
            "probability": 0.0030307769775390625
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -5.828125,
            "text": "Run",
            "probability": 0.0002753734588623047
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -5.9375,
            "text": "Runt related factor",
            "probability": 0.00024700164794921875
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -6.49609375,
            "text": "Runt",
            "probability": 0.000141143798828125
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -6.625,
            "text": "Runt related",
            "probability": 0.00012362003326416016
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -6.75390625,
            "text": "Runt related factor-",
            "probability": 0.00010907649993896484
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 1.9931640625,
            "text": "2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 1.173828125,
            "text": "(",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 1.173828125,
            "text": "2 (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -3.02734375,
            "text": "Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -3.4296875,
            "text": "Runx2",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -3.02734375,
            "text": "(Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -3.4296875,
            "text": "(Runx2",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -3.02734375,
            "text": "2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -3.02734375,
            "text": ")",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -3.4296875,
            "text": "2 (Runx2",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_1": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.1484375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.181640625,
            "text": "calcitonin",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -2.455078125,
            "end_logit": 10.1484375,
            "text": "receptor",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -6.0859375,
            "text": "calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.1484375,
            "text": "peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.453125,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.453125,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.5,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 10.1484375,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 10.1484375,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.7578125,
            "text": "calcitonin gene-related peptide receptor occupancy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.1484375,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0859375,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.09375,
            "text": "calcitonin gene-related peptide receptor occupancy by",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.1875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.203125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.21875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.1484375,
            "text": "In vivo quantification of calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.2890625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.328125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_2": [
        {
            "start_logit": 6.6328125,
            "end_logit": 7.19140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.9892578125
        },
        {
            "start_logit": 6.6328125,
            "end_logit": 2.44140625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0085601806640625
        },
        {
            "start_logit": 0.32470703125,
            "end_logit": 7.19140625,
            "text": "CGRP) receptor",
            "probability": 0.0017948150634765625
        },
        {
            "start_logit": -3.677734375,
            "end_logit": 7.19140625,
            "text": "novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 3.2842159271240234e-05
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -3.7890625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -5.03515625,
            "end_logit": 7.19140625,
            "text": "receptor",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -5.82421875,
            "text": "calcitonin",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -6.90625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.19140625,
            "text": "(CGRP) receptor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.28515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.30859375,
            "text": "calcitonin gene-related",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 7.19140625,
            "text": "peptide (CGRP) receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.19140625,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.64453125,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.6484375,
            "text": "calcitonin gene-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.66796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 7.19140625,
            "text": ") receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 7.19140625,
            "text": "a novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.6328125,
            "end_logit": -7.83203125,
            "text": "calcitonin gene-related peptide (",
            "probability": 2.980232238769531e-07
        }
    ],
    "55032efde9bde69634000035_3": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.0703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5244140625,
            "text": "calcitonin gene-related peptide",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -2.001953125,
            "end_logit": 8.0703125,
            "text": "CGRP) receptor",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -3.095703125,
            "text": "calcitonin",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.5,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 8.0703125,
            "text": "receptor",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0703125,
            "text": "calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.484375,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.61328125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.28125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -8.328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.0703125,
            "text": "a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.0703125,
            "text": ") receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.0703125,
            "text": "(CGRP) receptor",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_4": [
        {
            "start_logit": 9.6484375,
            "end_logit": 9.7265625,
            "text": "Calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -2.703125,
            "text": "Calcitonin",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -3.111328125,
            "end_logit": 9.7265625,
            "text": "receptor",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -5.8046875,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -6.578125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -7.1328125,
            "text": "Calcitonin gene",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -7.60546875,
            "text": "Calcitonin gene-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -7.7109375,
            "text": "Calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 9.7265625,
            "text": "peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -7.8828125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.0546875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.1171875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.1484375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.1796875,
            "text": "Calcitonin gene-related peptide receptor antagonists",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.1875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.234375,
            "text": "Calcitonin gene-related peptide receptor antagonists,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.28125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.7265625,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.7265625,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.3203125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_5": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.59375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.984375
        },
        {
            "start_logit": 3.962890625,
            "end_logit": 8.59375,
            "text": "CGRP) receptor",
            "probability": 0.0146026611328125
        },
        {
            "start_logit": 8.171875,
            "end_logit": 0.876953125,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0004374980926513672
        },
        {
            "start_logit": -3.638671875,
            "end_logit": 8.59375,
            "text": "receptor",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 8.171875,
            "end_logit": -3.982421875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 8.171875,
            "end_logit": -4.3203125,
            "text": "calcitonin",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.3984375,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.40625,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.55078125,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.60546875,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.59375,
            "text": ") receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.59375,
            "text": "peptide (CGRP) receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.90625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.09375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olce",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.1171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-ol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.59375,
            "text": "The calcitonin gene-related peptide (CGRP) receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.1484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.1796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.171875,
            "end_logit": -8.1796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_6": [
        {
            "start_logit": 9.8203125,
            "end_logit": 10.046875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.357421875,
            "text": "calcitonin",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -2.658203125,
            "end_logit": 10.046875,
            "text": "receptor",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -5.875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 10.046875,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.3125,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": -7.765625,
            "end_logit": 10.046875,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 10.046875,
            "text": "a calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -7.7421875,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.046875,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.0625,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.046875,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.046875,
            "text": "Telcagepant, a calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide receptor antagonist, is",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3671875,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -2.357421875,
            "text": "a calcitonin",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_7": [
        {
            "start_logit": 9.7109375,
            "end_logit": 9.96875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -2.734375,
            "end_logit": 9.96875,
            "text": "receptor",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -2.59375,
            "text": "calcitonin",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -5.2265625,
            "text": "calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.96875,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -7.3671875,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -7.39453125,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -7.421875,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 9.96875,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.96875,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.21875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.96875,
            "text": "potent calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.28125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepan",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.2890625,
            "text": "calcitonin gene-related peptide receptor antagonist, tel",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.296875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist, telca",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcage",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.3203125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.328125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_8": [
        {
            "start_logit": 8.3984375,
            "end_logit": 6.515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.98095703125
        },
        {
            "start_logit": 8.3984375,
            "end_logit": 2.5390625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0183868408203125
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -2.095703125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.00017893314361572266
        },
        {
            "start_logit": -0.5107421875,
            "end_logit": 6.515625,
            "text": "CGRP) receptor",
            "probability": 0.0001329183578491211
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -4.23828125,
            "text": "calcitonin",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -5.75,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -4.93359375,
            "end_logit": 6.515625,
            "text": "receptor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.01171875,
            "text": "calcitonin gene-related",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.4296875,
            "text": "calcitonin gene-",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.5078125,
            "text": "calcitonin gene",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.87890625,
            "text": "calcitonin gene-related peptide (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.28125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.28125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (NTG).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.3515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, tel",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepan",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 6.515625,
            "text": "(CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.515625,
            "text": ") receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_9": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.0,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.294921875,
            "text": "calcitonin",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.755859375,
            "end_logit": 10.0,
            "text": "receptor",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -5.78515625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.22265625,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 10.0,
            "text": "peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.4609375,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.6875,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 10.0,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 10.0,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": 10.0,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1953125,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2578125,
            "text": "calcitonin gene-related peptide receptor antagonist which is",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.28125,
            "text": "calcitonin gene-related peptide receptor antagonist which is being",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3515625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3515625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.359375,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3984375,
            "text": "calcitonin gene-related peptide receptor antagonist which",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.0,
            "text": "-related peptide receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_10": [
        {
            "start_logit": 9.484375,
            "end_logit": 9.2734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.3779296875,
            "end_logit": 9.2734375,
            "text": "CGRP) receptor",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.484375,
            "end_logit": -2.556640625,
            "text": "calcitonin",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -3.3203125,
            "end_logit": 9.2734375,
            "text": "receptor",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.484375,
            "end_logit": -3.95703125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 9.484375,
            "end_logit": -5.76171875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.484375,
            "end_logit": -6.9921875,
            "text": "calcitonin gene-related peptide (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.50390625,
            "text": "calcitonin gene",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.55078125,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.2734375,
            "text": ") receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -7.65625,
            "text": "calcitonin gene-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.046875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.1015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.34375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepan",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and tel",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.3828125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepan",
            "probability": 0.0
        },
        {
            "start_logit": 9.484375,
            "end_logit": -8.3984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.2734375,
            "text": "(CGRP) receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_11": [
        {
            "start_logit": 8.6171875,
            "end_logit": 8.28125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.6171875,
            "end_logit": 0.54443359375,
            "text": "Calcitonin gene-related peptide",
            "probability": 0.0004336833953857422
        },
        {
            "start_logit": 0.583984375,
            "end_logit": 8.28125,
            "text": "CGRP) receptor",
            "probability": 0.0003223419189453125
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -3.78515625,
            "text": "Calcitonin",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -4.08203125,
            "text": "Calcitonin gene-related peptide (CGRP",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -4.20703125,
            "end_logit": 8.28125,
            "text": "receptor",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.140625,
            "text": "Calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.421875,
            "text": "Calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.45703125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.73828125,
            "text": "Calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.9140625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.9140625,
            "text": "Calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.953125,
            "text": "Calcitonin gene-related peptide (CGRP)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.1171875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.1640625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.046875,
            "end_logit": 8.28125,
            "text": "(CGRP) receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.583984375,
            "end_logit": -4.08203125,
            "text": "CGRP",
            "probability": 0.0
        },
        {
            "start_logit": 0.583984375,
            "end_logit": -7.45703125,
            "text": "CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine",
            "probability": 0.0
        },
        {
            "start_logit": 0.583984375,
            "end_logit": -7.9140625,
            "text": "CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine.",
            "probability": 0.0
        },
        {
            "start_logit": 0.583984375,
            "end_logit": -7.953125,
            "text": "CGRP)",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_12": [
        {
            "start_logit": 9.0625,
            "end_logit": 7.58203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -0.7890625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.00023233890533447266
        },
        {
            "start_logit": 9.0625,
            "end_logit": -3.220703125,
            "text": "calcitonin",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -2.302734375,
            "end_logit": 7.58203125,
            "text": "CGRP) receptor",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -4.3984375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -4.51171875,
            "end_logit": 7.58203125,
            "text": "receptor",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.8125,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.26171875,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.28125,
            "text": "calcitonin gene-related peptide (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.39453125,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.5859375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.94921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.9921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.0625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.21875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.2734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -8.3515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.58203125,
            "text": ") receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.796875,
            "end_logit": 7.58203125,
            "text": "a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.58203125,
            "text": "(CGRP) receptor",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_13": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.2109375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -2.333984375,
            "end_logit": 10.2109375,
            "text": "peptide",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -2.115234375,
            "text": "calcitonin",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.15625,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.2890625,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 10.2109375,
            "text": "gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.2109375,
            "text": "related peptide",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.484375,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.5234375,
            "text": "calcitonin gene-related peptide antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.2109375,
            "text": "3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.2109375,
            "text": "the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.2109375,
            "text": "-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.2109375,
            "text": "In 3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.2109375,
            "text": ") the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.2109375,
            "text": "1585) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.2109375,
            "text": "5) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.2109375,
            "text": "randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.2109375,
            "text": "(n = 1585) the calcitonin gene-related peptide",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2265625,
            "text": "calcitonin gene-related peptide antagonist tel",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.25,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_14": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.171875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.111328125,
            "text": "calcitonin",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -2.44140625,
            "end_logit": 10.171875,
            "text": "receptor",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -5.8671875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 10.171875,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.1953125,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.5,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.5078125,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 10.171875,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 10.171875,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.171875,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.0625,
            "text": "calcitonin gene-related peptide receptor antagonist with",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.21875,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2890625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.171875,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.328125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3359375,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3828125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral triptans",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3828125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigr",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_15": [
        {
            "start_logit": 7.296875,
            "end_logit": 5.1875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.83935546875
        },
        {
            "start_logit": 7.296875,
            "end_logit": 3.53515625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.16015625
        },
        {
            "start_logit": 7.296875,
            "end_logit": -2.873046875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0002646446228027344
        },
        {
            "start_logit": -2.076171875,
            "end_logit": 5.1875,
            "text": "CGRP) receptor",
            "probability": 7.11679458618164e-05
        },
        {
            "start_logit": 7.296875,
            "end_logit": -5.16015625,
            "text": "calcitonin",
            "probability": 2.7000904083251953e-05
        },
        {
            "start_logit": 7.296875,
            "end_logit": -6.6640625,
            "text": "calcitonin gene-related peptide (",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -6.90234375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.11328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.33203125,
            "text": "calcitonin gene-related",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.6484375,
            "text": "calcitonin gene-",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 5.1875,
            "text": "receptor",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.75390625,
            "text": "calcitonin gene",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.15625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.1875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.2265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.25,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist tel",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation)",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.296875,
            "end_logit": -8.3125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet",
            "probability": 1.1324882507324219e-06
        }
    ],
    "55032efde9bde69634000035_16": [
        {
            "start_logit": 6.51171875,
            "end_logit": 6.703125,
            "text": "calcitonin gene-related peptide",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -1.1884765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.0003724098205566406
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -1.884765625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0001850128173828125
        },
        {
            "start_logit": -5.99609375,
            "end_logit": 6.703125,
            "text": "peptide",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -5.97265625,
            "text": "calcitonin",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -6.6328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -6.7890625,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.578125,
            "text": "calcitonin gene",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.66796875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.75,
            "text": "calcitonin gene-related",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 6.703125,
            "text": "the calcitonin gene-related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.8984375,
            "text": "calcitonin gene-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -8.0,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 6.703125,
            "text": "previous randomized, placebo-controlled trial of the calcitonin gene-related peptide",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -1.1884765625,
            "text": "CGRP) receptor",
            "probability": 0.0
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -1.884765625,
            "text": "CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -1.1884765625,
            "text": "peptide (CGRP) receptor",
            "probability": 0.0
        },
        {
            "start_logit": -5.99609375,
            "end_logit": -1.884765625,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -1.1884765625,
            "text": "receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -1.1884765625,
            "text": "the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_17": [
        {
            "start_logit": 8.203125,
            "end_logit": 7.28125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.97607421875
        },
        {
            "start_logit": 8.203125,
            "end_logit": 3.38671875,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0199432373046875
        },
        {
            "start_logit": 2.580078125,
            "end_logit": 7.28125,
            "text": "CGRP) receptor",
            "probability": 0.003520965576171875
        },
        {
            "start_logit": 8.203125,
            "end_logit": -0.385986328125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0004563331604003906
        },
        {
            "start_logit": 8.203125,
            "end_logit": -4.2578125,
            "text": "calcitonin",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": -4.30078125,
            "end_logit": 7.28125,
            "text": "receptor",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 2.580078125,
            "end_logit": -0.385986328125,
            "text": "CGRP",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.05078125,
            "text": "calcitonin gene-related peptide (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.49609375,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5390625,
            "text": "calcitonin gene-related",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.56640625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.71875,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.1875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.2109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist tel",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.3828125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telca",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.3984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepan",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.28125,
            "text": "peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_18": [
        {
            "start_logit": 9.875,
            "end_logit": 10.1015625,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.224609375,
            "text": "calcitonin",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -2.51953125,
            "end_logit": 10.1015625,
            "text": "receptor",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -5.87890625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 10.1015625,
            "text": "peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.3671875,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.453125,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.45703125,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 10.1015625,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": 10.1015625,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0546875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2578125,
            "text": "calcitonin gene-related peptide receptor antagonist tel",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.265625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3046875,
            "text": "calcitonin gene-related peptide receptor antagonist telca",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3515625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-09",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.359375,
            "text": "calcitonin gene-related peptide receptor antagonist telcage",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.359375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepan",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3671875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3671875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in",
            "probability": 0.0
        },
        {
            "start_logit": -2.51953125,
            "end_logit": -8.0546875,
            "text": "receptor antagonist",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_19": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.9375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.53515625,
            "text": "calcitonin",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -2.80078125,
            "end_logit": 9.9375,
            "text": "receptor",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.703125,
            "end_logit": -5.06640625,
            "text": "calcitonin gene-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.9375,
            "text": "the calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.9375,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.5390625,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.9375,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.58203125,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": 9.9375,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.0390625,
            "text": "calcitonin gene-related peptide receptor blockers",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.9375,
            "text": "drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.9375,
            "text": "igraine drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.9375,
            "text": "antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.9375,
            "text": "aine drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.296875,
            "text": "calcitonin gene-related peptide receptor blockers.",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.9375,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.9375,
            "text": "cagepant represents a new class of antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.9375,
            "text": "Telcagepant represents a new class of antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_20": [
        {
            "start_logit": 9.828125,
            "end_logit": 10.0546875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -2.3046875,
            "text": "calcitonin",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -2.6484375,
            "end_logit": 10.0546875,
            "text": "receptor",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.828125,
            "end_logit": -5.57421875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 10.0546875,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 10.0546875,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.30078125,
            "text": "calcitonin gene-related",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 10.0546875,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 10.0546875,
            "text": "an oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 10.0546875,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.6875,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.828125,
            "end_logit": -7.73828125,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.0546875,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0546875,
            "text": ", an oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.0546875,
            "text": "t, an oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.0546875,
            "text": "tolerability of telcagepant, an oral calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": -2.3046875,
            "text": "oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -2.3046875,
            "text": "an oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -2.3046875,
            "text": ", an oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -2.3046875,
            "text": "t, an oral calcitonin",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_21": [
        {
            "start_logit": 9.859375,
            "end_logit": 10.1796875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -2.421875,
            "end_logit": 10.1796875,
            "text": "receptor",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -2.271484375,
            "text": "calcitonin",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -5.52734375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 10.1796875,
            "text": "selective calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 10.1796875,
            "text": "peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.109375,
            "text": "calcitonin gene-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 10.1796875,
            "text": "gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": 10.1796875,
            "text": "related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.515625,
            "text": "calcitonin gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.56640625,
            "text": "calcitonin gene-",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1796875,
            "text": ", and selective calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.1796875,
            "text": "-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.1796875,
            "text": "novel, orally active, and selective calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 10.1796875,
            "text": "orally active, and selective calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.1796875,
            "text": "and selective calcitonin gene-related peptide receptor",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2109375,
            "text": "calcitonin gene-related peptide receptor antagonist being",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.234375,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.1796875,
            "text": "active, and selective calcitonin gene-related peptide receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_22": [
        {
            "start_logit": 7.16796875,
            "end_logit": 7.68359375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -1.4853515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -1.9130859375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 7.68359375,
            "text": "peptide",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -5.38671875,
            "text": "calcitonin",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -5.93359375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -7.28515625,
            "text": "calcitonin gene-related peptide (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 7.68359375,
            "text": "gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -7.54296875,
            "text": "calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.68359375,
            "text": "Studies were conducted in human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 7.68359375,
            "text": "to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 7.68359375,
            "text": "coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.296875,
            "end_logit": 7.68359375,
            "text": "vascular effects of the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -7.8203125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -7.87109375,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 7.68359375,
            "text": "explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4375,
            "end_logit": 7.68359375,
            "text": "in human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4375,
            "end_logit": 7.68359375,
            "text": "related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -8.046875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.16796875,
            "end_logit": -8.1484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrict",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_23": [
        {
            "start_logit": 5.65234375,
            "end_logit": 4.65625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.6123046875
        },
        {
            "start_logit": 5.65234375,
            "end_logit": 4.19921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.386474609375
        },
        {
            "start_logit": -0.383544921875,
            "end_logit": 4.19921875,
            "text": "CGRP) receptor",
            "probability": 0.0009245872497558594
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -2.755859375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.00036907196044921875
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -6.58984375,
            "text": "calcitonin",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.30859375,
            "text": "calcitonin gene-related",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.36328125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 4.65625,
            "text": "novel oral calcitonin gene-related peptide",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 4.19921875,
            "text": "receptor",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.7265625,
            "text": "calcitonin gene-",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 4.65625,
            "text": "oral calcitonin gene-related peptide",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.75,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.76953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.83984375,
            "text": "calcitonin gene",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.92578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -7.98046875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 4.19921875,
            "text": "novel oral calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -8.0390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -8.0703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.65234375,
            "end_logit": -8.109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is",
            "probability": 1.7285346984863281e-06
        }
    ],
    "5c6ab4c17c78d6947100001d_1": [
        {
            "start_logit": 8.3671875,
            "end_logit": 6.9765625,
            "text": "MATLAB environment",
            "probability": 0.984375
        },
        {
            "start_logit": 8.3671875,
            "end_logit": 2.833984375,
            "text": "MATLAB",
            "probability": 0.0156707763671875
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -4.640625,
            "text": "MAT",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -4.0,
            "end_logit": 6.9765625,
            "text": "environment",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.95703125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.61328125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.70703125,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.72265625,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -7.75,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.9765625,
            "text": "LAB environment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.9765625,
            "text": "the MATLAB environment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.9765625,
            "text": "under the MATLAB environment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 6.9765625,
            "text": "runs under the MATLAB environment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 6.9765625,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 2.833984375,
            "text": "LAB",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 2.833984375,
            "text": "the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 2.833984375,
            "text": "under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 2.833984375,
            "text": "runs under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 2.833984375,
            "text": "SELANSI runs under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -1.66015625,
            "end_logit": -4.8515625,
            "text": "SEmi-LAgrangian SImulation of GRNs",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_2": [
        {
            "start_logit": 9.5078125,
            "end_logit": 7.1953125,
            "text": "MATLAB environment",
            "probability": 0.97802734375
        },
        {
            "start_logit": 9.5078125,
            "end_logit": 3.384765625,
            "text": "MATLAB",
            "probability": 0.0216064453125
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -2.962890625,
            "text": "MAT",
            "probability": 3.802776336669922e-05
        },
        {
            "start_logit": -4.20703125,
            "end_logit": 7.1953125,
            "text": "environment",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.6875,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.7265625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.7734375,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.77734375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.8984375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.9296875,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.96484375,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.98828125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.015625,
            "text": "MATLAB environment, and is available under",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.046875,
            "text": "MATLAB environment, and is available under GPLv3 license at https",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0546875,
            "text": "MATLAB environment, and is available under GP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0859375,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.109375,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.109375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_3": [
        {
            "start_logit": 9.5078125,
            "end_logit": 9.421875,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": 0.2052001953125,
            "text": "MATLAB",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -2.953125,
            "text": "MAT",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -2.978515625,
            "end_logit": 9.421875,
            "text": "environment",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.421875,
            "text": "the MATLAB environment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.51171875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.79296875,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.8203125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.94921875,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.9765625,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -7.984375,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0234375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 9.421875,
            "text": "LAB environment",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.421875,
            "text": "under the MATLAB environment",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0546875,
            "text": "MATLAB environment, and is available under GPLv3 license at https:",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.078125,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 0.0
        },
        {
            "start_logit": 9.5078125,
            "end_logit": -8.0859375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.421875,
            "text": "runs under the MATLAB environment",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 0.2052001953125,
            "text": "the MATLAB",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_4": [
        {
            "start_logit": 9.46875,
            "end_logit": 7.26953125,
            "text": "MATLAB environment",
            "probability": 0.94287109375
        },
        {
            "start_logit": 9.46875,
            "end_logit": 4.4609375,
            "text": "MATLAB",
            "probability": 0.05706787109375
        },
        {
            "start_logit": 9.46875,
            "end_logit": -3.021484375,
            "text": "MAT",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -4.140625,
            "end_logit": 7.26953125,
            "text": "environment",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.078125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.64453125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.6953125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.70703125,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.71875,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.7890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.87890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.8828125,
            "text": "MATLAB environment, and is available under",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.92578125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.93359375,
            "text": "MATLAB environment, and is available under GPLv",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.94140625,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.94921875,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.96875,
            "text": "MATLAB environment, and is available under GP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -7.9765625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -8.0,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.46875,
            "end_logit": -8.03125,
            "text": "MATLAB environment, and",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a992b371d1251d03b00000a_1": [
        {
            "start_logit": 9.5390625,
            "end_logit": 8.390625,
            "text": "Metagenomics of the Human Intestinal Tract",
            "probability": 0.98095703125
        },
        {
            "start_logit": 9.5390625,
            "end_logit": 4.484375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome.",
            "probability": 0.0195770263671875
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -2.81640625,
            "text": "Metagen",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -3.69140625,
            "end_logit": 8.390625,
            "text": "Tract",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -5.02734375,
            "text": "Metagenomics",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -5.55078125,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -5.9453125,
            "text": "Metagenomics of the Human Intestinal Tract (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.8125,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -6.83203125,
            "text": "Metagenomics of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.01953125,
            "text": "Metagenomics of the Human Intestinal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.62890625,
            "text": "Metagenomics of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.66015625,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.7421875,
            "text": "Metagenomics of the Human",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5390625,
            "end_logit": -7.7890625,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.390625,
            "text": "and Metagenomics of the Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.390625,
            "text": "consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.69140625,
            "end_logit": 4.484375,
            "text": "Tract (MetaHIT) project are focusing mainly on the human microbiome.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.390625,
            "text": "Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.390625,
            "text": "omics of the Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.390625,
            "text": "several consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        }
    ],
    "530c7f52970c65fa6b000010_1": [
        {
            "start_logit": -0.83642578125,
            "end_logit": 7.99609375,
            "text": "Oxantel disrupts polymicrobial biofilm development",
            "probability": 0.763671875
        },
        {
            "start_logit": -2.712890625,
            "end_logit": 7.99609375,
            "text": "polymicrobial biofilm development",
            "probability": 0.11663818359375
        },
        {
            "start_logit": -2.884765625,
            "end_logit": 7.99609375,
            "text": "biofilm development",
            "probability": 0.0982666015625
        },
        {
            "start_logit": -4.91015625,
            "end_logit": 7.99609375,
            "text": "development",
            "probability": 0.01297760009765625
        },
        {
            "start_logit": -5.640625,
            "end_logit": 7.99609375,
            "text": "disrupts polymicrobial biofilm development",
            "probability": 0.006256103515625
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.99609375,
            "text": "icrobial biofilm development",
            "probability": 0.0008463859558105469
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.99609375,
            "text": "robial biofilm development",
            "probability": 0.0006618499755859375
        },
        {
            "start_logit": -8.078125,
            "end_logit": 7.99609375,
            "text": "ntel disrupts polymicrobial biofilm development",
            "probability": 0.0005464553833007812
        },
        {
            "start_logit": -0.83642578125,
            "end_logit": -0.88232421875,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.00010675191879272461
        },
        {
            "start_logit": -2.712890625,
            "end_logit": -0.88232421875,
            "text": "polymicrobial biofilm development of periodontal pathogens",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -2.884765625,
            "end_logit": -0.88232421875,
            "text": "biofilm development of periodontal pathogens",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -4.91015625,
            "end_logit": -0.88232421875,
            "text": "development of periodontal pathogens",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -5.640625,
            "end_logit": -0.88232421875,
            "text": "disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": -0.88232421875,
            "text": "periodontal pathogens",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -0.83642578125,
            "end_logit": -7.3203125,
            "text": "Oxantel disrupts polymicrobial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.83642578125,
            "end_logit": -7.36328125,
            "text": "Oxantel disrupts polymicrobial biofilm development of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": -0.88232421875,
            "text": "icrobial biofilm development of periodontal pathogens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -0.88232421875,
            "text": "of periodontal pathogens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.83642578125,
            "end_logit": -7.8671875,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -0.88232421875,
            "text": "robial biofilm development of periodontal pathogens",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_1": [
        {
            "start_logit": 9.84375,
            "end_logit": 9.125,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.216796875,
            "text": "Chaperone",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -3.568359375,
            "end_logit": 9.125,
            "text": "autophagy",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -5.55078125,
            "text": "Chaperone-mediated autophagy (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.01953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.15234375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.234375,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.8984375,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.9765625,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.49609375,
            "text": "Chaperone-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.6171875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1484375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.296875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_2": [
        {
            "start_logit": 9.84375,
            "end_logit": 9.125,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.216796875,
            "text": "Chaperone",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -3.568359375,
            "end_logit": 9.125,
            "text": "autophagy",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -5.55078125,
            "text": "Chaperone-mediated autophagy (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.01953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.15234375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.234375,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.8984375,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.9765625,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.49609375,
            "text": "Chaperone-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.6171875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1484375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.296875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_3": [
        {
            "start_logit": 9.8984375,
            "end_logit": 9.3515625,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.0859375,
            "text": "Chaperone",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": -3.240234375,
            "end_logit": 9.3515625,
            "text": "autophagy",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -5.33984375,
            "text": "Chaperone-mediated autophagy (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -5.42578125,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -6.06640625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -6.79296875,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -6.9140625,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.44921875,
            "text": "Chaperone-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.6640625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.0,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.3515625,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.203125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.21875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.234375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.2421875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.25,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_4": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.203125,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": 10.203125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -1.88671875,
            "end_logit": 10.203125,
            "text": "autophagy",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -1.91015625,
            "text": "chaperone",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -6.7421875,
            "text": "chaperone-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.08203125,
            "text": "chaperone-mediated autophagy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 10.203125,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.44921875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.49609375,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 10.203125,
            "text": "by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.65625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.66015625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": 10.203125,
            "text": "-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 10.203125,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.75,
            "text": "chaperone-mediated autophagy (CMA), in",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.203125,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.203125,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -1.91015625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -3.19921875,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -6.7421875,
            "text": "Macroautophagy is followed by chaperone-mediated",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_5": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.203125,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": 10.203125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -1.88671875,
            "end_logit": 10.203125,
            "text": "autophagy",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -1.91015625,
            "text": "chaperone",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -6.7421875,
            "text": "chaperone-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.08203125,
            "text": "chaperone-mediated autophagy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 10.203125,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.44921875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.49609375,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 10.203125,
            "text": "by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.65625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70)",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.66015625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": 10.203125,
            "text": "-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 10.203125,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.75,
            "text": "chaperone-mediated autophagy (CMA), in",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.203125,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.203125,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -1.91015625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -3.19921875,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.6669921875,
            "end_logit": -6.7421875,
            "text": "Macroautophagy is followed by chaperone-mediated",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_6": [
        {
            "start_logit": 9.96875,
            "end_logit": 9.890625,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -1.9287109375,
            "text": "Chaperone",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -2.6328125,
            "end_logit": 9.890625,
            "text": "autophagy",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -5.515625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.40625,
            "text": "Chaperone-mediated autophagy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.82421875,
            "text": "Chaperone-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.06640625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.20703125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.6328125,
            "text": "Chaperone-",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.890625,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": 9.890625,
            "text": "-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.9453125,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.03125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2890625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.2890625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_7": [
        {
            "start_logit": 9.859375,
            "end_logit": 9.3671875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -2.169921875,
            "text": "Chaperone",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": -3.224609375,
            "end_logit": 9.3671875,
            "text": "autophagy",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -5.265625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -5.57421875,
            "text": "Chaperone-mediated autophagy (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -6.2265625,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -6.8203125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -6.83984375,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.50390625,
            "text": "Chaperone-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.63671875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.9765625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.0546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.3671875,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.1796875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.1875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2109375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2109375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.21875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.234375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_8": [
        {
            "start_logit": 9.8828125,
            "end_logit": 10.1484375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 0.163818359375,
            "end_logit": 10.1484375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.9619140625,
            "end_logit": 10.1484375,
            "text": "autophagy",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -1.9990234375,
            "text": "chaperone",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -6.76953125,
            "text": "chaperone-mediated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.13671875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.17578125,
            "text": "chaperone-mediated autophagy (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 10.1484375,
            "text": "mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.421875,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 10.1484375,
            "text": "by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.61328125,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.65234375,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70)",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 10.1484375,
            "text": "-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": 10.1484375,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.1484375,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.1484375,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.163818359375,
            "end_logit": -1.9990234375,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": 0.163818359375,
            "end_logit": -3.103515625,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": 0.163818359375,
            "end_logit": -6.76953125,
            "text": "Macroautophagy is followed by chaperone-mediated",
            "probability": 0.0
        },
        {
            "start_logit": 0.163818359375,
            "end_logit": -7.13671875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "5ac138aa95d0062724000001_1": [
        {
            "start_logit": 9.4609375,
            "end_logit": 10.015625,
            "text": "N-arginine dibasic convertase",
            "probability": 1.0
        },
        {
            "start_logit": -2.662109375,
            "end_logit": 10.015625,
            "text": "ase",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -2.822265625,
            "text": "N",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.03515625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.5078125,
            "text": "N-arginine dibasic convert",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 10.015625,
            "text": "convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 10.015625,
            "text": "-arginine dibasic convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 10.015625,
            "text": "arginine dibasic convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 10.015625,
            "text": "dibasic convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 10.015625,
            "text": "asic convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.25390625,
            "text": "N-arginine dibasic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.51953125,
            "text": "N-arginine dibasic convertase;",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.53515625,
            "text": "N-arginine dib",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.5625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.76171875,
            "text": "N-arginine",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.78515625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.015625,
            "text": "Nardilysin (N-arginine dibasic convertase",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.8515625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of",
            "probability": 0.0
        },
        {
            "start_logit": -2.662109375,
            "end_logit": -6.03515625,
            "text": "ase; Nrdc) is a metalloendopeptidase",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_1": [
        {
            "start_logit": 8.96875,
            "end_logit": 7.6015625,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": 8.96875,
            "end_logit": -2.439453125,
            "text": "Wnt signaling",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.96875,
            "end_logit": -8.03125,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -8.109375,
            "text": "Wnt signaling is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -8.1171875,
            "text": "Wnt signaling is known to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -8.1953125,
            "text": "Wnt signaling is known",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -8.25,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.73046875,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.73046875,
            "text": "it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -7.73046875,
            "text": "signal transduction, it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -7.73046875,
            "text": "not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -7.73046875,
            "text": "turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -7.97265625,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": -7.73046875,
            "text": "is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.97265625,
            "text": "it is not clear how Dishevelled-mediated signaling is turned",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -7.73046875,
            "text": "clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -7.73046875,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": -7.73046875,
            "text": "signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -7.73046875,
            "text": "Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -7.73046875,
            "text": "mediated signaling is turned off",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_2": [
        {
            "start_logit": 9.53125,
            "end_logit": 5.81640625,
            "text": "Wnt signaling",
            "probability": 0.59814453125
        },
        {
            "start_logit": 9.53125,
            "end_logit": 5.4140625,
            "text": "Wnt",
            "probability": 0.401611328125
        },
        {
            "start_logit": 0.364990234375,
            "end_logit": 5.81640625,
            "text": "canonical Wnt signaling",
            "probability": 6.264448165893555e-05
        },
        {
            "start_logit": 0.364990234375,
            "end_logit": 5.4140625,
            "text": "canonical Wnt",
            "probability": 4.208087921142578e-05
        },
        {
            "start_logit": 9.53125,
            "end_logit": -7.75390625,
            "text": "Wnt signaling,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 5.81640625,
            "text": "signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.81640625,
            "text": "via canonical Wnt signaling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 5.4140625,
            "text": "via canonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 5.81640625,
            "text": "fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 5.81640625,
            "text": "ly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 5.81640625,
            "text": "Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": 5.81640625,
            "text": "same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 5.81640625,
            "text": "cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 5.4140625,
            "text": "fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 5.4140625,
            "text": "ly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 5.4140625,
            "text": "Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": 5.4140625,
            "text": "same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 5.4140625,
            "text": "cell fate via canonical Wnt",
            "probability": 0.0
        },
        {
            "start_logit": 0.364990234375,
            "end_logit": -7.3984375,
            "text": "canonical",
            "probability": 0.0
        },
        {
            "start_logit": 0.364990234375,
            "end_logit": -7.75390625,
            "text": "canonical Wnt signaling,",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_3": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.8828125,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.0078125,
            "text": "Wnt signaling pathways",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.34375,
            "text": "Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.8828125,
            "text": "canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.8828125,
            "text": ", are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.8828125,
            "text": "noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.8828125,
            "text": "Dishevelled (DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.8828125,
            "text": "components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.8828125,
            "text": "al Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.8828125,
            "text": "been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.8828125,
            "text": "of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.8828125,
            "text": "have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.8828125,
            "text": "three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.8828125,
            "text": "identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.8828125,
            "text": "anonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.8828125,
            "text": "highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -8.25,
            "text": "Wnt signaling pathways.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.0078125,
            "text": "canonical and noncanonical Wnt signaling pathways",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -7.0078125,
            "text": "pathways",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.34375,
            "text": "canonical and noncanonical Wnt signaling",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_1": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.234375,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -2.3359375,
            "end_logit": 10.234375,
            "text": "1",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.45703125,
            "text": "ABC",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -5.96484375,
            "text": "ABCC1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 10.234375,
            "text": "in ABCC11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 10.234375,
            "text": "C11",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 10.234375,
            "text": "A single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.234375,
            "text": "single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0390625,
            "text": "ABCC11 affects",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.046875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0625,
            "text": "ABCC11 affects the cerumen VOC profiles of",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.078125,
            "text": "ABCC11 affects the cerumen VOC profiles",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0859375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descent",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.234375,
            "text": "SNP) in ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.171875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.1796875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.203125,
            "text": "ABCC11 affects the cerumen",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.234375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.234375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.2421875,
            "text": "ABCC11 affects the cerumen VOC",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_2": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.3828125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.978515625,
            "end_logit": 10.3828125,
            "text": "1",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.287109375,
            "text": "ABC",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.03125,
            "text": "ABCC1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 10.3828125,
            "text": "C11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 10.3828125,
            "text": "findings also reveal that ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 10.3828125,
            "text": "Our findings also reveal that ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.3828125,
            "text": "also reveal that ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.3828125,
            "text": "that ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.3828125,
            "text": "reveal that ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.8203125,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.85546875,
            "text": "ABCC11 genotype",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.86328125,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.87109375,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways must",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.09375,
            "text": "ABCC11 genotype alone",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1015625,
            "text": "ABCC11 genotype alone does",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1171875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1640625,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1640625,
            "text": "ABCC11 genotype alone does not predict",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1796875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_3": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.3203125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -2.15234375,
            "end_logit": 10.3203125,
            "text": "1",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.1015625,
            "text": "ABC",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -6.1875,
            "text": "ABCC1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 10.3203125,
            "text": "C11",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.76953125,
            "text": "ABCC11 encodes an ATP-driven efflux pump",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.921875,
            "text": "ABCC11 encodes",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.9921875,
            "text": "ABCC11 encodes an ATP-driven",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.99609375,
            "text": "ABCC11 encodes an ATP-driven efflux",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.046875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.0703125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.09375,
            "text": "ABCC11 encodes an ATP-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1640625,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1875,
            "text": "ABCC11 encodes an",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1953125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2265625,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.234375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.234375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2578125,
            "text": "ABCC11 encodes an ATP",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_4": [
        {
            "start_logit": 9.4296875,
            "end_logit": 10.1953125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -2.3671875,
            "end_logit": 10.1953125,
            "text": "1",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -3.6796875,
            "end_logit": 10.1953125,
            "text": "the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -3.107421875,
            "text": "ABC",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.078125,
            "end_logit": 10.1953125,
            "text": "(ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -5.875,
            "text": "ABCC1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 10.1953125,
            "text": "C11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 10.1953125,
            "text": "adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.1953125,
            "text": "member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.1953125,
            "text": ", member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.1953125,
            "text": ") binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.1953125,
            "text": "gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.1953125,
            "text": "ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.1953125,
            "text": "in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.1953125,
            "text": ", sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.1953125,
            "text": "a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.1953125,
            "text": "family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.1953125,
            "text": "(ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.1953125,
            "text": "cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.859375,
            "text": "ABCC11)",
            "probability": 0.0
        }
    ],
    "62265b4a3a8413c653000083_1": [
        {
            "start_logit": 9.6171875,
            "end_logit": 9.75,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 1.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": 9.75,
            "text": ".",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -2.072265625,
            "text": "Run",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -4.8125,
            "end_logit": 9.75,
            "text": "adipogenesis.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -4.89453125,
            "text": "Runt-related transcription factor 1 (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -5.07421875,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -5.2890625,
            "text": "Runt-related transcription factor 1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -6.22265625,
            "text": "Runt-related transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 9.75,
            "text": "RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -6.71875,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -6.88671875,
            "text": "Runt-related transcription factor 1 (RUNX1T1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 9.75,
            "text": "(RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.01953125,
            "text": "Runt-related transcription",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 9.75,
            "text": "isoforms are involved in adipogenesis.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.14453125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.21875,
            "text": "Runt",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.34765625,
            "text": "Runt-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.43359375,
            "text": "Runt-related transcription factor 1 (RUNX1T1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.46875,
            "text": "Runt-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.55859375,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e8c7220fc566b149000002_1": [
        {
            "start_logit": -0.41455078125,
            "end_logit": 9.4453125,
            "text": "nucleus",
            "probability": 0.99609375
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 9.4453125,
            "text": "the nucleus",
            "probability": 0.0015459060668945312
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.4453125,
            "text": "S100A4 interacts with p53 in the nucleus",
            "probability": 0.0010461807250976562
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.4453125,
            "text": "p53 in the nucleus",
            "probability": 0.000759124755859375
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 9.4453125,
            "text": "in the nucleus",
            "probability": 0.0006647109985351562
        },
        {
            "start_logit": -8.640625,
            "end_logit": 9.4453125,
            "text": "with p53 in the nucleus",
            "probability": 0.0002665519714355469
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.546875,
            "text": "S100A4 interacts with p53",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.65234375,
            "text": "S100A4 interacts with p53 in",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.671875,
            "text": "S100A4 interacts",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.68359375,
            "text": "S100A4",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.546875,
            "text": "p53",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.91796875,
            "text": "S100A4 interacts with",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.65234375,
            "text": "p53 in",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -7.65234375,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -8.265625,
            "text": "S100A",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -7.546875,
            "text": "with p53",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -7.65234375,
            "text": "with p53 in",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": -7.91796875,
            "text": "with",
            "probability": 0.0
        }
    ],
    "54e8c7220fc566b149000002_2": [
        {
            "start_logit": 6.25,
            "end_logit": 9.7421875,
            "text": "nucleus",
            "probability": 1.0
        },
        {
            "start_logit": -4.078125,
            "end_logit": 9.7421875,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 9.7421875,
            "text": "cell nucleus",
            "probability": 7.808208465576172e-06
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 9.7421875,
            "text": "using proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 9.7421875,
            "text": "we show that the interaction takes place in the cell nucleus",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 9.7421875,
            "text": ", we show that the interaction takes place in the cell nucleus",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.7421875,
            "text": "the interaction takes place in the cell nucleus",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.7421875,
            "text": "interaction takes place in the cell nucleus",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.7421875,
            "text": "the cell nucleus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 9.7421875,
            "text": "that the interaction takes place in the cell nucleus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.7421875,
            "text": "show that the interaction takes place in the cell nucleus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 9.7421875,
            "text": "place in the cell nucleus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.7421875,
            "text": "takes place in the cell nucleus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.7421875,
            "text": "in the cell nucleus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -5.4140625,
            "text": "nucleus.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.078125,
            "end_logit": -3.78515625,
            "text": "proximity ligation assay",
            "probability": 0.0
        },
        {
            "start_logit": -4.078125,
            "end_logit": -5.4140625,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -6.4921875,
            "end_logit": -3.78515625,
            "text": "using proximity ligation assay",
            "probability": 0.0
        },
        {
            "start_logit": -5.5078125,
            "end_logit": -5.4140625,
            "text": "cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -4.078125,
            "end_logit": -7.1796875,
            "text": "proximity ligation assay, we show",
            "probability": 0.0
        }
    ],
    "58f0b0c070f9fc6f0f000006_1": [
        {
            "start_logit": 10.0234375,
            "end_logit": 10.203125,
            "text": "tardive dyskinesia",
            "probability": 1.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -1.873046875,
            "text": "tard",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -2.40625,
            "end_logit": 10.203125,
            "text": "dyskinesia",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -6.734375,
            "text": "tardive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 10.203125,
            "text": "ive dyskinesia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 10.203125,
            "text": "treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.87890625,
            "text": "tardive dyskinesia.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.203125,
            "text": "Valbenazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.203125,
            "text": "for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.203125,
            "text": "breakthrough drug status for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.203125,
            "text": "drug status for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.203125,
            "text": "status for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.203125,
            "text": "ine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -1.873046875,
            "text": "treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -1.873046875,
            "text": "Valbenazine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -1.873046875,
            "text": "for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -2.40625,
            "end_logit": -7.87890625,
            "text": "dyskinesia.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -1.873046875,
            "text": "breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -1.873046875,
            "text": "drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -1.873046875,
            "text": "status for treating tard",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_1": [
        {
            "start_logit": 9.4765625,
            "end_logit": 7.96484375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 1.0
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -0.2353515625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0002758502960205078
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -2.884765625,
            "text": "Borderline",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -6.21484375,
            "text": "Borderline oxacillin-resistant",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 7.96484375,
            "text": "aureus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -6.703125,
            "text": "Borderline oxacillin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.16015625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.18359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.2109375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.46484375,
            "text": "Borderline oxacillin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.73828125,
            "text": "Borderline oxa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.78515625,
            "text": "Borderline oxacil",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.90625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.96484375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.96484375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.96484375,
            "text": "resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.96484375,
            "text": "Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -0.2353515625,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -0.2353515625,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -0.2353515625,
            "text": "(",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_2": [
        {
            "start_logit": 8.453125,
            "end_logit": 8.5625,
            "text": "MRSA",
            "probability": 1.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": 8.5625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.2421875,
            "text": "MRSA) in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.5625,
            "text": "(MRSA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.5625,
            "text": "misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.453125,
            "end_logit": -7.953125,
            "text": "MRSA) in the clinical laboratory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.5625,
            "text": "may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.5625,
            "text": "be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.5625,
            "text": "identified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -5.87890625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -6.59765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -6.65234375,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.015625,
            "text": "Borderline oxacillin",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.2421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA) in",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.359375,
            "text": "Borderline oxa",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.44140625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.5,
            "text": "Borderline oxacillin-",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.53125,
            "text": "Borderline oxacil",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.61328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as",
            "probability": 0.0
        },
        {
            "start_logit": -4.4609375,
            "end_logit": -7.62890625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_3": [
        {
            "start_logit": 9.375,
            "end_logit": 7.72265625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -3.01953125,
            "text": "borderline",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.01171875,
            "text": "borderline oxacillin-resistant",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -4.859375,
            "end_logit": 7.72265625,
            "text": "aureus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.57421875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.609375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u2265",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.90625,
            "text": "borderline oxacillin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.04296875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.0859375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/L",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.140625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.21875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.43359375,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.4921875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.62109375,
            "text": "borderline oxacillin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.65234375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.67578125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.6953125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.71484375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.875,
            "text": "borderline oxacil",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.91796875,
            "text": "borderline oxa",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5aae6499fcf456587200000c_4": [
        {
            "start_logit": 9.296875,
            "end_logit": 5.55859375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.296875,
            "end_logit": -2.625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.",
            "probability": 0.0002777576446533203
        },
        {
            "start_logit": 9.296875,
            "end_logit": -3.15234375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0001633167266845703
        },
        {
            "start_logit": 9.296875,
            "end_logit": -3.23046875,
            "text": "Borderline",
            "probability": 0.00015103816986083984
        },
        {
            "start_logit": 9.296875,
            "end_logit": -5.8125,
            "text": "Borderline oxacillin-resistant",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.4609375,
            "text": "Borderline oxacillin",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.57421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.15625,
            "text": "Borderline oxacillin-",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.2578125,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.31640625,
            "text": "Borderline oxa",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.453125,
            "text": "Borderline oxacil",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.78515625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.80078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.84375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.8515625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.94921875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.9765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.1953125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.203125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 5.55859375,
            "text": "aureus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5aae6499fcf456587200000c_5": [
        {
            "start_logit": 8.40625,
            "end_logit": 2.9609375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.40625,
            "end_logit": -4.36328125,
            "text": "Borderline",
            "probability": 0.0006589889526367188
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.08203125,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.0001176595687866211
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.23046875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.00010216236114501953
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.5546875,
            "text": "Borderline oxacillin",
            "probability": 7.361173629760742e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.75390625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1",
            "probability": 6.008148193359375e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.046875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1),",
            "probability": 4.500150680541992e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.17578125,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 3.93986701965332e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.33984375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.35546875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit",
            "probability": 3.314018249511719e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.36328125,
            "text": "Borderline oxa",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.3828125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values",
            "probability": 3.212690353393555e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.390625,
            "text": "Borderline oxacillin-",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.47265625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 3.796875,
            "text": "mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 3.796875,
            "text": ".",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.421875,
            "end_logit": 3.796875,
            "text": "lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 3.796875,
            "text": ", but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 3.796875,
            "text": "but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 3.796875,
            "text": "), but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5aae6499fcf456587200000c_6": [
        {
            "start_logit": 9.453125,
            "end_logit": 7.72265625,
            "text": "borderline oxacillin resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.453125,
            "end_logit": 0.5517578125,
            "text": "borderline oxacillin resistant Staphylococcus aureus (",
            "probability": 0.0007729530334472656
        },
        {
            "start_logit": 9.453125,
            "end_logit": -2.943359375,
            "text": "borderline",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.01171875,
            "text": "borderline oxacillin resistant",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.703125,
            "text": "borderline oxacillin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": 7.72265625,
            "text": "aureus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.0078125,
            "text": "borderline oxacillin resistant Staphylococcus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.23046875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.46875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BOR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.796875,
            "text": "borderline oxa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.83984375,
            "text": "borderline oxacil",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -7.90625,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.72265625,
            "text": "oxacillin resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.72265625,
            "text": "resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 7.72265625,
            "text": "cillin resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 7.72265625,
            "text": "Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 7.72265625,
            "text": "lin resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -5.125,
            "end_logit": 0.5517578125,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 0.5517578125,
            "text": "(",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 0.5517578125,
            "text": "oxacillin resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_7": [
        {
            "start_logit": 9.4765625,
            "end_logit": 7.96484375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 1.0
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -0.2353515625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0002758502960205078
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -2.884765625,
            "text": "borderline",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -6.21484375,
            "text": "borderline oxacillin-resistant",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 7.96484375,
            "text": "aureus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -6.703125,
            "text": "borderline oxacillin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.16015625,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.18359375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.2109375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.46484375,
            "text": "borderline oxacillin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.73828125,
            "text": "borderline oxa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.78515625,
            "text": "borderline oxacil",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4765625,
            "end_logit": -7.90625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.96484375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 7.96484375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.96484375,
            "text": "resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 7.96484375,
            "text": "Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": -0.2353515625,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -0.2353515625,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -0.2353515625,
            "text": "(",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_8": [
        {
            "start_logit": 9.4609375,
            "end_logit": 7.46484375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.845703125
        },
        {
            "start_logit": 9.4609375,
            "end_logit": 5.76171875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.154052734375
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -2.890625,
            "text": "borderline",
            "probability": 2.7000904083251953e-05
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.296875,
            "text": "borderline oxacillin-resistant",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.828125,
            "text": "borderline oxacillin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.015625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.03515625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.11328125,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 7.46484375,
            "text": "aureus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -3.4921875,
            "end_logit": 5.76171875,
            "text": "(",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.5234375,
            "text": "borderline oxacillin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.8203125,
            "text": "borderline oxa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.8359375,
            "text": "borderline oxacil",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.16015625,
            "end_logit": 5.76171875,
            "text": "aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.46484375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 7.46484375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.46484375,
            "text": "Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.46484375,
            "text": "resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 7.46484375,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": 5.76171875,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_1": [
        {
            "start_logit": 9.640625,
            "end_logit": 10.09375,
            "text": "Parkinson's Disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.607421875,
            "end_logit": 10.09375,
            "text": "Disease",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.640625,
            "end_logit": -2.689453125,
            "text": "Parkinson",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 10.09375,
            "text": "'s Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 10.09375,
            "text": "s Disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.640625,
            "end_logit": -7.20703125,
            "text": "Parkinson's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.640625,
            "end_logit": -7.4921875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 10.09375,
            "text": "Unified Parkinson's Disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.09375,
            "text": "the Unified Parkinson's Disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -7.8515625,
            "text": "Parkinson'",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -7.94921875,
            "text": "Parkinson's Disease Rating",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.09375,
            "text": "scale, the Unified Parkinson's Disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.09375,
            "text": "each study visit, the Fahn-Tolosa-Marin (FTM) scale, the Unified Parkinson's Disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.2265625,
            "text": "Parkinson's Disease Rating Scale",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.2890625,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.3359375,
            "text": "Parkinson's Disease Rating Scale, and the Quality of",
            "probability": 0.0
        },
        {
            "start_logit": -2.607421875,
            "end_logit": -7.4921875,
            "text": "Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -2.607421875,
            "end_logit": -7.94921875,
            "text": "Disease Rating",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -2.689453125,
            "text": "Unified Parkinson",
            "probability": 0.0
        },
        {
            "start_logit": -2.607421875,
            "end_logit": -8.2265625,
            "text": "Disease Rating Scale",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_2": [
        {
            "start_logit": 9.6328125,
            "end_logit": 10.1796875,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -2.353515625,
            "end_logit": 10.1796875,
            "text": "tremor",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -2.64453125,
            "text": "essential",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 10.1796875,
            "text": "Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.1796875,
            "text": "for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.1796875,
            "text": "for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.1796875,
            "text": "large trials for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.8359375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.83984375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.1796875,
            "text": "trials for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.1796875,
            "text": "The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -7.99609375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.0546875,
            "text": "essential tremor (ET), but its anchors",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.09375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.1015625,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.109375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.1484375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably",
            "probability": 0.0
        },
        {
            "start_logit": 9.6328125,
            "end_logit": -8.1875,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor (",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -2.64453125,
            "text": "Tremor (FTM) has been used in large trials for essential",
            "probability": 0.0
        },
        {
            "start_logit": -2.353515625,
            "end_logit": -7.8359375,
            "text": "tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_3": [
        {
            "start_logit": 7.9609375,
            "end_logit": 9.1015625,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": 9.1015625,
            "text": "Tremor",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -4.59765625,
            "text": "Essential",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -5.97265625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 9.1015625,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.0625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.9609375,
            "end_logit": -8.078125,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -5.97265625,
            "text": "Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -5.046875,
            "text": "tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -6.484375,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -8.0625,
            "text": "Tremor Rating Scale, and the Tremor Research Group",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -8.078125,
            "text": "Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -6.6484375,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -6.89453125,
            "text": "tremor severity",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -5.375,
            "text": "Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -4.59765625,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -7.73828125,
            "text": "tremor severity scales",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -7.80078125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -5.375,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -7.8984375,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor Rating Scale",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_4": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.3984375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -3.2890625,
            "end_logit": 9.3984375,
            "text": "tremor",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -3.541015625,
            "text": "essential",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 9.3984375,
            "text": "Tremor Rating Scale (TRS) in essential tremor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.3984375,
            "text": "in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.3984375,
            "text": "study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 9.3984375,
            "text": "reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.3984375,
            "text": "was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.3984375,
            "text": "TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 9.3984375,
            "text": "to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.3984375,
            "text": "evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.3984375,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 9.3984375,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.3984375,
            "text": "S) in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -5.80078125,
            "end_logit": -3.541015625,
            "text": "Tremor Rating Scale (TRS) in essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -3.541015625,
            "text": "in essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.541015625,
            "text": "study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential",
            "probability": 0.0
        },
        {
            "start_logit": -5.80078125,
            "end_logit": -5.27734375,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -3.541015625,
            "text": "reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -3.541015625,
            "text": "this study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_5": [
        {
            "start_logit": 8.8046875,
            "end_logit": 8.2109375,
            "text": "essential tremor",
            "probability": 0.9892578125
        },
        {
            "start_logit": 4.21875,
            "end_logit": 8.2109375,
            "text": "Tremor Rating Scale in essential tremor",
            "probability": 0.0100860595703125
        },
        {
            "start_logit": 4.21875,
            "end_logit": 3.521484375,
            "text": "Tremor",
            "probability": 9.28640365600586e-05
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -4.03125,
            "text": "essential",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -4.34765625,
            "end_logit": 8.2109375,
            "text": "tremor",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.921875,
            "end_logit": 8.2109375,
            "text": "in essential tremor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -8.2265625,
            "text": "essential tremor.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.2109375,
            "text": "reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.21875,
            "end_logit": -4.03125,
            "text": "Tremor Rating Scale in essential",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.2109375,
            "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.2109375,
            "text": "the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.2109375,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.2109375,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.2109375,
            "text": "Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.2109375,
            "text": "Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.2109375,
            "text": "Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.2109375,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.2109375,
            "text": "and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 8.2109375,
            "text": "ter reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.2109375,
            "text": "-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_6": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.0234375,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.2421875,
            "text": "Essential",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.72265625,
            "end_logit": 10.0234375,
            "text": "Tremor",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -8.25,
            "end_logit": 10.0234375,
            "text": "the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2421875,
            "text": "Essential Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 10.0234375,
            "text": "and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3359375,
            "text": "Essential Tremor Rating Assessment Scale.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.390625,
            "text": "Essential Tremor Rating Assessment",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.0234375,
            "text": "Clinical Rating Scale and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.0234375,
            "text": "the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 10.0234375,
            "text": "Scale and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 10.0234375,
            "text": "Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.71875,
            "end_logit": 10.0234375,
            "text": "Rating Scale and the Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -2.2421875,
            "text": "the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -2.2421875,
            "text": "and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": -2.2421875,
            "text": "Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -2.2421875,
            "text": "the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -2.2421875,
            "text": "Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": -2.2421875,
            "text": "Fahn-Tolosa-Marin Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.71875,
            "end_logit": -2.2421875,
            "text": "Rating Scale and the Essential",
            "probability": 0.0
        }
    ],
    "58f4b1a170f9fc6f0f000010_1": [
        {
            "start_logit": -6.67578125,
            "end_logit": -5.51171875,
            "text": "Amanita phalloides",
            "probability": 0.262451171875
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -6.234375,
            "text": "Amanita phalloides poisoning",
            "probability": 0.1279296875
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -5.51171875,
            "text": "in Amanita phalloides",
            "probability": 0.09356689453125
        },
        {
            "start_logit": -7.9375,
            "end_logit": -5.51171875,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.073974609375
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -6.234375,
            "text": "in Amanita phalloides poisoning",
            "probability": 0.04522705078125
        },
        {
            "start_logit": -8.6015625,
            "end_logit": -5.51171875,
            "text": "anita phalloides",
            "probability": 0.038421630859375
        },
        {
            "start_logit": -7.9375,
            "end_logit": -6.234375,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.03607177734375
        },
        {
            "start_logit": -8.6875,
            "end_logit": -5.51171875,
            "text": "loides",
            "probability": 0.034942626953125
        },
        {
            "start_logit": -8.71875,
            "end_logit": -5.51171875,
            "text": "post liver transplantation survival in Amanita phalloides",
            "probability": 0.033905029296875
        },
        {
            "start_logit": -8.71875,
            "end_logit": -5.51171875,
            "text": "liver transplantation survival in Amanita phalloides",
            "probability": 0.033905029296875
        },
        {
            "start_logit": -8.7265625,
            "end_logit": -5.51171875,
            "text": "patients' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.033905029296875
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -7.57421875,
            "text": "Amanita",
            "probability": 0.033355712890625
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -7.84375,
            "text": "Amanita phal",
            "probability": 0.02557373046875
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -8.015625,
            "text": "Amanita phallo",
            "probability": 0.02154541015625
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -8.0546875,
            "text": "Amani",
            "probability": 0.0205535888671875
        },
        {
            "start_logit": -8.6015625,
            "end_logit": -6.234375,
            "text": "anita phalloides poisoning",
            "probability": 0.0185699462890625
        },
        {
            "start_logit": -8.6875,
            "end_logit": -6.234375,
            "text": "loides poisoning",
            "probability": 0.0170440673828125
        },
        {
            "start_logit": -8.71875,
            "end_logit": -6.234375,
            "text": "post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.016510009765625
        },
        {
            "start_logit": -8.71875,
            "end_logit": -6.234375,
            "text": "liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.016510009765625
        },
        {
            "start_logit": -8.7265625,
            "end_logit": -6.234375,
            "text": "patients' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.016387939453125
        }
    ],
    "58aa0c6f396a458e50000008_1": [
        {
            "start_logit": 8.125,
            "end_logit": 9.015625,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.015625,
            "text": "neurohypophysial hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.015625,
            "text": "The neurohypophysial hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.015625,
            "text": "ypophysial hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.015625,
            "text": "hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.03125,
            "text": "oxytocin (OXT) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.078125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition, pair bonding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.109375,
            "text": "oxytocin (OXT) and its receptor (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.125,
            "text": "oxytocin (OXT) and its receptor (OXTR)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.140625,
            "text": "oxytocin (OXT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.1484375,
            "text": "oxytocin (OXT)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.1484375,
            "text": "oxytocin (OXT) and its receptor (OXTR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.15625,
            "text": "oxytocin (OXT) and its",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.1875,
            "text": "oxytocin (OXT) and its receptor (OX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.234375,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.234375,
            "text": "oxytocin (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.125,
            "end_logit": -8.2421875,
            "text": "oxytocin (OXT) and its receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.078125,
            "text": "pair bonding",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.1171875,
            "text": "pair bonding, parental behavior, and stress-",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_2": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.8671875,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.8671875,
            "text": "hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.8671875,
            "text": "Neuropeptide hormone oxytocin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.99609375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.0546875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.0546875,
            "text": "oxytocin has roles in social bonding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.125,
            "text": "oxytocin has roles",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.140625,
            "text": "oxytocin has roles in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.1484375,
            "text": "oxytocin has roles in social bonding, energy metabolism",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.1484375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.15625,
            "text": "oxytocin has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.1796875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.1953125,
            "text": "oxytocin has roles in social bonding, energy metabolism, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.2265625,
            "text": "oxytocin has roles in social bonding,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.28125,
            "text": "oxytocin has roles in social bonding, energy metabolism,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.3671875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.390625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.40625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.99609375,
            "text": "social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.0546875,
            "text": "social bonding, energy metabolism, and wound healing contributing",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_3": [
        {
            "start_logit": 8.3984375,
            "end_logit": 8.5546875,
            "text": "Oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -6.09765625,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.796875,
            "text": "Oxytocin is known as the 'love hormone' due",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.81640625,
            "text": "Oxytocin is known as the 'love hormone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.0078125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.015625,
            "text": "Oxytocin is known as the 'love hormone' due its",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.0234375,
            "text": "Oxytocin is known as the 'love hormone' due its role in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.0234375,
            "text": "Oxytocin is known as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.046875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.0625,
            "text": "Oxytocin is known as the 'love hormone'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.1171875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.1171875,
            "text": "Oxytocin is known as the 'love",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.1171875,
            "text": "Oxytocin is known",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.1484375,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.171875,
            "text": "Oxytocin is known as the 'lov",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.1796875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.2109375,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.2734375,
            "text": "Oxytocin is known as the 'love hormone' due its role",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -8.328125,
            "text": "Oxytocin is known as the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8125,
            "end_logit": -6.09765625,
            "text": "known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_4": [
        {
            "start_logit": 7.3125,
            "end_logit": 7.7109375,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.3125,
            "end_logit": -6.23828125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding behavior",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -6.84375,
            "text": "oxytocin (OT",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -6.953125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.7109375,
            "text": "The oxytocin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.4296875,
            "text": "oxytocin (OT) hormone",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.5,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.5078125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.515625,
            "text": "oxytocin (OT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.7109375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.71484375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.7265625,
            "text": "oxytocin (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.73046875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.796875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.8515625,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.86328125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.87890625,
            "text": "oxytocin (OT) hormone pathway is involved in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.9453125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.15625,
            "end_logit": -6.23828125,
            "text": "pair bonding behavior",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -6.953125,
            "text": "pair bonding",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_5": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.9453125,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.65234375,
            "text": "oxytocin, a hormone involved in parent-offspring bonding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.74609375,
            "text": "oxytocin, a hormone involved in parent-offspring",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.796875,
            "text": "oxytocin, a hormone involved in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.8203125,
            "text": "oxytocin, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.8984375,
            "text": "oxytocin, a hormone involved in parent-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -8.0390625,
            "text": "oxytocin, a hormone involved in parent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -8.0703125,
            "text": "oxytocin, a hormone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -8.1484375,
            "text": "oxytocin, a hormone involved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.234375,
            "end_logit": -8.3125,
            "text": "oxytocin,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.65234375,
            "text": "parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.74609375,
            "text": "parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.65234375,
            "text": ", a hormone involved in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -7.8984375,
            "text": "parent-",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.74609375,
            "text": ", a hormone involved in parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -7.65234375,
            "text": "hormone involved in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.796875,
            "text": ", a hormone involved in",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": -7.8203125,
            "text": ", a",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -8.0390625,
            "text": "parent",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -7.74609375,
            "text": "hormone involved in parent-offspring",
            "probability": 0.0
        }
    ],
    "58a5b1fe60087bc10a000024_1": [
        {
            "start_logit": 2.07421875,
            "end_logit": -3.6875,
            "text": "The small ubiquitin-like modifier (SUMO) pathway",
            "probability": 0.388671875
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -3.814453125,
            "text": "The small ubiquitin-like modifier (SUMO) pathway in",
            "probability": 0.342529296875
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -5.45703125,
            "text": "The small ubiquitin-like modifier",
            "probability": 0.06622314453125
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -5.9765625,
            "text": "The small ubiquitin-like modifier (SUMO",
            "probability": 0.039398193359375
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -6.58984375,
            "text": "The small ubiquitin-like modifier (SUMO)",
            "probability": 0.0213470458984375
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -6.67578125,
            "text": "The small ubiquitin-like modifier (",
            "probability": 0.01959228515625
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -6.71875,
            "text": "The small ubiquitin-like modifier (SUMO) pathway in eukaryotes is",
            "probability": 0.0187530517578125
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -6.86328125,
            "text": "The small ubiquitin",
            "probability": 0.0162353515625
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -7.13671875,
            "text": "The small ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification",
            "probability": 0.01235198974609375
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -7.15625,
            "text": "The small ubiquitin-like",
            "probability": 0.012115478515625
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -7.24609375,
            "text": "The small ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required",
            "probability": 0.01107025146484375
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -7.26953125,
            "text": "The small ubiquitin-",
            "probability": 0.01081085205078125
        },
        {
            "start_logit": -1.513671875,
            "end_logit": -3.6875,
            "text": "small ubiquitin-like modifier (SUMO) pathway",
            "probability": 0.01073455810546875
        },
        {
            "start_logit": 2.07421875,
            "end_logit": -7.390625,
            "text": "The small ubiquitin-like modifier (SUMO) pathway in eukaryotes",
            "probability": 0.00958251953125
        },
        {
            "start_logit": -1.513671875,
            "end_logit": -3.814453125,
            "text": "small ubiquitin-like modifier (SUMO) pathway in",
            "probability": 0.00946807861328125
        },
        {
            "start_logit": -5.55859375,
            "end_logit": -0.2861328125,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.005657196044921875
        },
        {
            "start_logit": -1.513671875,
            "end_logit": -5.45703125,
            "text": "small ubiquitin-like modifier",
            "probability": 0.0018358230590820312
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -0.2861328125,
            "text": "SUMO pathway.",
            "probability": 0.0014638900756835938
        },
        {
            "start_logit": -1.513671875,
            "end_logit": -5.9765625,
            "text": "small ubiquitin-like modifier (SUMO",
            "probability": 0.0010881423950195312
        },
        {
            "start_logit": -7.5,
            "end_logit": -0.2861328125,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.0008111000061035156
        }
    ],
    "58a5b1fe60087bc10a000024_2": [
        {
            "start_logit": 4.23046875,
            "end_logit": 8.359375,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.9990234375
        },
        {
            "start_logit": -3.197265625,
            "end_logit": 8.359375,
            "text": ".",
            "probability": 0.0005927085876464844
        },
        {
            "start_logit": -4.87109375,
            "end_logit": 8.359375,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.00011050701141357422
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 8.359375,
            "text": "sumoylation.",
            "probability": 7.897615432739258e-05
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 8.359375,
            "text": "UBC9 and is a novel target for sumoylation.",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.359375,
            "text": "80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.359375,
            "text": "9 and is a novel target for sumoylation.",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.359375,
            "text": "C9 and is a novel target for sumoylation.",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.359375,
            "text": "for sumoylation.",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.359375,
            "text": "target for sumoylation.",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.359375,
            "text": "the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.359375,
            "text": "ylation.",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.359375,
            "text": "novel target for sumoylation.",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.359375,
            "text": "enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 8.359375,
            "text": "a novel target for sumoylation.",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 4.23046875,
            "end_logit": -5.66796875,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 4.23046875,
            "end_logit": -5.78515625,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 4.23046875,
            "end_logit": -6.171875,
            "text": "RAP",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.23046875,
            "end_logit": -6.85546875,
            "text": "RAP80 interacts with the SUMO-conjug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.23046875,
            "end_logit": -6.9765625,
            "text": "RAP80 interacts with the SUMO-conjugating",
            "probability": 2.384185791015625e-07
        }
    ],
    "58a5b1fe60087bc10a000024_3": [
        {
            "start_logit": -3.509765625,
            "end_logit": -4.66015625,
            "text": "enhance",
            "probability": 0.34033203125
        },
        {
            "start_logit": -3.509765625,
            "end_logit": -5.1328125,
            "text": "enhance Ets-1 sumoylation",
            "probability": 0.213134765625
        },
        {
            "start_logit": -3.509765625,
            "end_logit": -5.51171875,
            "text": "enhance Ets-1 sumoylation, while a SUMO protease, SENP1",
            "probability": 0.145263671875
        },
        {
            "start_logit": -3.509765625,
            "end_logit": -6.46875,
            "text": "enhance Ets-1 sumo",
            "probability": 0.0560302734375
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -5.63671875,
            "text": "sumoylation",
            "probability": 0.038177490234375
        },
        {
            "start_logit": -3.509765625,
            "end_logit": -6.90625,
            "text": "enhance Ets-1 sumoylation, while a SUMO protease",
            "probability": 0.036163330078125
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.0390625,
            "text": "sumoylation deficient version (Ets-1 K15R/K227R)",
            "probability": 0.02545166015625
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.23046875,
            "text": "sumoylation deficient",
            "probability": 0.021087646484375
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.3203125,
            "text": "sumoylation deficient version (Ets-1 K15R/K227R",
            "probability": 0.0192108154296875
        },
        {
            "start_logit": -6.796875,
            "end_logit": -4.66015625,
            "text": "we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.012786865234375
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.734375,
            "text": "sumoylation deficient version (Ets-1 K15R/K227",
            "probability": 0.0126953125
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.76171875,
            "text": "sumoylation deficient version (Ets-1 K15R/K227R), as well as WT or mutant proteins of the SUMO pathway,",
            "probability": 0.0124053955078125
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.78515625,
            "text": "sumoylation deficient version (Ets-1",
            "probability": 0.01201629638671875
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -6.88671875,
            "text": "sumoylation deficient version (Ets-1 K1",
            "probability": 0.0109405517578125
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -7.0859375,
            "text": "sumoylation deficient version (Ets-1 K15",
            "probability": 0.0089263916015625
        },
        {
            "start_logit": -7.203125,
            "end_logit": -4.66015625,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.00852203369140625
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -4.66015625,
            "text": "PIASy, can enhance",
            "probability": 0.008392333984375
        },
        {
            "start_logit": -6.796875,
            "end_logit": -5.1328125,
            "text": "we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.00794219970703125
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -5.1328125,
            "text": "sumoylation",
            "probability": 0.00533294677734375
        },
        {
            "start_logit": -7.203125,
            "end_logit": -5.1328125,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.005290985107421875
        }
    ],
    "58a5b1fe60087bc10a000024_4": [
        {
            "start_logit": -6.30078125,
            "end_logit": 0.250732421875,
            "text": "NF-kappaB",
            "probability": 0.32080078125
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -2.23046875,
            "text": "The results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.2607421875
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 0.250732421875,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.11041259765625
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 0.250732421875,
            "text": "alternative NF-kappaB",
            "probability": 0.085693359375
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 0.250732421875,
            "text": ", inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.058197021484375
        },
        {
            "start_logit": -5.859375,
            "end_logit": -2.23046875,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.041595458984375
        },
        {
            "start_logit": -6.08203125,
            "end_logit": -2.23046875,
            "text": "results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.033416748046875
        },
        {
            "start_logit": -6.6171875,
            "end_logit": -2.23046875,
            "text": "basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0196533203125
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -5.25,
            "text": "The results show",
            "probability": 0.01268768310546875
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -2.23046875,
            "text": "p100 phosphorylation and",
            "probability": 0.00972747802734375
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -2.23046875,
            "text": "show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0078125
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -2.23046875,
            "text": "and",
            "probability": 0.007282257080078125
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -2.23046875,
            "text": "phosphorylation and",
            "probability": 0.00711822509765625
        },
        {
            "start_logit": -7.859375,
            "end_logit": -2.23046875,
            "text": "stimuli-induced p100 phosphorylation and",
            "probability": 0.0056304931640625
        },
        {
            "start_logit": -8.09375,
            "end_logit": -2.23046875,
            "text": "required for stimuli-induced p100 phosphorylation and",
            "probability": 0.004451751708984375
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -6.51953125,
            "text": "The results show that basal SUMO modification is",
            "probability": 0.00357818603515625
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -6.609375,
            "text": "The results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation",
            "probability": 0.00325775146484375
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -6.80078125,
            "text": "The results show that basal SUMO modification is required for stimuli-induced p100",
            "probability": 0.0026988983154296875
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -6.86328125,
            "text": "The results show that basal SUMO modification is required",
            "probability": 0.0025386810302734375
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -6.9375,
            "text": "The results show that",
            "probability": 0.002346038818359375
        }
    ],
    "58a5b1fe60087bc10a000024_5": [
        {
            "start_logit": 5.515625,
            "end_logit": 9.7109375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.9794921875,
            "end_logit": 9.7109375,
            "text": ".",
            "probability": 0.0005545616149902344
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 9.7109375,
            "text": "viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.7109375,
            "text": "crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": 5.515625,
            "end_logit": -1.67578125,
            "text": "SUMO-conjugating enzyme E2",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 9.7109375,
            "text": "reproduction of white spot syndrome virus.",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 9.7109375,
            "text": "mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 9.7109375,
            "text": "facilitate reproduction of white spot syndrome virus.",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 9.7109375,
            "text": "of white spot syndrome virus.",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.7109375,
            "text": "white spot syndrome virus.",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.7109375,
            "text": "UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.7109375,
            "text": "protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.7109375,
            "text": "SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.7109375,
            "text": "C9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.7109375,
            "text": "in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 9.7109375,
            "text": "immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.90625,
            "end_logit": 9.7109375,
            "text": "9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.515625,
            "end_logit": -5.96484375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.515625,
            "end_logit": -6.125,
            "text": "SUMO",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.515625,
            "end_logit": -6.47265625,
            "text": "SUMO-conjugating enzyme",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5b1fe60087bc10a000024_6": [
        {
            "start_logit": -1.904296875,
            "end_logit": -1.1708984375,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.59423828125
        },
        {
            "start_logit": -2.7890625,
            "end_logit": -1.1708984375,
            "text": "E2 SUMO-conjugating enzyme.",
            "probability": 0.244873046875
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -3.302734375,
            "text": "Tax SUMOylation",
            "probability": 0.0704345703125
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -4.2890625,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.026214599609375
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -1.1708984375,
            "text": "SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.015899658203125
        },
        {
            "start_logit": -2.7890625,
            "end_logit": -4.2890625,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.0108489990234375
        },
        {
            "start_logit": -6.5625,
            "end_logit": -1.1708984375,
            "text": "SUMO-conjugating enzyme.",
            "probability": 0.005626678466796875
        },
        {
            "start_logit": -6.59765625,
            "end_logit": -1.1708984375,
            "text": "we revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00543212890625
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -6.09375,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjug",
            "probability": 0.00431060791015625
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -1.1708984375,
            "text": "revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00310516357421875
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -1.1708984375,
            "text": "unique E2 SUMO-conjugating enzyme.",
            "probability": 0.002696990966796875
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -6.59765625,
            "text": "Tax SUMOylation using",
            "probability": 0.00261688232421875
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -6.78125,
            "text": "Tax SUMO",
            "probability": 0.0021686553955078125
        },
        {
            "start_logit": -1.904296875,
            "end_logit": -6.87109375,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating",
            "probability": 0.00199127197265625
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -3.302734375,
            "text": "SUMOylation",
            "probability": 0.0018835067749023438
        },
        {
            "start_logit": -2.7890625,
            "end_logit": -6.09375,
            "text": "E2 SUMO-conjug",
            "probability": 0.0017843246459960938
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -1.1708984375,
            "text": "role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0017290115356445312
        },
        {
            "start_logit": -7.875,
            "end_logit": -1.1708984375,
            "text": ".",
            "probability": 0.001514434814453125
        },
        {
            "start_logit": -8.0,
            "end_logit": -1.1708984375,
            "text": "Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0013360977172851562
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.1708984375,
            "text": "of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0013256072998046875
        }
    ],
    "5c011057133db5eb78000025_1": [
        {
            "start_logit": 9.59375,
            "end_logit": 10.296875,
            "text": "phase II",
            "probability": 1.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": 10.296875,
            "text": "II",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -2.611328125,
            "text": "phase",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.296875,
            "text": "in phase II",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.296875,
            "text": "been evaluated in phase II",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.296875,
            "text": "have been evaluated in phase II",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.296875,
            "text": "evaluated in phase II",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.80078125,
            "text": "phase II clinical trials",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.296875,
            "text": ") have been evaluated in phase II",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.296875,
            "text": ", while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.328125,
            "text": "phase II clinical",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -7.80078125,
            "text": "II clinical trials",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -8.328125,
            "text": "II clinical",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -2.611328125,
            "text": "in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": -2.611328125,
            "text": "been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -2.611328125,
            "text": "have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -2.611328125,
            "text": "evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -2.611328125,
            "text": ") have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.5390625,
            "end_logit": -2.611328125,
            "text": ", while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -7.80078125,
            "text": "in phase II clinical trials",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_1": [
        {
            "start_logit": 9.875,
            "end_logit": 10.265625,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": 10.265625,
            "text": "y",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.09765625,
            "text": "primary",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -6.52734375,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.02734375,
            "text": "primary microcephal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 10.265625,
            "text": "microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": 10.265625,
            "text": "ephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.45703125,
            "text": "primary microc",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 10.265625,
            "text": "cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.79296875,
            "text": "primary microcephaly and",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.80859375,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.265625,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.91015625,
            "text": "primary microcephaly and define a novel laminopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.265625,
            "text": "variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.265625,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.109375,
            "text": "primary microcephaly and define a",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.171875,
            "text": "primary microcephaly and define a novel",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.265625,
            "text": "lamin B2 variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.3515625,
            "text": "primary microcephaly and define",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -6.52734375,
            "text": "y and define a novel laminopathy",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_2": [
        {
            "start_logit": 6.16015625,
            "end_logit": 4.4765625,
            "text": "primary microcephaly",
            "probability": 0.998046875
        },
        {
            "start_logit": 2.24609375,
            "end_logit": 1.8408203125,
            "text": "lamin \u0251-helical rod domain",
            "probability": 0.0014209747314453125
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -2.76953125,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.0007085800170898438
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -6.2890625,
            "text": "primary",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": -3.349609375,
            "end_logit": 2.912109375,
            "text": "microcephaly",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.53515625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 4.4765625,
            "text": "microcephaly",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 4.4765625,
            "text": "y",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -5.20703125,
            "end_logit": 1.8408203125,
            "text": "\u0251-helical rod domain",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 2.912109375,
            "text": "novel microcephaly",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 2.24609375,
            "end_logit": -6.3671875,
            "text": "lamin \u0251-helical rod",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 2.912109375,
            "text": "ephaly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.24609375,
            "end_logit": -6.8125,
            "text": "lamin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 2.912109375,
            "text": "y",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.16796875,
            "end_logit": -2.76953125,
            "text": "laminopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 1.8408203125,
            "text": "helical rod domain",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.57421875,
            "end_logit": -2.41015625,
            "text": "extreme microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.24609375,
            "end_logit": -7.46875,
            "text": "lamin \u0251-helical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 1.8408203125,
            "text": "rod domain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 1.8408203125,
            "text": "the lamin \u0251-helical rod domain",
            "probability": 5.960464477539063e-08
        }
    ],
    "601bfa531cb411341a000008_3": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.2734375,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": 10.2734375,
            "text": "y",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.1875,
            "text": "primary",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -4.4140625,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.00390625,
            "text": "primary microcephal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 10.2734375,
            "text": "microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 10.2734375,
            "text": "ephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.48046875,
            "text": "primary microc",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.55859375,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 10.2734375,
            "text": "cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.80859375,
            "text": "primary microcephaly and",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 10.2734375,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.2734375,
            "text": "variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.2734375,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.140625,
            "text": "primary microcephaly and define a novel",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.1875,
            "text": "primary microcephaly and define a",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -4.4140625,
            "text": "y and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -7.55859375,
            "text": "y and define a novel lamin",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -7.80859375,
            "text": "y and",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -8.140625,
            "text": "y and define a novel",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_4": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.21875,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": -2.119140625,
            "end_logit": 10.21875,
            "text": "y",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -1.9697265625,
            "text": "primary",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.84375,
            "end_logit": -5.171875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 10.21875,
            "text": "microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 10.21875,
            "text": "ephaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -6.84375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 10.21875,
            "text": "of primary microcephaly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.58203125,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.74609375,
            "text": "primary microcephal",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.74609375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.75,
            "text": "primary microcephaly,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.21875,
            "text": "genetic cause of primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.984375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy.",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.015625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.21875,
            "text": "identify dominant pathogenic variants in LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 0.0
        },
        {
            "start_logit": -2.119140625,
            "end_logit": -5.171875,
            "text": "y, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -2.119140625,
            "end_logit": -6.84375,
            "text": "y, implicating a major structural component of the nuclear envelope",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -1.9697265625,
            "text": "of primary",
            "probability": 0.0
        },
        {
            "start_logit": -2.119140625,
            "end_logit": -7.58203125,
            "text": "y, implicating a major structural component of the nuclear envelope in",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_1": [
        {
            "start_logit": 6.83984375,
            "end_logit": 5.66015625,
            "text": "malaria",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.1805419921875,
            "end_logit": 5.66015625,
            "text": "100% protection against controlled human malaria",
            "probability": 0.0012798309326171875
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.92578125,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.03125,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.046875,
            "text": "malaria infection",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 5.66015625,
            "text": "live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 5.66015625,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 5.66015625,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 5.66015625,
            "text": "up to 100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.34375,
            "end_logit": 5.66015625,
            "text": "Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 5.66015625,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.359375,
            "end_logit": 5.66015625,
            "text": "attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 5.66015625,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.453125,
            "end_logit": 5.66015625,
            "text": "sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.46875,
            "end_logit": 5.66015625,
            "text": "PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 5.66015625,
            "text": "Z Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.53125,
            "end_logit": 5.66015625,
            "text": "protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.53125,
            "end_logit": 5.66015625,
            "text": "SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.1805419921875,
            "end_logit": -4.75,
            "text": "100",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.1805419921875,
            "end_logit": -6.2265625,
            "text": "100%",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_2": [
        {
            "start_logit": 8.6015625,
            "end_logit": 4.41015625,
            "text": "100% against homologous controlled human malaria",
            "probability": 0.958984375
        },
        {
            "start_logit": 5.2734375,
            "end_logit": 4.41015625,
            "text": "malaria",
            "probability": 0.034393310546875
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -0.7919921875,
            "text": "100",
            "probability": 0.005252838134765625
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -2.337890625,
            "text": "100%",
            "probability": 0.0011224746704101562
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -7.8046875,
            "text": "100% against",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 4.41015625,
            "text": "vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 4.41015625,
            "text": "of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 4.41015625,
            "text": "VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 4.41015625,
            "text": "shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 4.41015625,
            "text": "administered to subjects taking weekly chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 4.41015625,
            "text": "to subjects taking weekly chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 4.41015625,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 4.41015625,
            "text": "have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 4.41015625,
            "text": "taking weekly chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 4.41015625,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -0.7919921875,
            "text": "vaccine efficacies (VEs) of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -0.7919921875,
            "text": "of 100",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -0.7919921875,
            "text": "VEs) of 100",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -0.7919921875,
            "text": "shown vaccine efficacies (VEs) of 100",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -0.7919921875,
            "text": "administered to subjects taking weekly chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_3": [
        {
            "start_logit": 8.6796875,
            "end_logit": 8.1015625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 8.1015625,
            "text": ") malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.62890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.70703125,
            "text": "malaria vaccine,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.71875,
            "text": "malaria vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.8828125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.15625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.203125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.2265625,
            "text": "malaria vaccine, PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.2421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.28125,
            "text": "malaria vaccine, PfSPZ Vaccine,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.1015625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 8.1015625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.1015625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.1015625,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.1015625,
            "text": "Z) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.1015625,
            "text": ") sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.1015625,
            "text": "SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 8.1015625,
            "text": "sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.1015625,
            "text": "Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        }
    ],
    "61f7d745882a024a10000038_4": [
        {
            "start_logit": 8.078125,
            "end_logit": 6.58203125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.75390625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.796875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.890625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.94921875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythro",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.09375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocyt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.58203125,
            "text": "review, we focus on four approaches to malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.58203125,
            "text": "to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.58203125,
            "text": "limited review, we focus on four approaches to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.58203125,
            "text": "we focus on four approaches to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.84375,
            "end_logit": -4.7890625,
            "text": "whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -4.7890625,
            "text": "2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -4.7890625,
            "text": "(RTS,S/AS01), (2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -4.7890625,
            "text": "(2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -4.7890625,
            "text": "Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle (RTS,S/AS01), (2) whole sporozoite",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_5": [
        {
            "start_logit": 8.078125,
            "end_logit": 6.58203125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.75390625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.796875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.890625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -7.94921875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythro",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic stages of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.078125,
            "end_logit": -8.09375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocyt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.58203125,
            "text": "review, we focus on four approaches to malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.58203125,
            "text": "to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.58203125,
            "text": "limited review, we focus on four approaches to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.58203125,
            "text": "we focus on four approaches to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.84375,
            "end_logit": -4.7890625,
            "text": "whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -4.7890625,
            "text": "2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -4.7890625,
            "text": "(RTS,S/AS01), (2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -4.7890625,
            "text": "(2) whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -4.7890625,
            "text": "Plasmodium falciparum (Pf) pre-erythrocytic stages of the parasite cycle (RTS,S/AS01), (2) whole sporozoite",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_6": [
        {
            "start_logit": 8.65625,
            "end_logit": 7.8203125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.65625,
            "end_logit": -6.9609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.0234375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.05078125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.94921875,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.9609375,
            "text": "malaria vaccine, Plasmodium falciparum spor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.0859375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.0859375,
            "text": "malaria vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.09375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.09375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.8203125,
            "text": "A live-attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 7.8203125,
            "text": "live-attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 7.8203125,
            "text": "attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.7265625,
            "text": "up to 14 mo",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.9609375,
            "text": "Plasmodium falciparum sporozoite vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -6.7265625,
            "text": "14 mo",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.0234375,
            "text": "Plasmodium falciparum sporozoite vaccine (",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.05078125,
            "text": "Plasmodium falciparum sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.234375,
            "text": "up",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -6.9609375,
            "text": "A live-attenuated malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_7": [
        {
            "start_logit": 8.828125,
            "end_logit": 7.578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.40625,
            "end_logit": 7.578125,
            "text": "Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.703125,
            "text": "malaria, but the features of the antibody response induced",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.96484375,
            "text": "malaria, but the features of the antibody response",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.99609375,
            "text": "malaria,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.0234375,
            "text": "malaria, but the features of the antibody response induced by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.15625,
            "text": "malaria, but the features of the antibody response induced by this treatment remain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.15625,
            "text": "malaria, but the features of the antibody response induced by this treatment remain unclear",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.578125,
            "text": "against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.578125,
            "text": "protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.578125,
            "text": "been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.578125,
            "text": "shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 7.578125,
            "text": "be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.578125,
            "text": "has been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 7.578125,
            "text": "PfSPZs) has been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 7.578125,
            "text": "PZs) has been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 7.578125,
            "text": "to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 7.578125,
            "text": "Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 7.578125,
            "text": "s) has been shown to be protective against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.40625,
            "end_logit": -7.36328125,
            "text": "Immunization with attenuated Plasmodium falciparum sporozoites (",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_8": [
        {
            "start_logit": 8.6171875,
            "end_logit": 8.46875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.96484375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.0859375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.1015625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.125,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.1328125,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.140625,
            "text": "malaria vaccines, which is based on human malaria sporozoites",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.2578125,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.2734375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.2734375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.296875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.296875,
            "text": "malaria vaccines, which is based on human malaria spor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.3046875,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.3203125,
            "text": "malaria vaccines,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.34375,
            "text": "malaria vaccines",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.46875,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.359375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.3828125,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -8.3828125,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.46875,
            "text": "candidate human malaria",
            "probability": 5.960464477539063e-08
        }
    ],
    "61f7d745882a024a10000038_9": [
        {
            "start_logit": 6.359375,
            "end_logit": 5.4375,
            "text": "malaria",
            "probability": 0.990234375
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": 5.4375,
            "text": "100% protection against controlled human malaria",
            "probability": 0.0100555419921875
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": -3.33203125,
            "text": "100",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.9609375,
            "text": "malaria infection",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 5.4375,
            "text": "live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 5.4375,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 5.4375,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 5.4375,
            "text": "attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.328125,
            "end_logit": 5.4375,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.359375,
            "end_logit": 5.4375,
            "text": "up to 100% protection against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.40625,
            "end_logit": 5.4375,
            "text": "Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 5.4375,
            "text": "controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 5.4375,
            "text": "PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 5.4375,
            "text": "sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.5625,
            "end_logit": 5.4375,
            "text": "SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.609375,
            "end_logit": 5.4375,
            "text": "has shown up to 100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": -5.984375,
            "text": "100%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": -7.8984375,
            "text": "100% protection against",
            "probability": 0.0
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": -7.90234375,
            "text": "100% protection",
            "probability": 0.0
        },
        {
            "start_logit": 1.7705078125,
            "end_logit": -7.9609375,
            "text": "100% protection against controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_10": [
        {
            "start_logit": 8.2421875,
            "end_logit": 6.92578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.8828125,
            "text": "malaria infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.96484375,
            "text": "malaria infection (CHMI) 3 weeks",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.0234375,
            "text": "malaria infection (CHMI) 3",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.046875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.1328125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.2109375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.2578125,
            "text": "malaria infection (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 6.92578125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 6.92578125,
            "text": "highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 6.92578125,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 6.92578125,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 6.92578125,
            "text": ") sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 6.92578125,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 6.92578125,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.11328125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine,",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.1875,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.51953125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.66796875,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ)",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.76171875,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_11": [
        {
            "start_logit": 1.5810546875,
            "end_logit": 2.119140625,
            "text": "malaria",
            "probability": 0.97265625
        },
        {
            "start_logit": -2.224609375,
            "end_logit": 2.119140625,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0216522216796875
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 2.119140625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0028839111328125
        },
        {
            "start_logit": -2.224609375,
            "end_logit": -0.51708984375,
            "text": "whole malaria",
            "probability": 0.0015506744384765625
        },
        {
            "start_logit": -4.23828125,
            "end_logit": -0.51708984375,
            "text": "malaria",
            "probability": 0.00020742416381835938
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 2.119140625,
            "text": "human malaria",
            "probability": 0.00018584728240966797
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 2.119140625,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.00017464160919189453
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 2.119140625,
            "text": "been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0001163482666015625
        },
        {
            "start_logit": -4.86328125,
            "end_logit": -0.51708984375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 0.00011098384857177734
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 2.119140625,
            "text": "replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.00010263919830322266
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 2.119140625,
            "text": "reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 9.79304313659668e-05
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 2.119140625,
            "text": "safe and protective against P falciparum controlled human malaria",
            "probability": 9.059906005859375e-05
        },
        {
            "start_logit": 1.5810546875,
            "end_logit": -7.265625,
            "text": "malaria infection in malaria-naive",
            "probability": 8.183717727661133e-05
        },
        {
            "start_logit": -7.84375,
            "end_logit": 2.119140625,
            "text": "P falciparum controlled human malaria",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 1.5810546875,
            "end_logit": -7.32421875,
            "text": "malaria infection",
            "probability": 7.748603820800781e-05
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 2.119140625,
            "text": "non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 6.943941116333008e-05
        },
        {
            "start_logit": -8.125,
            "end_logit": 2.119140625,
            "text": "has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 5.942583084106445e-05
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 2.119140625,
            "text": "controlled human malaria",
            "probability": 5.5789947509765625e-05
        },
        {
            "start_logit": 1.5810546875,
            "end_logit": -7.65234375,
            "text": "malaria infection in malaria",
            "probability": 5.5789947509765625e-05
        },
        {
            "start_logit": -7.0390625,
            "end_logit": -0.51708984375,
            "text": ", whole malaria",
            "probability": 1.2636184692382812e-05
        }
    ],
    "61f7d745882a024a10000038_12": [
        {
            "start_logit": 8.65625,
            "end_logit": 8.5234375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.65625,
            "end_logit": -7.98828125,
            "text": "malaria by chemoattenuated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.046875,
            "text": "malaria by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.2578125,
            "text": "malaria by chemoatten",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.28125,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 8.5234375,
            "text": "Sterile protection against human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.3515625,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.3671875,
            "text": "malaria by chemoattenuated PfS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.3984375,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.65625,
            "end_logit": -8.4765625,
            "text": "malaria by chemoat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.5234375,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.5234375,
            "text": "protection against human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -7.98828125,
            "text": "chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.98828125,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.046875,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.2578125,
            "text": "chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.28125,
            "text": "chemoattenuated PfSPZ vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.2421875,
            "text": "Sterile protection against",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.3515625,
            "text": "chemoattenuated PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.2578125,
            "text": "Sterile protection against human malaria by chemoatten",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_13": [
        {
            "start_logit": 8.75,
            "end_logit": 8.171875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.75,
            "end_logit": -8.3046875,
            "text": "malaria.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.171875,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.171875,
            "text": "attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1875,
            "end_logit": 8.171875,
            "text": "of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.171875,
            "text": "aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.171875,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.171875,
            "text": "-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.171875,
            "text": "cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.171875,
            "text": ", aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.171875,
            "text": "sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.171875,
            "text": "purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.171875,
            "text": "against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.171875,
            "text": ", is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -8.015625,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -8.109375,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -8.1875,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -8.015625,
            "text": "attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.015625,
            "text": "of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -8.28125,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI)",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_14": [
        {
            "start_logit": 8.7265625,
            "end_logit": 8.1328125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.0703125,
            "text": "malaria vaccines because",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.1328125,
            "text": "been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.1640625,
            "text": "malaria vaccines because of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.203125,
            "text": "malaria vaccines because of its unparalleled",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.21875,
            "text": "malaria vaccines because of its unparall",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.25,
            "text": "malaria vaccines because of its unpara",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -8.328125,
            "text": "malaria vaccines because of its",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.1328125,
            "text": "gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 8.1328125,
            "text": "radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.1328125,
            "text": "has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.1328125,
            "text": "The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 8.1328125,
            "text": "considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.1328125,
            "text": "for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.1328125,
            "text": "PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.1328125,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.1328125,
            "text": "Z) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.1328125,
            "text": "vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.1328125,
            "text": "PZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.1328125,
            "text": "ozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539063e-08
        }
    ],
    "61f7d745882a024a10000038_15": [
        {
            "start_logit": 8.7421875,
            "end_logit": 8.1640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.85546875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1640625,
            "text": ") malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.96484375,
            "text": "malaria vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.0234375,
            "text": "malaria vaccine,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.0390625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.21875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.234375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.2890625,
            "text": "malaria vaccine, PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.296875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -8.3046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.1640625,
            "text": "GROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.1640625,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.1640625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.1640625,
            "text": "CKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.1640625,
            "text": "Z) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.1640625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.1640625,
            "text": "SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.1640625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -7.85546875,
            "text": ") malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_16": [
        {
            "start_logit": 9.09375,
            "end_logit": 7.8671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.015625,
            "text": "malaria chemoprophylaxis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.21875,
            "text": "malaria chemoprophylax",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.234375,
            "text": "malaria chemoprop",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.234375,
            "text": "malaria chemo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.265625,
            "text": "malaria chemoprophyla",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -8.265625,
            "text": "malaria chemoprophy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.8671875,
            "text": "on malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 7.8671875,
            "text": "while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 7.8671875,
            "text": "volunteers after intravenous (IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 7.8671875,
            "text": "who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 7.8671875,
            "text": "those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 7.8671875,
            "text": "of volunteers after intravenous (IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 7.8671875,
            "text": "intravenous (IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 7.8671875,
            "text": "were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 7.8671875,
            "text": ") inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 7.8671875,
            "text": "inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -8.015625,
            "text": "on malaria chemoprophylaxis",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.0546875,
            "text": "otective efficacy has been demonstrated",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -8.21875,
            "text": "on malaria chemoprophylax",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_17": [
        {
            "start_logit": 9.15625,
            "end_logit": 7.57421875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 9.15625,
            "end_logit": -8.40625,
            "text": "malaria (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 7.57421875,
            "text": "to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.57421875,
            "text": "exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.57421875,
            "text": "irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.57421875,
            "text": "whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 7.57421875,
            "text": "individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 7.57421875,
            "text": "an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 7.57421875,
            "text": "); or individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 7.57421875,
            "text": "); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -8.40625,
            "text": "to malaria (",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.3515625,
            "text": "vaccine RTS,S",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.359375,
            "text": "vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.375,
            "text": "vaccine RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -8.359375,
            "text": "01 (mAbs 317 and 311); an irradiated whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.3515625,
            "text": "CSP vaccine RTS,S",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.359375,
            "text": "CSP vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": -8.375,
            "text": "CSP vaccine RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -8.40625,
            "text": "exposed to malaria (",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.4765625,
            "text": "vaccine RTS,S/AS01 (mAbs 317 and 311); an irradiated whole sporozoite vaccine PfSPZ (",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_18": [
        {
            "start_logit": 8.8828125,
            "end_logit": 8.265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.0390625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.2109375,
            "text": "malaria by a simple chemoattenuated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.2578125,
            "text": "malaria by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.28125,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.4140625,
            "text": "malaria by a simple chemoattenuated PfSP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.4296875,
            "text": "malaria by a simple chemoatten",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.453125,
            "text": "malaria by a simple chemoattenuated PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.453125,
            "text": "malaria by a simple chemoattenuated PfS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -8.5234375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.265625,
            "text": "Heterologous protection against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.265625,
            "text": "against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.265625,
            "text": "protection against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.0390625,
            "text": "chemoattenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.0390625,
            "text": "simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.0390625,
            "text": "Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -8.0390625,
            "text": "against malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.2109375,
            "text": "chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.2109375,
            "text": "simple chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.0390625,
            "text": "vaccine regimen in",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_19": [
        {
            "start_logit": 9.0078125,
            "end_logit": 8.1171875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.1015625,
            "text": "malaria at",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.3125,
            "text": "malaria at 1 year and immune correlates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.328125,
            "text": "malaria at 1 year and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.3984375,
            "text": "malaria at 1 year and immune correlates following",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.421875,
            "text": "malaria at 1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.453125,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.484375,
            "text": "malaria at 1 year",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.1171875,
            "text": "Protection against malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.1015625,
            "text": "Protection against malaria at",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -8.3125,
            "text": "immune correlates",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.3125,
            "text": "year and immune correlates",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.328125,
            "text": "year and",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.3125,
            "text": "Protection against malaria at 1 year and immune correlates",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.328125,
            "text": "Protection against malaria at 1 year and",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -8.3984375,
            "text": "immune correlates following",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.3515625,
            "text": "Protection against",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -8.3125,
            "text": "1 year and immune correlates",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": -8.328125,
            "text": "1 year and",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -8.453125,
            "text": "PfSPZ vaccination.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_20": [
        {
            "start_logit": 9.0078125,
            "end_logit": 8.0703125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.0625,
            "text": "malaria infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -8.4453125,
            "text": "malaria infection.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.0703125,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.0703125,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.0703125,
            "text": "Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.0703125,
            "text": "heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.0703125,
            "text": "protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.0703125,
            "text": "durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.0703125,
            "text": "Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.0703125,
            "text": "PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.0703125,
            "text": "PZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.0703125,
            "text": "strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.0703125,
            "text": "Z Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 8.0703125,
            "text": "T cells and durable protection against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.0703125,
            "text": "against heterologous controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.0625,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -8.0625,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -8.0625,
            "text": "controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.0625,
            "text": "Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_21": [
        {
            "start_logit": 9.7734375,
            "end_logit": 10.9765625,
            "text": "Plasmodium falciparum malaria",
            "probability": 1.0
        },
        {
            "start_logit": 1.2724609375,
            "end_logit": 10.9765625,
            "text": "malaria",
            "probability": 0.0002034902572631836
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -2.01953125,
            "text": "Plasmodium",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -5.59375,
            "text": "Plasmodium falciparum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 10.9765625,
            "text": "falciparum malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 10.9765625,
            "text": "Protection against Plasmodium falciparum malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 10.9765625,
            "text": "against Plasmodium falciparum malaria",
            "probability": 0.0
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -8.0859375,
            "text": "Plasmodium falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": 1.2724609375,
            "end_logit": -8.0859375,
            "text": "malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -2.01953125,
            "text": "Protection against Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -2.01953125,
            "text": "against Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -5.59375,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -5.59375,
            "text": "Protection against Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -5.59375,
            "text": "against Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -8.0859375,
            "text": "falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -8.0859375,
            "text": "Protection against Plasmodium falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -8.375,
            "text": "Protection against",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.0859375,
            "text": "against Plasmodium falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -8.375,
            "text": "against",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_22": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.34375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.140625,
            "text": "malaria by chemoattenuated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.140625,
            "text": "malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.2109375,
            "text": "malaria by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.3671875,
            "text": "malaria by chemoatten",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.4140625,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.46875,
            "text": "malaria by chemoattenuated PfS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.4765625,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.828125,
            "end_logit": -8.484375,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.34375,
            "text": "Sterile protection against human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.34375,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.34375,
            "text": "protection against human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.140625,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.140625,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.140625,
            "text": "chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.140625,
            "text": "chemoattenuated PfSPZ vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.2109375,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.3125,
            "text": "Sterile protection against",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.3671875,
            "text": "Sterile protection against human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -8.40625,
            "text": "Sterile protection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_23": [
        {
            "start_logit": 8.921875,
            "end_logit": 8.21875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.1953125,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.3203125,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.3515625,
            "text": "malaria in infants in western Kenya: a double-blind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.40625,
            "text": "malaria in infants in western Kenya: a double-blind,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.40625,
            "text": "malaria in infants in western Kenya: a double-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4140625,
            "text": "malaria in infants in western Kenya:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4140625,
            "text": "malaria in infants in western Kenya: a double-blind, randomized,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4609375,
            "text": "malaria in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4609375,
            "text": "malaria in infants in western Kenya: a double",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.4609375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -8.484375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.21875,
            "text": "against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.21875,
            "text": "PfSPZ Vaccine against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.21875,
            "text": "Z Vaccine against malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.21875,
            "text": "Vaccine against malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.21875,
            "text": "PZ Vaccine against malaria",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -8.1953125,
            "text": "against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": -8.1953125,
            "text": "a double-blind, randomized, placebo-controlled",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_24": [
        {
            "start_logit": 8.859375,
            "end_logit": 8.2734375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.171875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.1953125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.28125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.328125,
            "text": "malaria infection (CHMI) by direct venous inoculation (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.34375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3671875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3671875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) spor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3671875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3828125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.2734375,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.2734375,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.2734375,
            "text": "We are using controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": -8.171875,
            "text": "infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -8.1953125,
            "text": "infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.171875,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.171875,
            "text": ") sporozoites (",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -8.265625,
            "text": "Challenge) to try to reduce time and costs of",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.1953125,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -8.171875,
            "text": "cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_25": [
        {
            "start_logit": 8.203125,
            "end_logit": 6.83984375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.87890625,
            "text": "malaria infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.99609375,
            "text": "malaria infection (CHMI) 3 weeks",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.015625,
            "text": "malaria infection (CHMI) 3",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.0703125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.1875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -8.2265625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.83984375,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 6.83984375,
            "text": "highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.140625,
            "end_logit": 6.83984375,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 6.83984375,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 6.83984375,
            "text": ") sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 6.83984375,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 6.83984375,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.875,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine,",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.0,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.45703125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -6.875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine,",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.61328125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ)",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -6.875,
            "text": ") sporozoite (SPZ) vaccine,",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_26": [
        {
            "start_logit": 8.9375,
            "end_logit": 8.1640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.125,
            "text": "malaria through long-lived tissue-resident T cells and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.1640625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.1875,
            "text": "malaria through",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.4140625,
            "text": "malaria through long-lived tissue-resident",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.4140625,
            "text": "malaria through long-lived tissue-resident T cells and that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.4453125,
            "text": "malaria through long-lived tissue-resident T cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.4609375,
            "text": "malaria through long-lived tissue-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.4609375,
            "text": "malaria through long-lived",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.46875,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -8.484375,
            "text": "malaria through long-lived tissue-resident T",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1640625,
            "text": "to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 8.1640625,
            "text": "Our findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.1640625,
            "text": "findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 8.1640625,
            "text": "durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.1640625,
            "text": "protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.1640625,
            "text": "Z Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.1640625,
            "text": "Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.1640625,
            "text": "PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.1640625,
            "text": "PZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539063e-08
        }
    ],
    "61f7d745882a024a10000038_27": [
        {
            "start_logit": 8.6796875,
            "end_logit": 7.70703125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.74609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.76953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.921875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.85546875,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.87890625,
            "text": "malaria vaccine, Plasmodium falciparum spor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.0546875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.0859375,
            "text": "malaria vaccine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.171875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.1953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.1953125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.70703125,
            "text": "A live-attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 7.70703125,
            "text": "live-attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 7.70703125,
            "text": "attenuated malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -6.74609375,
            "text": "Plasmodium falciparum sporozoite vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -6.76953125,
            "text": "Plasmodium falciparum sporozoite vaccine (",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -6.921875,
            "text": "Plasmodium falciparum sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -6.74609375,
            "text": "A live-attenuated malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_28": [
        {
            "start_logit": 7.78515625,
            "end_logit": 5.71484375,
            "text": "malaria",
            "probability": 0.990234375
        },
        {
            "start_logit": 3.08984375,
            "end_logit": 5.71484375,
            "text": "P falciparum infection throughout an entire malaria",
            "probability": 0.0090484619140625
        },
        {
            "start_logit": 3.08984375,
            "end_logit": 2.8125,
            "text": "P falciparum",
            "probability": 0.0004968643188476562
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -7.83203125,
            "text": "malaria season",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -8.1640625,
            "text": "malaria season.FUNDING:",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -8.234375,
            "text": "malaria season.FUNDING: US National",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -8.265625,
            "text": "malaria season.FUNDING: US National In",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.78515625,
            "end_logit": -8.28125,
            "text": "malaria season.FUNDING: US",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 5.71484375,
            "text": "falciparum infection throughout an entire malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 5.71484375,
            "text": "significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 5.71484375,
            "text": "African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 5.71484375,
            "text": "entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 5.71484375,
            "text": "ON: PfSPZ Vaccine was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 5.71484375,
            "text": "infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 5.71484375,
            "text": "protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 5.71484375,
            "text": "against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 5.71484375,
            "text": "well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 5.71484375,
            "text": "in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 5.71484375,
            "text": "adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 5.71484375,
            "text": "safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_29": [
        {
            "start_logit": 8.5546875,
            "end_logit": 7.91015625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 7.91015625,
            "text": ") malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.65625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.79296875,
            "text": "malaria vaccine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.8125,
            "text": "malaria vaccine,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.90234375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.15625,
            "text": "malaria vaccine, PfSPZ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.1796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2109375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2109375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2734375,
            "text": "malaria vaccine, PfSPZ Vaccine,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.28125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.91015625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 7.91015625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 7.91015625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 7.91015625,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 7.91015625,
            "text": ") sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.91015625,
            "text": "Z) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 7.91015625,
            "text": "sporozoite (SPZ) malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 7.91015625,
            "text": "SPZ) malaria",
            "probability": 5.960464477539063e-08
        }
    ],
    "61f7d745882a024a10000038_30": [
        {
            "start_logit": 2.685546875,
            "end_logit": 2.84765625,
            "text": "malaria",
            "probability": 0.9970703125
        },
        {
            "start_logit": -3.693359375,
            "end_logit": 2.84765625,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0016984939575195312
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 2.84765625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.000354766845703125
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 2.84765625,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 5.996227264404297e-05
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 2.84765625,
            "text": "human malaria",
            "probability": 5.167722702026367e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 2.84765625,
            "text": "replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 3.993511199951172e-05
        },
        {
            "start_logit": 2.685546875,
            "end_logit": -7.35546875,
            "text": "malaria infection",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 2.84765625,
            "text": "been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 3.4689903259277344e-05
        },
        {
            "start_logit": 2.685546875,
            "end_logit": -7.51953125,
            "text": "malaria infection in malaria",
            "probability": 3.135204315185547e-05
        },
        {
            "start_logit": 2.685546875,
            "end_logit": -7.60546875,
            "text": "malaria infection in malaria-naive",
            "probability": 2.8789043426513672e-05
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 2.84765625,
            "text": "reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 2.685546875,
            "end_logit": -7.625,
            "text": "malaria infection in",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 2.84765625,
            "text": "non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 2.84765625,
            "text": "safe and protective against P falciparum controlled human malaria",
            "probability": 2.664327621459961e-05
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 2.84765625,
            "text": "P falciparum controlled human malaria",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -8.109375,
            "end_logit": 2.84765625,
            "text": "has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -8.15625,
            "end_logit": 2.84765625,
            "text": "controlled human malaria",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": -8.25,
            "end_logit": 2.84765625,
            "text": "falciparum controlled human malaria",
            "probability": 1.7702579498291016e-05
        },
        {
            "start_logit": -3.693359375,
            "end_logit": -2.943359375,
            "text": "whole malaria",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -2.943359375,
            "text": "malaria",
            "probability": 1.0728836059570312e-06
        }
    ],
    "61f7d745882a024a10000038_31": [
        {
            "start_logit": 8.859375,
            "end_logit": 8.2265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.2265625,
            "text": "malaria infection ten",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.2578125,
            "text": "malaria infection ten weeks after",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.265625,
            "text": "malaria infection ten weeks after the last dose",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3046875,
            "text": "malaria infection ten weeks after the last",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.859375,
            "end_logit": -8.3125,
            "text": "malaria infection ten weeks after the last dose (group III",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.2265625,
            "text": "Challenge at 28-day intervals were well tolerated and safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 8.2265625,
            "text": "human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.2265625,
            "text": "infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.2265625,
            "text": "controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.2265625,
            "text": "volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.2265625,
            "text": ", and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.2265625,
            "text": "safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.2265625,
            "text": "underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.2265625,
            "text": "and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.15625,
            "text": "Three doses of 5.12 \u00d7 104 PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.15625,
            "text": "Three doses of 5",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.1875,
            "text": "Three doses of 5.12 \u00d7 104 PfSPZ of PfSPZ Challenge at",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.203125,
            "text": "Three doses of 5.12",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -8.21875,
            "text": "Three doses",
            "probability": 0.0
        }
    ],
    "622d1ed13a8413c6530000a3_1": [
        {
            "start_logit": -1.6025390625,
            "end_logit": 9.1953125,
            "text": ".",
            "probability": 0.61474609375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -3.005859375,
            "text": "The",
            "probability": 0.16943359375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -3.119140625,
            "text": "The daughterless (da) gene in Drosophila",
            "probability": 0.1517333984375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.171875,
            "text": "The daughterless (da) gene",
            "probability": 0.0071563720703125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.1875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator",
            "probability": 0.00704193115234375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.46875,
            "text": "The daughterless (da",
            "probability": 0.00531768798828125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.4765625,
            "text": "The daughterless (da) gene in",
            "probability": 0.005275726318359375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.50390625,
            "text": "The daughterless (da) gene in Drosophila encodes",
            "probability": 0.00513458251953125
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 9.1953125,
            "text": "daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been extensively examined.",
            "probability": 0.004638671875
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.83984375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis",
            "probability": 0.00366973876953125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.0234375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose",
            "probability": 0.0030536651611328125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.08984375,
            "text": "The daughterless (da)",
            "probability": 0.0028591156005859375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.1328125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination",
            "probability": 0.0027370452880859375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.14453125,
            "text": "The daughterless (da) gene in Drosophila encodes a",
            "probability": 0.0027065277099609375
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.16796875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly",
            "probability": 0.0026416778564453125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.20703125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and",
            "probability": 0.0025424957275390625
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.23046875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been",
            "probability": 0.002483367919921875
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.265625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed",
            "probability": 0.0023975372314453125
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.26953125,
            "text": "The daughterless",
            "probability": 0.00238800048828125
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.1953125,
            "text": "sex determination and neurogenesis have been extensively examined.",
            "probability": 0.002033233642578125
        }
    ],
    "56bc9268ac7ad1001900001b_1": [
        {
            "start_logit": 9.515625,
            "end_logit": 9.828125,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -0.11126708984375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -3.015625,
            "end_logit": 9.828125,
            "text": "17",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 9.515625,
            "end_logit": -2.99609375,
            "text": "interleukin",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.515625,
            "end_logit": -6.625,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -6.84765625,
            "text": "interleukin-17 receptor A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.6484375,
            "end_logit": -0.11126708984375,
            "text": "psoriasis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.828125,
            "text": "-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.015625,
            "text": "interleukin-17 receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.828125,
            "text": "-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.828125,
            "text": "anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.0625,
            "text": "interleukin-17 receptor A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.828125,
            "text": "BACKGROUND: Early clinical studies suggested that the anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 9.828125,
            "text": "Early clinical studies suggested that the anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.828125,
            "text": "the anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.3359375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.34375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.40625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.421875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab",
            "probability": 0.0
        },
        {
            "start_logit": 9.515625,
            "end_logit": -8.4609375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in",
            "probability": 0.0
        }
    ],
    "56bc9268ac7ad1001900001b_2": [
        {
            "start_logit": 9.4296875,
            "end_logit": 9.7890625,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -1.5029296875,
            "text": "interleukin-17-receptor antibody for psoriasis",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -3.033203125,
            "end_logit": 9.7890625,
            "text": "17",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -3.123046875,
            "text": "interleukin",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -6.90234375,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 9.7890625,
            "text": "anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": 9.7890625,
            "text": "-17",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.7890625,
            "text": "-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.7890625,
            "text": "an anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.0234375,
            "text": "interleukin-17-receptor",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.7890625,
            "text": "Brodalumab, an anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.1875,
            "text": "interleukin-17-",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.7890625,
            "text": "dalumab, an anti-interleukin-17",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.25,
            "text": "interleukin-17-receptor antibody for psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.390625,
            "text": "interleukin-17-receptor antibody",
            "probability": 0.0
        },
        {
            "start_logit": 1.1796875,
            "end_logit": -1.5029296875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.033203125,
            "end_logit": -1.5029296875,
            "text": "17-receptor antibody for psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": 1.1796875,
            "end_logit": -8.25,
            "text": "psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -1.5029296875,
            "text": "for psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -1.5029296875,
            "text": "anti-interleukin-17-receptor antibody for psoriasis",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_1": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.0078125,
            "text": "essential hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": 8.0078125,
            "text": "hypertension",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -3.27734375,
            "text": "essential",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.0078125,
            "text": "with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.0078125,
            "text": "to patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 8.0078125,
            "text": "patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.0078125,
            "text": ") administered for 3 years to patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.015625,
            "end_logit": -3.27734375,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -3.27734375,
            "text": "to patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -3.27734375,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": -3.27734375,
            "text": ") administered for 3 years to patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.16015625,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.828125,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.96875,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.140625,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1484375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1796875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1953125,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.2109375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.16015625,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_2": [
        {
            "start_logit": 3.119140625,
            "end_logit": 9.2421875,
            "text": "essential hypertension",
            "probability": 0.9873046875
        },
        {
            "start_logit": -1.2919921875,
            "end_logit": 9.2421875,
            "text": "hypertension",
            "probability": 0.01200103759765625
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 9.2421875,
            "text": "antihypertensive drug in blacks with essential hypertension",
            "probability": 5.84721565246582e-05
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.2421875,
            "text": "with essential hypertension",
            "probability": 2.5570392608642578e-05
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.2421875,
            "text": "blacks with essential hypertension",
            "probability": 2.288818359375e-05
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.2421875,
            "text": "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.2421875,
            "text": "in blacks with essential hypertension",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.2421875,
            "text": "effective antihypertensive drug in blacks with essential hypertension",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -6.96875,
            "text": "essential",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -7.8828125,
            "text": "essential hypertension,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -7.95703125,
            "text": "essential hypertension, resulting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.046875,
            "text": "essential hypertension, resulting in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.09375,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.1171875,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.125,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.140625,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.15625,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.1796875,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.1875,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness and mass and",
            "probability": 0.0
        },
        {
            "start_logit": 3.119140625,
            "end_logit": -8.21875,
            "text": "essential hypertension, resulting in regression of left ventricular wall thickness",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_3": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.0078125,
            "text": "essential hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": 8.0078125,
            "text": "hypertension",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -3.27734375,
            "text": "essential",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.0078125,
            "text": "with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.0078125,
            "text": "to patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 8.0078125,
            "text": "patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.296875,
            "end_logit": 8.0078125,
            "text": ") administered for 3 years to patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.015625,
            "end_logit": -3.27734375,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": -3.27734375,
            "text": "to patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -3.27734375,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": -3.27734375,
            "text": ") administered for 3 years to patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.16015625,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.828125,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.96875,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.140625,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1484375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1796875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.1953125,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -8.2109375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -7.16015625,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_4": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.234375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.234375,
            "text": "moderate hypertension",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.234375,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.234375,
            "text": "45 patients with mild-to-moderate hypertension",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.890625,
            "text": "hypertension (mean age 59",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.91015625,
            "text": "hypertension (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.96875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 8.234375,
            "text": "in 45 patients with mild-to-moderate hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.0546875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.109375,
            "text": "hypertension (mean age 59 years",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.1171875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.140625,
            "end_logit": 8.234375,
            "text": "The antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 8.234375,
            "text": "patients with mild-to-moderate hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.1875,
            "text": "hypertension (mean age",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.21875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.28125,
            "text": "hypertension (mean age 59 years) using casual and ambulatory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.2890625,
            "text": "hypertension (mean age 59 years) using",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -8.296875,
            "text": "hypertension (mean age 59 years) using casual and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.234375,
            "text": "with mild-to-moderate hypertension",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c3184050c68dd416000003_5": [
        {
            "start_logit": -0.60791015625,
            "end_logit": 0.826171875,
            "text": "arterial hypertension",
            "probability": 0.490478515625
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": 0.826171875,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.470703125
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -2.046875,
            "text": "antihypertensive",
            "probability": 0.026611328125
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 0.826171875,
            "text": "hypertension",
            "probability": 0.003803253173828125
        },
        {
            "start_logit": -5.74609375,
            "end_logit": 0.826171875,
            "text": "coronary flow reserve in patients with arterial hypertension",
            "probability": 0.002872467041015625
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 0.826171875,
            "text": "in patients with arterial hypertension",
            "probability": 0.0010814666748046875
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 0.826171875,
            "text": "patients with arterial hypertension",
            "probability": 0.0010814666748046875
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 0.826171875,
            "text": "with arterial hypertension",
            "probability": 0.0007090568542480469
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 0.826171875,
            "text": "Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0006356239318847656
        },
        {
            "start_logit": -7.328125,
            "end_logit": 0.826171875,
            "text": "Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0005927085876464844
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 0.826171875,
            "text": "[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.00046133995056152344
        },
        {
            "start_logit": -0.60791015625,
            "end_logit": -6.78125,
            "text": "arterial hypertension and microvascular angina]",
            "probability": 0.00024318695068359375
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -6.78125,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina]",
            "probability": 0.0002338886260986328
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -7.3515625,
            "text": "antihypertensive therapy",
            "probability": 0.0001322031021118164
        },
        {
            "start_logit": -0.60791015625,
            "end_logit": -7.76953125,
            "text": "arterial hypertension and microvascular angina].",
            "probability": 9.083747863769531e-05
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -7.76953125,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 8.672475814819336e-05
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -7.8359375,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve",
            "probability": 8.14199447631836e-05
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -8.046875,
            "text": "antihypertensive therapy with",
            "probability": 6.592273712158203e-05
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -8.125,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow",
            "probability": 6.097555160522461e-05
        },
        {
            "start_logit": -0.64892578125,
            "end_logit": -8.171875,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary",
            "probability": 5.817413330078125e-05
        }
    ],
    "56c3184050c68dd416000003_6": [
        {
            "start_logit": 8.484375,
            "end_logit": 7.0234375,
            "text": "arterial hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 8.484375,
            "end_logit": -3.583984375,
            "text": "arterial",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 7.0234375,
            "text": "hypertension",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.11328125,
            "text": "arterial hypertension in motor vehicle drivers",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.734375,
            "text": "arterial hypertension in motor vehicle",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -7.80078125,
            "text": "arterial hypertension in motor vehicle drivers]",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.484375,
            "end_logit": -8.3359375,
            "text": "arterial hypertension in motor vehicle drivers].",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.0234375,
            "text": "[Isradipine in arterial hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.0234375,
            "text": "Isradipine in arterial hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.0234375,
            "text": "in arterial hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -3.583984375,
            "text": "[Isradipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -3.583984375,
            "text": "Isradipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -3.583984375,
            "text": "in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -7.11328125,
            "text": "hypertension in motor vehicle drivers",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -7.11328125,
            "text": "motor vehicle drivers",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -7.734375,
            "text": "hypertension in motor vehicle",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -7.80078125,
            "text": "hypertension in motor vehicle drivers]",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -7.734375,
            "text": "motor vehicle",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -7.80078125,
            "text": "motor vehicle drivers]",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -8.3359375,
            "text": "hypertension in motor vehicle drivers].",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_7": [
        {
            "start_logit": 9.7109375,
            "end_logit": 9.90625,
            "text": "essential hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -2.28515625,
            "text": "essential",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.484375,
            "end_logit": 9.90625,
            "text": "hypertension",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.90625,
            "text": "with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.90625,
            "text": "elderly patients with essential hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 9.90625,
            "text": "patients with essential hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.90625,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 0.0
        },
        {
            "start_logit": 9.7109375,
            "end_logit": -8.015625,
            "text": "essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.90625,
            "text": "in elderly patients with essential hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.90625,
            "text": "isradipine in elderly patients with essential hypertension",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -2.28515625,
            "text": "with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -2.28515625,
            "text": "elderly patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -2.28515625,
            "text": "patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -2.28515625,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -2.484375,
            "end_logit": -8.015625,
            "text": "hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -2.28515625,
            "text": "in elderly patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -2.28515625,
            "text": "isradipine in elderly patients with essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -8.015625,
            "text": "with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -8.015625,
            "text": "elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -8.015625,
            "text": "patients with essential hypertension.",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_8": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.671875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 8.671875,
            "text": "treatment of hypertension",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.671875,
            "text": "of hypertension",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.671875,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6953125,
            "text": "hypertension.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 8.671875,
            "text": "multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.671875,
            "text": "the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.671875,
            "text": "isradipine and atenolol in the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.671875,
            "text": "atenolol in the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.671875,
            "text": "pine and atenolol in the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.671875,
            "text": "dipine and atenolol in the treatment of hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.1484375,
            "end_logit": -7.6953125,
            "text": "treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.6953125,
            "text": "of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.6953125,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -7.6953125,
            "text": "multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -7.6953125,
            "text": "the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -8.234375,
            "text": "A multicenter evaluation of the safety and",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -7.6953125,
            "text": "isradipine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -7.6953125,
            "text": "atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -7.6953125,
            "text": "pine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_9": [
        {
            "start_logit": 8.40625,
            "end_logit": 8.28125,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.28125,
            "text": "for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.40625,
            "end_logit": -8.015625,
            "text": "hypertension and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.28125,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.28125,
            "text": "very careful in the use of isradipine as a therapy for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.28125,
            "text": "therapy for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.28125,
            "text": "is advisable to be very careful in the use of isradipine as a therapy for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.28125,
            "text": "careful in the use of isradipine as a therapy for hypertension",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.40625,
            "end_logit": -8.4765625,
            "text": "hypertension and other indications.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -8.015625,
            "text": "for hypertension and",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -8.4765625,
            "text": "other indications.",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.015625,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension and",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.234375,
            "text": "it is advisable to be very careful in the use of isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -8.4765625,
            "text": "indications.",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.015625,
            "text": "very careful in the use of isradipine as a therapy for hypertension and",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.296875,
            "text": "it is advisable to be very careful in",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.3046875,
            "text": "it is advisable",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.3046875,
            "text": "it is advisable to be very careful in the use",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.015625,
            "text": "therapy for hypertension and",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -8.015625,
            "text": "is advisable to be very careful in the use of isradipine as a therapy for hypertension and",
            "probability": 0.0
        }
    ],
    "56ffd08bcf1c325851000009_1": [
        {
            "start_logit": 1.4013671875,
            "end_logit": 6.765625,
            "text": "the 7SL RNA gene.",
            "probability": 0.8447265625
        },
        {
            "start_logit": -0.54736328125,
            "end_logit": 6.765625,
            "text": "from the 7SL RNA gene.",
            "probability": 0.12078857421875
        },
        {
            "start_logit": 2.74609375,
            "end_logit": 1.7509765625,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 0.0215606689453125
        },
        {
            "start_logit": 1.4013671875,
            "end_logit": 1.7509765625,
            "text": "the 7SL RNA gene",
            "probability": 0.005626678466796875
        },
        {
            "start_logit": -4.04296875,
            "end_logit": 6.765625,
            "text": ".",
            "probability": 0.003662109375
        },
        {
            "start_logit": -5.31640625,
            "end_logit": 6.765625,
            "text": "originate from the 7SL RNA gene.",
            "probability": 0.0010251998901367188
        },
        {
            "start_logit": -0.54736328125,
            "end_logit": 1.7509765625,
            "text": "from the 7SL RNA gene",
            "probability": 0.00080108642578125
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 6.765625,
            "text": "300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0007467269897460938
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 6.765625,
            "text": "and originate from the 7SL RNA gene.",
            "probability": 0.00018012523651123047
        },
        {
            "start_logit": -7.109375,
            "end_logit": 6.765625,
            "text": "7SL RNA gene.",
            "probability": 0.00017058849334716797
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.765625,
            "text": ", and originate from the 7SL RNA gene.",
            "probability": 0.00014030933380126953
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.765625,
            "text": "about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0001380443572998047
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.765625,
            "text": "gene.",
            "probability": 8.314847946166992e-05
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.765625,
            "text": "size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 7.62939453125e-05
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.765625,
            "text": ", fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 7.337331771850586e-05
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.765625,
            "text": "identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 7.164478302001953e-05
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 6.765625,
            "text": "bp, and originate from the 7SL RNA gene.",
            "probability": 6.222724914550781e-05
        },
        {
            "start_logit": 2.74609375,
            "end_logit": -4.25390625,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp,",
            "probability": 5.322694778442383e-05
        },
        {
            "start_logit": 2.74609375,
            "end_logit": -5.29296875,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": 2.74609375,
            "end_logit": -6.296875,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA",
            "probability": 6.9141387939453125e-06
        }
    ],
    "58cf5c5a8acda34529000003_1": [
        {
            "start_logit": 2.4921875,
            "end_logit": 6.5234375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.9990234375
        },
        {
            "start_logit": -5.18359375,
            "end_logit": 6.5234375,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0004634857177734375
        },
        {
            "start_logit": -5.65625,
            "end_logit": 6.5234375,
            "text": "cil",
            "probability": 0.00028896331787109375
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 6.5234375,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 7.027387619018555e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 6.5234375,
            "text": "D-glucosyl-hydroxymethyluracil",
            "probability": 6.29425048828125e-05
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.5234375,
            "text": "glucosyl-hydroxymethyluracil",
            "probability": 6.246566772460938e-05
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.5234375,
            "text": "uracil",
            "probability": 5.91278076171875e-05
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.5234375,
            "text": "hydroxymethyluracil",
            "probability": 5.4717063903808594e-05
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.5234375,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 4.678964614868164e-05
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.5234375,
            "text": "osyl-hydroxymethyluracil",
            "probability": 4.607439041137695e-05
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -3.458984375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 4.607439041137695e-05
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.5234375,
            "text": "-glucosyl-hydroxymethyluracil",
            "probability": 3.6716461181640625e-05
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.5234375,
            "text": "-hydroxymethyluracil",
            "probability": 3.641843795776367e-05
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -5.76953125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -6.4140625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats (99",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -6.72265625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -7.29296875,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1%",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -7.33203125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -7.57421875,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 2.4921875,
            "end_logit": -7.6171875,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil)",
            "probability": 7.152557373046875e-07
        }
    ],
    "58cf5c5a8acda34529000003_2": [
        {
            "start_logit": 2.32421875,
            "end_logit": 6.52734375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.9990234375
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 6.52734375,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.00046896934509277344
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 6.52734375,
            "text": "cil",
            "probability": 0.00033926963806152344
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 6.52734375,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 8.744001388549805e-05
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.52734375,
            "text": "D-glucosyl-hydroxymethyluracil",
            "probability": 7.361173629760742e-05
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.52734375,
            "text": "glucosyl-hydroxymethyluracil",
            "probability": 7.194280624389648e-05
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.52734375,
            "text": "uracil",
            "probability": 6.914138793945312e-05
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 6.52734375,
            "text": "hydroxymethyluracil",
            "probability": 6.246566772460938e-05
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.52734375,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 5.555152893066406e-05
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.52734375,
            "text": "osyl-hydroxymethyluracil",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 6.52734375,
            "text": "-glucosyl-hydroxymethyluracil",
            "probability": 4.363059997558594e-05
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.52734375,
            "text": "-hydroxymethyluracil",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -4.0703125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -5.8125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -6.4609375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats (99",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -6.609375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -7.31640625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -7.41015625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1%",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -7.65625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 2.32421875,
            "end_logit": -7.71484375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric",
            "probability": 6.556510925292969e-07
        }
    ],
    "61f86c03882a024a10000044_1": [
        {
            "start_logit": 10.0078125,
            "end_logit": 10.359375,
            "text": "recessive hereditary motor neuropathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.8916015625,
            "end_logit": 10.359375,
            "text": "neuropathy",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -1.5927734375,
            "text": "recessive",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -6.640625,
            "end_logit": 10.359375,
            "text": "motor neuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.046875,
            "end_logit": 10.359375,
            "text": "hereditary motor neuropathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -7.390625,
            "text": "recessive hereditary motor neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 10.359375,
            "text": "causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -7.6640625,
            "text": "recessive hereditary motor",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.359375,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.359375,
            "text": "VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.359375,
            "text": "ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.359375,
            "text": "A1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.359375,
            "text": "in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.359375,
            "text": "10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.3125,
            "text": "recessive hereditary",
            "probability": 0.0
        },
        {
            "start_logit": -1.8916015625,
            "end_logit": -7.390625,
            "text": "neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -1.5927734375,
            "text": "causes recessive",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -1.5927734375,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -1.5927734375,
            "text": "VWA1 causes recessive",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -1.5927734375,
            "text": "ancestral 10-bp repeat expansion in VWA1 causes recessive",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_1": [
        {
            "start_logit": 9.5546875,
            "end_logit": 10.1328125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 10.1328125,
            "text": "fibrosis",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -2.896484375,
            "text": "cystic",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 10.1328125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.1328125,
            "text": "BACKGROUND: Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.1328125,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.1328125,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.953125,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.95703125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.078125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.0859375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.109375,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.125,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.1328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.15625,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.1640625,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.1875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.21875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.234375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.25,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_2": [
        {
            "start_logit": -1.21875,
            "end_logit": -4.203125,
            "text": "cystic fibrosis",
            "probability": 0.580078125
        },
        {
            "start_logit": -1.21875,
            "end_logit": -5.53515625,
            "text": "cystic fibrosis transmembrane conductance regulator",
            "probability": 0.153076171875
        },
        {
            "start_logit": -1.21875,
            "end_logit": -6.8203125,
            "text": "cystic fibrosis transmembrane",
            "probability": 0.0423583984375
        },
        {
            "start_logit": -1.21875,
            "end_logit": -6.85546875,
            "text": "cystic fibrosis transmembrane conductance regulator)",
            "probability": 0.04071044921875
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.21484375,
            "text": "cystic fibrosis transmembrane conductance",
            "probability": 0.0284423828125
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.25390625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations",
            "probability": 0.0275726318359375
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.73046875,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride",
            "probability": 0.0169830322265625
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.734375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as",
            "probability": 0.0169830322265625
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.91015625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to",
            "probability": 0.0142974853515625
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.9453125,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations",
            "probability": 0.0137481689453125
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.9609375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well",
            "probability": 0.0135345458984375
        },
        {
            "start_logit": -1.21875,
            "end_logit": -7.99609375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and",
            "probability": 0.01302337646484375
        },
        {
            "start_logit": -1.21875,
            "end_logit": -8.0625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate",
            "probability": 0.012237548828125
        },
        {
            "start_logit": -1.21875,
            "end_logit": -8.140625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and",
            "probability": 0.01131439208984375
        },
        {
            "start_logit": -1.21875,
            "end_logit": -8.1484375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the",
            "probability": 0.01122283935546875
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -4.203125,
            "text": "(cystic fibrosis",
            "probability": 0.001201629638671875
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -4.203125,
            "text": "CFTR (cystic fibrosis",
            "probability": 0.0010442733764648438
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -4.203125,
            "text": "To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 0.0007939338684082031
        },
        {
            "start_logit": -8.046875,
            "end_logit": -4.203125,
            "text": "Objective: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 0.0006279945373535156
        },
        {
            "start_logit": -8.078125,
            "end_logit": -4.203125,
            "text": "associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 0.0006093978881835938
        }
    ],
    "5c6e16eb7c78d6947100004e_3": [
        {
            "start_logit": 9.59375,
            "end_logit": 10.3515625,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.974609375,
            "end_logit": 10.3515625,
            "text": "Fibrosis",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -2.794921875,
            "text": "Cystic",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.35546875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.3515625,
            "text": "The Sweat Metabolome of Screen-Positive Cystic Fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.3515625,
            "text": "Sweat Metabolome of Screen-Positive Cystic Fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.9609375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.97265625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.0,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.015625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.0234375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.078125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.109375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.1328125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.140625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.15625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.171875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.1796875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in support",
            "probability": 0.0
        },
        {
            "start_logit": 9.59375,
            "end_logit": -8.1796875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_4": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.2578125,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.265625,
            "end_logit": 10.2578125,
            "text": "Fibrosis",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.296875,
            "text": "Cystic",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 10.2578125,
            "text": "of Cystic Fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.9921875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.2578125,
            "text": "Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1640625,
            "text": "Cystic Fibrosis Patients.The diagnosis is",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1796875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1796875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2265625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2421875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2734375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.28125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.296875,
            "text": "Cystic Fibrosis Patients.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.328125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3359375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3515625,
            "text": "Cystic Fibrosis Patients.The diagnosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.359375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -2.296875,
            "text": "of Cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_5": [
        {
            "start_logit": 9.0390625,
            "end_logit": 10.0703125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": 10.0703125,
            "text": "In cystic fibrosis",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -2.6171875,
            "end_logit": 10.0703125,
            "text": "fibrosis",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -3.6953125,
            "text": "cystic",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.6484375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.8203125,
            "text": "cystic fibrosis (CF), sweat chloride",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.83203125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.86328125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.9765625,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.03125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR.",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.0390625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.0546875,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.0859375,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1015625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1171875,
            "text": "cystic fibrosis (CF), sweat chloride concentration",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.140625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1484375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1640625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been",
            "probability": 0.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -8.1953125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_6": [
        {
            "start_logit": 9.6171875,
            "end_logit": 10.0859375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.61328125,
            "end_logit": 10.0859375,
            "text": "fibrosis",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -2.80078125,
            "text": "cystic",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 10.0859375,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.0859375,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.92578125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.95703125,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0859375,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.0625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.078125,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1015625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1484375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.171875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1953125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.21875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.2421875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.25,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.25,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.265625,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_7": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": 10.1640625,
            "text": "fibrosis",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.458984375,
            "text": "cystic",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.1640625,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.1640625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.1640625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.1640625,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.1640625,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.25,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.453125,
            "text": "cystic fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -2.458984375,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -2.458984375,
            "text": "of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": -8.25,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.458984375,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.458984375,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": -8.453125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -2.458984375,
            "text": "gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -2.458984375,
            "text": "chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -8.25,
            "text": "diagnosis of cystic fibrosis (",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_8": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.25,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.271484375,
            "end_logit": 10.25,
            "text": "fibrosis",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.3046875,
            "text": "cystic",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.734375,
            "end_logit": 10.25,
            "text": "The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": 10.25,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 10.25,
            "text": "confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.25,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.25,
            "text": "sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.94921875,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.0546875,
            "text": "cystic fibrosis (CF) in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.0703125,
            "text": "cystic fibrosis (CF) in support",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.25,
            "text": "gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.09375,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.109375,
            "text": "cystic fibrosis (CF) in support of",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.171875,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.21875,
            "text": "cystic fibrosis (CF) in support of universal newborn",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2265625,
            "text": "cystic fibrosis (CF) in support of universal",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.265625,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3046875,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -2.3046875,
            "text": "The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_9": [
        {
            "start_logit": 9.8125,
            "end_logit": 10.109375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.533203125,
            "end_logit": 10.109375,
            "text": "fibrosis",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -2.359375,
            "text": "cystic",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.109375,
            "text": "for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.109375,
            "text": "biomarker for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.109375,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.265625,
            "text": "cystic fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.40625,
            "text": "cystic fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -2.359375,
            "text": "for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.359375,
            "text": "biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -2.359375,
            "text": "Sweat chloride is of interest as a biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.533203125,
            "end_logit": -8.265625,
            "text": "fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -2.533203125,
            "end_logit": -8.40625,
            "text": "fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.265625,
            "text": "for cystic fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -8.2265625,
            "text": "Sweat chloride is of interest as",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -8.265625,
            "text": "biomarker for cystic fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -8.265625,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -8.265625,
            "text": "electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.40625,
            "text": "for cystic fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -8.296875,
            "text": "Sweat chloride is",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_10": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": 10.1640625,
            "text": "fibrosis",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.458984375,
            "text": "cystic",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.1640625,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.1640625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.1640625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.1640625,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.1640625,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.25,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.453125,
            "text": "cystic fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -2.458984375,
            "text": "diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -2.458984375,
            "text": "of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": -8.25,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.458984375,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.458984375,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.451171875,
            "end_logit": -8.453125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -2.458984375,
            "text": "gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -2.458984375,
            "text": "chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -8.25,
            "text": "diagnosis of cystic fibrosis (",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_11": [
        {
            "start_logit": 9.6171875,
            "end_logit": 10.0859375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.61328125,
            "end_logit": 10.0859375,
            "text": "fibrosis",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -2.80078125,
            "text": "cystic",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 10.0859375,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.0859375,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.92578125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.95703125,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0859375,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.0625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.078125,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1015625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1484375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.171875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.1953125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.21875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.2421875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.25,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.25,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.265625,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_12": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.171875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": 10.171875,
            "text": "fibrosis",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.18359375,
            "text": "cystic",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.171875,
            "text": "BACKGROUND Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.171875,
            "text": "for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.171875,
            "text": "Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.171875,
            "text": "gold standard test for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.171875,
            "text": "chloride test is the gold standard test for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.375,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.421875,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -2.18359375,
            "text": "BACKGROUND Sweat chloride test is the gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -2.18359375,
            "text": "for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -2.18359375,
            "text": "Sweat chloride test is the gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -2.18359375,
            "text": "gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -2.18359375,
            "text": "chloride test is the gold standard test for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.375,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -2.435546875,
            "end_logit": -8.421875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -8.0390625,
            "text": "BACKGROUND Sweat chloride test is the gold standard",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -8.25,
            "text": "BACKGROUND Sweat chloride test is the gold standard test",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": -8.3359375,
            "text": "BACKGROUND Sweat chloride test is the gold",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_13": [
        {
            "start_logit": 9.8125,
            "end_logit": 10.0859375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.61328125,
            "end_logit": 10.0859375,
            "text": "fibrosis",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -2.380859375,
            "text": "cystic",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 10.0859375,
            "text": "the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.859375,
            "text": "cystic fibrosis due",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.0859375,
            "text": "screening test for the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.0859375,
            "text": "Sweat chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.9921875,
            "text": "cystic fibrosis due to",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.1171875,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.1171875,
            "text": "cystic fibrosis due to the fact that",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 10.0859375,
            "text": "chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.1640625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.0859375,
            "text": "known to be a screening test for the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.0859375,
            "text": "test is known to be a screening test for the cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.2734375,
            "text": "cystic fibrosis due to the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.3046875,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.3203125,
            "text": "cystic fibrosis due to the fact",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.390625,
            "text": "cystic fibrosis due to the fact that electrolyte",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.3984375,
            "text": "cystic fibrosis due to the fact that electrolyte levels",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -2.380859375,
            "text": "the cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_14": [
        {
            "start_logit": 9.8125,
            "end_logit": 10.1484375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": 10.1484375,
            "text": "fibrosis",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -2.384765625,
            "text": "cystic",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 10.1484375,
            "text": "for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.015625,
            "end_logit": 10.1484375,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.1484375,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.1484375,
            "text": "diagnostic tool for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.1484375,
            "text": "standard diagnostic tool for cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.234375,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.3125,
            "text": "cystic fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.4609375,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -2.384765625,
            "text": "for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -2.384765625,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -8.234375,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -8.3125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -2.384765625,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -2.384765625,
            "text": "diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -2.384765625,
            "text": "standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -8.4609375,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -8.234375,
            "text": "for cystic fibrosis (",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_15": [
        {
            "start_logit": 9.578125,
            "end_logit": 10.0625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.66015625,
            "end_logit": 10.0625,
            "text": "fibrosis",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.8671875,
            "text": "cystic",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 10.0625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.8671875,
            "text": "cystic fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.0625,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.9375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.98046875,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.0625,
            "text": "of cystic fibrosis",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0546875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.109375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1328125,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1484375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1640625,
            "text": "cystic fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.1953125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling,",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.2421875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.2421875,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 0.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.2734375,
            "text": "cystic fibrosis (CF)",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_1": [
        {
            "start_logit": 7.625,
            "end_logit": 11.0703125,
            "text": "bladder cancer",
            "probability": 0.984375
        },
        {
            "start_logit": 3.470703125,
            "end_logit": 11.0703125,
            "text": "cancer",
            "probability": 0.0155487060546875
        },
        {
            "start_logit": 7.625,
            "end_logit": -4.2109375,
            "text": "bladder",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.46875,
            "end_logit": 11.0703125,
            "text": "Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.578125,
            "end_logit": 11.0703125,
            "text": "for bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.9453125,
            "text": "bladder cancer:",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.2578125,
            "text": "bladder cancer: a review",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.3046875,
            "text": "bladder cancer: a review of",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.328125,
            "text": "bladder cancer: a review of immunological aspects",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.3359375,
            "text": "bladder cancer: a review of immunological aspects,",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.359375,
            "text": "bladder cancer: a review of immunological",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.40625,
            "text": "bladder cancer: a review of immunological aspects, clinical",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.4375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.4453125,
            "text": "bladder cancer: a review of immunological aspects, clinical effects",
            "probability": 0.0
        },
        {
            "start_logit": 7.625,
            "end_logit": -8.4609375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and BCG infections.",
            "probability": 0.0
        },
        {
            "start_logit": 3.470703125,
            "end_logit": -7.9453125,
            "text": "cancer:",
            "probability": 0.0
        },
        {
            "start_logit": 3.470703125,
            "end_logit": -8.2578125,
            "text": "cancer: a review",
            "probability": 0.0
        },
        {
            "start_logit": 3.470703125,
            "end_logit": -8.3046875,
            "text": "cancer: a review of",
            "probability": 0.0
        },
        {
            "start_logit": 3.470703125,
            "end_logit": -8.328125,
            "text": "cancer: a review of immunological aspects",
            "probability": 0.0
        },
        {
            "start_logit": 3.470703125,
            "end_logit": -8.3359375,
            "text": "cancer: a review of immunological aspects,",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_2": [
        {
            "start_logit": 7.5234375,
            "end_logit": 9.6015625,
            "text": "cancer",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.34375,
            "end_logit": 9.6015625,
            "text": "bladder cancer",
            "probability": 0.00206756591796875
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.6015625,
            "text": "for bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 9.6015625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -7.63671875,
            "text": "cancer has been used since",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -7.92578125,
            "text": "cancer has been",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.0078125,
            "text": "cancer has been used since 1976",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.015625,
            "text": "cancer has",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.0390625,
            "text": "cancer has been used since 1976 when",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.1171875,
            "text": "cancer has been used",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.2578125,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.3359375,
            "text": "cancer has been used since 1976 when the first evidence of",
            "probability": 0.0
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -8.34375,
            "text": "cancer has been used since 1976 when the first evidence of its ability to",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.27734375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.63671875,
            "text": "bladder cancer has been used since",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -7.92578125,
            "text": "bladder cancer has been",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -8.0078125,
            "text": "bladder cancer has been used since 1976",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -8.015625,
            "text": "bladder cancer has",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -8.0390625,
            "text": "bladder cancer has been used since 1976 when",
            "probability": 0.0
        },
        {
            "start_logit": 1.34375,
            "end_logit": -8.1171875,
            "text": "bladder cancer has been used",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_3": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.9765625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.9765625,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.9765625,
            "text": "bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.9765625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.9765625,
            "text": "BCG immunotherapy is the choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.9765625,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.9765625,
            "text": "muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.9765625,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.9765625,
            "text": "-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.3359375,
            "text": "cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.34375,
            "text": "cancer (NMIBC) after",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.3515625,
            "text": "cancer (NMIBC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.40625,
            "text": "cancer (NMIBC)",
            "probability": 0.0
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.4296875,
            "text": "cancer (NMIBC) after transurethral resection",
            "probability": 0.0
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.515625,
            "text": "cancer (NMIBC) after transurethral resection.",
            "probability": 0.0
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -8.5390625,
            "text": "cancer (NMIBC) after transurethral",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -8.3359375,
            "text": "high-grade non-muscle invasive bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -8.34375,
            "text": "high-grade non-muscle invasive bladder cancer (NMIBC) after",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -8.3359375,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -8.3515625,
            "text": "high-grade non-muscle invasive bladder cancer (NMIBC",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_4": [
        {
            "start_logit": 8.5546875,
            "end_logit": 8.6328125,
            "text": "Tuberculosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -5.04296875,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.6328125,
            "text": "Renal Tuberculosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.0,
            "text": "Tuberculosis Following",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2578125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2734375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2890625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.2890625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.3203125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.3203125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.3515625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.359375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.3671875,
            "text": "Tuberculosis Following Intravesical Bacillus Calm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.390625,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.421875,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.4609375,
            "text": "Tuberculosis Following Intravesical Bacillus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -8.5,
            "text": "Tuberculosis Following Intravesical",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.75,
            "end_logit": -5.04296875,
            "text": "Bladder Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -4.2734375,
            "end_logit": -5.04296875,
            "text": "Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -8.390625,
            "text": "Bladder Cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_5": [
        {
            "start_logit": 8.5,
            "end_logit": 8.734375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.65283203125,
            "end_logit": 8.734375,
            "text": "bladder cancer",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.734375,
            "text": "superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.734375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.734375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 8.734375,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5,
            "end_logit": -8.1328125,
            "text": "cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.734375,
            "text": "is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.734375,
            "text": "treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.734375,
            "text": "to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.734375,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.734375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.65283203125,
            "end_logit": -8.0859375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -0.65283203125,
            "end_logit": -8.1328125,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -8.0859375,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -8.1328125,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -7.80859375,
            "text": "nearly 40 years",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -7.96484375,
            "text": "nearly 40 years since",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -7.9765625,
            "text": "nearly 40",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -8.0859375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_6": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.9140625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.21484375,
            "end_logit": 8.9140625,
            "text": "bladder cancer",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -7.77734375,
            "text": "cancer can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.9140625,
            "text": "with bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.9140625,
            "text": "Prostatic urethral mucosal involvement with bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.9140625,
            "text": "mucosal involvement with bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.0703125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.1953125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.21875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.25,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.265625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3203125,
            "text": "cancer can be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3359375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.34375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.359375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.3671875,
            "text": "cancer can be effectively treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.375,
            "text": "cancer can be effectively treated with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.390625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.40625,
            "text": "cancer can be effectively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -8.4296875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_7": [
        {
            "start_logit": 7.7734375,
            "end_logit": 9.40625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.16796875,
            "end_logit": 9.40625,
            "text": "bladder cancer",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 9.40625,
            "text": "nonmuscle invasive bladder cancer",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 9.40625,
            "text": "in nonmuscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 9.40625,
            "text": "invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.40625,
            "text": "uscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.40625,
            "text": "Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.40625,
            "text": "le invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -8.390625,
            "text": "cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.16796875,
            "end_logit": -8.390625,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -8.390625,
            "text": "nonmuscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -8.3984375,
            "text": "nonmusc",
            "probability": 0.0
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -8.421875,
            "text": "nonmuscle",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.390625,
            "text": "in nonmuscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.3984375,
            "text": "in nonmusc",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -8.390625,
            "text": "invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -8.421875,
            "text": "in nonmuscle",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -8.15625,
            "text": "Recombinant Mycobacterium bovis BCG for",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -8.25,
            "text": "Recombinant Mycobacterium bovis",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_8": [
        {
            "start_logit": 7.21875,
            "end_logit": 9.7734375,
            "text": "cancer",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.0771484375,
            "end_logit": 9.7734375,
            "text": "bladder cancer",
            "probability": 0.002132415771484375
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 9.7734375,
            "text": "superficial bladder cancer",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.7734375,
            "text": "The advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.7734375,
            "text": "in superficial bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.1171875,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.125,
            "text": "cancer has been most apparent in patients with carcinoma in situ (",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.140625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.1484375,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.1484375,
            "text": "cancer has been most apparent in patients with carcinoma in situ",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.15625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.203125,
            "text": "cancer has been",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.2109375,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.21875,
            "text": "cancer has been most apparent",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.2265625,
            "text": "cancer has been most apparent in patients with carcinoma in",
            "probability": 0.0
        },
        {
            "start_logit": 7.21875,
            "end_logit": -8.2578125,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more",
            "probability": 0.0
        },
        {
            "start_logit": 1.0771484375,
            "end_logit": -7.84765625,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 1.0771484375,
            "end_logit": -8.1171875,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than",
            "probability": 0.0
        },
        {
            "start_logit": 1.0771484375,
            "end_logit": -8.125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (",
            "probability": 0.0
        },
        {
            "start_logit": 1.0771484375,
            "end_logit": -8.140625,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_9": [
        {
            "start_logit": 8.6328125,
            "end_logit": 8.578125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.578125,
            "text": "bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -8.2578125,
            "text": "cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -8.328125,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -8.34375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -8.359375,
            "text": "cancer (NMIBC) and carcinoma in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -8.3984375,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.578125,
            "text": "has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.578125,
            "text": "dministration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.578125,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.578125,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.578125,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.578125,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.578125,
            "text": "non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": -8.2578125,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -8.328125,
            "text": "bladder cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most a",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -8.34375,
            "text": "bladder cancer (NMIBC) and carcinoma in-situ (CIS) in terms",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -8.359375,
            "text": "bladder cancer (NMIBC) and carcinoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -8.3984375,
            "text": "bladder cancer (NMIBC) and carcinoma in-",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -8.2109375,
            "text": "has become the standard of care",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_10": [
        {
            "start_logit": 9.6015625,
            "end_logit": 10.28125,
            "text": "bladder cancer",
            "probability": 1.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": 10.28125,
            "text": "cancer",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -2.095703125,
            "text": "bladder",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 10.28125,
            "text": ") bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.28125,
            "text": "is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.28125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.28125,
            "text": "stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.28125,
            "text": "G3) bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.1015625,
            "text": "bladder cancer (BC), though its efficacy is limited",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.140625,
            "text": "bladder cancer (BC), though its efficacy is limited by",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.203125,
            "text": "bladder cancer (BC), though its efficacy is",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.21875,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.234375,
            "text": "bladder cancer (BC), though",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.2578125,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence",
            "probability": 0.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -8.2734375,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -8.1015625,
            "text": "cancer (BC), though its efficacy is limited",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -8.140625,
            "text": "cancer (BC), though its efficacy is limited by",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -8.203125,
            "text": "cancer (BC), though its efficacy is",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -8.21875,
            "text": "cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -1.4296875,
            "end_logit": -8.234375,
            "text": "cancer (BC), though",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_11": [
        {
            "start_logit": 8.5078125,
            "end_logit": 8.734375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.734375,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.734375,
            "text": "The standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.734375,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.734375,
            "text": "with non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.234375,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.734375,
            "text": "-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.734375,
            "text": "muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.734375,
            "text": "standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.2890625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.734375,
            "text": "patients with non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3046875,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.734375,
            "text": "most patients with non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3125,
            "text": "cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.328125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3359375,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.34375,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3515625,
            "text": "cancer (NMIBC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3671875,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette",
            "probability": 5.960464477539063e-08
        }
    ],
    "60292d191cb411341a00010e_12": [
        {
            "start_logit": 8.375,
            "end_logit": 8.859375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 0.007633209228515625,
            "end_logit": 8.859375,
            "text": "bladder cancer",
            "probability": 0.00023233890533447266
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.859375,
            "text": "superficial bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.859375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.859375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.859375,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.859375,
            "text": "treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.859375,
            "text": "is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.859375,
            "text": "to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.859375,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.859375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.375,
            "end_logit": -8.3203125,
            "text": "cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.007633209228515625,
            "end_logit": -7.8046875,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 0.007633209228515625,
            "end_logit": -8.3203125,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -7.8046875,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -8.3203125,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.7265625,
            "text": "nearly 40 years",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.8046875,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.9375,
            "text": "nearly 40",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.9375,
            "text": "nearly 40 years since",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_13": [
        {
            "start_logit": 8.6640625,
            "end_logit": 8.5625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.1640625,
            "text": "cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.2734375,
            "text": "cancer (NMIBC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.3125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6640625,
            "end_logit": -8.3125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIB",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.5625,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.5625,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 8.5625,
            "text": "-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.5625,
            "text": "bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.5625,
            "text": "Intravesical immunotherapy with bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.1640625,
            "text": "non-muscle-invasive bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.2734375,
            "text": "non-muscle-invasive bladder cancer (NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.296875,
            "text": "non-muscle-invasive",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.3125,
            "text": "non-muscle-invasive bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.3125,
            "text": "non-muscle-invasive bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIB",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": -8.3203125,
            "text": "non-muscle-",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -8.2734375,
            "text": "NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -8.1640625,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -8.3125,
            "text": "NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -8.3125,
            "text": "NMIBC), with proven effects on reducing recurrence, progression, and death from NMIB",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_14": [
        {
            "start_logit": 6.6796875,
            "end_logit": 10.0859375,
            "text": "cancer",
            "probability": 0.998046875
        },
        {
            "start_logit": 0.172119140625,
            "end_logit": 10.0859375,
            "text": "bladder cancer",
            "probability": 0.0014886856079101562
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.0859375,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.0859375,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.0859375,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0859375,
            "text": "first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0859375,
            "text": "intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.0859375,
            "text": "ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.0859375,
            "text": "many decades ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -7.8046875,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-40",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -7.9921875,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.0703125,
            "text": "cancer, its long-term efficacy is still arguable as",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.0859375,
            "text": "cancer,",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.140625,
            "text": "cancer, its long-term",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.1484375,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.15625,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-40%",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.1796875,
            "text": "cancer, its long-term efficacy is still arguable",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.265625,
            "text": "cancer, its long-term efficacy is still arguable as a",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.2734375,
            "text": "cancer, its long-term efficacy is",
            "probability": 0.0
        },
        {
            "start_logit": 6.6796875,
            "end_logit": -8.2734375,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_15": [
        {
            "start_logit": 8.9453125,
            "end_logit": 8.1015625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.375,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related atypia seen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.40625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.4140625,
            "text": "cancer and urothelial CIS and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.4140625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.421875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related atypia seen in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -8.421875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.1015625,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1875,
            "end_logit": 8.1015625,
            "text": "bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.1015625,
            "text": "intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.1015625,
            "text": "bladder tumour to reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.1015625,
            "text": "high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.1015625,
            "text": "tumour to reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.1015625,
            "text": "reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.1015625,
            "text": "recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 8.1015625,
            "text": "treat high-risk non-muscle-invasive bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.1015625,
            "text": "of bladder tumour to reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.1015625,
            "text": "risk non-muscle-invasive bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -8.375,
            "text": "bladder cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related atypia seen",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -8.40625,
            "text": "bladder cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_16": [
        {
            "start_logit": 8.9765625,
            "end_logit": 8.109375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.109375,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.3203125,
            "text": "cancer and urothelial carcinoma in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.390625,
            "text": "cancer and urothelial carcinoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.4296875,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.4375,
            "text": "cancer and urothelial carcinoma in situ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.4453125,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.4765625,
            "text": "cancer and urothelial carcinoma in situ, and platinum-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.484375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.5078125,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.515625,
            "text": "cancer and urothelial carcinoma in situ, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.53125,
            "text": "cancer and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.53125,
            "text": "cancer and urothelial",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -8.5390625,
            "text": "cancer and urothelial carcinoma in situ, and platinum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.109375,
            "text": "high risk non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.109375,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.109375,
            "text": "non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.109375,
            "text": "muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.109375,
            "text": "to treat high risk non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.109375,
            "text": "intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        }
    ],
    "60292d191cb411341a00010e_17": [
        {
            "start_logit": 6.0703125,
            "end_logit": 10.3359375,
            "text": "cancer",
            "probability": 0.63671875
        },
        {
            "start_logit": 5.51171875,
            "end_logit": 10.3359375,
            "text": "bladder cancer",
            "probability": 0.36279296875
        },
        {
            "start_logit": -7.875,
            "end_logit": 10.3359375,
            "text": "of bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 10.3359375,
            "text": "comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.3359375,
            "text": "review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.15625,
            "end_logit": 10.3359375,
            "text": "This comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.3359375,
            "text": "recent developments in intravesical therapy of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -5.328125,
            "text": "bladder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.1484375,
            "text": "cancer and summarizes the mechanisms of",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.15625,
            "text": "cancer and summarizes the mechanisms of action",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.234375,
            "text": "cancer and summarizes the mechanisms of action of",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.3671875,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.390625,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.4140625,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.4296875,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.46875,
            "text": "cancer and summarizes the mechanisms",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.484375,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherap",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.5,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.5078125,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role",
            "probability": 0.0
        },
        {
            "start_logit": 6.0703125,
            "end_logit": -8.5234375,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_18": [
        {
            "start_logit": 8.8671875,
            "end_logit": 8.28125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.28125,
            "text": "review summarises the history and development of BCG as a modern cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.28125,
            "text": "This review summarises the history and development of BCG as a modern cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.3125,
            "text": "cancer treatment, appraises current optimal application of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.328125,
            "text": "cancer treatment, appraises current optimal application",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.375,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses promising new therapies closely related to BCG, and briefly explores",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.40625,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.4140625,
            "text": "cancer treatment,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -8.4296875,
            "text": "cancer treatment, appraises",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.28125,
            "text": "summarises the history and development of BCG as a modern cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.3125,
            "text": "review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.328125,
            "text": "review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.328125,
            "text": "review summarises the history and",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.34375,
            "text": "review summarises the history and development",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.3515625,
            "text": "review summarises the history",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.359375,
            "text": "review summarises the history and development of",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.40625,
            "text": "review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.4140625,
            "text": "review summarises the history and development of BCG as a modern cancer treatment,",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.4140625,
            "text": "review summarises the",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -8.4140625,
            "text": "review summarises the history and development of BCG as",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_19": [
        {
            "start_logit": 8.46875,
            "end_logit": 8.78125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.53369140625,
            "end_logit": 8.78125,
            "text": "bladder cancer",
            "probability": 0.0001233816146850586
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.78125,
            "text": "superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.78125,
            "text": "Immunotherapy by intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.46875,
            "end_logit": -8.078125,
            "text": "cancer.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.78125,
            "text": "recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.78125,
            "text": "prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.78125,
            "text": "intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.78125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.78125,
            "text": "treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.78125,
            "text": "delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.78125,
            "text": "and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.78125,
            "text": "of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.578125,
            "end_logit": 8.78125,
            "text": "the recurrence of superficial bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.53369140625,
            "end_logit": -7.9375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -0.53369140625,
            "end_logit": -8.078125,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.9375,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -8.078125,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -7.9375,
            "text": "Immunotherapy by intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -7.9375,
            "text": "recurrence of superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_20": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.5390625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.1484375,
            "text": "cancer and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2265625,
            "text": "cancer and one",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.2421875,
            "text": "cancer and one of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.265625,
            "text": "cancer and one of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.703125,
            "end_logit": -8.3046875,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 8.5390625,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.5390625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.5390625,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 8.5390625,
            "text": "most effective treatment of non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.5390625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.1484375,
            "text": "bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.2265625,
            "text": "bladder cancer and one",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.2421875,
            "text": "bladder cancer and one of",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.265625,
            "text": "bladder cancer and one of the",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.3046875,
            "text": "bladder cancer and one of the most successful applications of immunotherapy to the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -8.109375,
            "text": "Bacillus Calmette-Gu\u00e9rin (",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -8.1484375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -8.1875,
            "text": "Bacillus Calmette-",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -8.21875,
            "text": "Bacillus Calmette-Gu\u00e9rin",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_21": [
        {
            "start_logit": 8.734375,
            "end_logit": 8.453125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.453125,
            "text": "bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -8.2578125,
            "text": "cancer (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -8.375,
            "text": "cancer (NMIBC) and carcinoma in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -8.40625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -8.421875,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.734375,
            "end_logit": -8.46875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.453125,
            "text": "has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.453125,
            "text": "The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.453125,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.453125,
            "text": ": The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.453125,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.453125,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.453125,
            "text": "administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.453125,
            "text": "non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.453125,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -8.2578125,
            "text": "bladder cancer (",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -8.375,
            "text": "bladder cancer (NMIBC) and carcinoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -8.40625,
            "text": "bladder cancer (NMIBC) and carcinoma in-situ (CIS) in terms",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -8.421875,
            "text": "bladder cancer (NMIBC) and carcinoma in-",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_22": [
        {
            "start_logit": 8.6796875,
            "end_logit": 8.5390625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.5390625,
            "text": "bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.171875,
            "text": "cancer is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.5390625,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.3359375,
            "text": "cancer is persistent or recurs shortly after",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.34375,
            "text": "cancer is persistent or recurs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.34375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.34375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.3671875,
            "text": "cancer is persistent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.375,
            "text": "cancer is persistent or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.3828125,
            "text": "cancer is persistent or recurs shortly after a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.390625,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus maintenance, further BCG is not likely",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -8.3984375,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.5390625,
            "text": "T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.5390625,
            "text": "high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.5390625,
            "text": "SUMMARY: When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.5390625,
            "text": "When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        }
    ],
    "60292d191cb411341a00010e_23": [
        {
            "start_logit": 8.546875,
            "end_logit": 8.703125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 8.703125,
            "text": "bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 8.703125,
            "text": "invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.703125,
            "text": "high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.703125,
            "text": "primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 8.703125,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.703125,
            "text": "muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -8.171875,
            "text": "cancer treated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.703125,
            "text": "grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.703125,
            "text": "-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.703125,
            "text": "patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.703125,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.703125,
            "text": "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.703125,
            "text": "pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.703125,
            "text": "-invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -8.46875,
            "text": "cancer treated with BCG immunotherapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -8.4765625,
            "text": "cancer treated with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.546875,
            "end_logit": -8.484375,
            "text": "cancer treated with BCG",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -8.171875,
            "text": "bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -8.46875,
            "text": "bladder cancer treated with BCG immunotherapy",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_24": [
        {
            "start_logit": 6.9453125,
            "end_logit": 9.9609375,
            "text": "cancer",
            "probability": 0.9560546875
        },
        {
            "start_logit": 3.8671875,
            "end_logit": 9.9609375,
            "text": "bladder cancer",
            "probability": 0.044036865234375
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.9609375,
            "text": "past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.9609375,
            "text": "In the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.03125,
            "end_logit": 9.9609375,
            "text": "the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.9609375,
            "text": "three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.9609375,
            "text": "treating bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.9609375,
            "text": "intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.9609375,
            "text": "Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.9453125,
            "end_logit": -8.15625,
            "text": "cancer and it still remains at the forefront",
            "probability": 0.0
        },
        {
            "start_logit": 6.9453125,
            "end_logit": -8.171875,
            "text": "cancer and",
            "probability": 0.0
        },
        {
            "start_logit": 6.9453125,
            "end_logit": -8.21875,
            "text": "cancer and it still remains at the foref",
            "probability": 0.0
        },
        {
            "start_logit": 3.8671875,
            "end_logit": -5.37890625,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": 3.8671875,
            "end_logit": -8.15625,
            "text": "bladder cancer and it still remains at the forefront",
            "probability": 0.0
        },
        {
            "start_logit": 3.8671875,
            "end_logit": -8.171875,
            "text": "bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": 3.8671875,
            "end_logit": -8.21875,
            "text": "bladder cancer and it still remains at the foref",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -5.37890625,
            "text": "past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -5.37890625,
            "text": "In the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -5.37890625,
            "text": "the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -5.37890625,
            "text": "three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_25": [
        {
            "start_logit": 7.8203125,
            "end_logit": 9.34375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.044525146484375,
            "end_logit": 9.34375,
            "text": "bladder cancer",
            "probability": 0.0003859996795654297
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.34375,
            "text": "invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 9.34375,
            "text": "tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.34375,
            "text": "of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.34375,
            "text": "muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.34375,
            "text": "kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.34375,
            "text": "most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.34375,
            "text": "Although BCG-based therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.34375,
            "text": "this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.34375,
            "text": "the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.1328125,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.1875,
            "text": "cancer, BCG is ineffective in approximately 30-40 %",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.1953125,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.2109375,
            "text": "cancer, BCG is ineffective in approximately 30-40",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.21875,
            "text": "cancer, BCG is ineffective in",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.234375,
            "text": "cancer, BCG is ineffective in approximately 30",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.2421875,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 %",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.25,
            "text": "cancer, BCG is ineffective in approximately 30-",
            "probability": 0.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -8.3359375,
            "text": "cancer, BCG is ineffective",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_26": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.984375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": 8.984375,
            "text": "bladder cancer",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.984375,
            "text": "less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.984375,
            "text": "search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.984375,
            "text": "genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.984375,
            "text": "the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1875,
            "end_logit": -8.1796875,
            "text": "cancer immunotherapy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -8.1796875,
            "text": "bladder cancer immunotherapy",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.0859375,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been appealing",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.1015625,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been appeal",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.109375,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.1171875,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.1328125,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been appealing in",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.1640625,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.171875,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -8.0859375,
            "text": "BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been appealing",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.1875,
            "text": "that BCG is considered an effective vehicle for",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -8.1015625,
            "text": "BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics, the genetic manipulation of these mycobacteria has been appeal",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.2109375,
            "text": "that BCG is considered an effective vehicle for delivery of antigens due to its unique characteristics",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.2109375,
            "text": "that BCG is considered an",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_27": [
        {
            "start_logit": 7.80859375,
            "end_logit": 9.390625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": 9.390625,
            "text": "bladder cancer",
            "probability": 0.00026535987854003906
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.390625,
            "text": "BCG immunotherapy of bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.390625,
            "text": "of bladder cancer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.1796875,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.1953125,
            "text": "cancer: inhibition of tumor recurrence",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.234375,
            "text": "cancer:",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.3359375,
            "text": "cancer: inhibition of",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.359375,
            "text": "cancer: inhibition of tumor recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.4375,
            "text": "cancer: inhibition of tumor recurrence and associated immune",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.4375,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.4921875,
            "text": "cancer: inhibition",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.53125,
            "text": "cancer: inhibition of tumor recurrence and associated",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -7.78125,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.1796875,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.1953125,
            "text": "bladder cancer: inhibition of tumor recurrence",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.234375,
            "text": "bladder cancer:",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.3359375,
            "text": "bladder cancer: inhibition of",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.359375,
            "text": "bladder cancer: inhibition of tumor recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": -0.423095703125,
            "end_logit": -8.4375,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune",
            "probability": 0.0
        }
    ],
    "5e776db8835f4e4777000011_1": [
        {
            "start_logit": 9.4609375,
            "end_logit": 9.984375,
            "text": "MannKind Corporation",
            "probability": 1.0
        },
        {
            "start_logit": 3.572265625,
            "end_logit": 4.328125,
            "text": "Sanofi",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": -2.705078125,
            "end_logit": 9.984375,
            "text": "tion",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -3.009765625,
            "text": "Mann",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -6.41796875,
            "text": "MannKind Corpora",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 9.984375,
            "text": "Kind Corporation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.984375,
            "text": "contrary, MannKind Corporation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.0,
            "text": "MannKind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.984375,
            "text": "d Corporation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.26953125,
            "text": "MannKind Corporation started",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 9.984375,
            "text": ", MannKind Corporation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.828125,
            "end_logit": 9.984375,
            "text": "Corporation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -7.8984375,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin Af",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -8.015625,
            "text": "MannKind Corporation started developing",
            "probability": 0.0
        },
        {
            "start_logit": 9.4609375,
            "end_logit": -8.078125,
            "text": "MannKin",
            "probability": 0.0
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 4.328125,
            "text": "by Sanofi",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": 4.328125,
            "text": "i",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 4.328125,
            "text": "ofi",
            "probability": 0.0
        },
        {
            "start_logit": 3.572265625,
            "end_logit": -7.16796875,
            "text": "Sanofi after",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 4.328125,
            "text": "been marketed since February, 2015 by Sanofi",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_1": [
        {
            "start_logit": 9.3828125,
            "end_logit": 5.2109375,
            "text": "Nox1 oxidase",
            "probability": 0.892578125
        },
        {
            "start_logit": 9.3828125,
            "end_logit": 3.08984375,
            "text": "Nox1",
            "probability": 0.10662841796875
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -3.146484375,
            "text": "Nox",
            "probability": 0.0002090930938720703
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.3203125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.3515625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.515625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.5703125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1)",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.61328125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.62890625,
            "text": "Nox1 oxidase,",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.6953125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.7265625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.765625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p4",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.7734375,
            "text": "Nox1 oxidase, functions",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.7734375,
            "text": "Nox1 oxidase, functions as",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.78515625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.80078125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox)",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.8125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.3828125,
            "end_logit": -7.82421875,
            "text": "Nox1 oxidase, functions as either",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 5.2109375,
            "text": "oxidase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 5.2109375,
            "text": "family, Nox1 oxidase",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a5a51060087bc10a000021_2": [
        {
            "start_logit": 9.9375,
            "end_logit": 9.28125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -1.8310546875,
            "text": "Nox",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": 9.9375,
            "end_logit": -3.5859375,
            "text": "Nox1.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -3.35546875,
            "end_logit": 9.28125,
            "text": "1",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 9.28125,
            "text": "Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.28125,
            "text": "superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.28125,
            "text": "of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": 9.28125,
            "text": "with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.28125,
            "text": "the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 9.28125,
            "text": "Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.28125,
            "text": "interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.28125,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.28125,
            "text": "a1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.28125,
            "text": "its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.28125,
            "text": "threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.28125,
            "text": "and the superoxide-producing activity of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -3.35546875,
            "end_logit": -3.5859375,
            "text": "1.",
            "probability": 0.0
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -1.8310546875,
            "text": "Noxa1 and the superoxide-producing activity of Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -1.8310546875,
            "text": "superoxide-producing activity of Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.8310546875,
            "text": "of Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_3": [
        {
            "start_logit": 9.7890625,
            "end_logit": 7.5546875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -1.888671875,
            "text": "Nox",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -5.45703125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.015625,
            "text": "Nox1, a member of the Nox",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.2734375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.32421875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.36328125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.38671875,
            "text": "Nox1,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.3984375,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.44140625,
            "text": "Nox1, a member of the Nox family",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 7.5546875,
            "text": "1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.44921875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.5546875,
            "text": "Superoxide production by Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.5546875,
            "text": "by Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -1.888671875,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -1.888671875,
            "text": "by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -5.45703125,
            "text": "1, a member of the Nox family NAPDH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.015625,
            "text": "1, a member of the Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.2734375,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.2734375,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_4": [
        {
            "start_logit": 10.125,
            "end_logit": 10.0625,
            "text": "Noxa1",
            "probability": 1.0
        },
        {
            "start_logit": 10.125,
            "end_logit": -1.4853515625,
            "text": "Nox",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": -2.427734375,
            "end_logit": 10.0625,
            "text": "a1",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 10.125,
            "end_logit": -5.7421875,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.125,
            "end_logit": -6.16796875,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 10.0625,
            "text": "sufficiently interact with Noxa1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 10.0625,
            "text": "interact with Noxa1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 10.0625,
            "text": "with Noxa1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.125,
            "end_logit": -7.09375,
            "text": "Noxa1, an interaction that participates in Nox1 activation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.125,
            "end_logit": -7.2265625,
            "text": "Noxa1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 10.0625,
            "text": "Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": 10.0625,
            "text": "to sufficiently interact with Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.0625,
            "text": "Noxo1 to sufficiently interact with Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": 10.0625,
            "text": "o1 to sufficiently interact with Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -1.4853515625,
            "text": "sufficiently interact with Nox",
            "probability": 0.0
        },
        {
            "start_logit": -2.427734375,
            "end_logit": -5.7421875,
            "text": "a1, an interaction that participates in Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -6.69921875,
            "end_logit": -1.4853515625,
            "text": "interact with Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -1.4853515625,
            "text": "with Nox",
            "probability": 0.0
        },
        {
            "start_logit": -2.427734375,
            "end_logit": -6.16796875,
            "text": "a1, an interaction that participates in Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -1.4853515625,
            "text": "Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_5": [
        {
            "start_logit": 10.0234375,
            "end_logit": 9.90625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -1.794921875,
            "text": "Nox",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -2.796875,
            "end_logit": 9.90625,
            "text": "1",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.4140625,
            "text": "Nox1 activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.72265625,
            "text": "Nox1 activity in",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -7.8359375,
            "text": "Nox1 activity in different",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 9.90625,
            "text": "regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 9.90625,
            "text": "to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 9.90625,
            "text": "appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 9.90625,
            "text": "Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 10.0234375,
            "end_logit": -8.2421875,
            "text": "Nox1 activity in different manner",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.90625,
            "text": "phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.90625,
            "text": "Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.90625,
            "text": "Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.90625,
            "text": "at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.90625,
            "text": "and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.90625,
            "text": "341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.90625,
            "text": "o1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.90625,
            "text": "Ser154 appears to regulate Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 9.90625,
            "text": "1 and at Ser154 appears to regulate Nox1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_6": [
        {
            "start_logit": 6.6953125,
            "end_logit": 1.28125,
            "text": "Nox1",
            "probability": 0.892578125
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -0.85205078125,
            "text": "Nox",
            "probability": 0.1058349609375
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -6.79296875,
            "text": "Nox1 is known to absolutely require both an organizer protein (p4",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -6.875,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.0002560615539550781
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -6.9453125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox) or Noxo1) andanactivatorprotein",
            "probability": 0.00023877620697021484
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -6.96484375,
            "text": "Nox1 is known",
            "probability": 0.0002332925796508789
        },
        {
            "start_logit": 6.6953125,
            "end_logit": -7.1328125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox) or Noxo1) andanactivator",
            "probability": 0.00019800662994384766
        },
        {
            "start_logit": -4.09765625,
            "end_logit": 1.28125,
            "text": "gp91(phox)/Nox2 and Nox1",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -5.03515625,
            "end_logit": 1.28125,
            "text": "Nox enzymes such as gp91(phox)/Nox2 and Nox1",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -6.01171875,
            "end_logit": 1.28125,
            "text": "other Nox enzymes such as gp91(phox)/Nox2 and Nox1",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -4.09765625,
            "end_logit": -0.85205078125,
            "text": "gp91(phox)/Nox2 and Nox",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 1.28125,
            "text": "and Nox1",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 1.28125,
            "text": "Nox2 and Nox1",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.03515625,
            "end_logit": -0.85205078125,
            "text": "Nox enzymes such as gp91(phox)/Nox2 and Nox",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 1.28125,
            "text": "The activity of other Nox enzymes such as gp91(phox)/Nox2 and Nox1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 1.28125,
            "text": "as gp91(phox)/Nox2 and Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 1.28125,
            "text": "1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 1.28125,
            "text": "2 and Nox1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 1.28125,
            "text": "/Nox2 and Nox1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.01171875,
            "end_logit": -0.85205078125,
            "text": "other Nox enzymes such as gp91(phox)/Nox2 and Nox",
            "probability": 2.980232238769531e-07
        }
    ],
    "58a5a51060087bc10a000021_7": [
        {
            "start_logit": 9.8984375,
            "end_logit": 9.4140625,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.01171875,
            "text": "NOX",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -3.279296875,
            "end_logit": 9.4140625,
            "text": "1",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -5.73828125,
            "text": "NOX1 was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.76171875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.4140625,
            "text": "of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.80078125,
            "text": "NOX1 was absolutely required",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.8203125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.83984375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.89453125,
            "text": "NOX1 was absolutely required for activation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.93359375,
            "text": "NOX1 was absolutely required for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.95703125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.96875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.984375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.4140625,
            "text": "the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": 9.4140625,
            "text": "Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.4140625,
            "text": "showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.4140625,
            "text": "C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.4140625,
            "text": "cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.4140625,
            "text": "that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_8": [
        {
            "start_logit": 9.953125,
            "end_logit": 9.140625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -1.751953125,
            "text": "Nox",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 9.953125,
            "end_logit": -2.677734375,
            "text": "Nox1.",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -3.583984375,
            "end_logit": 9.140625,
            "text": "1",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.140625,
            "text": "of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.140625,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 9.140625,
            "text": "the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.140625,
            "text": "shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": 9.140625,
            "text": "Additionally, NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 9.140625,
            "text": ", NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 9.140625,
            "text": "NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.140625,
            "text": "is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.140625,
            "text": "region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.140625,
            "text": "interact with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.140625,
            "text": "with the NADPH-binding region of Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -3.583984375,
            "end_logit": -2.677734375,
            "text": "1.",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -1.751953125,
            "text": "of Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -1.751953125,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.751953125,
            "text": "the NADPH-binding region of Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -1.751953125,
            "text": "shown to interact with the NADPH-binding region of Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_9": [
        {
            "start_logit": 9.875,
            "end_logit": 9.9375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.15234375,
            "text": "Nox",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -2.810546875,
            "end_logit": 9.9375,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 9.9375,
            "text": "NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.02734375,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.0625,
            "text": "Nox1, complexed with p22(phox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.203125,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.40234375,
            "text": "Nox1,",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.6328125,
            "text": "Nox1, complexed with p22",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.7109375,
            "text": "Nox1, complexed with p22(phox) at the membrane,",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.7109375,
            "text": "Nox1, complexed with p2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": 9.9375,
            "text": "oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.85546875,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.86328125,
            "text": "Nox1, complexed with p22(",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.9375,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.03125,
            "text": "Nox1, complexed",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 9.9375,
            "text": "phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.140625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.15625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Nox",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.9375,
            "text": "producing NADPH oxidase Nox1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_10": [
        {
            "start_logit": 7.7265625,
            "end_logit": 6.34375,
            "text": "NADPH oxidase 1",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -0.1695556640625,
            "text": "NADPH oxidase",
            "probability": 0.0014829635620117188
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -5.359375,
            "text": "NADPH oxidase 1 assembly and activation.",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -5.3671875,
            "text": "NADPH",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -7.0703125,
            "text": "NADPH oxidase 1 assembly and activation",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -7.48046875,
            "text": "NADPH oxidase 1 assembly and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.7265625,
            "end_logit": -7.59375,
            "text": "NADPH oxidase 1 assembly",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 6.34375,
            "text": "1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.34375,
            "text": "optimal NADPH oxidase 1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.34375,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.34375,
            "text": "critical for optimal NADPH oxidase 1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 6.34375,
            "text": "is critical for optimal NADPH oxidase 1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": -0.1695556640625,
            "text": "optimal NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -0.1695556640625,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -0.1695556640625,
            "text": "critical for optimal NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -0.1695556640625,
            "text": "is critical for optimal NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -6.35546875,
            "end_logit": -5.359375,
            "text": "1 assembly and activation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -5.359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -5.359375,
            "text": "activation.",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -5.359375,
            "text": "optimal NADPH oxidase 1 assembly and activation.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_11": [
        {
            "start_logit": 9.8359375,
            "end_logit": 9.9453125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -2.279296875,
            "text": "Nox",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -2.85546875,
            "end_logit": 9.9453125,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -6.77734375,
            "text": "Nox1 requires",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.9453125,
            "text": "NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.484375,
            "text": "Nox1 requires both",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.67578125,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 9.9453125,
            "text": "oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.9453125,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 9.9453125,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.8984375,
            "text": "Nox1 requires both the organizer",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.96875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.0234375,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.03125,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.0390625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.046875,
            "text": "Nox1 requires both the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.0859375,
            "text": "Nox1 requires both the organize",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 9.9453125,
            "text": "the superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.9453125,
            "text": "producing NADPH oxidase Nox1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_12": [
        {
            "start_logit": 9.578125,
            "end_logit": 7.8203125,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.3828125,
            "text": "NOX",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 9.578125,
            "end_logit": -5.4296875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.67578125,
            "text": "NOX1, an NADPH oxidase",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.0,
            "end_logit": 7.8203125,
            "text": "1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.23828125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.48046875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.484375,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.484375,
            "text": "NOX1,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.54296875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0,
            "end_logit": -5.4296875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.67578125,
            "text": "1, an NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.078125,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOX",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.23828125,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.48046875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.484375,
            "text": "1, an NADPH oxidase homologue that",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.484375,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -7.54296875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -5.4296875,
            "text": "(NOX organizing protein 1)",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -5.953125,
            "text": "and NOXA1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_13": [
        {
            "start_logit": 9.1328125,
            "end_logit": 7.4375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -2.919921875,
            "text": "Nox",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.81640625,
            "text": "Nox1, an oxidase",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 7.4375,
            "text": "1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.140625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p4",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2109375,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.359375,
            "text": "Nox1, an oxidase that is likely involved in host defence",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.37890625,
            "text": "Nox1, an",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.38671875,
            "text": "Nox1, an oxidase that",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.39453125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.40625,
            "text": "Nox1,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.5390625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.5625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.59375,
            "text": "Nox1, an oxidase that is likely involved in host defence at",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.61328125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.62890625,
            "end_logit": 2.00390625,
            "text": "Noxa1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.4375,
            "text": "Activation of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 7.4375,
            "text": "of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 2.00390625,
            "text": "a1",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": 2.00390625,
            "text": "likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox, designated Noxo1 and Noxa1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_14": [
        {
            "start_logit": 0.471435546875,
            "end_logit": 4.23046875,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.9326171875
        },
        {
            "start_logit": 0.471435546875,
            "end_logit": 1.3896484375,
            "text": "NADPH oxidase 1 with betaPix",
            "probability": 0.05438232421875
        },
        {
            "start_logit": -4.74609375,
            "end_logit": 4.23046875,
            "text": "Nox Organizer 1.",
            "probability": 0.005046844482421875
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 4.23046875,
            "text": "Molecular interaction of NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.002979278564453125
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 4.23046875,
            "text": "betaPix and Nox Organizer 1.",
            "probability": 0.0015707015991210938
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 4.23046875,
            "text": ".",
            "probability": 0.0014810562133789062
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 4.23046875,
            "text": "x and Nox Organizer 1.",
            "probability": 0.0006995201110839844
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 4.23046875,
            "text": "Pix and Nox Organizer 1.",
            "probability": 0.0004096031188964844
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 4.23046875,
            "text": "and Nox Organizer 1.",
            "probability": 0.00028705596923828125
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 4.23046875,
            "text": "with betaPix and Nox Organizer 1.",
            "probability": 0.0002416372299194336
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 1.3896484375,
            "text": "Molecular interaction of NADPH oxidase 1 with betaPix",
            "probability": 0.00017404556274414062
        },
        {
            "start_logit": -8.171875,
            "end_logit": 4.23046875,
            "text": "interaction of NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.00016486644744873047
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 4.23046875,
            "text": "of NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.00011873245239257812
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 1.3896484375,
            "text": "betaPix",
            "probability": 9.179115295410156e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 1.3896484375,
            "text": "x",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 1.3896484375,
            "text": "Pix",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": 0.471435546875,
            "end_logit": -6.62109375,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 0.471435546875,
            "end_logit": -6.73828125,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 1.3896484375,
            "text": "with betaPix",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 0.471435546875,
            "end_logit": -7.00390625,
            "text": "NADPH oxidase 1 with betaPix and Nox",
            "probability": 1.233816146850586e-05
        }
    ],
    "58a5a51060087bc10a000021_15": [
        {
            "start_logit": 9.4453125,
            "end_logit": 6.6875,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -0.6025390625,
            "text": "NOX",
            "probability": 0.0006880760192871094
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -5.26171875,
            "text": "NOX1)",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.28125,
            "text": "NOX1),",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.390625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.55078125,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.56640625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.67578125,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.7109375,
            "text": "NOX1), which is mainly expressed",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.4140625,
            "end_logit": 6.6875,
            "text": "1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 6.6875,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.6875,
            "text": "Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.6875,
            "text": "by NADPH oxidase 1 (NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.6875,
            "text": "(NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -0.6025390625,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -0.6025390625,
            "text": "Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -0.6025390625,
            "text": "by NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -0.6025390625,
            "text": "(NOX",
            "probability": 0.0
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -5.26171875,
            "text": "1)",
            "probability": 0.0
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -5.09375,
            "text": "NADPH oxidase",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_16": [
        {
            "start_logit": 9.546875,
            "end_logit": 7.8984375,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.546875,
            "end_logit": -2.4453125,
            "text": "NOX",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": 9.546875,
            "end_logit": -5.6484375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -4.9453125,
            "end_logit": 7.8984375,
            "text": "1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -6.796875,
            "text": "NOX1, an NADPH oxidase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.24609375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.40234375,
            "text": "NOX1,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.44921875,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.5390625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.546875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.546875,
            "end_logit": -7.57421875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -5.6484375,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -6.796875,
            "text": "1, an NADPH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.05078125,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and NOX",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.24609375,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.40234375,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.44921875,
            "text": "1, an NADPH oxidase homologue that",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.5390625,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells,",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.546875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1) and",
            "probability": 0.0
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.57421875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_17": [
        {
            "start_logit": 9.7421875,
            "end_logit": 9.8984375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -2.45703125,
            "text": "Nox",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -2.93359375,
            "end_logit": 9.8984375,
            "text": "1",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -6.74609375,
            "text": "Nox1 requires",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 9.8984375,
            "text": "NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.41015625,
            "text": "Nox1 requires both",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 9.8984375,
            "text": "oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 9.8984375,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 9.8984375,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.69921875,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.8984375,
            "text": "Nox1 requires both the organizer",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.98828125,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.015625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.015625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.0234375,
            "text": "Nox1 requires both the",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.0625,
            "text": "Nox1 requires both the organize",
            "probability": 0.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -8.109375,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.8984375,
            "text": "the superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.8984375,
            "text": "producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 9.8984375,
            "text": "of the superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_18": [
        {
            "start_logit": 9.8359375,
            "end_logit": 9.9140625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -2.21875,
            "text": "Nox",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -2.849609375,
            "end_logit": 9.9140625,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 9.9140625,
            "text": "NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -6.765625,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -6.85546875,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -6.86328125,
            "text": "Nox1, complexed with p22(phox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.40234375,
            "text": "Nox1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.5546875,
            "text": "Nox1, complexed with p22",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.58203125,
            "text": "Nox1, complexed with p22(phox) at the membrane,",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.63671875,
            "text": "Nox1, complexed with p2",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.9140625,
            "text": "oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.9140625,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.78125,
            "text": "Nox1, complexed with p22(",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.83984375,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.921875,
            "text": "Nox1, complexed with p22(phox) at the membrane",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.9453125,
            "text": "Nox1, complexed",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -7.98046875,
            "text": "Nox1, complexed with p22(phox) at the",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.9140625,
            "text": "phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.9140625,
            "text": "producing NADPH oxidase Nox1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_19": [
        {
            "start_logit": 6.890625,
            "end_logit": 4.09375,
            "text": "Nox1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.890625,
            "end_logit": -4.08203125,
            "text": "Nox",
            "probability": 0.00028228759765625
        },
        {
            "start_logit": 6.890625,
            "end_logit": -5.44140625,
            "text": "Nox1) is",
            "probability": 7.2479248046875e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -6.03515625,
            "text": "Nox1) is a",
            "probability": 3.999471664428711e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -6.19921875,
            "text": "Nox1)",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -6.69921875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -6.83984375,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -6.91015625,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organize",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.0625,
            "text": "Nox1) is a multicomponent enzyme",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.06640625,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.11328125,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.1171875,
            "text": "Nox1) is a multicomponent",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.1796875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1)",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.2265625,
            "text": "Nox1) is a multicomponent enzyme consisting",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.265625,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.890625,
            "end_logit": -7.3125,
            "text": "Nox1) is a multicomponent enzyme consisting of p22",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -5.46875,
            "end_logit": 4.09375,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 4.09375,
            "text": "1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 4.09375,
            "text": "(Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.46875,
            "end_logit": -4.08203125,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_20": [
        {
            "start_logit": 9.9453125,
            "end_logit": 9.0546875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -1.9033203125,
            "text": "Nox",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -3.96484375,
            "end_logit": 9.0546875,
            "text": "1",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -6.04296875,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 9.0546875,
            "text": "Superoxide production by Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.27734375,
            "text": "Nox1, a member of the Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.34375,
            "text": "Nox1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.359375,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.4453125,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.5546875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.5546875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.59375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.9453125,
            "end_logit": -7.7421875,
            "text": "Nox1, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 9.0546875,
            "text": "by Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.0546875,
            "text": "UNLABELLED: Superoxide production by Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -1.9033203125,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": -1.9033203125,
            "text": "by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -3.96484375,
            "end_logit": -6.04296875,
            "text": "1, a member of the Nox family NAPDH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": -1.9033203125,
            "text": "UNLABELLED: Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -3.96484375,
            "end_logit": -7.27734375,
            "text": "1, a member of the Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_21": [
        {
            "start_logit": 10.1875,
            "end_logit": 8.7421875,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 10.1875,
            "end_logit": 0.1846923828125,
            "text": "NOX",
            "probability": 0.00019109249114990234
        },
        {
            "start_logit": -4.1171875,
            "end_logit": 8.7421875,
            "text": "1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 10.1875,
            "end_logit": -7.5859375,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.1875,
            "end_logit": -7.73046875,
            "text": "NOX1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 8.7421875,
            "text": "activation of NADPH oxidase 1 (NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 8.7421875,
            "text": "(NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 8.7421875,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.7421875,
            "text": "of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.7421875,
            "text": "dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.7421875,
            "text": "The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 8.7421875,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.7421875,
            "text": "NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.7421875,
            "text": "NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 0.1846923828125,
            "text": "activation of NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 0.1846923828125,
            "text": "(NOX",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 0.1846923828125,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 0.1846923828125,
            "text": "of NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": 0.1846923828125,
            "text": "dependent activation of NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 0.1846923828125,
            "text": "The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_22": [
        {
            "start_logit": 9.8984375,
            "end_logit": 9.4140625,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.01171875,
            "text": "NOX",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -3.279296875,
            "end_logit": 9.4140625,
            "text": "1",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -5.73828125,
            "text": "NOX1 was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.76171875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.4140625,
            "text": "of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.80078125,
            "text": "NOX1 was absolutely required",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.8203125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.83984375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.89453125,
            "text": "NOX1 was absolutely required for activation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.93359375,
            "text": "NOX1 was absolutely required for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.95703125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.96875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.984375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.4140625,
            "text": "the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": 9.4140625,
            "text": "Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.4140625,
            "text": "showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.4140625,
            "text": "C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 9.4140625,
            "text": "cytoplasmic domain of NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.4140625,
            "text": "that the C-terminal cytoplasmic domain of NOX1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_23": [
        {
            "start_logit": 9.0625,
            "end_logit": 8.1796875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -3.013671875,
            "text": "Nox",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -4.7265625,
            "text": "Nox1.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 8.1796875,
            "text": "1",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1796875,
            "text": "regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.1796875,
            "text": "NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.1796875,
            "text": "the NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.1796875,
            "text": "oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.1796875,
            "text": "Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 8.1796875,
            "text": "conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.1796875,
            "text": "in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.1796875,
            "text": "with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -5.2578125,
            "end_logit": -2.3203125,
            "text": "p67(phox) that",
            "probability": 0.0
        },
        {
            "start_logit": -4.57421875,
            "end_logit": -4.7265625,
            "text": "1.",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -2.3203125,
            "text": "of p67(phox) that",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -3.013671875,
            "text": "regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": -2.3203125,
            "text": "homologue of p67(phox) that",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -3.013671875,
            "text": "NADPH oxidase Nox",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": -2.3203125,
            "text": "a homologue of p67(phox) that",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -2.3203125,
            "text": "NoxA1) is a homologue of p67(phox) that",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_24": [
        {
            "start_logit": 9.6015625,
            "end_logit": 8.8515625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -2.40234375,
            "text": "Nox",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -3.966796875,
            "end_logit": 8.8515625,
            "text": "1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.0,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.53515625,
            "text": "Nox1 is highly expressed in the colon, and requires",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.59765625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.6171875,
            "text": "Nox1 is highly expressed in the colon, and requires two",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.6484375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.76171875,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.86328125,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organize",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.87109375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.8828125,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.89453125,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6015625,
            "end_logit": -7.90625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.0,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 0.0
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.53515625,
            "text": "1 is highly expressed in the colon, and requires",
            "probability": 0.0
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.59765625,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit Nox",
            "probability": 0.0
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.6171875,
            "text": "1 is highly expressed in the colon, and requires two",
            "probability": 0.0
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.6484375,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and",
            "probability": 0.0
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.72265625,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1, as well as",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_25": [
        {
            "start_logit": 9.5859375,
            "end_logit": 8.5625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -2.314453125,
            "text": "Nox",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": -4.20703125,
            "end_logit": 8.5625,
            "text": "1",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -6.30078125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.1015625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.39453125,
            "text": "Nox1 is highly expressed in the colon, and it requires two",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.49609375,
            "text": "Nox1 is highly expressed in the colon, and it requires",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.546875,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.64453125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, Nox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.73046875,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.76953125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.80078125,
            "text": "Nox1 is highly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.8671875,
            "text": "Nox1 is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.96484375,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5859375,
            "end_logit": -7.984375,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -6.30078125,
            "text": "1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1",
            "probability": 0.0
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -6.63671875,
            "text": "1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase,",
            "probability": 0.0
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -7.1015625,
            "text": "1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 0.0
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -7.39453125,
            "text": "1 is highly expressed in the colon, and it requires two",
            "probability": 0.0
        },
        {
            "start_logit": -4.20703125,
            "end_logit": -7.49609375,
            "text": "1 is highly expressed in the colon, and it requires",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_26": [
        {
            "start_logit": 9.59375,
            "end_logit": 6.453125,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.59375,
            "end_logit": -0.2086181640625,
            "text": "NOX",
            "probability": 0.0012750625610351562
        },
        {
            "start_logit": 9.59375,
            "end_logit": -5.06640625,
            "text": "NOX1)",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.29296875,
            "text": "NOX1),",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.3515625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.53125,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.54296875,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.59375,
            "end_logit": -7.640625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.515625,
            "end_logit": 6.453125,
            "text": "1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.15625,
            "end_logit": 6.453125,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.453125,
            "text": "Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.453125,
            "text": "(NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.453125,
            "text": "by NADPH oxidase 1 (NOX1",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -0.2086181640625,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -0.2086181640625,
            "text": "Reactive oxygen species (ROS) production by NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -0.2086181640625,
            "text": "(NOX",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -0.2086181640625,
            "text": "by NADPH oxidase 1 (NOX",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -3.818359375,
            "text": "NOXA1",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -5.06640625,
            "text": "1)",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -3.818359375,
            "text": "(NOXA1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_27": [
        {
            "start_logit": 9.7890625,
            "end_logit": 7.5546875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -1.888671875,
            "text": "Nox",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -5.45703125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.015625,
            "text": "Nox1, a member of the Nox",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.2734375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.32421875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.36328125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.38671875,
            "text": "Nox1,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.3984375,
            "text": "Nox1, a member of the Nox family NAPDH",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.44140625,
            "text": "Nox1, a member of the Nox family",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.2109375,
            "end_logit": 7.5546875,
            "text": "1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.44921875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.5546875,
            "text": "Superoxide production by Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.15625,
            "end_logit": 7.5546875,
            "text": "by Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -1.888671875,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": -1.888671875,
            "text": "by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -5.45703125,
            "text": "1, a member of the Nox family NAPDH oxidase",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.015625,
            "text": "1, a member of the Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.2734375,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1) and Nox",
            "probability": 0.0
        },
        {
            "start_logit": -5.2109375,
            "end_logit": -7.2734375,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_1": [
        {
            "start_logit": 10.21875,
            "end_logit": 10.4765625,
            "text": "IFN signature",
            "probability": 1.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -1.244140625,
            "text": "IFN",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 10.4765625,
            "text": "signature",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -7.796875,
            "end_logit": 10.4765625,
            "text": "type I IFN signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": 10.4765625,
            "text": "A five gene type I IFN signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 10.4765625,
            "text": "five gene type I IFN signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 10.4765625,
            "text": "I IFN signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.078125,
            "text": "IFN signature was",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.4765625,
            "text": "gene type I IFN signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.15625,
            "text": "IFN signature was assessed",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.171875,
            "text": "IFN signature was assessed in these subjects to",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.203125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.2421875,
            "text": "IFN signature was assessed in",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.265625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.3203125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.3359375,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease-",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.34375,
            "text": "IFN signature was assessed in these subjects to identify",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.3515625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.3515625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood",
            "probability": 0.0
        },
        {
            "start_logit": 10.21875,
            "end_logit": -8.3515625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_2": [
        {
            "start_logit": 10.171875,
            "end_logit": 10.4609375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -1.380859375,
            "text": "interferon",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": 10.4609375,
            "text": "signature",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 10.4609375,
            "text": "an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.0,
            "text": "interferon signature similar to but less intense than that seen",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.0234375,
            "text": "interferon signature similar",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 10.4609375,
            "text": "Gene expression analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.4609375,
            "text": "demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.1875,
            "text": "interferon signature similar to but",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.4609375,
            "text": "sclerosis demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.4609375,
            "text": "patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.4609375,
            "text": "multiple sclerosis demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.296875,
            "text": "interferon signature similar to but less intense than",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.3125,
            "text": "interferon signature similar to but less intense than that seen in",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 10.4609375,
            "text": "with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.3515625,
            "text": "interferon signature similar to but less intense than that",
            "probability": 0.0
        },
        {
            "start_logit": 10.171875,
            "end_logit": -8.359375,
            "text": "interferon signature similar to",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -1.380859375,
            "text": "an interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -8.0,
            "text": "signature similar to but less intense than that seen",
            "probability": 0.0
        },
        {
            "start_logit": -1.6884765625,
            "end_logit": -8.0234375,
            "text": "signature similar",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_3": [
        {
            "start_logit": 10.0390625,
            "end_logit": 10.375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": -1.9482421875,
            "end_logit": 10.375,
            "text": "signature",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 10.0390625,
            "end_logit": -1.7802734375,
            "text": "interferon",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 10.375,
            "text": "the interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 10.375,
            "text": "termed the interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.375,
            "text": "psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.375,
            "text": ", termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.375,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.375,
            "text": "patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.375,
            "text": "with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.375,
            "text": ", psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.375,
            "text": "fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.375,
            "text": "omyositis, psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.375,
            "text": "of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": -1.7802734375,
            "text": "the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -1.7802734375,
            "text": "termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -1.7802734375,
            "text": "psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -1.7802734375,
            "text": ", termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -1.7802734375,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -1.7802734375,
            "text": "patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_4": [
        {
            "start_logit": 10.078125,
            "end_logit": 10.3359375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -1.673828125,
            "text": "interferon",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -1.9951171875,
            "end_logit": 10.3359375,
            "text": "signature",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 10.3359375,
            "text": ". interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 10.3359375,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 10.3359375,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 10.3359375,
            "text": "autoimmune disorders, have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.25,
            "text": "interferon signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -1.673828125,
            "text": ". interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -1.673828125,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -1.673828125,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -1.673828125,
            "text": "autoimmune disorders, have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.9951171875,
            "end_logit": -8.25,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.609375,
            "text": "differential gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -7.609375,
            "text": "More recently, large-scale differential gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.7890625,
            "text": "differential gene expression studies performed on selected tissues from patients with autoimmune disorders, have led to",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.86328125,
            "text": "differential gene expression studies performed on selected tissues from patients with autoimmune disorders, have led",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -7.7890625,
            "text": ", have led to",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -7.609375,
            "text": "recently, large-scale differential gene expression",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -7.7890625,
            "text": "More recently, large-scale differential gene expression studies performed on selected tissues from patients with autoimmune disorders, have led to",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_5": [
        {
            "start_logit": 10.1328125,
            "end_logit": 10.375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 10.1328125,
            "end_logit": -1.51171875,
            "text": "interferon",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": 10.375,
            "text": "signature",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 10.375,
            "text": "type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 10.375,
            "text": "I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.375,
            "text": "Relationship between the type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.375,
            "text": "the type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.1328125,
            "end_logit": -8.3671875,
            "text": "interferon signature and the response to",
            "probability": 0.0
        },
        {
            "start_logit": 10.1328125,
            "end_logit": -8.4140625,
            "text": "interferon signature and the response to rituximab in",
            "probability": 0.0
        },
        {
            "start_logit": 10.1328125,
            "end_logit": -8.4296875,
            "text": "interferon signature and",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.51171875,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -1.51171875,
            "text": "I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": -1.51171875,
            "text": "Relationship between the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -1.51171875,
            "text": "the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -8.3671875,
            "text": "signature and the response to",
            "probability": 0.0
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -8.4140625,
            "text": "signature and the response to rituximab in",
            "probability": 0.0
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": -8.4296875,
            "text": "signature and",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -8.3671875,
            "text": "type I interferon signature and the response to",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -8.4140625,
            "text": "type I interferon signature and the response to rituximab in",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -8.4296875,
            "text": "type I interferon signature and",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_6": [
        {
            "start_logit": 10.1484375,
            "end_logit": 10.3984375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -1.46875,
            "text": "interferon",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -1.865234375,
            "end_logit": 10.3984375,
            "text": "signature",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 10.3984375,
            "text": "type I interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.3984375,
            "text": "I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 10.3984375,
            "text": "the type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.3984375,
            "text": "application to the type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.3984375,
            "text": "to the type I interferon signature",
            "probability": 0.0
        },
        {
            "start_logit": 10.1484375,
            "end_logit": -8.28125,
            "text": "interferon signature in",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -1.46875,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -1.46875,
            "text": "I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -1.46875,
            "text": "the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -1.46875,
            "text": "application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -1.46875,
            "text": "to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.865234375,
            "end_logit": -8.28125,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.9765625,
            "text": "type I",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -8.28125,
            "text": "type I interferon signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -7.9765625,
            "text": "I",
            "probability": 0.0
        },
        {
            "start_logit": -7.98828125,
            "end_logit": -7.9765625,
            "text": "the type I",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -8.28125,
            "text": "I interferon signature in",
            "probability": 0.0
        }
    ],
    "517170c48ed59a060a00000d_1": [
        {
            "start_logit": 8.4921875,
            "end_logit": 8.6015625,
            "text": "25",
            "probability": 1.0
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.07421875,
            "text": "25 selenoproteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.69921875,
            "text": "25 selenoproteins.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4921875,
            "end_logit": -7.80078125,
            "text": "25 selen",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 8.6015625,
            "text": "The human selenoproteome consists of 25",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.03125,
            "end_logit": 8.6015625,
            "text": "human selenoproteome consists of 25",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.078125,
            "end_logit": 8.6015625,
            "text": "of 25",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 8.6015625,
            "text": "selenoproteome consists of 25",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.6015625,
            "text": "consists of 25",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.07421875,
            "text": "selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.07421875,
            "text": "The human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.07421875,
            "text": "human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.07421875,
            "text": "of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -7.07421875,
            "text": "selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.69921875,
            "text": "selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.80078125,
            "text": "selen",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.53515625,
            "text": "The human selenoproteome",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -7.625,
            "text": "The human selenoproteome consists",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.53515625,
            "text": "human selenoproteome",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": -7.07421875,
            "text": "consists of 25 selenoproteins",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_1": [
        {
            "start_logit": 9.8359375,
            "end_logit": 10.2578125,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.2265625,
            "end_logit": 10.2578125,
            "text": "Y",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -2.2109375,
            "text": "XX",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.2578125,
            "text": "Klinefelter syndrome (XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.2578125,
            "text": "(XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.8359375,
            "end_logit": -8.0703125,
            "text": "XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -2.2265625,
            "end_logit": -8.0703125,
            "text": "Y)",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -2.2109375,
            "text": "Klinefelter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -2.2109375,
            "text": "(XX",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.0703125,
            "text": "Klinefelter syndrome (XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -8.0703125,
            "text": "(XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.265625,
            "text": "Klinefelt",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.28125,
            "text": "Klinefe",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.2890625,
            "text": "Klinefelter syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -8.296875,
            "text": "Klinefelter",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -8.0703125,
            "text": ")",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_2": [
        {
            "start_logit": 5.33203125,
            "end_logit": 9.6875,
            "text": "X",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": 9.6875,
            "text": "extra X",
            "probability": 0.0011425018310546875
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 9.6875,
            "text": "an extra X",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.6875,
            "text": "with an extra X",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.6875,
            "text": "About 1 in 650 boys are born with an extra X",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -8.578125,
            "end_logit": 9.6875,
            "text": "born with an extra X",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -6.32421875,
            "text": "X chromosome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -6.41796875,
            "text": "X chromosome (47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.078125,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.1015625,
            "text": "X chromosome (47,XX",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.2421875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.3046875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.34375,
            "text": "X chromosome (47,",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.3671875,
            "text": "X chromosome (47,XXY or Klinefelt",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.3984375,
            "text": "X chromosome (47,XXY or Klinefelter syndrome",
            "probability": 0.0
        },
        {
            "start_logit": 5.33203125,
            "end_logit": -8.40625,
            "text": "X chromosome (47,XXY or Klinefe",
            "probability": 0.0
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.32421875,
            "text": "extra X chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.41796875,
            "text": "extra X chromosome (47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -8.078125,
            "text": "extra X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -8.1015625,
            "text": "extra X chromosome (47,XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_3": [
        {
            "start_logit": 6.68359375,
            "end_logit": 8.2578125,
            "text": "X",
            "probability": 0.927734375
        },
        {
            "start_logit": 6.68359375,
            "end_logit": 5.6796875,
            "text": "X chromosome in males (47,XXY",
            "probability": 0.0704345703125
        },
        {
            "start_logit": 3.28515625,
            "end_logit": 5.6796875,
            "text": "47,XXY",
            "probability": 0.00237274169921875
        },
        {
            "start_logit": -4.7734375,
            "end_logit": 8.2578125,
            "text": "additional X",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -4.23828125,
            "text": "X chromosome",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -4.7734375,
            "end_logit": 5.6796875,
            "text": "additional X chromosome in males (47,XXY",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.2578125,
            "text": "an additional X",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.2578125,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -6.3984375,
            "text": "X chromosome in males (47,XX",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.2578125,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 8.2578125,
            "text": "by an additional X",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.2578125,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.2578125,
            "text": "chromosomal abnormality caused by an additional X",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.2578125,
            "text": "inefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 5.6796875,
            "text": "Y",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 5.6796875,
            "text": "(47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -7.84375,
            "text": "X chromosome in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -8.234375,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -8.296875,
            "text": "X chromosome in males (47,XXY),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -8.328125,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_4": [
        {
            "start_logit": 9.875,
            "end_logit": 10.21875,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.251953125,
            "end_logit": 10.21875,
            "text": "Y",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.15234375,
            "text": "47",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -5.66796875,
            "text": "47, XX",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.875,
            "end_logit": -6.9921875,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 10.21875,
            "text": ", XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.21875,
            "text": "XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.38671875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.49609375,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.68359375,
            "text": "47, XXY; the extra sex",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.75390625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.81640625,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.21875,
            "text": "is 47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.9375,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -7.95703125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0625,
            "text": "47, XXY; the extra sex chromosome is due",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.109375,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondis",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.21875,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1796875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.21875,
            "text": "inefelter syndrome is 47, XXY",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_5": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.6875,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": -4.6015625,
            "end_logit": 8.6875,
            "text": "additional X",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.6875,
            "text": "an additional X",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.35546875,
            "text": "X chromosome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.38671875,
            "text": "X chromosome in males leading to a karyotype of 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.51171875,
            "text": "X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.6875,
            "text": "Klinefelter syndrome (KS) is characterized by an additional X",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.87890625,
            "text": "X chromosome in males leading to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.6875,
            "text": "by an additional X",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.9609375,
            "text": "X chromosome in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.6875,
            "text": "characterized by an additional X",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.6875,
            "text": "inefelter syndrome (KS) is characterized by an additional X",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.1484375,
            "text": "X chromosome in males leading to a karyotype of 47,XX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.265625,
            "text": "X chromosome in males leading",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.3125,
            "text": "X chromosome in males leading to a karyotype",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -8.3125,
            "text": "X chromosome in males leading to a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6015625,
            "end_logit": -7.35546875,
            "text": "additional X chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -4.6015625,
            "end_logit": -7.38671875,
            "text": "additional X chromosome in males leading to a karyotype of 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -4.6015625,
            "end_logit": -7.51171875,
            "text": "additional X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 0.0
        },
        {
            "start_logit": -4.6015625,
            "end_logit": -7.87890625,
            "text": "additional X chromosome in males leading to",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_6": [
        {
            "start_logit": 9.125,
            "end_logit": 10.3125,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.9736328125,
            "end_logit": 10.3125,
            "text": "Y",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -4.51171875,
            "end_logit": 10.3125,
            "text": "a 47,XXY",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -3.513671875,
            "text": "47",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.359375,
            "text": "47,XX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 10.3125,
            "text": "XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 10.3125,
            "text": ",XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.84375,
            "text": "47,XXY chromosomal abnormality",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.3125,
            "text": "Klinefelter syndrome (KS), a 47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.58984375,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.609375,
            "text": "47,XXY chromosomal abnormality, has been shown",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.65234375,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.81640625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.87890625,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.8828125,
            "text": "47,XXY chromosomal",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.98046875,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.984375,
            "text": "47,XXY chromosomal abnormality, has been shown to",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -8.0390625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -8.0546875,
            "text": "47,XXY chromosomal abnormality, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.125,
            "end_logit": -8.0546875,
            "text": "47,XXY chromosomal abnormality, has been",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_7": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.2109375,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.2578125,
            "end_logit": 10.2109375,
            "text": "Y",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.201171875,
            "text": "47",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -5.6875,
            "text": "47, XX",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -6.29296875,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 10.2109375,
            "text": ", XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.2109375,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 10.2109375,
            "text": "XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.48828125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.765625,
            "text": "47, XXY; the extra sex",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.796875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.8359375,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.91015625,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.2109375,
            "text": "is 47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.97265625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.99609375,
            "text": "47, XXY; the extra sex chromosome is due",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.140625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondis",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.2109375,
            "text": "formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.2109375,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_8": [
        {
            "start_logit": 9.9140625,
            "end_logit": 9.9765625,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -1.890625,
            "text": "XX",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -2.533203125,
            "end_logit": 9.9765625,
            "text": "Y",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -6.8515625,
            "text": "XXY chromosomal abnormality",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.9765625,
            "text": "teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.9765625,
            "text": "mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -7.6796875,
            "text": "XXY chromosomal abnormality may",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 9.9765625,
            "text": "reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 9.9765625,
            "text": "development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 9.9765625,
            "text": "the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.9765625,
            "text": "is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": 9.9765625,
            "text": "a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.9765625,
            "text": "ocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.2265625,
            "text": "XXY chromosomal abnormality may be",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.2890625,
            "text": "XXY chromosomal abnormality may be more than coincidental",
            "probability": 0.0
        },
        {
            "start_logit": 9.9140625,
            "end_logit": -8.3125,
            "text": "XXY chromosomal abnormality may be more than",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.9765625,
            "text": "suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 0.0
        },
        {
            "start_logit": -2.533203125,
            "end_logit": -6.8515625,
            "text": "Y chromosomal abnormality",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.890625,
            "text": "teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -1.890625,
            "text": "mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XX",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_9": [
        {
            "start_logit": 7.05859375,
            "end_logit": 9.9609375,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": 9.9609375,
            "text": "a 47, XXY",
            "probability": 9.101629257202148e-05
        },
        {
            "start_logit": -2.490234375,
            "end_logit": 9.9609375,
            "text": "Y",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 9.9609375,
            "text": ", XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.9609375,
            "text": "XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 9.9609375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 9.9609375,
            "text": "by a 47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -5.18359375,
            "text": "47, XXY karyotype",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -5.26953125,
            "text": "47, XX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.9609375,
            "text": "characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.9609375,
            "text": "chromosomal abnormality characterised by a 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -5.796875,
            "text": "47",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.0703125,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.0859375,
            "text": "47, XXY karyotype associated",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.171875,
            "text": "47, XXY karyotype associated with hypogonadism",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.171875,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 0.0
        },
        {
            "start_logit": 7.05859375,
            "end_logit": -8.25,
            "text": "47, XXY karyotype associated with hypogonadism and",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -5.18359375,
            "text": "a 47, XXY karyotype",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -5.26953125,
            "text": "a 47, XX",
            "probability": 0.0
        },
        {
            "start_logit": -2.490234375,
            "end_logit": -5.18359375,
            "text": "Y karyotype",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_10": [
        {
            "start_logit": 8.3515625,
            "end_logit": 9.8984375,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -0.50146484375,
            "text": "47,XXY) and Y",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -2.525390625,
            "end_logit": 9.8984375,
            "text": "Y",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -3.384765625,
            "text": "47,XXY) and Y chromosome microdeletions",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -4.34375,
            "text": "47",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -5.25,
            "text": "47,XX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 9.8984375,
            "text": "numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 9.8984375,
            "text": "XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.8984375,
            "text": "(47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.8984375,
            "text": "nonobstructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 9.8984375,
            "text": ",XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.8984375,
            "text": "with nonobstructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.8984375,
            "text": "including Klinefelter syndrome (47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.8984375,
            "text": "Klinefelter syndrome (47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.0234375,
            "text": "47,XXY) and Y chromosome microd",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.708984375,
            "end_logit": -0.50146484375,
            "text": "Y",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.26953125,
            "text": "47,XXY) and Y chromosome microdelet",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.484375,
            "text": "47,XXY) and Y chromosome",
            "probability": 0.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.609375,
            "text": "47,XXY) and Y chromosome microdeletions.",
            "probability": 0.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.6484375,
            "text": "47,XXY)",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_11": [
        {
            "start_logit": 6.8515625,
            "end_logit": 8.515625,
            "text": "X",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.8515625,
            "end_logit": 2.642578125,
            "text": "X chromosome in males (47,XXY",
            "probability": 0.0028018951416015625
        },
        {
            "start_logit": -3.73828125,
            "end_logit": 8.515625,
            "text": "additional X",
            "probability": 2.5033950805664062e-05
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -2.46484375,
            "text": "X chromosome",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": 0.85498046875,
            "end_logit": 2.642578125,
            "text": "47,XXY",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 8.515625,
            "text": "an additional X",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.0,
            "end_logit": 8.515625,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.515625,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.515625,
            "text": "by an additional X",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.515625,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.6015625,
            "text": "X chromosome in males (47,XX",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.80078125,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.49609375,
            "text": "X chromosome in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.73828125,
            "end_logit": 2.642578125,
            "text": "additional X chromosome in males (47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.1953125,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.203125,
            "text": "X chromosome in males (47,XXY),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.3046875,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.3125,
            "text": "X chromosome in males (47,XXY), and the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.3203125,
            "text": "X chromosome in males (47,XXY)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -8.3515625,
            "text": "X chromosome in males (47,XXY), and the characteristic",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_12": [
        {
            "start_logit": 9.4921875,
            "end_logit": 10.328125,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.9375,
            "end_logit": 10.328125,
            "text": "Y",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 9.4921875,
            "end_logit": -2.849609375,
            "text": "47",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.4921875,
            "end_logit": -4.8671875,
            "text": "47, XX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 10.328125,
            "text": "39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 10.328125,
            "text": "(47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 10.328125,
            "text": ", XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 10.328125,
            "text": "XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 10.328125,
            "text": "were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 10.328125,
            "text": "(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 10.328125,
            "text": ", 39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 10.328125,
            "text": ") were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 10.328125,
            "text": "which Klinefelter's syndrome (47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4921875,
            "end_logit": -7.0625,
            "text": "47, XXY) was the most common chromosomal aberration",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": 10.328125,
            "text": "patients, 39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.328125,
            "text": "chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 10.328125,
            "text": "found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 10.328125,
            "text": "have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.4921875,
            "end_logit": -7.7734375,
            "text": "47, XXY) was the most common",
            "probability": 0.0
        },
        {
            "start_logit": 9.4921875,
            "end_logit": -7.84765625,
            "text": "47,",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_13": [
        {
            "start_logit": 7.31640625,
            "end_logit": 10.0390625,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.3984375,
            "end_logit": 10.0390625,
            "text": "Y",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -2.626953125,
            "end_logit": 10.0390625,
            "text": "a 47, XXY",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 10.0390625,
            "text": "XXY",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 10.0390625,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 10.0390625,
            "text": ", XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 10.0390625,
            "text": "by a 47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -5.22265625,
            "text": "47, XX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -5.54296875,
            "text": "47",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.0390625,
            "text": "characterized by a 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.0390625,
            "text": "chromosome abnormality characterized by a 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -6.32421875,
            "text": "47, XXY karyotype",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -7.97265625,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 0.0
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -8.0234375,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -8.09375,
            "text": "47, XXY karyotype associated",
            "probability": 0.0
        },
        {
            "start_logit": 7.31640625,
            "end_logit": -8.2734375,
            "text": "47, XXY karyotype associated with hypogonadism and",
            "probability": 0.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": -5.22265625,
            "text": "a 47, XX",
            "probability": 0.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": -5.54296875,
            "text": "a 47",
            "probability": 0.0
        },
        {
            "start_logit": -2.3984375,
            "end_logit": -6.32421875,
            "text": "Y karyotype",
            "probability": 0.0
        },
        {
            "start_logit": -2.626953125,
            "end_logit": -6.32421875,
            "text": "a 47, XXY karyotype",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_14": [
        {
            "start_logit": 9.8125,
            "end_logit": 9.3359375,
            "text": "sex chromosome anomalies",
            "probability": 1.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -1.8916015625,
            "text": "sex",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -3.05859375,
            "end_logit": 9.3359375,
            "text": "anomalies",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -5.07421875,
            "text": "sex chromosome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.8125,
            "end_logit": -6.84375,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.02734375,
            "text": "sex chromosome anomalies including XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.171875,
            "text": "sex chromosome anomalies including XX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 9.3359375,
            "text": "different sex chromosome anomalies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.68359375,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.73828125,
            "text": "sex chromosome anomalies including",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.82421875,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.88671875,
            "text": "sex chromosome anomalies including XXY, XX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.3359375,
            "text": "Klinefelter's syndrome may be associated with a variety of different sex chromosome anomalies",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.90625,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.921875,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.9375,
            "text": "sex chromosome anomalies including XXY, XXYY, XX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.9765625,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXX",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.0,
            "text": "sex chromosome anomalies including XXY,",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.3359375,
            "text": "chromosome anomalies",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.1171875,
            "text": "sex chromosome anomalies including XXY, XXYY",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_15": [
        {
            "start_logit": 9.6640625,
            "end_logit": 10.390625,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.8955078125,
            "end_logit": 10.390625,
            "text": "Y",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -2.642578125,
            "text": "47",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -5.21875,
            "text": "47,XX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 10.390625,
            "text": "a 47,XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 10.390625,
            "text": "XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 10.390625,
            "text": ",XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -6.99609375,
            "text": "47,XXY chromosomal pattern",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.44921875,
            "text": "47,XXY chromosomal",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.390625,
            "text": "by a 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.390625,
            "text": "Klinefelter's syndrome, characterised by a 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 10.390625,
            "text": "characterised by a 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.390625,
            "text": "inefelter's syndrome, characterised by a 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.78515625,
            "text": "47,",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.390625,
            "text": "syndrome, characterised by a 47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.1875,
            "text": "47,XXY chromosomal pattern, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.2421875,
            "text": "47,XXY chromosomal pattern,",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.25,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical abnormalities.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.3359375,
            "text": "47,XXY chromosomal pattern, has largely",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.3359375,
            "text": "47,XXY chromosomal pattern, has largely been",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_16": [
        {
            "start_logit": 8.4765625,
            "end_logit": 8.65625,
            "text": "46,XXY",
            "probability": 1.0
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -1.7568359375,
            "text": "46,XXY,t(13q;14q)",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -3.6953125,
            "end_logit": 8.65625,
            "text": "Y",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -4.2734375,
            "text": "46",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 8.65625,
            "text": "abnormality 46,XXY",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.7109375,
            "text": "46,XX",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 8.65625,
            "text": "translocation abnormality 46,XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.71484375,
            "text": "46,XXY,t(13q;",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.78125,
            "text": "46,XXY,t(13q;14",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.78125,
            "text": "46,XXY,t(13q;14q",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.9765625,
            "text": "46,XXY,t(13q",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -7.17578125,
            "text": "46,XXY,t(13q;14q).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -7.26953125,
            "text": "46,XXY,t",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.912109375,
            "end_logit": -1.7568359375,
            "text": "t(13q;14q)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -7.37109375,
            "text": "46,XXY,t(13",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -7.62890625,
            "text": "46,XXY,t(",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.65625,
            "text": ",XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.65625,
            "text": "XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -7.76171875,
            "text": "46,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 8.65625,
            "text": "Klinefelter syndrome associated with 13/14 translocation abnormality 46,XXY",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c8f4615795f9a73e00001a_1": [
        {
            "start_logit": 9.8828125,
            "end_logit": 10.3125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": 10.3125,
            "text": "e",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -2.212890625,
            "text": "GBs",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -6.796875,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 10.3125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.0859375,
            "text": "GBshape: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.15625,
            "text": "GBshape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2265625,
            "text": "GBshape:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2265625,
            "text": "GBshape: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.234375,
            "text": "GBshape: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.234375,
            "text": "GBshape: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2890625,
            "text": "GBshape: a genome",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.0859375,
            "text": "e: a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.15625,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.2265625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.2265625,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.234375,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.154296875,
            "end_logit": -8.2890625,
            "text": "e: a genome",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -6.796875,
            "text": "hap",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_2": [
        {
            "start_logit": 9.7890625,
            "end_logit": 10.1015625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.59375,
            "end_logit": 10.1015625,
            "text": "e",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -2.3515625,
            "text": "GBs",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 10.1015625,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.515625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.671875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.71484375,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.1015625,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.875,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.8828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.890625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.91015625,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -7.9296875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.1015625,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.0,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.1015625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.046875,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.0546875,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.0859375,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.7890625,
            "end_logit": -8.1171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_3": [
        {
            "start_logit": 9.859375,
            "end_logit": 10.328125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": 10.328125,
            "text": "e",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -2.22265625,
            "text": "GBs",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 10.328125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.16015625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.03125,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.25,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2734375,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.03125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.1953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.25,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2734375,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.3125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_4": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.234375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.328125,
            "end_logit": 10.234375,
            "text": "e",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.1875,
            "text": "GBs",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 10.234375,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.33203125,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.625,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 10.234375,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.7578125,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.765625,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.78125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.81640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.8203125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.9140625,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.9453125,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.96875,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.99609375,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_5": [
        {
            "start_logit": 9.859375,
            "end_logit": 10.328125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": 10.328125,
            "text": "e",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -2.22265625,
            "text": "GBs",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 10.328125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.16015625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.03125,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.25,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2734375,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.03125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.1953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.25,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2734375,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.3125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_6": [
        {
            "start_logit": 9.8828125,
            "end_logit": 10.359375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": 10.359375,
            "text": "e",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -2.166015625,
            "text": "GBs",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 10.359375,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -7.078125,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.015625,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2109375,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.234375,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.8828125,
            "end_logit": -8.28125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.015625,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.2109375,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.234375,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.2421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.28125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -7.078125,
            "text": "hap",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_7": [
        {
            "start_logit": 9.8046875,
            "end_logit": 10.0390625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -2.34375,
            "text": "GBs",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -2.693359375,
            "end_logit": 10.0390625,
            "text": "e",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 10.0390625,
            "text": "(GBshape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 10.0390625,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.1796875,
            "text": "GBshape;",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.29296875,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.80859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.81640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.8203125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0390625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.8515625,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.89453125,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.96484375,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.97265625,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.0390625,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.0390625,
            "text": "fine-tunes the DNA binding specificities of some transcription factor families. Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -6.9609375,
            "end_logit": -2.34375,
            "text": "(GBs",
            "probability": 0.0
        },
        {
            "start_logit": -2.693359375,
            "end_logit": -7.1796875,
            "text": "e;",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_8": [
        {
            "start_logit": 9.5546875,
            "end_logit": 10.0546875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": 10.0546875,
            "text": "e",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -2.791015625,
            "text": "GBs",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 10.0546875,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.35546875,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.0546875,
            "text": "Additional genomes can easily be added using the GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.0546875,
            "text": "genomes can easily be added using the GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.0546875,
            "text": "the GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.0546875,
            "text": "added using the GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.953125,
            "text": "GBshape framework",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -7.95703125,
            "text": "GBshape framework. GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.0078125,
            "text": "GBshape framework. GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.03125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.078125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.09375,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.140625,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.1796875,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.21875,
            "text": "GBshape framework. GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.5546875,
            "end_logit": -8.2578125,
            "text": "GBshape framework. GBshap",
            "probability": 0.0
        },
        {
            "start_logit": -2.609375,
            "end_logit": -7.953125,
            "text": "e framework",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_9": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.15625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": 10.15625,
            "text": "e",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.228515625,
            "text": "GBs",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 10.15625,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.375,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.40234375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.55859375,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": 10.15625,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.7734375,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.8046875,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.8125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.83984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.84375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 10.15625,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.15625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.92578125,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.97265625,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.984375,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.015625,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.0546875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_10": [
        {
            "start_logit": 9.859375,
            "end_logit": 10.328125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": 10.328125,
            "text": "e",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 9.859375,
            "end_logit": -2.22265625,
            "text": "GBs",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 10.328125,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.859375,
            "end_logit": -7.16015625,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.03125,
            "text": "GBshape can",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.1953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.25,
            "text": "GBshape can be used",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2578125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.2734375,
            "text": "GBshape can be used to",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        },
        {
            "start_logit": 9.859375,
            "end_logit": -8.3359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.03125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.1953125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.25,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2578125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.2734375,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -2.13671875,
            "end_logit": -8.3125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_11": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.234375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -2.328125,
            "end_logit": 10.234375,
            "text": "e",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.1875,
            "text": "GBs",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 10.234375,
            "text": "hape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.33203125,
            "text": "GBshap",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.625,
            "text": "GBshape;",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 10.234375,
            "text": "(GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.7578125,
            "text": "GBshape; freely available at http:/",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.765625,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.78125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.81640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.8203125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.9140625,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.234375,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.9453125,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.96875,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.99609375,
            "text": "GBshape; freely available at http:",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.234375,
            "text": "Genome Browser for DNA shape annotations (GBshape",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 0.0
        }
    ],
    "5e36cf8eb5b409ea53000007_1": [
        {
            "start_logit": 7.52734375,
            "end_logit": 4.1796875,
            "text": "melanocyte",
            "probability": 1.0
        },
        {
            "start_logit": 7.52734375,
            "end_logit": -4.31640625,
            "text": "melan",
            "probability": 0.00020503997802734375
        },
        {
            "start_logit": 7.52734375,
            "end_logit": -7.4765625,
            "text": "melanocyte umbrella above the kidney marrow",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 4.1796875,
            "text": "ocyte",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 4.1796875,
            "text": "kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 4.1796875,
            "text": "the kidney marrow in teleost fish. Here we show that a melanocyte",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.671875,
            "end_logit": -2.89453125,
            "text": "melanocytes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -2.89453125,
            "text": "bone marrow, which is protected from ultraviolet light by the cortical bone around the marrow. Our studies reveal that melanocytes",
            "probability": 0.0
        },
        {
            "start_logit": -2.671875,
            "end_logit": -7.61328125,
            "text": "melanocytes above the haematopoietic niche",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -2.89453125,
            "text": "the bone marrow, which is protected from ultraviolet light by the cortical bone around the marrow. Our studies reveal that melanocytes",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -4.31640625,
            "text": "kidney marrow in teleost fish. Here we show that a melan",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -4.6328125,
            "text": "bone marrow",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -4.1015625,
            "text": "the haematopoietic niche",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -5.16796875,
            "text": "melanocytes",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -4.1015625,
            "text": "haematopoietic niche",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": -4.6328125,
            "text": "the bone marrow",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -4.1015625,
            "text": "Haematopoietic stem and progenitor cells (HSPCs) require a specific microenvironment, the haematopoietic niche",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -4.31640625,
            "text": "the kidney marrow in teleost fish. Here we show that a melan",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -5.9609375,
            "text": "bone marrow in adult mammals, whereas it is found in other locations in non-mammalian vertebrates, for example, in the kidney marrow",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -6.4921875,
            "text": "melanocytes above the stem cell niche",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_1": [
        {
            "start_logit": 8.0546875,
            "end_logit": 7.96875,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -5.0078125,
            "text": "SPIN",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.1328125,
            "end_logit": 7.96875,
            "text": "5",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.5390625,
            "text": "SPINK",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.69140625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 7.96875,
            "text": "gene SPINK5",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.3359375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.96875,
            "text": "Netherton syndrome (NS) is a serious inherited skin disorder caused by mutations in the gene SPINK5",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.51171875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.6328125,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.63671875,
            "text": "SPINK5 (serine protease inhibitor Kazal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.96875,
            "text": "mutations in the gene SPINK5",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.6484375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal type",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.65234375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.671875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.6796875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.68359375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Ka",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.70703125,
            "text": "SPINK5 (serine protease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.71484375,
            "text": "SPINK5 (serine protease inhibitor Kazal type",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.71484375,
            "text": "SPINK5 (serine protease inhibitor Ka",
            "probability": 1.7881393432617188e-07
        }
    ],
    "54ff45966ad7dcbc12000010_2": [
        {
            "start_logit": -0.98681640625,
            "end_logit": 3.349609375,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5",
            "probability": 0.57666015625
        },
        {
            "start_logit": -1.46484375,
            "end_logit": 3.349609375,
            "text": "SPINK5",
            "probability": 0.357177734375
        },
        {
            "start_logit": -1.46484375,
            "end_logit": 0.8154296875,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0283660888671875
        },
        {
            "start_logit": -1.4921875,
            "end_logit": 0.8154296875,
            "text": "LEKTI",
            "probability": 0.0276031494140625
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 3.349609375,
            "text": "(SPINK5",
            "probability": 0.0057830810546875
        },
        {
            "start_logit": -0.98681640625,
            "end_logit": -3.177734375,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5)",
            "probability": 0.0008435249328613281
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 3.349609375,
            "text": "5",
            "probability": 0.0007047653198242188
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 3.349609375,
            "text": "K5",
            "probability": 0.0006723403930664062
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -3.177734375,
            "text": "SPINK5)",
            "probability": 0.0005235671997070312
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 0.8154296875,
            "text": "(SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.00046062469482421875
        },
        {
            "start_logit": -5.60546875,
            "end_logit": 0.8154296875,
            "text": "(LEKTI",
            "probability": 0.0004513263702392578
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 3.349609375,
            "text": "the serine protease inhibitor Kazal type 5 (SPINK5",
            "probability": 0.0003597736358642578
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 0.8154296875,
            "text": "gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 8.064508438110352e-05
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 0.8154296875,
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 7.75456428527832e-05
        },
        {
            "start_logit": -7.40625,
            "end_logit": 0.8154296875,
            "text": "KTI",
            "probability": 7.456541061401367e-05
        },
        {
            "start_logit": -0.98681640625,
            "end_logit": -5.65234375,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene",
            "probability": 7.11679458618164e-05
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 0.8154296875,
            "text": "5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.626678466796875e-05
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 0.8154296875,
            "text": "K5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.328655242919922e-05
        },
        {
            "start_logit": -7.75,
            "end_logit": 0.8154296875,
            "text": "to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 0.8154296875,
            "text": "leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.125999450683594e-05
        }
    ],
    "54ff45966ad7dcbc12000010_3": [
        {
            "start_logit": 9.734375,
            "end_logit": 10.1015625,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": -2.587890625,
            "end_logit": 10.1015625,
            "text": "5",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.548828125,
            "text": "SPIN",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -6.30078125,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.734375,
            "end_logit": -6.90625,
            "text": "SPINK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 10.1015625,
            "text": "K5",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.5,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.890625,
            "text": "SPINK5 gene",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.90625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LE",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.9140625,
            "text": "SPINK5 gene and",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.046875,
            "text": "SPINK5 gene and to",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0546875,
            "text": "SPINK5 gene and to the consequent lack of expression of its",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.1015625,
            "text": "NS is due to loss-of-function mutations in the SPINK5",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.09375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKT",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.1015625,
            "text": "the SPINK5",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.125,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1328125,
            "text": "SPINK5 gene and to the consequent lack of",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1328125,
            "text": "SPINK5 gene and to the consequent lack",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1484375,
            "text": "SPINK5 gene and to the",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.1015625,
            "text": "is due to loss-of-function mutations in the SPINK5",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_4": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.3359375,
            "text": "LEKTI",
            "probability": 1.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": 9.3359375,
            "text": "I",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -3.576171875,
            "text": "LE",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 9.3359375,
            "text": "(LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.3515625,
            "text": "LEKT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.3359375,
            "text": "KTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.59765625,
            "text": "LEKTI)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 9.3359375,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.98046875,
            "text": "LEKTI) is the defective protein of the ichthyosiform",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.0078125,
            "text": "LEKTI) is the defective protein of the ichthyosi",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.0078125,
            "text": "LEKTI) is",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.0703125,
            "text": "LEKTI) is the defective protein",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.0703125,
            "text": "LEKTI) is the defective protein of",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.2109375,
            "text": "LEKTI) is the defective",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -8.21875,
            "text": "LEKTI) is the defective protein of the ichthyosiform condition Netherton syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -8.6875,
            "end_logit": 9.3359375,
            "text": "epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -3.576171875,
            "text": "(LE",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -7.59765625,
            "text": "I)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -3.576171875,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LE",
            "probability": 0.0
        },
        {
            "start_logit": -3.77734375,
            "end_logit": -7.98046875,
            "text": "I) is the defective protein of the ichthyosiform",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_5": [
        {
            "start_logit": 9.71875,
            "end_logit": 9.8984375,
            "text": "LEKTI",
            "probability": 1.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -2.498046875,
            "text": "LE",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -2.962890625,
            "end_logit": 9.8984375,
            "text": "I",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.8984375,
            "text": "KTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.359375,
            "text": "LEKT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.8984375,
            "text": "inhibitor LEKTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.96875,
            "text": "LEKTI is the etiological origin",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.98828125,
            "text": "LEKTI is",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.8984375,
            "text": "serine protease inhibitor LEKTI",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.8984375,
            "text": "Deficiency in the serine protease inhibitor LEKTI",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1953125,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.2109375,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.234375,
            "text": "LEKTI is the etiological",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.234375,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.265625,
            "text": "LEKTI is the",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.296875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.3125,
            "text": "LEKTI is the etiological origin of",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -2.498046875,
            "text": "inhibitor LE",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -2.498046875,
            "text": "serine protease inhibitor LE",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -2.498046875,
            "text": "Deficiency in the serine protease inhibitor LE",
            "probability": 0.0
        }
    ],
    "53175e9fb166e2b80600000a_1": [
        {
            "start_logit": -0.7626953125,
            "end_logit": -2.3203125,
            "text": "Wnt-signaling pathway",
            "probability": 0.47802734375
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -2.3203125,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.357421875
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -4.796875,
            "text": "Wnt-signaling",
            "probability": 0.040191650390625
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -4.796875,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling",
            "probability": 0.02996826171875
        },
        {
            "start_logit": -3.8515625,
            "end_logit": -2.3203125,
            "text": "controlling the Wnt-signaling pathway",
            "probability": 0.021759033203125
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -5.58984375,
            "text": "Wnt-signaling pathway and",
            "probability": 0.0181732177734375
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -5.58984375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and",
            "probability": 0.01361083984375
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -6.66015625,
            "text": "Wnt-signaling pathway and activation",
            "probability": 0.00623321533203125
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -6.66015625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and activation",
            "probability": 0.004669189453125
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -7.04296875,
            "text": "Wnt-signaling pathway and activation of the pathway",
            "probability": 0.00424957275390625
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -7.12109375,
            "text": "Wnt-",
            "probability": 0.003932952880859375
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.04296875,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and activation of the pathway",
            "probability": 0.0031833648681640625
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -7.37109375,
            "text": "Wnt",
            "probability": 0.0030612945556640625
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.12109375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-",
            "probability": 0.0029449462890625
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.23046875,
            "text": "Recent functional genetic studies have pointed out",
            "probability": 0.0026378631591796875
        },
        {
            "start_logit": -0.7626953125,
            "end_logit": -7.58203125,
            "text": "Wnt-signaling pathway and activation of the pathway as",
            "probability": 0.00247955322265625
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.37109375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt",
            "probability": 0.002292633056640625
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.5625,
            "text": "Recent functional genetic studies",
            "probability": 0.0018854141235351562
        },
        {
            "start_logit": -1.052734375,
            "end_logit": -7.58203125,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and activation of the pathway as",
            "probability": 0.001857757568359375
        },
        {
            "start_logit": -3.8515625,
            "end_logit": -4.796875,
            "text": "controlling the Wnt-signaling",
            "probability": 0.0018281936645507812
        }
    ],
    "5a9d31711d1251d03b00001c_1": [
        {
            "start_logit": 10.0546875,
            "end_logit": 10.296875,
            "text": "100 nm",
            "probability": 1.0
        },
        {
            "start_logit": 10.0546875,
            "end_logit": -1.666015625,
            "text": "100",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -2.1015625,
            "end_logit": 10.296875,
            "text": "nm",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -7.9375,
            "end_logit": 10.296875,
            "text": "diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.296875,
            "text": "maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.296875,
            "text": "constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 10.296875,
            "text": "number remained relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.296875,
            "text": "increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.296875,
            "text": "vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.296875,
            "text": "relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.296875,
            "text": "attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.296875,
            "text": "while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.296875,
            "text": "the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": 10.0546875,
            "end_logit": -8.1015625,
            "text": "100 nm.",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.296875,
            "text": "of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 10.296875,
            "text": "until they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.296875,
            "text": "they attained their maximum diamtere of 100 nm",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -1.666015625,
            "text": "diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -1.666015625,
            "text": "maximum diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -1.666015625,
            "text": "constant while the size of the vesicles increased until they attained their maximum diamtere of 100",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_1": [
        {
            "start_logit": 4.22265625,
            "end_logit": 9.625,
            "text": "drug abuse",
            "probability": 0.95361328125
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": 9.625,
            "text": "intravenous drug abuse",
            "probability": 0.045989990234375
        },
        {
            "start_logit": -3.3125,
            "end_logit": 9.625,
            "text": "abuse",
            "probability": 0.00051116943359375
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 9.625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.0002510547637939453
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.625,
            "text": "complication of intravenous drug abuse",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 9.625,
            "text": "of intravenous drug abuse",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.921875,
            "text": "drug abuse.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.92578125,
            "text": "drug",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": -6.921875,
            "text": "intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": -6.92578125,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -3.3125,
            "end_logit": -6.921875,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -6.921875,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -6.92578125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.99609375,
            "text": "Puffy hand syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.1171875,
            "text": "Puffy hand syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.140625,
            "text": "Puffy hand syndrome is an",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.1953125,
            "text": "Puffy hand",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_2": [
        {
            "start_logit": 5.60546875,
            "end_logit": 9.859375,
            "text": "intravenous drug abuse",
            "probability": 0.9697265625
        },
        {
            "start_logit": 2.150390625,
            "end_logit": 9.859375,
            "text": "drug abuse",
            "probability": 0.03045654296875
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 9.859375,
            "text": "abuse",
            "probability": 0.0001825094223022461
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 9.859375,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.859375,
            "text": "complication of intravenous drug abuse",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 9.859375,
            "text": "of intravenous drug abuse",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -8.15625,
            "end_logit": 9.859375,
            "text": "BACKGROUND: Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -8.34375,
            "end_logit": 9.859375,
            "text": "a complication of intravenous drug abuse",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.859375,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.859375,
            "text": ": Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -6.73046875,
            "text": "intravenous",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -7.81640625,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -7.8203125,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -7.98046875,
            "text": "intravenous drug abuse, which has no",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -7.984375,
            "text": "intravenous drug abuse, which has",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -8.2109375,
            "text": "intravenous drug abuse, which",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -8.25,
            "text": "intravenous drug abuse, which has no current",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -8.3203125,
            "text": "intravenous drug abuse, which has no current available treatment",
            "probability": 0.0
        },
        {
            "start_logit": 5.60546875,
            "end_logit": -8.375,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 0.0
        },
        {
            "start_logit": 2.150390625,
            "end_logit": -7.81640625,
            "text": "drug abuse, which has no current available treatment.",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_3": [
        {
            "start_logit": 5.3046875,
            "end_logit": 9.75,
            "text": "intravenous drug abuse",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.8466796875,
            "end_logit": 9.75,
            "text": "drug abuse",
            "probability": 0.000782012939453125
        },
        {
            "start_logit": -2.7578125,
            "end_logit": 9.75,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.00031495094299316406
        },
        {
            "start_logit": -3.130859375,
            "end_logit": 9.75,
            "text": "abuse",
            "probability": 0.00021636486053466797
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.75,
            "text": "complication of intravenous drug abuse",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.75,
            "text": "of intravenous drug abuse",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.75,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.75,
            "text": "a complication of intravenous drug abuse",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.87890625,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -7.0625,
            "text": "intravenous",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -7.7109375,
            "text": "intravenous drug abuse, which has no",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -7.7109375,
            "text": "intravenous drug abuse, which has",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.03125,
            "text": "intravenous drug abuse, which has no current",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.03125,
            "text": "intravenous drug abuse, which",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.140625,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.1484375,
            "text": "intravenous drug abuse, which has no current available treatment",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.25,
            "text": "intravenous drug abuse,",
            "probability": 0.0
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -8.34375,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -1.8466796875,
            "end_logit": -6.87890625,
            "text": "drug abuse, which has no current available treatment.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8466796875,
            "end_logit": -7.7109375,
            "text": "drug abuse, which has no",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_4": [
        {
            "start_logit": 4.22265625,
            "end_logit": 9.625,
            "text": "drug abuse",
            "probability": 0.95361328125
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": 9.625,
            "text": "intravenous drug abuse",
            "probability": 0.045989990234375
        },
        {
            "start_logit": -3.3125,
            "end_logit": 9.625,
            "text": "abuse",
            "probability": 0.00051116943359375
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 9.625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.0002510547637939453
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.625,
            "text": "complication of intravenous drug abuse",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -8.109375,
            "end_logit": 9.625,
            "text": "of intravenous drug abuse",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.921875,
            "text": "drug abuse.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.92578125,
            "text": "drug",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": -6.921875,
            "text": "intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": 1.1845703125,
            "end_logit": -6.92578125,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -3.3125,
            "end_logit": -6.921875,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -6.921875,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -6.92578125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -7.99609375,
            "text": "Puffy hand syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.1171875,
            "text": "Puffy hand syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.140625,
            "text": "Puffy hand syndrome is an",
            "probability": 0.0
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -8.1953125,
            "text": "Puffy hand",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_5": [
        {
            "start_logit": 6.34375,
            "end_logit": 9.515625,
            "text": "drug abuse",
            "probability": 0.9716796875
        },
        {
            "start_logit": 2.798828125,
            "end_logit": 9.515625,
            "text": "intravenous drug abuse",
            "probability": 0.027984619140625
        },
        {
            "start_logit": -3.40625,
            "end_logit": 9.515625,
            "text": "abuse",
            "probability": 5.6624412536621094e-05
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 9.515625,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 9.515625,
            "text": "complication of intravenous drug abuse",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 9.515625,
            "text": "of intravenous drug abuse",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 9.515625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -5.34375,
            "text": "drug",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.05859375,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.75390625,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and sometimes the forearms and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.85546875,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 0.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.984375,
            "text": "drug abuse this",
            "probability": 0.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -8.0078125,
            "text": "drug abuse this painless syndrome appears",
            "probability": 0.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -8.0625,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -5.34375,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -7.05859375,
            "text": "intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -7.75390625,
            "text": "intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and sometimes the forearms and",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -7.85546875,
            "text": "intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -7.984375,
            "text": "intravenous drug abuse this",
            "probability": 0.0
        },
        {
            "start_logit": 2.798828125,
            "end_logit": -8.0078125,
            "text": "intravenous drug abuse this painless syndrome appears",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_6": [
        {
            "start_logit": 8.328125,
            "end_logit": 9.859375,
            "text": "intravenous drug abuse",
            "probability": 1.0
        },
        {
            "start_logit": -2.716796875,
            "end_logit": 9.859375,
            "text": "abuse",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -2.837890625,
            "end_logit": 9.859375,
            "text": "drug abuse",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 8.328125,
            "end_logit": -4.40625,
            "text": "intravenous",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 9.859375,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 9.859375,
            "text": "complication of intravenous drug abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -7.5234375,
            "text": "intravenous drug abuse which has no current available treatment arm and forearm edema are voluminous and cause functional and aesthetic disturbances we",
            "probability": 0.0
        },
        {
            "start_logit": -2.716796875,
            "end_logit": -7.5234375,
            "text": "abuse which has no current available treatment arm and forearm edema are voluminous and cause functional and aesthetic disturbances we",
            "probability": 0.0
        },
        {
            "start_logit": -2.837890625,
            "end_logit": -7.5234375,
            "text": "drug abuse which has no current available treatment arm and forearm edema are voluminous and cause functional and aesthetic disturbances we",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -4.40625,
            "text": "puffy hand syndrome is a complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -5.796875,
            "text": "multilayer bandaging",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -4.40625,
            "text": "complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -5.796875,
            "text": "both intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -5.953125,
            "text": "both intravenous drug users",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -5.4921875,
            "text": "forearm edema are voluminous and cause functional and aesthetic disturbances we report two cases successfully treated by low stretch bandages",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -5.4921875,
            "text": "low stretch bandages",
            "probability": 0.0
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -5.796875,
            "text": "daily multilayer bandaging",
            "probability": 0.0
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -7.05859375,
            "text": "multilayer bandaging lymphedema",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -5.796875,
            "text": "intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -5.953125,
            "text": "intravenous drug users",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_1": [
        {
            "start_logit": 9.296875,
            "end_logit": 5.59765625,
            "text": "T-type calcium channels",
            "probability": 0.9541015625
        },
        {
            "start_logit": 9.296875,
            "end_logit": 2.548828125,
            "text": "T-type",
            "probability": 0.04534912109375
        },
        {
            "start_logit": 9.296875,
            "end_logit": -3.24609375,
            "text": "T",
            "probability": 0.00013768672943115234
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.18359375,
            "text": "T-type calcium",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.4296875,
            "text": "T-",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.984375,
            "text": "T-type calcium channels,",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.0390625,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.09375,
            "text": "T-type calcium channels, we examined if more selective T-type calcium",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.1875,
            "text": "T-type calcium channels, we examined if more selective T-type",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -8.1953125,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 5.59765625,
            "text": "channels",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 5.59765625,
            "text": "block T-type calcium channels",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 5.59765625,
            "text": "type calcium channels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 5.59765625,
            "text": "calcium channels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 5.59765625,
            "text": "-type calcium channels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 5.59765625,
            "text": "to block T-type calcium channels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 5.59765625,
            "text": "known to block T-type calcium channels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.40625,
            "end_logit": 5.59765625,
            "text": "Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type calcium channels",
            "probability": 0.0
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 2.548828125,
            "text": "block T-type",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 2.548828125,
            "text": "type",
            "probability": 0.0
        }
    ],
    "6026ed981cb411341a0000d2_1": [
        {
            "start_logit": -2.423828125,
            "end_logit": -3.9140625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.456787109375
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -4.44921875,
            "text": "calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.2666015625
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -5.28125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.11639404296875
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -6.58984375,
            "text": "calcitonin gene-related peptide (",
            "probability": 0.031341552734375
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -6.81640625,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403",
            "probability": 0.0249786376953125
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.28515625,
            "text": "calcitonin gene",
            "probability": 0.015625
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.44921875,
            "text": "calcitonin gene-related",
            "probability": 0.0132598876953125
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.65625,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab)",
            "probability": 0.01082611083984375
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.7578125,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab",
            "probability": 0.0097808837890625
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.76171875,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinez",
            "probability": 0.00970458984375
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.78125,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab",
            "probability": 0.009552001953125
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.80078125,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (eren",
            "probability": 0.00933074951171875
        },
        {
            "start_logit": -2.423828125,
            "end_logit": -7.80859375,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD40",
            "probability": 0.0092620849609375
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -3.9140625,
            "text": "the calcitonin gene-related peptide",
            "probability": 0.0048065185546875
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -3.9140625,
            "text": "migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.00286865234375
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -4.44921875,
            "text": "the calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.0028018951416015625
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -4.44921875,
            "text": "migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.00168609619140625
        },
        {
            "start_logit": -8.046875,
            "end_logit": -3.9140625,
            "text": "chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.0016469955444335938
        },
        {
            "start_logit": -8.046875,
            "end_logit": -3.9140625,
            "text": "targeting the calcitonin gene-related peptide",
            "probability": 0.0016469955444335938
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -3.9140625,
            "text": "prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.0016345977783203125
        }
    ],
    "587e0116ae05ffb474000002_1": [
        {
            "start_logit": 9.9375,
            "end_logit": 10.21875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": 10.21875,
            "text": "per",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 9.9375,
            "end_logit": -2.087890625,
            "text": "Cis",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 9.9375,
            "end_logit": -6.4453125,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 10.21875,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.1015625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.1796875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.1953125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.21875,
            "text": "CisMapper:",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.2421875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.265625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.265625,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.296875,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": 9.9375,
            "end_logit": -8.3359375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.1015625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.1796875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.1953125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.21875,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.2421875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -8.265625,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_2": [
        {
            "start_logit": 9.875,
            "end_logit": 10.0546875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -2.22265625,
            "text": "Cis",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -2.708984375,
            "end_logit": 10.0546875,
            "text": "per",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 9.875,
            "end_logit": -6.9765625,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 10.0546875,
            "text": "Mapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 10.0546875,
            "text": "present CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0234375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.0625,
            "text": "CisMapper,",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.09375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.125,
            "text": "CisMapper, which predicts the regulatory targets of",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.15625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1796875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.1875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF'",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2109375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and the expression of",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.21875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "CisMapper, which predicts the regulatory",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "CisMapper, which predicts the regulatory targets",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.234375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2421875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's",
            "probability": 0.0
        },
        {
            "start_logit": 9.875,
            "end_logit": -8.2421875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_3": [
        {
            "start_logit": 9.9609375,
            "end_logit": 10.28125,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -2.220703125,
            "end_logit": 10.28125,
            "text": "per",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -1.9990234375,
            "text": "Cis",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -6.91796875,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 10.28125,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 10.28125,
            "text": "that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -7.8203125,
            "text": "CisMapper is",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 10.28125,
            "text": "show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -7.97265625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.0625,
            "text": "CisMapper is more accurate at",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.09375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.09375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.28125,
            "text": "we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.1328125,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9609375,
            "end_logit": -8.1484375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.28125,
            "text": "both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.28125,
            "text": ", we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.28125,
            "text": "Using both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.28125,
            "text": "chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_4": [
        {
            "start_logit": 10.0703125,
            "end_logit": 10.4296875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": 10.4296875,
            "text": "per",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -1.6923828125,
            "text": "Cis",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -5.9765625,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -6.94140625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance.",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 10.4296875,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.703125,
            "text": "CisMapper also predicts which TF binding sites regulate",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.8515625,
            "text": "CisMapper also predicts which TF binding sites regulate a",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -7.8671875,
            "text": "CisMapper also predicts which TF binding sites",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.0234375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.1171875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.125,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately",
            "probability": 0.0
        },
        {
            "start_logit": 10.0703125,
            "end_logit": -8.125,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -6.94140625,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -7.703125,
            "text": "per also predicts which TF binding sites regulate",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -7.8515625,
            "text": "per also predicts which TF binding sites regulate a",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -7.8671875,
            "text": "per also predicts which TF binding sites",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -8.0234375,
            "text": "per also predicts which TF binding sites regulate a given gene more",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -8.1171875,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using",
            "probability": 0.0
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": -8.125,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_5": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.2734375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": 10.2734375,
            "text": "per",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -2.0,
            "text": "Cis",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.41796875,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 10.2734375,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.234375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3203125,
            "text": "CisMapper:",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3359375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3515625,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3828125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3828125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.390625,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.234375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3203125,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3359375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3515625,
            "text": "per: predicting regulatory interactions",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3828125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3828125,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_6": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.2734375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": 10.2734375,
            "text": "per",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -2.0,
            "text": "Cis",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.41796875,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 10.2734375,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.234375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3203125,
            "text": "CisMapper:",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3359375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3515625,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3828125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.3828125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.390625,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.234375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3203125,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3359375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3515625,
            "text": "per: predicting regulatory interactions",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3828125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -2.203125,
            "end_logit": -8.3828125,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_7": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.296875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -2.1875,
            "end_logit": 10.296875,
            "text": "per",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -1.978515625,
            "text": "Cis",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.89453125,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 10.296875,
            "text": "Mapper",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 10.296875,
            "text": "that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.82421875,
            "text": "CisMapper is",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.296875,
            "text": "show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.9765625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0703125,
            "text": "CisMapper is more accurate at",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.078125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.09375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.296875,
            "text": "we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1328125,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.140625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.15625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.296875,
            "text": "both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1796875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1796875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.296875,
            "text": ", we show that CisMapper",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_1": [
        {
            "start_logit": 8.609375,
            "end_logit": 2.37890625,
            "text": "inflammation of the aorta due to various causes.",
            "probability": 0.7900390625
        },
        {
            "start_logit": 8.609375,
            "end_logit": 1.0380859375,
            "text": "inflammation of the aorta",
            "probability": 0.207763671875
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.751953125,
            "text": "inflammation",
            "probability": 0.0017290115356445312
        },
        {
            "start_logit": -0.7099609375,
            "end_logit": 2.37890625,
            "text": "Aortitis is the inflammation of the aorta due to various causes.",
            "probability": 7.134675979614258e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.15625,
            "text": "inflammation of the aorta due to",
            "probability": 5.733966827392578e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.5078125,
            "text": "inflammation of the",
            "probability": 4.029273986816406e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.6484375,
            "text": "inflammation of the aorta due to various",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.67578125,
            "text": "inflammation of",
            "probability": 3.421306610107422e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.69921875,
            "text": "inflammation of the aorta due to various causes",
            "probability": 3.314018249511719e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -8.078125,
            "text": "inflammation of the aorta due",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -0.7099609375,
            "end_logit": 1.0380859375,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": -2.814453125,
            "end_logit": 2.37890625,
            "text": "aorta due to various causes.",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -2.814453125,
            "end_logit": 1.0380859375,
            "text": "aorta",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 2.37890625,
            "text": "the inflammation of the aorta due to various causes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 2.37890625,
            "text": "due to various causes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.7099609375,
            "end_logit": -3.751953125,
            "text": "Aortitis is the inflammation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 2.37890625,
            "text": ".",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 2.37890625,
            "text": "the aorta due to various causes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 2.37890625,
            "text": "itis is the inflammation of the aorta due to various causes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 1.0380859375,
            "text": "the inflammation of the aorta",
            "probability": 5.960464477539063e-08
        }
    ],
    "60314c361cb411341a00012e_2": [
        {
            "start_logit": 4.765625,
            "end_logit": 6.50390625,
            "text": "inflammation of the aorta",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.291015625,
            "end_logit": 6.50390625,
            "text": "aorta",
            "probability": 0.0008625984191894531
        },
        {
            "start_logit": -4.84375,
            "end_logit": 6.50390625,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 6.705522537231445e-05
        },
        {
            "start_logit": 4.765625,
            "end_logit": -4.796875,
            "text": "inflammation",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 6.50390625,
            "text": "the aorta",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.50390625,
            "text": "the inflammation of the aorta",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.50390625,
            "text": "of the aorta",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -8.34375,
            "end_logit": 6.50390625,
            "text": "REVIEW: Aortitis is the inflammation of the aorta",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 4.765625,
            "end_logit": -7.0625,
            "text": "inflammation of the aorta due",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.765625,
            "end_logit": -7.9140625,
            "text": "inflammation of the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.765625,
            "end_logit": -7.9765625,
            "text": "inflammation of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.291015625,
            "end_logit": -7.0625,
            "text": "aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -4.796875,
            "text": "Aortitis is the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -7.0625,
            "text": "Aortitis is the inflammation of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -7.6171875,
            "text": "Aortitis is",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -4.796875,
            "text": "the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -7.734375,
            "text": "Aortitis",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -7.9140625,
            "text": "Aortitis is the inflammation of the",
            "probability": 0.0
        },
        {
            "start_logit": -4.84375,
            "end_logit": -7.9765625,
            "text": "Aortitis is the inflammation of",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": -4.796875,
            "text": "REVIEW: Aortitis is the inflammation",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_3": [
        {
            "start_logit": 6.87109375,
            "end_logit": 7.9453125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 0.83203125
        },
        {
            "start_logit": 6.87109375,
            "end_logit": 6.33984375,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.1676025390625
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 7.9453125,
            "text": "inflammation of the aorta.",
            "probability": 0.00025200843811035156
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 6.33984375,
            "text": "inflammation of the aorta",
            "probability": 5.042552947998047e-05
        },
        {
            "start_logit": -4.046875,
            "end_logit": 7.9453125,
            "text": ".",
            "probability": 1.5139579772949219e-05
        },
        {
            "start_logit": -4.3984375,
            "end_logit": 7.9453125,
            "text": "aorta.",
            "probability": 1.0669231414794922e-05
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 7.9453125,
            "text": "the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 7.9453125,
            "text": "all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -4.89453125,
            "text": "Aort",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -4.3984375,
            "end_logit": 6.33984375,
            "text": "aorta",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 6.33984375,
            "text": "the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 7.9453125,
            "text": "term ascribed to inflammation of the aorta.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.9453125,
            "text": "itis is the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.9453125,
            "text": "ascribed to inflammation of the aorta.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 6.33984375,
            "text": "all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.9453125,
            "text": "pathological term ascribed to inflammation of the aorta.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.9453125,
            "text": "to inflammation of the aorta.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.9453125,
            "text": "the aorta.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.9453125,
            "text": "of the aorta.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.703125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5891c90949702f2e01000001_1": [
        {
            "start_logit": 10.0078125,
            "end_logit": 10.1796875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -1.8837890625,
            "text": "INC",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -2.412109375,
            "end_logit": 10.1796875,
            "text": "A",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.234375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.2578125,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.265625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.3203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.328125,
            "text": "INCA: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.34375,
            "text": "INCA:",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.34375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.359375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.203125,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.234375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.2578125,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.265625,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.3203125,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.328125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.34375,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.34375,
            "text": "A: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_2": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.1171875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -3.138671875,
            "text": "INC",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -4.00390625,
            "end_logit": 9.1171875,
            "text": "A",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.9140625,
            "text": "INCA) provides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.1171875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -8.0625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 9.1171875,
            "text": "(INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -8.0703125,
            "text": "INCA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -8.0703125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -8.1171875,
            "text": "INCA) provides an array of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.34375,
            "end_logit": -8.125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -3.138671875,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -3.138671875,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -7.9140625,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -8.0625,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -8.0703125,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -8.0703125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -8.1171875,
            "text": "A) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": -4.00390625,
            "end_logit": -8.125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -7.0078125,
            "text": "interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_3": [
        {
            "start_logit": 9.8203125,
            "end_logit": 9.90625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -2.267578125,
            "text": "INC",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 9.90625,
            "text": "A",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 9.90625,
            "text": "(INCA",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 9.90625,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.046875,
            "text": "INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.0546875,
            "text": "INCA) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.15625,
            "text": "INCA) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.1640625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.1796875,
            "text": "INCA) provides an",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.1796875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.2109375,
            "text": "INCA) provides an array",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.90625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3046875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8203125,
            "end_logit": -8.3046875,
            "text": "INCA) provides an array of features useful in",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 9.90625,
            "text": ": INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": -8.7109375,
            "end_logit": 9.90625,
            "text": "Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -2.267578125,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": -2.267578125,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -2.267578125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_4": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.1640625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.068359375,
            "text": "INC",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -2.447265625,
            "end_logit": 10.1640625,
            "text": "A",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.09375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.1640625,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2109375,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.2265625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.234375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.265625,
            "text": "INCA: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.3203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.328125,
            "text": "INCA:",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.34375,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.09375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.1640625,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.2109375,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.2265625,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.234375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.265625,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -2.447265625,
            "end_logit": -8.3203125,
            "text": "A: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_5": [
        {
            "start_logit": 9.734375,
            "end_logit": 9.8828125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -2.509765625,
            "text": "INC",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 9.8828125,
            "text": "A",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.921875,
            "text": "INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -7.94140625,
            "text": "INCA) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.0859375,
            "text": "INCA) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.140625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.140625,
            "text": "INCA) provides an array",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.1796875,
            "text": "INCA) provides an",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.2265625,
            "text": "INCA) provides an array of features useful in",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.234375,
            "text": "INCA)",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.2421875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.265625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.0
        },
        {
            "start_logit": 9.734375,
            "end_logit": -8.2890625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.8828125,
            "text": "(INCA",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.8828125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": -2.970703125,
            "end_logit": -7.921875,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -2.970703125,
            "end_logit": -7.94140625,
            "text": "A) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": -2.970703125,
            "end_logit": -8.0859375,
            "text": "A) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": -2.970703125,
            "end_logit": -8.140625,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_6": [
        {
            "start_logit": 9.796875,
            "end_logit": 9.953125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -2.376953125,
            "text": "INC",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -2.83984375,
            "end_logit": 9.953125,
            "text": "A",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.0234375,
            "text": "INCA) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.0703125,
            "text": "INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.125,
            "text": "INCA) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.1953125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.203125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.2265625,
            "text": "INCA) provides an array",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.265625,
            "text": "INCA) provides an",
            "probability": 0.0
        },
        {
            "start_logit": 9.796875,
            "end_logit": -8.28125,
            "text": "INCA) provides an array of features useful in",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.953125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.953125,
            "text": "(INCA",
            "probability": 0.0
        },
        {
            "start_logit": -2.83984375,
            "end_logit": -8.0234375,
            "text": "A) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": -2.83984375,
            "end_logit": -8.0703125,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -2.83984375,
            "end_logit": -8.125,
            "text": "A) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -2.376953125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": -2.376953125,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -2.83984375,
            "end_logit": -8.1953125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -2.83984375,
            "end_logit": -8.203125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_7": [
        {
            "start_logit": 8.09375,
            "end_logit": 7.6875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": 7.6875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 4.506111145019531e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -4.2421875,
            "text": "INC",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 7.6875,
            "text": "A",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.37890625,
            "text": "INCA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.87890625,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.98046875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -8.015625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.6875,
            "text": "(INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 7.6875,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -4.2421875,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -6.6875,
            "text": "INteractive Codon usage Analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.22265625,
            "text": "INteractive Codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.37890625,
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.8203125,
            "text": "INteractive Codon usage Analysis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.87890625,
            "text": "INteractive Codon usage Analysis (INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.9765625,
            "text": "INteractive Codon",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -7.98046875,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.9140625,
            "end_logit": -8.015625,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -4.2421875,
            "text": "(INC",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_8": [
        {
            "start_logit": 9.6640625,
            "end_logit": 9.5703125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -2.515625,
            "text": "INC",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -3.40625,
            "end_logit": 9.5703125,
            "text": "A",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.234375,
            "end_logit": 9.5703125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.89453125,
            "text": "INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -7.93359375,
            "text": "INCA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 9.5703125,
            "text": "(INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.0234375,
            "text": "INCA) provides an array",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.0625,
            "text": "INCA) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.0703125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.078125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.078125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.6640625,
            "end_logit": -8.078125,
            "text": "INCA) provides an",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 9.5703125,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 0.0
        },
        {
            "start_logit": -6.234375,
            "end_logit": -2.515625,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -2.515625,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": -2.515625,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -3.40625,
            "end_logit": -7.89453125,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -3.40625,
            "end_logit": -7.93359375,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -3.40625,
            "end_logit": -8.0234375,
            "text": "A) provides an array",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_9": [
        {
            "start_logit": 9.71875,
            "end_logit": 9.5234375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -2.537109375,
            "text": "INC",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -3.5625,
            "end_logit": 9.5234375,
            "text": "A",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.71875,
            "end_logit": -6.7421875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.5859375,
            "text": "INCA has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 9.5234375,
            "text": "of INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.94140625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.98046875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 9.5234375,
            "text": "'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.5234375,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -2.537109375,
            "text": "of INC",
            "probability": 0.0
        },
        {
            "start_logit": -3.5625,
            "end_logit": -6.7421875,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -2.537109375,
            "text": "'codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -2.537109375,
            "text": "codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -3.5625,
            "end_logit": -7.5859375,
            "text": "A has",
            "probability": 0.0
        },
        {
            "start_logit": -3.5625,
            "end_logit": -7.94140625,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -3.5625,
            "end_logit": -7.98046875,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -6.59765625,
            "text": "Finally, INCA includes a specific unsupervised neural network",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -6.7265625,
            "text": "the self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -6.7421875,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_10": [
        {
            "start_logit": 9.7265625,
            "end_logit": 10.109375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.560546875,
            "end_logit": 10.109375,
            "text": "A",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -2.515625,
            "text": "INC",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -6.2734375,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.59375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.109375,
            "text": ", INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.89453125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.93359375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.9375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.109375,
            "text": "Finally, INCA",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.97265625,
            "text": "INCA includes a specific unsupervised neural network algorithm",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.0390625,
            "text": "INCA includes",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.0546875,
            "text": "INCA includes a specific unsupervised neural network algorithm,",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.0703125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.09375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1015625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1484375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.171875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_11": [
        {
            "start_logit": 10.0078125,
            "end_logit": 10.1796875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -1.8837890625,
            "text": "INC",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -2.412109375,
            "end_logit": 10.1796875,
            "text": "A",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.234375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.2578125,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.265625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.3203125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.328125,
            "text": "INCA: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.34375,
            "text": "INCA:",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.34375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        },
        {
            "start_logit": 10.0078125,
            "end_logit": -8.359375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.203125,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.234375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.2578125,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.265625,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.3203125,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.328125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.34375,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -2.412109375,
            "end_logit": -8.34375,
            "text": "A: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_1": [
        {
            "start_logit": 3.5703125,
            "end_logit": 1.4501953125,
            "text": "acetaminophen",
            "probability": 1.0
        },
        {
            "start_logit": 3.5703125,
            "end_logit": -7.98828125,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 3.5703125,
            "end_logit": -8.09375,
            "text": "acetaminophen for",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -7.140625,
            "end_logit": 1.4501953125,
            "text": "substitutes such as acetaminophen",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 1.4501953125,
            "text": "it is recommended to use substitutes such as acetaminophen",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": -7.90625,
            "end_logit": 1.4501953125,
            "text": "elongation of treatment duration and exacerbation of the clinical course of patients with COVID-19, it is recommended to use substitutes such as acetaminophen",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -4.05078125,
            "text": "NSAIDs",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -7.203125,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -7.9140625,
            "text": "NSAIDs have",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -8.0078125,
            "text": "NSAIDs have been effective",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -8.0234375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -8.125,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.98828125,
            "text": "substitutes such as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -8.09375,
            "text": "substitutes such as acetaminophen for",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -7.98828125,
            "text": "NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.765625,
            "text": "it is recommended",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -7.765625,
            "text": "elongation of treatment duration and exacerbation of the clinical course of patients with COVID-19, it is recommended",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.921875,
            "text": "it is recommended to use",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -7.8125,
            "text": "elongation of treatment duration",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.98828125,
            "text": "it is recommended to use substitutes such as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_2": [
        {
            "start_logit": 5.0078125,
            "end_logit": 4.875,
            "text": "pain",
            "probability": 1.0
        },
        {
            "start_logit": 5.0078125,
            "end_logit": -5.9453125,
            "text": "pain management",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 4.875,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 4.875,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 5.0078125,
            "end_logit": -7.76171875,
            "text": "pain management in children",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 4.875,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 4.875,
            "text": "safely administered for pain",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 5.0078125,
            "end_logit": -7.875,
            "text": "pain management in",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 4.875,
            "text": "be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 4.875,
            "text": "for pain",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 4.875,
            "text": "As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 4.875,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 4.875,
            "text": "non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -8.171875,
            "end_logit": 4.875,
            "text": "used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.21484375,
            "text": "Pharmacological approaches like acetaminophen, NSAIDS, spasmolytics etc. can",
            "probability": 0.0
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.2578125,
            "text": "Pharmacological approaches like acetaminophen, NSAIDS, spasmolytics etc",
            "probability": 0.0
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.33984375,
            "text": "Pharmacological approaches like acetaminophen, NSAIDS, spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence",
            "probability": 0.0
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.44140625,
            "text": "Pharmacological",
            "probability": 0.0
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.55859375,
            "text": "Pharmacological approaches",
            "probability": 0.0
        },
        {
            "start_logit": -5.0390625,
            "end_logit": -7.609375,
            "text": "Pharmacological approaches like acetaminophen, NSAIDS, spasmolytics etc. can be used if non-pharmacological therapy is",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_3": [
        {
            "start_logit": 3.626953125,
            "end_logit": 4.4765625,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -6.7109375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.140625,
            "text": "Paracetamol (acetaminophen",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.85546875,
            "text": "Paracetamol (acetaminophen) has been proposed",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.890625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.9140625,
            "text": "Paracetamol (acetaminophen)",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -7.9453125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -8.0078125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses.",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -8.0859375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 3.626953125,
            "end_logit": -8.1875,
            "text": "Paracetamol (acetaminophen) has been proposed as",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -3.376953125,
            "text": "NSAIDs",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.51953125,
            "end_logit": -3.376953125,
            "text": "NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -3.376953125,
            "text": "liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -7.5390625,
            "text": "NSAIDs should",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -7.62890625,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -7.71875,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -7.75390625,
            "text": "NSAIDs should not",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -3.376953125,
            "text": "alternative to NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -8.0625,
            "end_logit": -3.376953125,
            "text": "issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -7.9921875,
            "text": "NSAIDs should not be used",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_4": [
        {
            "start_logit": 6.078125,
            "end_logit": 5.5625,
            "text": "paracetamol",
            "probability": 0.9208984375
        },
        {
            "start_logit": 6.078125,
            "end_logit": 3.009765625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.071533203125
        },
        {
            "start_logit": 3.76953125,
            "end_logit": 3.009765625,
            "text": "pain",
            "probability": 0.00714111328125
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 5.5625,
            "text": "analgesia, paracetamol",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -6.40625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.12109375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.33203125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -4.7109375,
            "end_logit": 3.009765625,
            "text": "NSAIDs can also be reliably used for pain",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.859375,
            "text": "paracetamol can",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.140625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.171875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.21875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.234375,
            "text": "paracetamol can be listed as",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.265625,
            "text": "paracetamol can be listed as the first option in",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -8.2734375,
            "text": "paracetamol can be listed as the",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 5.5625,
            "text": "provide analgesia, paracetamol",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 5.5625,
            "text": ", paracetamol",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 5.5625,
            "text": "To provide analgesia, paracetamol",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 3.009765625,
            "text": "analgesia, paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.76953125,
            "end_logit": -7.12109375,
            "text": "pain management",
            "probability": 2.980232238769531e-07
        }
    ],
    "6277e4ee56bf9aee6f000008_5": [
        {
            "start_logit": 6.83984375,
            "end_logit": 7.6640625,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -6.19140625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.046875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.18359375,
            "text": "Paracetamol (acetaminophen",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.328125,
            "text": "Paracetamol (acetaminophen) has been proposed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.6640625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.76953125,
            "text": "Paracetamol (acetaminophen)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.8046875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.84375,
            "text": "Paracetamol (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.84765625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.94921875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.94921875,
            "text": "Paracetamol (acetaminophen) has been proposed as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -7.96484375,
            "text": "Paracetamol (acetaminophen) has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.0,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.234375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -8.25,
            "text": "Paracetamol (acetaminophen) has been proposed as an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -6.19140625,
            "text": "liver toxicity",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -7.046875,
            "text": "liver",
            "probability": 0.0
        },
        {
            "start_logit": -4.3359375,
            "end_logit": -7.8046875,
            "text": "liver toxicity at",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.859375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.859375,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.859375,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.859375,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.859375,
            "text": "a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.859375,
            "text": "antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.859375,
            "text": "survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.859375,
            "text": "disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.859375,
            "text": "for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.859375,
            "text": "as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.1875,
            "text": "monoclonal antibody against disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.2265625,
            "text": "monoclonal antibody against disialoganglioside,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.2421875,
            "text": "monoclonal antibody against disialogangli",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.2578125,
            "text": "monoclonal antibody against disialog",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.265625,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.265625,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.3046875,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.3125,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -8.3125,
            "text": "monoclonal antibody against disial",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": -8.1875,
            "text": "a monoclonal antibody against disialoganglioside",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_2": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.9765625,
            "text": "Neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.9765625,
            "text": "Risk Neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.9765625,
            "text": "High-Risk Neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 8.9765625,
            "text": "in High-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 8.9765625,
            "text": "Review in High-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": 8.9765625,
            "text": "A Review in High-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.9765625,
            "text": "-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.9765625,
            "text": "Dinutuximab: A Review in High-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.9765625,
            "text": "utuximab: A Review in High-Risk Neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": -8.359375,
            "text": "Dinutuximab:",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": -8.359375,
            "text": "utuximab:",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_3": [
        {
            "start_logit": 8.0234375,
            "end_logit": 9.1015625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.1015625,
            "text": "surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.1015625,
            "text": "of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.1015625,
            "text": "highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.7265625,
            "text": "neuroblastoma cells. This intravenous drug is approved",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.91015625,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.0546875,
            "text": "neuroblastoma cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.078125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.140625,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.7265625,
            "text": "approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -7.7265625,
            "text": "is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -7.7265625,
            "text": "intravenous drug is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.734375,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -7.7265625,
            "text": "drug is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.91015625,
            "text": "approved in the EU",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -7.7265625,
            "text": "surface of neuroblastoma cells. This intravenous drug is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -7.91015625,
            "text": "is approved in the EU",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -7.7265625,
            "text": "of neuroblastoma cells. This intravenous drug is approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -7.734375,
            "text": "; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": -7.7265625,
            "text": "highly expressed on the surface of neuroblastoma cells. This intravenous drug is approved",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_4": [
        {
            "start_logit": 7.79296875,
            "end_logit": 9.171875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 9.171875,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.171875,
            "text": "advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.171875,
            "text": "important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.171875,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.171875,
            "text": "GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.171875,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.171875,
            "text": "an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.171875,
            "text": "the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -7.99609375,
            "text": "neuroblastoma, with its benefits outweigh",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.0625,
            "text": "neuroblastoma, with its benefits outweighing its risks in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.109375,
            "text": "neuroblastoma, with its benefits outweighing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.79296875,
            "end_logit": -8.21875,
            "text": "neuroblastoma, with its benefits outweighing its",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.99609375,
            "text": "risk neuroblastoma, with its benefits outweigh",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -8.0625,
            "text": "risk neuroblastoma, with its benefits outweighing its risks in",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -8.109375,
            "text": "risk neuroblastoma, with its benefits outweighing",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -8.21875,
            "text": "risk neuroblastoma, with its benefits outweighing its",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": -7.99609375,
            "text": "advance in the postconsolidation treatment of patients with high-risk neuroblastoma, with its benefits outweigh",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -7.99609375,
            "text": "important advance in the postconsolidation treatment of patients with high-risk neuroblastoma, with its benefits outweigh",
            "probability": 0.0
        },
        {
            "start_logit": -8.2734375,
            "end_logit": -7.99609375,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma, with its benefits outweigh",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_5": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.90625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.90625,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.90625,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.90625,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.90625,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.90625,
            "text": "with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.90625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.90625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.90625,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.90625,
            "text": "-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.25,
            "text": "neuroblastoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -8.25,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -8.25,
            "text": "high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.25,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.25,
            "text": "pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.25,
            "text": "treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.2578125,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.25,
            "text": "with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -8.25,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -8.2578125,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_6": [
        {
            "start_logit": 7.57421875,
            "end_logit": 8.9453125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.9453125,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 8.9453125,
            "text": "maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.9453125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.0078125,
            "text": "neuroblastoma who",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.140625,
            "text": "neuroblastoma who achieve at least a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.1640625,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.21875,
            "text": "neuroblastoma who achieve",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -8.2265625,
            "text": "neuroblastoma who achieve at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.078125,
            "end_logit": -7.51171875,
            "text": "hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.51171875,
            "text": "capillary leak syndrome, and hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -7.8671875,
            "text": "hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -7.98828125,
            "text": "hypotension.<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.7734375,
            "text": "capillary leak syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -8.03125,
            "text": "hypotension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -8.078125,
            "text": "hypotension.<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -8.078125,
            "text": "hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.8671875,
            "text": "capillary leak syndrome, and hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -8.1953125,
            "text": "hypotension.<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.98828125,
            "text": "capillary leak syndrome, and hypotension.<br>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_7": [
        {
            "start_logit": 7.17578125,
            "end_logit": 8.109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.109375,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.109375,
            "text": "maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.109375,
            "text": "with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.109375,
            "text": "high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.109375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.109375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -8.046875,
            "text": "neuroblastoma who",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.453125,
            "text": "anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.609375,
            "text": "anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.453125,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.7421875,
            "text": "anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.609375,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.453125,
            "text": ", anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.91015625,
            "text": "anti-GD2 monoclonal antibody approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.94921875,
            "text": "anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -7.453125,
            "text": "human-murine, anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.7421875,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.0234375,
            "text": "anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.609375,
            "text": ", anti-GD2 monoclonal antibody",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_8": [
        {
            "start_logit": 7.69140625,
            "end_logit": 8.9921875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.9921875,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.9921875,
            "text": "high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.9921875,
            "text": "combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.9921875,
            "text": "efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 8.9921875,
            "text": "part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.9921875,
            "text": "immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.9921875,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.9921875,
            "text": "is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.9921875,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -8.15625,
            "text": "neuroblastoma.<br>",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -8.359375,
            "text": "neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -7.53125,
            "text": "5 mg",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -7.9375,
            "text": "5 mg/m",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.0625,
            "text": "5 mg/",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.1015625,
            "text": "5 mg/m<br>",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.2109375,
            "text": "5",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.28125,
            "text": "5 mg/m<br><b>CONCLUSION</b>",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.3046875,
            "text": "5 mg/m<br><b>CONCLUSION<",
            "probability": 0.0
        },
        {
            "start_logit": -4.17578125,
            "end_logit": -8.34375,
            "text": "5 mg/m<br><b>CONCLUSION</b",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_9": [
        {
            "start_logit": 7.7578125,
            "end_logit": 9.2109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.2109375,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.2109375,
            "text": "important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.2109375,
            "text": "high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.2109375,
            "text": "advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.2109375,
            "text": "treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.2109375,
            "text": "an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.2109375,
            "text": "uximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.2109375,
            "text": "the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.2109375,
            "text": "pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.2109375,
            "text": "therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -7.69921875,
            "text": "neuroblastoma and is now",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.03125,
            "text": "neuroblastoma and is now considered",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.078125,
            "text": "neuroblastoma and is now considered part of standard of care in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.140625,
            "text": "neuroblastoma and is now considered part",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.1875,
            "text": "neuroblastoma and",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.2578125,
            "text": "neuroblastoma and is now considered part of standard of care",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.2734375,
            "text": "neuroblastoma and is now considered part of standard",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.328125,
            "text": "neuroblastoma and is now considered part of standard of care in this patient population",
            "probability": 0.0
        },
        {
            "start_logit": 7.7578125,
            "end_logit": -8.359375,
            "text": "neuroblastoma and is now considered part of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_10": [
        {
            "start_logit": 7.80859375,
            "end_logit": 9.15625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.15625,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 9.15625,
            "text": "therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.203125,
            "end_logit": 9.15625,
            "text": "administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.15625,
            "text": "safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.15625,
            "text": "pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.15625,
            "text": "pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.15625,
            "text": "dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.15625,
            "text": "the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.8359375,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.0546875,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.1484375,
            "text": "neuroblastoma are reviewed.<br>",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.203125,
            "text": "neuroblastoma are",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.21875,
            "text": "neuroblastoma are reviewed.<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.234375,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United",
            "probability": 0.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -8.2890625,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.8359375,
            "text": "reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -8.0546875,
            "text": "reviewed.<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics)",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -8.1484375,
            "text": "reviewed.<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -8.21875,
            "text": "reviewed.<br><b>",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_11": [
        {
            "start_logit": 7.484375,
            "end_logit": 9.015625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 9.015625,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.015625,
            "text": "high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.015625,
            "text": "combination with granulocyte macrophage colony-stimulating factor, interleukin-2 and 13-cis retinoic acid) in the treatment of paediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.015625,
            "text": "with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.015625,
            "text": "with granulocyte macrophage colony-stimulating factor, interleukin-2 and 13-cis retinoic acid) in the treatment of paediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.484375,
            "end_logit": -8.1171875,
            "text": "neuroblastoma who achieve at least partial response to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.484375,
            "end_logit": -8.2109375,
            "text": "neuroblastoma who achieve at least partial response",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.484375,
            "end_logit": -8.21875,
            "text": "neuroblastoma who",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.484375,
            "end_logit": -8.25,
            "text": "neuroblastoma who achieve at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.0390625,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to this first approval",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.1015625,
            "text": "This article summarizes the milestones",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.109375,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.109375,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.0390625,
            "text": "article summarizes the milestones in the development of dinutuximab leading to this first approval",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.171875,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to this first",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.1015625,
            "text": "article summarizes the milestones",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.109375,
            "text": "article summarizes the milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -8.109375,
            "text": "article summarizes the milestones in the development of dinutuximab leading to",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.1875,
            "text": "This article summarizes the milestones in the development",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_12": [
        {
            "start_logit": 8.03125,
            "end_logit": 9.046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.046875,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.046875,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.046875,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.046875,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.046875,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.046875,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.046875,
            "text": "utuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.046875,
            "text": "-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.046875,
            "text": "of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.046875,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.140625,
            "text": "neuroblastoma in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": -8.140625,
            "text": "risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.90234375,
            "text": "The US FDA has recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.90234375,
            "text": "The US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -8.140625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.90234375,
            "text": "US FDA has recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.90234375,
            "text": "US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -8.1953125,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_13": [
        {
            "start_logit": 8.1171875,
            "end_logit": 8.6875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.6875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 8.6875,
            "text": "of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.6875,
            "text": "treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.6875,
            "text": "monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.6875,
            "text": "(Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.6875,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -8.046875,
            "text": "neuroblastoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 8.6875,
            "text": "the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.6875,
            "text": "a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 8.6875,
            "text": "developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.078125,
            "text": "United Therapeutics Corporation",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.45703125,
            "text": "United Therapeutics Corporation and the National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -6.45703125,
            "text": "National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.33984375,
            "text": "United Therapeutics Corpora",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -6.45703125,
            "text": "the National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.6328125,
            "text": "United Therapeutics Corporation and the National Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.71875,
            "text": "United Therapeutics Corporation and",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.76171875,
            "text": "United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -6.45703125,
            "text": "Cancer Institute",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_14": [
        {
            "start_logit": 7.66796875,
            "end_logit": 9.3515625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 9.3515625,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.3515625,
            "text": "high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.3515625,
            "text": "Immunotherapy of high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.625,
            "end_logit": 9.3515625,
            "text": "PURPOSE: Immunotherapy of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -7.640625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.0078125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.0078125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.015625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.0390625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC)",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.0703125,
            "text": "neuroblastoma using",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.09375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.09375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.1171875,
            "text": "neuroblastoma using the anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.1484375,
            "text": "neuroblastoma using the anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.171875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.1796875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.2578125,
            "text": "neuroblastoma using the anti-GD2 antibody",
            "probability": 0.0
        },
        {
            "start_logit": 7.66796875,
            "end_logit": -8.265625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -7.640625,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_15": [
        {
            "start_logit": 7.17578125,
            "end_logit": 8.109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 8.109375,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.109375,
            "text": "maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.109375,
            "text": "with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.109375,
            "text": "high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.109375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.109375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.17578125,
            "end_logit": -8.046875,
            "text": "neuroblastoma who",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.453125,
            "text": "anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.609375,
            "text": "anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.453125,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.7421875,
            "text": "anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.609375,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.453125,
            "text": ", anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.91015625,
            "text": "anti-GD2 monoclonal antibody approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -7.94921875,
            "text": "anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -7.453125,
            "text": "human-murine, anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -8.03125,
            "end_logit": -7.7421875,
            "text": "Dinutuximab is a chimeric, human-murine, anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -8.0234375,
            "text": "anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -7.609375,
            "text": ", anti-GD2 monoclonal antibody",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_16": [
        {
            "start_logit": 7.734375,
            "end_logit": 9.203125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 9.203125,
            "text": "risk neuroblastoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.171875,
            "end_logit": 9.203125,
            "text": "maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 9.203125,
            "text": "high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.203125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.203125,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.203125,
            "text": "with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.46875,
            "end_logit": 9.203125,
            "text": "combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.0546875,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.1015625,
            "text": "neuroblastoma who achieve at least a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.125,
            "text": "neuroblastoma who",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.15625,
            "text": "neuroblastoma who achieve at least a partial response",
            "probability": 0.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.21875,
            "text": "neuroblastoma who achieve",
            "probability": 0.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.2890625,
            "text": "neuroblastoma who achieve at",
            "probability": 0.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.2890625,
            "text": "neuroblastoma who achieve at least",
            "probability": 0.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -8.3359375,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -8.0546875,
            "text": "risk neuroblastoma who achieve at least a partial response to",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -8.1015625,
            "text": "risk neuroblastoma who achieve at least a",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -8.125,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.83203125,
            "text": "anti-GD2",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_17": [
        {
            "start_logit": 8.1171875,
            "end_logit": 8.6875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.6875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1875,
            "end_logit": 8.6875,
            "text": "of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.6875,
            "text": "treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.6875,
            "text": "monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.6875,
            "text": "(Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.6875,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -8.046875,
            "text": "neuroblastoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 8.6875,
            "text": "the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.625,
            "end_logit": 8.6875,
            "text": "a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 8.6875,
            "text": "developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.078125,
            "text": "United Therapeutics Corporation",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.45703125,
            "text": "United Therapeutics Corporation and the National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -6.45703125,
            "text": "National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.33984375,
            "text": "United Therapeutics Corpora",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -6.45703125,
            "text": "the National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.6328125,
            "text": "United Therapeutics Corporation and the National Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.71875,
            "text": "United Therapeutics Corporation and",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.76171875,
            "text": "United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": -6.45703125,
            "text": "Cancer Institute",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_18": [
        {
            "start_logit": 8.1171875,
            "end_logit": 8.4375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.4375,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.4375,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.4375,
            "text": "combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.4375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.4375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.4375,
            "text": "with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.4375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.4375,
            "text": "with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.375,
            "end_logit": -7.9609375,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -8.0078125,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics)",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.078125,
            "text": "recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -7.9609375,
            "text": "Unituxin, United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -8.140625,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -8.078125,
            "text": "novel monoclonal antibody recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.140625,
            "text": "recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.15625,
            "text": "recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": -7.9609375,
            "text": "Dinutuximab (Unituxin, United Therapeutics",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -8.1875,
            "text": "SUMMARY Dinutuximab (Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.1875,
            "text": "recently approved for use in combination with granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_19": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 8.875,
            "text": "risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.875,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.875,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.875,
            "text": "combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.875,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 8.875,
            "text": "is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.875,
            "text": "antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.875,
            "text": "monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.875,
            "text": "immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.875,
            "text": "part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.875,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.875,
            "text": "efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.875,
            "text": "utuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.390625,
            "text": "neuroblastoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -8.390625,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.2578125,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.2578125,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.2578125,
            "text": "combination immunotherapy in",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_20": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.7109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.7109375,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.7109375,
            "text": "monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.7109375,
            "text": "been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.7109375,
            "text": "disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 8.7109375,
            "text": "antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.7109375,
            "text": ", a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.7109375,
            "text": "in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.7109375,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.7109375,
            "text": "improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.7109375,
            "text": "shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.7109375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.7109375,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -7.91015625,
            "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.0,
            "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -7.91015625,
            "text": "monoclonal antibody targeting the disialoganglioside GD2,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.0625,
            "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -7.91015625,
            "text": "disialoganglioside GD2,",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.140625,
            "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -8.0,
            "text": "monoclonal antibody targeting the disialoganglioside GD2",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_21": [
        {
            "start_logit": 7.9921875,
            "end_logit": 8.9296875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.9296875,
            "text": "of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.9296875,
            "text": "highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 8.9296875,
            "text": "surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.9296875,
            "text": "chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.9296875,
            "text": "antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 8.9296875,
            "text": "expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.65625,
            "end_logit": 8.9296875,
            "text": "binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.65625,
            "end_logit": 8.9296875,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.9921875,
            "end_logit": -7.98828125,
            "text": "neuroblastoma cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": -7.4453125,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -7.4453125,
            "text": "; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -7.65234375,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -7.65234375,
            "text": "; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside,",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": -7.4453125,
            "text": "chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -7.7578125,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": -7.4453125,
            "text": "antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -7.7578125,
            "text": "; Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -7.4453125,
            "text": "binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": -7.4453125,
            "text": "ialoganglioside",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_22": [
        {
            "start_logit": 8.03125,
            "end_logit": 9.046875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.046875,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 9.046875,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.046875,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.046875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.046875,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 9.046875,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.046875,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.046875,
            "text": "utuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.046875,
            "text": "-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.046875,
            "text": "of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.046875,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.03125,
            "end_logit": -8.140625,
            "text": "neuroblastoma in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": -8.140625,
            "text": "risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.90234375,
            "text": "The US FDA has recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.90234375,
            "text": "The US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -8.140625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.90234375,
            "text": "US FDA has recently approved",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -7.90234375,
            "text": "US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -8.1953125,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_23": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.90625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.90625,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 8.90625,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.90625,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.90625,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 8.90625,
            "text": "with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.46875,
            "end_logit": 8.90625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.90625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.90625,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.59375,
            "end_logit": 8.90625,
            "text": "-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -8.25,
            "text": "neuroblastoma.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -8.25,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": -8.25,
            "text": "high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": -8.25,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": -8.25,
            "text": "pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.25,
            "text": "treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.2578125,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": -8.25,
            "text": "with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -8.25,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": -8.2578125,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_24": [
        {
            "start_logit": 8.1484375,
            "end_logit": 8.9453125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.9453125,
            "text": "risk neuroblastoma",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 8.9453125,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.9453125,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.9453125,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.9453125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.9453125,
            "text": "with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.9453125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.9453125,
            "text": "dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.9453125,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.9453125,
            "text": "-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 8.9453125,
            "text": "unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.9453125,
            "text": "treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -8.1015625,
            "text": "neuroblastoma:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -8.1953125,
            "text": "neuroblastoma: A case series",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -8.34375,
            "text": "neuroblastoma: A case series.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -8.3828125,
            "text": "neuroblastoma: A case",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.1015625,
            "text": "risk neuroblastoma:",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.1953125,
            "text": "risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -8.34375,
            "text": "risk neuroblastoma: A case series.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_25": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.8359375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 8.8359375,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 8.8359375,
            "text": "randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 8.8359375,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.8359375,
            "text": "the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.8359375,
            "text": "the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.8359375,
            "text": "study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.8359375,
            "text": "approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 8.8359375,
            "text": "BL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.359375,
            "end_logit": 8.8359375,
            "text": "led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.8359375,
            "text": "phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 8.8359375,
            "text": "treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4375,
            "end_logit": 8.8359375,
            "text": "high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 8.8359375,
            "text": "to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.8671875,
            "text": "Findings of the randomized phase III",
            "probability": 0.0
        },
        {
            "start_logit": -8.1171875,
            "end_logit": -7.8671875,
            "text": "randomized phase III",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -8.09375,
            "text": "Findings of the randomized phase III study (ANBL0032) led to",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -8.1328125,
            "text": "Findings of the randomized phase III study (ANBL0032) led",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -7.8671875,
            "text": "the randomized phase III",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -8.25,
            "text": "Findings of",
            "probability": 0.0
        }
    ],
    "5c8cd26a0101eac870000003_1": [
        {
            "start_logit": 4.05859375,
            "end_logit": 3.779296875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.9931640625
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -2.51953125,
            "text": "secreted protein content (exoproteome) revealed",
            "probability": 0.0018301010131835938
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -2.51953125,
            "text": "Comparative analyses of the secreted protein content (exoproteome) revealed",
            "probability": 0.0012578964233398438
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -2.896484375,
            "text": "secreted protein content",
            "probability": 0.0012578964233398438
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -2.896484375,
            "text": "Comparative analyses of the secreted protein content",
            "probability": 0.0008645057678222656
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -3.712890625,
            "text": "secreted protein content (",
            "probability": 0.0005536079406738281
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -3.712890625,
            "text": "Comparative analyses of the secreted protein content (",
            "probability": 0.00038051605224609375
        },
        {
            "start_logit": -4.703125,
            "end_logit": 3.779296875,
            "text": "many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.00015616416931152344
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -5.3046875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis",
            "probability": 0.00011336803436279297
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 3.779296875,
            "text": "exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.00010985136032104492
        },
        {
            "start_logit": -5.19140625,
            "end_logit": 3.779296875,
            "text": ".",
            "probability": 9.542703628540039e-05
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -5.578125,
            "text": "secreted protein",
            "probability": 8.553266525268555e-05
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -5.3046875,
            "text": "Comparative analyses of the secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis",
            "probability": 7.790327072143555e-05
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -5.91796875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were",
            "probability": 6.115436553955078e-05
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -5.578125,
            "text": "Comparative analyses of the secreted protein",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 3.68359375,
            "end_logit": -5.91796875,
            "text": "Comparative analyses of the secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -6.99609375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -7.04296875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -6.953125,
            "end_logit": 3.779296875,
            "text": "enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": 4.05859375,
            "end_logit": -7.3203125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22",
            "probability": 1.5079975128173828e-05
        }
    ],
    "5cb0e4a6ecadf2e73f00005b_1": [
        {
            "start_logit": 5.1484375,
            "end_logit": 7.171875,
            "text": "surfaceome predictor",
            "probability": 0.853515625
        },
        {
            "start_logit": 2.98046875,
            "end_logit": 7.171875,
            "text": "surfaceome, we developed the surfaceome predictor",
            "probability": 0.0980224609375
        },
        {
            "start_logit": 2.98046875,
            "end_logit": 6.47265625,
            "text": "surfaceome",
            "probability": 0.04852294921875
        },
        {
            "start_logit": 5.1484375,
            "end_logit": -1.20703125,
            "text": "surfaceome predictor SURFY, based on machine learning.",
            "probability": 0.00019669532775878906
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 7.171875,
            "text": "predictor",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": 2.98046875,
            "end_logit": -1.20703125,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning.",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 7.171875,
            "text": "ome, we developed the surfaceome predictor",
            "probability": 2.104043960571289e-05
        },
        {
            "start_logit": -5.70703125,
            "end_logit": 7.171875,
            "text": "the surfaceome predictor",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 6.47265625,
            "text": "ome",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": -6.375,
            "end_logit": 7.171875,
            "text": "we developed the surfaceome predictor",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 7.171875,
            "text": "enable analysis of the human surfaceome, we developed the surfaceome predictor",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.171875,
            "text": "human surfaceome, we developed the surfaceome predictor",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.171875,
            "text": "analysis of the human surfaceome, we developed the surfaceome predictor",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.171875,
            "text": "o enable analysis of the human surfaceome, we developed the surfaceome predictor",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.47265625,
            "text": "enable analysis of the human surfaceome",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.828125,
            "end_logit": 7.171875,
            "text": "ome predictor",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 7.171875,
            "text": "developed the surfaceome predictor",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 7.171875,
            "text": ", we developed the surfaceome predictor",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 7.171875,
            "text": "the human surfaceome, we developed the surfaceome predictor",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 5.1484375,
            "end_logit": -5.96875,
            "text": "surfaceome",
            "probability": 1.6689300537109375e-06
        }
    ],
    "550618f58e1671127b000007_1": [
        {
            "start_logit": 1.935546875,
            "end_logit": -1.75,
            "text": "protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.453125
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -1.943359375,
            "text": "protein phosphatase inhibitor-1 (PPI-1",
            "probability": 0.37353515625
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -3.23046875,
            "text": "protein phosphatase inhibitor-1 (PPI",
            "probability": 0.10308837890625
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -4.96484375,
            "text": "protein phosphatase inhibitor",
            "probability": 0.0182037353515625
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -5.49609375,
            "text": "protein phosphatase inhibitor-1 (PPI-",
            "probability": 0.0106964111328125
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -1.75,
            "text": ", protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.00923919677734375
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -5.69140625,
            "text": "protein phosphatase inhibitor-1",
            "probability": 0.0088043212890625
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -1.943359375,
            "text": ", protein phosphatase inhibitor-1 (PPI-1",
            "probability": 0.007610321044921875
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -5.98046875,
            "text": "protein phosphatase",
            "probability": 0.006565093994140625
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -6.625,
            "text": "protein phosphatase inhibitor-1 (",
            "probability": 0.0034580230712890625
        },
        {
            "start_logit": 1.935546875,
            "end_logit": -6.8984375,
            "text": "protein phosphatase inhibitor-",
            "probability": 0.00263214111328125
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -3.23046875,
            "text": ", protein phosphatase inhibitor-1 (PPI",
            "probability": 0.00209808349609375
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -4.96484375,
            "text": ", protein phosphatase inhibitor",
            "probability": 0.00037026405334472656
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -5.49609375,
            "text": ", protein phosphatase inhibitor-1 (PPI-",
            "probability": 0.00021767616271972656
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -5.69140625,
            "text": ", protein phosphatase inhibitor-1",
            "probability": 0.00017905235290527344
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -5.98046875,
            "text": ", protein phosphatase",
            "probability": 0.0001341104507446289
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -6.625,
            "text": ", protein phosphatase inhibitor-1 (",
            "probability": 7.009506225585938e-05
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -6.8984375,
            "text": ", protein phosphatase inhibitor-",
            "probability": 5.334615707397461e-05
        },
        {
            "start_logit": -7.46875,
            "end_logit": -1.75,
            "text": "(PPI-1)",
            "probability": 3.725290298461914e-05
        },
        {
            "start_logit": -7.46875,
            "end_logit": -1.943359375,
            "text": "(PPI-1",
            "probability": 3.063678741455078e-05
        }
    ],
    "550618f58e1671127b000007_2": [
        {
            "start_logit": 6.59765625,
            "end_logit": -3.28125,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.464599609375
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -4.04296875,
            "text": "Inhibitor 1",
            "probability": 0.2169189453125
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -5.06640625,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.07794189453125
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -5.375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0572509765625
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -5.6484375,
            "text": "Inhibitor",
            "probability": 0.043548583984375
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.25390625,
            "text": "Inhibitor 1 (I-",
            "probability": 0.023773193359375
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 0.017730712890625
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.64453125,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.016082763671875
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.69140625,
            "text": "Inhibitor 1 (I",
            "probability": 0.01535797119140625
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.7265625,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0148162841796875
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.78515625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 0.01396942138671875
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.7890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 0.01392364501953125
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.90625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.0123748779296875
        },
        {
            "start_logit": 6.59765625,
            "end_logit": -6.9765625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 0.01154327392578125
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -3.28125,
            "text": "(I-1) is",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -5.06640625,
            "text": "(I-1)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -5.375,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -6.25390625,
            "text": "(I-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -6.546875,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.04296875,
            "end_logit": -6.64453125,
            "text": "(I-1) is a",
            "probability": 5.960464477539063e-08
        }
    ],
    "550618f58e1671127b000007_3": [
        {
            "start_logit": 5.2578125,
            "end_logit": 7.36328125,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.0
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 7.36328125,
            "text": ".",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -2.560546875,
            "text": "Ser67-phosphorylated inhibitor 1 is",
            "probability": 4.869699478149414e-05
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 7.36328125,
            "text": "protein phosphatase 1 inhibitor.",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.36328125,
            "text": "inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -5.328125,
            "text": "Ser67-phosphorylated inhibitor 1",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.36328125,
            "text": "potent protein phosphatase 1 inhibitor.",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.36328125,
            "text": "67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.9375,
            "end_logit": 7.36328125,
            "text": "-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -5.890625,
            "text": "Ser67-phosphorylated inhibitor 1 is a",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -8.1171875,
            "end_logit": 7.36328125,
            "text": "inhibitor.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 7.36328125,
            "text": "1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -8.171875,
            "end_logit": 7.36328125,
            "text": "phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -6.27734375,
            "text": "Ser",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 7.36328125,
            "text": "a potent protein phosphatase 1 inhibitor.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -6.66796875,
            "text": "Ser67-phosphorylated",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -6.6796875,
            "text": "Ser67",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -6.70703125,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -7.01953125,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.2578125,
            "end_logit": -7.27734375,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor",
            "probability": 4.172325134277344e-07
        }
    ],
    "550618f58e1671127b000007_4": [
        {
            "start_logit": 8.609375,
            "end_logit": -0.29296875,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.5244140625
        },
        {
            "start_logit": 8.609375,
            "end_logit": -0.472412109375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.441650390625
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.98046875,
            "text": "Inhibitor",
            "probability": 0.01317596435546875
        },
        {
            "start_logit": 8.609375,
            "end_logit": -4.9375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 0.005062103271484375
        },
        {
            "start_logit": 8.609375,
            "end_logit": -5.2734375,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.0036163330078125
        },
        {
            "start_logit": 8.609375,
            "end_logit": -5.6015625,
            "text": "Inhibitor 1",
            "probability": 0.0026035308837890625
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.04296875,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.001674652099609375
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.1484375,
            "text": "Inhibitor 1 (I",
            "probability": 0.0015077590942382812
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.25390625,
            "text": "Inhibitor 1 (I-",
            "probability": 0.0013570785522460938
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.59375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.0009660720825195312
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.765625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 0.0008134841918945312
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 0.0006337165832519531
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.078125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 0.0005950927734375
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.203125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 0.0005249977111816406
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.31640625,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 0.0004687309265136719
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.3203125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 0.00046706199645996094
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.42578125,
            "text": "Inhibitor 1 (",
            "probability": 0.0004203319549560547
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 1.6025390625,
            "text": "heart.",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 1.6025390625,
            "text": ".",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 1.6025390625,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.",
            "probability": 5.364418029785156e-07
        }
    ],
    "550618f58e1671127b000007_5": [
        {
            "start_logit": 8.609375,
            "end_logit": 6.65234375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 1.0
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.23828125,
            "text": "Inhibitor 1 (I-1)",
            "probability": 5.066394805908203e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.55078125,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -3.966796875,
            "text": "Inhibitor",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 8.609375,
            "end_logit": -5.75390625,
            "text": "Inhibitor 1",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -3.837890625,
            "end_logit": 6.65234375,
            "text": ".",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -5.9921875,
            "text": "Inhibitor 1 (I",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.265625,
            "text": "Inhibitor 1 (I-1",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.3203125,
            "text": "Inhibitor 1 (I-",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.3828125,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -6.90234375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.10546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.11328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.19140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.28515625,
            "text": "Inhibitor 1 (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.30078125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.41015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.4375,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.609375,
            "end_logit": -7.5859375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.65234375,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "550618f58e1671127b000007_6": [
        {
            "start_logit": 8.03125,
            "end_logit": -0.982421875,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.494140625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -1.0654296875,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.455322265625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -4.61328125,
            "text": "Inhibitor",
            "probability": 0.01312255859375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -4.92578125,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.0095977783203125
        },
        {
            "start_logit": 8.03125,
            "end_logit": -5.515625,
            "text": "Inhibitor 1",
            "probability": 0.005321502685546875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -5.84375,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0038318634033203125
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.0546875,
            "text": "Inhibitor 1 (I",
            "probability": 0.0031032562255859375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.1796875,
            "text": "Inhibitor 1 (I-",
            "probability": 0.00273895263671875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.35546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.0022983551025390625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.6015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 0.001796722412109375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.83984375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 0.0014162063598632812
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.9921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 0.0012149810791015625
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.12890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 0.00106048583984375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.12890625,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 0.00106048583984375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.19921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 0.000988006591796875
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.23828125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 0.0009503364562988281
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.35546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 0.0008449554443359375
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.38671875,
            "text": "Inhibitor 1 (",
            "probability": 0.0008192062377929688
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -0.982421875,
            "text": "(I-1) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -1.0654296875,
            "text": "(I-1)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5881f9b65bf093691f000001_1": [
        {
            "start_logit": 9.4296875,
            "end_logit": 10.03125,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": 10.03125,
            "text": "neurons",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -2.984375,
            "text": "Parasympathetic",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.33203125,
            "text": "Parasympathetic neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.34765625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -7.72265625,
            "text": "Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.234375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.359375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.4296875,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.4921875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": 9.4296875,
            "end_logit": -8.5,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -7.33203125,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -7.34765625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -7.72265625,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -8.234375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -8.359375,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -8.4296875,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -8.4921875,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -2.287109375,
            "end_logit": -8.5,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.34765625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_2": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.859375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 9.859375,
            "text": "neurons",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -2.9375,
            "text": "Parasympathetic",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.34375,
            "text": "Parasympathetic neurons originate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.67578125,
            "text": "Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.97265625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.0390625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.859375,
            "text": ". Parasympathetic neurons",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.859375,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.1796875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.34375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.375,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.3828125,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.390625,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.34375,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.67578125,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.97265625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.0390625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.1796875,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.34375,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_3": [
        {
            "start_logit": 9.5,
            "end_logit": 10.2265625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": 10.2265625,
            "text": "neurons",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 9.5,
            "end_logit": -2.81640625,
            "text": "Parasympathetic",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 9.5,
            "end_logit": -7.2265625,
            "text": "Parasympathetic neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -7.59765625,
            "text": "Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.21875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.28125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.3046875,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.3203125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.34375,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": 9.5,
            "end_logit": -8.3515625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -7.2265625,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -7.59765625,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.21875,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.28125,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.3046875,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.3203125,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.34375,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.05078125,
            "end_logit": -8.3515625,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -8.21875,
            "text": "peripheral glial progenitors",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_4": [
        {
            "start_logit": 9.4453125,
            "end_logit": 9.859375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": 9.859375,
            "text": "neurons",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -2.9375,
            "text": "Parasympathetic",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.34375,
            "text": "Parasympathetic neurons originate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.67578125,
            "text": "Parasympathetic neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -7.97265625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.0390625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.859375,
            "text": ". Parasympathetic neurons",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 9.859375,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.1796875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.34375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.375,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.3828125,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": 9.4453125,
            "end_logit": -8.390625,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.34375,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.67578125,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -7.97265625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.0390625,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.1796875,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.56640625,
            "end_logit": -8.34375,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_1": [
        {
            "start_logit": 9.84375,
            "end_logit": 10.0234375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -2.310546875,
            "text": "Clostridium",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -2.619140625,
            "end_logit": 10.0234375,
            "text": "difficile",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 10.0234375,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.4140625,
            "text": "Clostridium difficile,",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.0234375,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -7.859375,
            "text": "Clostridium difficile, a",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.0234375,
            "text": "patients suffering from recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2109375,
            "text": "Clostridium difficile, a common hospital",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2421875,
            "text": "Clostridium difficile, a common hospital-acquired",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.265625,
            "text": "Clostridium difficile, a common hospital-",
            "probability": 0.0
        },
        {
            "start_logit": 9.84375,
            "end_logit": -8.2734375,
            "text": "Clostridium difficile, a common",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0234375,
            "text": "from recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -2.310546875,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.619140625,
            "end_logit": -7.4140625,
            "text": "difficile,",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -2.310546875,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.619140625,
            "end_logit": -7.859375,
            "text": "difficile, a",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -2.310546875,
            "text": "patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.310546875,
            "text": "from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.619140625,
            "end_logit": -8.2109375,
            "text": "difficile, a common hospital",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_2": [
        {
            "start_logit": 9.640625,
            "end_logit": 9.484375,
            "text": "Clostridium difficile Proctitis",
            "probability": 1.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -2.6875,
            "text": "Clostridium",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -3.185546875,
            "end_logit": 9.484375,
            "text": "itis",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 9.640625,
            "end_logit": -3.462890625,
            "text": "Clostridium difficile",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 9.640625,
            "end_logit": -5.86328125,
            "text": "Clostridium difficile Proct",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.484375,
            "text": "difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -7.91015625,
            "text": "Clostridium difficile Proctitis Following",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.484375,
            "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.078125,
            "text": "Clostridium difficile Proctitis Following Total Colectomy.",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.1171875,
            "text": "Clostridium difficile Proctitis Following Total Colectomy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 9.484375,
            "text": "of Clostridium difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.640625,
            "end_logit": -8.359375,
            "text": "Clostridium difficile Proctitis Following Total",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.484375,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.484375,
            "text": "Treatment of Clostridium difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.484375,
            "text": "-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -2.6875,
            "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -2.6875,
            "text": "of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.25,
            "end_logit": -2.6875,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -2.6875,
            "text": "Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -3.185546875,
            "end_logit": -7.91015625,
            "text": "itis Following",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_3": [
        {
            "start_logit": 9.71875,
            "end_logit": 10.109375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": 10.109375,
            "text": "difficile",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.71875,
            "end_logit": -2.578125,
            "text": "Clostridium",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.33984375,
            "text": "Clostridium difficile carriage",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 10.109375,
            "text": "asymptomatic Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.796875,
            "text": "Clostridium difficile carriage rates following fecal microbiota transplantation",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.890625,
            "text": "Clostridium difficile carriage rates",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.9765625,
            "text": "Clostridium difficile carriage rates following fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.109375,
            "text": "We aimed to assess the asymptomatic Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 10.109375,
            "text": "assess the asymptomatic Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.03125,
            "text": "Clostridium difficile carriage rates following",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.109375,
            "text": "aimed to assess the asymptomatic Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.109375,
            "text": "the asymptomatic Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.421875,
            "text": "Clostridium difficile carriage rates following fecal",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.33984375,
            "text": "difficile carriage",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.796875,
            "text": "difficile carriage rates following fecal microbiota transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.890625,
            "text": "difficile carriage rates",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -7.9765625,
            "text": "difficile carriage rates following fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -2.470703125,
            "end_logit": -8.03125,
            "text": "difficile carriage rates following",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": -2.578125,
            "text": "asymptomatic Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_4": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.1171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.162109375,
            "text": "Clostridium",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -2.439453125,
            "end_logit": 10.1171875,
            "text": "difficile",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 10.1171875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 10.1171875,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.6640625,
            "text": "Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.1171875,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 10.1171875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.1171875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 10.1171875,
            "text": "intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1171875,
            "text": "of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1171875,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.1171875,
            "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.1171875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.1171875,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.21875,
            "text": "Clostridium difficile infection, and case reports document",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -2.162109375,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -2.162109375,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -2.162109375,
            "text": "decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.439453125,
            "end_logit": -7.6640625,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_5": [
        {
            "start_logit": 9.578125,
            "end_logit": 8.8671875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.578125,
            "end_logit": -1.7626953125,
            "text": "Clostridium difficile Infection",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.578125,
            "end_logit": -2.859375,
            "text": "Clostridium",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -3.98046875,
            "end_logit": 8.8671875,
            "text": "difficile",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.578125,
            "end_logit": -6.8984375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.15234375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.27734375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.56640625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.64453125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96875,
            "end_logit": 8.8671875,
            "text": "Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.72265625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.78515625,
            "text": "Clostridium difficile Infection in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -7.8046875,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FM",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0234375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.578125,
            "end_logit": -8.0546875,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.8671875,
            "text": "Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 8.8671875,
            "text": "Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.8671875,
            "text": "Treat Patients with Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.171875,
            "end_logit": 8.8671875,
            "text": "Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.8671875,
            "text": "Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_6": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.0,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.248046875,
            "text": "Clostridium",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.6875,
            "end_logit": 10.0,
            "text": "difficile",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -7.61328125,
            "text": "Clostridium difficile Infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.0,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.140625,
            "text": "Clostridium difficile Infection following Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.0,
            "text": "Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.203125,
            "text": "Clostridium difficile Infection following",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.203125,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0,
            "text": "Recovery from Recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3828125,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -7.61328125,
            "text": "difficile Infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -2.248046875,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": -2.248046875,
            "text": "Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": -2.248046875,
            "text": "Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -8.140625,
            "text": "difficile Infection following Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -8.203125,
            "text": "difficile Infection following",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -8.203125,
            "text": "difficile Infection following Fecal Microbiota Transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -2.6875,
            "end_logit": -8.3828125,
            "text": "difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -7.61328125,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_7": [
        {
            "start_logit": 9.8984375,
            "end_logit": 10.1171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -2.162109375,
            "text": "Clostridium",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -2.439453125,
            "end_logit": 10.1171875,
            "text": "difficile",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 10.1171875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 10.1171875,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -7.6640625,
            "text": "Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 10.1171875,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.046875,
            "end_logit": 10.1171875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.1171875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.1875,
            "end_logit": 10.1171875,
            "text": "intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1171875,
            "text": "of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1171875,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 10.1171875,
            "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.1171875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.1171875,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8984375,
            "end_logit": -8.21875,
            "text": "Clostridium difficile infection, and case reports document",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -2.162109375,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -2.162109375,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.88671875,
            "end_logit": -2.162109375,
            "text": "decades to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.439453125,
            "end_logit": -7.6640625,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_8": [
        {
            "start_logit": 9.78125,
            "end_logit": 9.84375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -2.443359375,
            "text": "Clostridium",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.904296875,
            "end_logit": 9.84375,
            "text": "difficile",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.015625,
            "text": "Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.30078125,
            "text": "Clostridium difficile infection, with near 90",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.84375,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.5703125,
            "text": "Clostridium difficile infection, with near 90%",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 9.84375,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0625,
            "text": "Clostridium difficile infection, with",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": 9.84375,
            "text": "treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.84375,
            "text": "incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -7.015625,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -2.443359375,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -7.30078125,
            "text": "difficile infection, with near 90",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -2.443359375,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -7.5703125,
            "text": "difficile infection, with near 90%",
            "probability": 0.0
        },
        {
            "start_logit": -8.4453125,
            "end_logit": -2.443359375,
            "text": "treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -8.0625,
            "text": "difficile infection, with",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": -2.443359375,
            "text": "incomparable efficacy to treat recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.015625,
            "text": "recurrent Clostridium difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_9": [
        {
            "start_logit": 9.8125,
            "end_logit": 9.8359375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -2.3671875,
            "text": "Clostridium",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -2.9609375,
            "end_logit": 9.8359375,
            "text": "difficile",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.24609375,
            "text": "Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.8359375,
            "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infection, has emerged",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": 9.8359375,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.87890625,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.93359375,
            "text": "Clostridium difficile infection, has emerged as",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -7.95703125,
            "text": "Clostridium difficile infection, has",
            "probability": 0.0
        },
        {
            "start_logit": 9.8125,
            "end_logit": -8.1484375,
            "text": "Clostridium difficile infection, has emerged as a",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 9.8359375,
            "text": "highly effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.8359375,
            "text": "effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -2.3671875,
            "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -2.3671875,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -7.24609375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -7.6328125,
            "text": "difficile infection, has emerged",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -2.3671875,
            "text": "highly effective treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -7.87890625,
            "text": "difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization",
            "probability": 0.0
        },
        {
            "start_logit": -2.9609375,
            "end_logit": -7.93359375,
            "text": "difficile infection, has emerged as",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_10": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.2265625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.60546875,
            "text": "Clostridium",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -3.513671875,
            "end_logit": 9.2265625,
            "text": "difficile",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 9.703125,
            "end_logit": -5.453125,
            "text": "Clostridium difficile infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.6796875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.76953125,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 9.2265625,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -7.98828125,
            "text": "Clostridium difficile infection (R-CDI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.0078125,
            "text": "Clostridium difficile infection (R",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.0234375,
            "text": "Clostridium difficile infection (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 9.2265625,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.2265625,
            "text": "OBJECTIVES Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.2265625,
            "text": "treatment of recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.2265625,
            "text": "increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -3.513671875,
            "end_logit": -5.453125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -2.60546875,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -2.60546875,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -2.60546875,
            "text": "OBJECTIVES Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -2.60546875,
            "text": "treatment of recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": -2.60546875,
            "text": "increasingly being used for treatment of recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_11": [
        {
            "start_logit": 9.3515625,
            "end_logit": 7.30859375,
            "text": "Clostridium difficile",
            "probability": 0.9873046875
        },
        {
            "start_logit": 9.3515625,
            "end_logit": 2.95703125,
            "text": "Clostridium difficile infection",
            "probability": 0.01282501220703125
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -3.28515625,
            "text": "Clostridium",
            "probability": 2.47955322265625e-05
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 7.30859375,
            "text": "difficile",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infection (CDI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -8.109375,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3515625,
            "end_logit": -8.1171875,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 7.30859375,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.30859375,
            "text": "with Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.125,
            "end_logit": 7.30859375,
            "text": "restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 7.30859375,
            "text": "gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 7.30859375,
            "text": "treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 7.30859375,
            "text": "may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.30859375,
            "text": "the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 7.30859375,
            "text": "BACKGROUND Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 7.30859375,
            "text": "diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 7.30859375,
            "text": "a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 7.30859375,
            "text": "effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 2.95703125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 2.95703125,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_12": [
        {
            "start_logit": 9.71875,
            "end_logit": 9.8984375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -2.56640625,
            "text": "Clostridium",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -2.77734375,
            "end_logit": 9.8984375,
            "text": "difficile",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 9.71875,
            "end_logit": -5.375,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.71875,
            "end_logit": -6.50390625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -6.81640625,
            "text": "Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.5078125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 9.8984375,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0078125,
            "text": "Clostridium difficile infection (",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0546875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT)",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 9.8984375,
            "text": "subjects treated for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.078125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FM",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.09375,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1796875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1953125,
            "text": "Clostridium difficile infection (rCDI",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.203125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.8984375,
            "text": "for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.8984375,
            "text": "Bacterial communities from subjects treated for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -2.77734375,
            "end_logit": -5.375,
            "text": "difficile infection (rCDI) by fecal microbiota transplantation",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_13": [
        {
            "start_logit": 9.7578125,
            "end_logit": 9.7109375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -2.5,
            "text": "Clostridium",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -3.111328125,
            "end_logit": 9.7109375,
            "text": "difficile",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -6.58984375,
            "text": "Clostridium difficile infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.7109375,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.0234375,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.125,
            "text": "Clostridium difficile infections, with",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": 9.7109375,
            "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.203125,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.3203125,
            "text": "Clostridium difficile infections, with potential applications",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.3359375,
            "text": "Clostridium difficile infections, with potential applications against",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.359375,
            "text": "Clostridium difficile infections,",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.7109375,
            "text": "compelling treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -3.111328125,
            "end_logit": -6.58984375,
            "text": "difficile infections",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -2.5,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.09375,
            "end_logit": -2.5,
            "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.5,
            "text": "compelling treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -3.111328125,
            "end_logit": -8.0234375,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -3.111328125,
            "end_logit": -8.125,
            "text": "difficile infections, with",
            "probability": 0.0
        },
        {
            "start_logit": -3.111328125,
            "end_logit": -8.203125,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_14": [
        {
            "start_logit": 9.7265625,
            "end_logit": 9.6328125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -2.5703125,
            "text": "Clostridium",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -3.234375,
            "end_logit": 9.6328125,
            "text": "difficile",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -5.93359375,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.6328125,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -7.8671875,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 9.6328125,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.03125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.0703125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.09375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.109375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1484375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1796875,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1796875,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long",
            "probability": 0.0
        },
        {
            "start_logit": 9.7265625,
            "end_logit": -8.1953125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.6328125,
            "text": "considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 9.6328125,
            "text": "promise as a therapy for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -3.234375,
            "end_logit": -5.93359375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -2.5703125,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -2.5703125,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_15": [
        {
            "start_logit": 9.6171875,
            "end_logit": 7.7109375,
            "text": "Clostridium difficile infection",
            "probability": 0.94140625
        },
        {
            "start_logit": 9.6171875,
            "end_logit": 4.94921875,
            "text": "Clostridium difficile",
            "probability": 0.059234619140625
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -2.740234375,
            "text": "Clostridium",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": -4.74609375,
            "end_logit": 7.7109375,
            "text": "infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.3515625,
            "text": "Clostridium difficile infection (CDI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.39453125,
            "text": "Clostridium difficile infection (CDI) and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 7.7109375,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.78125,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.78515625,
            "text": "Clostridium difficile infection (CDI) and is considered",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.9453125,
            "text": "Clostridium difficile infection (CDI) and is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -7.953125,
            "text": "Clostridium difficile infection (CDI) and is considered as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.6171875,
            "end_logit": -8.0,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 7.7109375,
            "text": "difficile infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.7109375,
            "text": "recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 7.7109375,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 4.94921875,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 4.94921875,
            "text": "difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 4.94921875,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 4.94921875,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -5.80078125,
            "end_logit": -2.740234375,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_16": [
        {
            "start_logit": 9.8671875,
            "end_logit": 9.8203125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.236328125,
            "text": "Clostridium",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -2.921875,
            "end_logit": 9.8203125,
            "text": "difficile",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -6.890625,
            "text": "Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.8203125,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.09375,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 9.8203125,
            "text": "effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 9.8203125,
            "text": "safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 9.8203125,
            "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.2890625,
            "text": "Clostridium difficile infection with",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3046875,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.8203125,
            "text": "perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.8203125,
            "text": "relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3671875,
            "text": "Clostridium difficile infection with ulcerative pancoli",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.8203125,
            "text": "well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3984375,
            "text": "Clostridium difficile infection with ulcerative pancolitis",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3984375,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3984375,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.40625,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.8203125,
            "text": "simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_17": [
        {
            "start_logit": 9.6484375,
            "end_logit": 9.9609375,
            "text": "Clostridium difficile infection",
            "probability": 1.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": 1.1865234375,
            "text": "Clostridium difficile",
            "probability": 0.00015473365783691406
        },
        {
            "start_logit": -2.630859375,
            "end_logit": 9.9609375,
            "text": "infection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -2.701171875,
            "text": "Clostridium",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.9609375,
            "text": "recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.9609375,
            "text": "difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.9609375,
            "text": "in recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 9.9609375,
            "text": "fecal microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.9609375,
            "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.9609375,
            "text": "microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.2578125,
            "text": "Clostridium difficile infection and",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.3203125,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel",
            "probability": 0.0
        },
        {
            "start_logit": 9.6484375,
            "end_logit": -8.34375,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 1.1865234375,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 1.1865234375,
            "text": "difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 1.1865234375,
            "text": "in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 1.1865234375,
            "text": "fecal microbiota transplantation in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 1.1865234375,
            "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 1.1865234375,
            "text": "microbiota transplantation in recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -2.701171875,
            "text": "recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_1": [
        {
            "start_logit": 8.8359375,
            "end_logit": 8.9921875,
            "text": "histone deacetylase",
            "probability": 1.0
        },
        {
            "start_logit": -2.4375,
            "end_logit": 8.9921875,
            "text": "proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": -3.619140625,
            "end_logit": 8.9921875,
            "text": "deacetylase",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -3.49609375,
            "text": "histone deacetylase (HDAC",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -3.66015625,
            "text": "histone",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -8.078125,
            "end_logit": 8.9921875,
            "text": ", histone deacetylase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.140625,
            "text": "histone deacetylase (HDAC)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.2109375,
            "text": "histone deacetylase (HDAC) inhibitors (Panobi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.21875,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinost",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.2265625,
            "text": "histone deacetylase (HDAC) inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.2421875,
            "text": "histone deacetylase (HDAC) inhibitors (Panobino",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.2734375,
            "text": "histone deacetylase (HDAC) inhibitors (Pan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.28125,
            "text": "histone deacetylase (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8359375,
            "end_logit": -8.3046875,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 8.9921875,
            "text": "), histone deacetylase",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.9921875,
            "text": "antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.0
        },
        {
            "start_logit": -2.4375,
            "end_logit": -1.84375,
            "text": "proteasome",
            "probability": 0.0
        },
        {
            "start_logit": -2.4375,
            "end_logit": -3.66015625,
            "text": "proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone",
            "probability": 0.0
        },
        {
            "start_logit": -3.619140625,
            "end_logit": -3.49609375,
            "text": "deacetylase (HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -4.109375,
            "end_logit": -3.49609375,
            "text": "HDAC",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_2": [
        {
            "start_logit": 8.0625,
            "end_logit": 9.046875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.046875,
            "text": "generation proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.046875,
            "text": "the second-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 9.046875,
            "text": "second-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.046875,
            "text": "Ixazomib (MLN9708-MLN2238), the second-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.046875,
            "text": "), the second-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 9.046875,
            "text": "08-MLN2238), the second-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.09375,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.1015625,
            "text": "proteasome inhibitor, selectivity and potency were similar to that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.1796875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.1953125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.25,
            "text": "proteasome inhibitor, selectivity and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.2578125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.2734375,
            "text": "proteasome inhibitor, selectivity and potency were similar to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.296875,
            "text": "proteasome inhibitor, selectivity and potency were",
            "probability": 0.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.3046875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib,",
            "probability": 0.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.3125,
            "text": "proteasome inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.328125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being",
            "probability": 0.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.3515625,
            "text": "proteasome inhibitor, selectivity and potency",
            "probability": 0.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -8.3671875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_3": [
        {
            "start_logit": 8.0234375,
            "end_logit": 9.0390625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 9.0390625,
            "text": "first oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 9.0390625,
            "text": "oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.0390625,
            "text": "last few weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 9.0390625,
            "text": "In the last few weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 9.0390625,
            "text": "the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.0390625,
            "text": ", the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.0390625,
            "text": "the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.0390625,
            "text": "FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 9.0390625,
            "text": "b, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 9.0390625,
            "text": "ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.0390625,
            "text": ", the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.0390625,
            "text": "weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 9.0390625,
            "text": "the last few weeks, the FDA approved three new therapies for multiple myeloma: ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.734375,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.0390625,
            "text": "proteasome inhibitor;",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.2734375,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.28125,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -8.3671875,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab,",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -7.734375,
            "text": "first oral proteasome inhibitor",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_4": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.84375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 8.84375,
            "text": "oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 8.84375,
            "text": "first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.84375,
            "text": "Ixazomib, the first oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.0625,
            "text": "proteasome inhibitor to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.1796875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and it may",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.203125,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.2265625,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.28125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.28125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.3359375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.3359375,
            "text": "proteasome inhibitor to be evaluated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.3828125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.390625,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -8.4140625,
            "text": "proteasome inhibitor to be",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -8.1796875,
            "text": "may",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -8.40625,
            "text": "may be an attractive option for",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": -8.0625,
            "text": "oral proteasome inhibitor to",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": -8.0625,
            "text": "first oral proteasome inhibitor to",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_5": [
        {
            "start_logit": 8.3125,
            "end_logit": 8.3671875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.3671875,
            "text": "generation proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -7.92578125,
            "text": "proteasome inhibitors",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.1640625,
            "text": "proteasome inhibitors have also been used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2578125,
            "end_logit": 8.3671875,
            "text": "Since the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.234375,
            "text": "proteasome inhibitors have also been used clinically",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.25,
            "text": "proteasome inhibitors have also been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.34375,
            "end_logit": 8.3671875,
            "text": "next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.3203125,
            "text": "proteasome inhibitors have also been used clinically,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.34375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ix",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.3515625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.3671875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.3671875,
            "text": "2003, several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3125,
            "end_logit": -8.375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.3671875,
            "text": "the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.453125,
            "end_logit": 8.3671875,
            "text": "several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5,
            "end_logit": 8.3671875,
            "text": "introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.3671875,
            "text": ", several next-generation proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.92578125,
            "text": "generation proteasome inhibitors",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -8.1640625,
            "text": "generation proteasome inhibitors have also been used",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_6": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.96875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 8.96875,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.203125,
            "end_logit": 8.96875,
            "text": "to characterize the pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.234375,
            "end_logit": 8.96875,
            "text": "study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2734375,
            "end_logit": 8.96875,
            "text": "pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3125,
            "end_logit": 8.96875,
            "text": "oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.390625,
            "end_logit": 8.96875,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.96875,
            "text": "The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.375,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment",
            "probability": 0.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.375,
            "text": "proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.4140625,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or",
            "probability": 0.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.421875,
            "text": "proteasome inhibitor, ixazomib, in",
            "probability": 0.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -8.4296875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment,",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.2109375,
            "text": "present study was to characterize the pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -8.203125,
            "end_logit": -8.2109375,
            "text": "to characterize the pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.375,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.375,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": -8.2109375,
            "text": "study was to characterize the pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.4140625,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.421875,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome inhibitor, ixazomib, in",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_7": [
        {
            "start_logit": 8.5078125,
            "end_logit": 8.6484375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.6484375,
            "text": "oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.1171875,
            "text": "proteasome inhibitor, in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 8.6484375,
            "text": "Pharmacokinetics of ixazomib, an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.2578125,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.265625,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3046875,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.3515625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.6484375,
            "text": "an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.421875,
            "text": "proteasome inhibitor, in solid tumour patients with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.6484375,
            "text": "ixazomib, an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -8.4375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 8.6484375,
            "text": "b, an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.609375,
            "end_logit": 8.6484375,
            "text": "azomib, an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -8.2578125,
            "text": "hepatic impairment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -8.3046875,
            "text": "hepatic impairment",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": -8.1171875,
            "text": "oral proteasome inhibitor, in",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -8.3515625,
            "text": "hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": -8.1171875,
            "text": "Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_8": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.8203125,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.8203125,
            "text": ", proteasome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.8203125,
            "text": "Ixazomib is the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.421875,
            "end_logit": 8.8203125,
            "text": "oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.94140625,
            "text": "proteasome inhibitor to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 8.8203125,
            "text": "first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5625,
            "end_logit": 8.8203125,
            "text": "azomib is the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 8.8203125,
            "text": "is the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 8.8203125,
            "text": "the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 8.8203125,
            "text": "mib is the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 8.8203125,
            "text": "b is the first oral, proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.2109375,
            "text": "proteasome inhibitor to reach",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.21875,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.21875,
            "text": "proteasome inhibitor to reach phase III",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.3203125,
            "text": "proteasome inhibitor to reach phase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.28125,
            "end_logit": -8.3671875,
            "text": "proteasome inhibitor to reach phase III trials",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.94140625,
            "text": ", proteasome inhibitor to",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -8.2109375,
            "text": ", proteasome inhibitor to reach",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -8.21875,
            "text": ", proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -8.21875,
            "text": ", proteasome inhibitor to reach phase III",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_9": [
        {
            "start_logit": 8.3515625,
            "end_logit": 8.8046875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 8.8046875,
            "text": "oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 8.8046875,
            "text": "MLN2238 (ixazomib), an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.8046875,
            "text": "an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.0625,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 8.8046875,
            "text": ", an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 8.8046875,
            "text": "N2238 (ixazomib), an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.203125,
            "text": "proteasome inhibitor, has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 8.8046875,
            "text": "8 (ixazomib), an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 8.8046875,
            "text": "b), an oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.3359375,
            "text": "proteasome inhibitor,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.3359375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.359375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.390625,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -8.3984375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -8.0625,
            "text": "oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -8.203125,
            "text": "oral proteasome inhibitor, has",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -8.0625,
            "text": "MLN2238 (ixazomib), an oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -8.3359375,
            "text": "oral proteasome inhibitor,",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": -8.3359375,
            "text": "oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_10": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.8125,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.8125,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.8125,
            "text": "This population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.8125,
            "text": "investigational oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3671875,
            "end_logit": 8.8125,
            "text": "oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.546875,
            "end_logit": 8.8125,
            "text": "pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.109375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.1171875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.140625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.1796875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.2109375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.2265625,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.2421875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.2734375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.3125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.3125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.3203125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.3359375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing, and the impact of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.359375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -8.3671875,
            "text": "proteasome inhibitor ix",
            "probability": 5.960464477539063e-08
        }
    ],
    "55201a316b348bb82c000019_1": [
        {
            "start_logit": 10.265625,
            "end_logit": 8.421875,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 10.265625,
            "end_logit": 0.0262603759765625,
            "text": "55",
            "probability": 0.00022518634796142578
        },
        {
            "start_logit": -4.328125,
            "end_logit": 8.421875,
            "text": "S",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 10.265625,
            "end_logit": -6.1796875,
            "text": "55 S, consisting of 39 S large and 28 S small subunits.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.78515625,
            "text": "55 S, consisting of 39 S large and 28 S small subunits",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.796875,
            "text": "55 S, consisting of 39 S large and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.90234375,
            "text": "55 S, consisting of 39 S large and 28 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.9296875,
            "text": "55 S, consisting of 39 S large and 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 10.265625,
            "end_logit": -7.99609375,
            "text": "55 S, consisting of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.421875,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.421875,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 8.421875,
            "text": "small sedimentation coefficient of 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.421875,
            "text": "mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 0.0262603759765625,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 0.0262603759765625,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 0.0262603759765625,
            "text": "small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 0.0262603759765625,
            "text": "mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -4.328125,
            "end_logit": -6.1796875,
            "text": "S, consisting of 39 S large and 28 S small subunits.",
            "probability": 0.0
        },
        {
            "start_logit": -4.328125,
            "end_logit": -7.78515625,
            "text": "S, consisting of 39 S large and 28 S small subunits",
            "probability": 0.0
        },
        {
            "start_logit": -4.328125,
            "end_logit": -7.796875,
            "text": "S, consisting of 39 S large and",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_2": [
        {
            "start_logit": 10.0859375,
            "end_logit": 4.4453125,
            "text": "55 S",
            "probability": 0.955078125
        },
        {
            "start_logit": 10.0859375,
            "end_logit": 1.3896484375,
            "text": "55",
            "probability": 0.0450439453125
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -4.89453125,
            "text": "55 S mammalian mitochondrial ribosome",
            "probability": 8.356571197509766e-05
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -6.55859375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\")",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.2890625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.32421875,
            "text": "55 S mammalian mitochondrial ribosome (referred to",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.38671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\"",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.48046875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich,",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.515625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.6328125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.66796875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as much protein as",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.67578125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.765625,
            "text": "55 S mammalian mitochondrial ribosome (referred to here",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 10.0859375,
            "end_logit": -7.78125,
            "text": "55 S mammalian mitochondrial ribosome (",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 4.4453125,
            "text": "S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 4.4453125,
            "text": "The 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 1.3896484375,
            "text": "The 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.78125,
            "end_logit": -1.7509765625,
            "text": "ribosome.",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_3": [
        {
            "start_logit": 10.1171875,
            "end_logit": 9.4296875,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 10.1171875,
            "end_logit": -1.0732421875,
            "text": "55",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -3.3359375,
            "end_logit": 9.4296875,
            "text": "S",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 10.1171875,
            "end_logit": -7.38671875,
            "text": "55 S.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.4296875,
            "text": "about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 9.4296875,
            "text": "intact monosome was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.4296875,
            "text": "The sedimentation coefficient of the intact monosome was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 9.4296875,
            "text": "monosome was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 9.4296875,
            "text": "ome was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 9.4296875,
            "text": "the intact monosome was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.4296875,
            "text": "was about 55 S",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -1.0732421875,
            "text": "about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -1.0732421875,
            "text": "intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -1.0732421875,
            "text": "The sedimentation coefficient of the intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.0732421875,
            "text": "monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -1.0732421875,
            "text": "ome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": -1.0732421875,
            "text": "the intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": -1.0732421875,
            "text": "was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -3.3359375,
            "end_logit": -7.38671875,
            "text": "S.",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.38671875,
            "text": "about 55 S.",
            "probability": 0.0
        }
    ],
    "5e2a1096aa19d7443100000e_1": [
        {
            "start_logit": 7.671875,
            "end_logit": 7.02734375,
            "text": "vascular endothelial growth factor A",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.671875,
            "end_logit": -0.3154296875,
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 0.0006437301635742188
        },
        {
            "start_logit": -2.671875,
            "end_logit": 7.02734375,
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 3.212690353393555e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -3.689453125,
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 7.671875,
            "end_logit": -4.921875,
            "text": "vascular",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 7.02734375,
            "text": "A",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -6.40234375,
            "text": "vascular endothelial growth factor",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.11328125,
            "text": "vascular endothelial growth factor A (VEGF-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.296875,
            "text": "vascular endothelial growth",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.02734375,
            "text": "encoding vascular endothelial growth factor A",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.49609375,
            "text": "vascular endothelial",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.6171875,
            "text": "vascular endothelial growth factor A (VEGF-A),",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.82421875,
            "text": "vascular endothelial growth factor A (VEGF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -7.8671875,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.02734375,
            "text": "mRNA encoding vascular endothelial growth factor A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -8.046875,
            "text": "vascular endothelial growth factor A (VEGF-A), in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.02734375,
            "text": "a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.02734375,
            "text": "endothelial growth factor A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -8.25,
            "text": "vascular endothelial growth factor A (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.671875,
            "end_logit": -8.3125,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo.",
            "probability": 2.384185791015625e-07
        }
    ],
    "5caa0247ecadf2e73f000055_1": [
        {
            "start_logit": 4.1953125,
            "end_logit": 5.5078125,
            "text": "moesin",
            "probability": 0.9990234375
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -1.8671875,
            "text": "moesin (Moe).",
            "probability": 0.0006260871887207031
        },
        {
            "start_logit": -5.765625,
            "end_logit": 5.5078125,
            "text": "esin",
            "probability": 4.7147274017333984e-05
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 5.5078125,
            "text": "of moesin",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -3.564453125,
            "text": "epidermal growth factor receptor (Egfr) pathway,",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.5859375,
            "text": "moesin (Mo",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.921875,
            "end_logit": 5.5078125,
            "text": ", is required for tracheal cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 5.5078125,
            "text": "propose is mediated by Crb recruitment of moesin",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 5.5078125,
            "text": "we propose is mediated by Crb recruitment of moesin",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 5.5078125,
            "text": "is required for tracheal cell apical constriction and for organising an actomyosin complex, which we propose is mediated by Crb recruitment of moesin",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -8.09375,
            "end_logit": 5.5078125,
            "text": "is mediated by Crb recruitment of moesin",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.9296875,
            "text": "moesin (Moe",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -6.93359375,
            "text": "moesin (",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.04296875,
            "text": "mo",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 4.1953125,
            "end_logit": -7.0546875,
            "text": "moesin (Moe)",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -5.08984375,
            "text": "epidermal growth factor receptor (Egfr) pathway",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -6.64453125,
            "text": "epidermal growth factor receptor (Egfr)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -6.84765625,
            "text": "epidermal growth factor receptor (Egfr",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -7.0859375,
            "text": "epidermal growth factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.3291015625,
            "end_logit": -7.13671875,
            "text": "epidermal growth factor receptor",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e4604d83f54159529000003_1": [
        {
            "start_logit": 9.921875,
            "end_logit": 10.421875,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.623046875,
            "end_logit": 10.421875,
            "text": "dissection",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 9.921875,
            "end_logit": -1.7587890625,
            "text": "carotid",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -4.390625,
            "end_logit": 10.421875,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 10.421875,
            "text": "artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 10.421875,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 10.421875,
            "text": "vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 10.421875,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.51171875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.421875,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.15625,
            "end_logit": 10.421875,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.421875,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.421875,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.421875,
            "text": "within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2890625,
            "end_logit": 10.421875,
            "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.421875,
            "text": "and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.421875,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.421875,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -7.9609375,
            "text": "carotid and vertebral artery",
            "probability": 0.0
        },
        {
            "start_logit": 9.921875,
            "end_logit": -8.2890625,
            "text": "carotid and",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_2": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.4375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.5810546875,
            "end_logit": 10.4375,
            "text": "dissection",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.673828125,
            "text": "carotid",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -4.8125,
            "end_logit": 10.4375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 10.4375,
            "text": "artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": "vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.4375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 10.4375,
            "text": "and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.4296875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 10.4375,
            "text": "AIMS  CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.4375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.4375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.4375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.4375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.4375,
            "text": "within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.4375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.90625,
            "text": "carotid and vertebral artery",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.46875,
            "text": "carotid and",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -1.673828125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_3": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.4375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.5810546875,
            "end_logit": 10.4375,
            "text": "dissection",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.673828125,
            "text": "carotid",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -4.8125,
            "end_logit": 10.4375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 10.4375,
            "text": "artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": "vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.4375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 10.4375,
            "text": "and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.4296875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 10.4375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.4375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.4375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.4375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.4375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.4375,
            "text": "within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.4375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.90625,
            "text": "carotid and vertebral artery",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.46875,
            "text": "carotid and",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -1.673828125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_4": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.4375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.5810546875,
            "end_logit": 10.4375,
            "text": "dissection",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.673828125,
            "text": "carotid",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -4.8125,
            "end_logit": 10.4375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 10.4375,
            "text": "artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": "vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 10.4375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 10.4375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 10.4375,
            "text": "and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.4296875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 10.4375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.4375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.4375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.2421875,
            "end_logit": 10.4375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.4375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.296875,
            "end_logit": 10.4375,
            "text": "within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.4375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.90625,
            "text": "carotid and vertebral artery",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.46875,
            "text": "carotid and",
            "probability": 0.0
        },
        {
            "start_logit": -4.8125,
            "end_logit": -1.673828125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_5": [
        {
            "start_logit": 9.78125,
            "end_logit": 10.390625,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.5732421875,
            "end_logit": 10.390625,
            "text": "dissection",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 9.78125,
            "end_logit": -1.9169921875,
            "text": "carotid",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -4.53515625,
            "end_logit": 10.390625,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 10.390625,
            "text": "artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 10.390625,
            "text": "vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 10.390625,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 10.390625,
            "text": "and vertebral artery dissection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 10.390625,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 10.390625,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -7.5625,
            "text": "carotid and vertebral artery dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -8.1796875,
            "end_logit": 10.390625,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.390625,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.390625,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 10.390625,
            "text": "within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.390625,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.390625,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 0.0
        },
        {
            "start_logit": 9.78125,
            "end_logit": -8.0625,
            "text": "carotid and vertebral artery",
            "probability": 0.0
        },
        {
            "start_logit": -4.53515625,
            "end_logit": -1.9169921875,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.203125,
            "end_logit": -1.9169921875,
            "text": ") carotid",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_1": [
        {
            "start_logit": 8.3515625,
            "end_logit": 9.6953125,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity.",
            "probability": 1.0
        },
        {
            "start_logit": -1.76953125,
            "end_logit": 9.6953125,
            "text": ".",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -2.7421875,
            "text": "Spermidine",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -4.41796875,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 9.6953125,
            "text": "protects against \u03b1-synuclein neurotoxicity.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.6953125,
            "text": "neurotoxicity.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.6953125,
            "text": "\u03b1-synuclein neurotoxicity.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -6.37109375,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 9.6953125,
            "text": "synuclein neurotoxicity.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 9.6953125,
            "text": "against \u03b1-synuclein neurotoxicity.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 9.6953125,
            "text": "-synuclein neurotoxicity.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -6.76953125,
            "text": "Spermidine protects against",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.51171875,
            "text": "Spermidine protects",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.734375,
            "text": "Spermidine protects against \u03b1",
            "probability": 0.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.8828125,
            "text": "Spermidine protects against \u03b1-",
            "probability": 0.0
        },
        {
            "start_logit": -6.578125,
            "end_logit": -4.41796875,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -4.41796875,
            "text": "\u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -4.41796875,
            "text": "synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -4.41796875,
            "text": "against \u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -4.41796875,
            "text": "-synuclein",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_2": [
        {
            "start_logit": -3.845703125,
            "end_logit": -2.294921875,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.79296875
        },
        {
            "start_logit": -6.67578125,
            "end_logit": -2.294921875,
            "text": "neurotoxicity",
            "probability": 0.046875
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -2.294921875,
            "text": "\u03b1-synuclein neurotoxicity",
            "probability": 0.02490234375
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -2.294921875,
            "text": "synuclein neurotoxicity",
            "probability": 0.024139404296875
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -5.90234375,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 0.0214691162109375
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -2.294921875,
            "text": "against \u03b1-synuclein neurotoxicity",
            "probability": 0.0183563232421875
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -2.294921875,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.0167236328125
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -2.294921875,
            "text": "-synuclein neurotoxicity",
            "probability": 0.0146484375
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -6.54296875,
            "text": "Spermidine protects against",
            "probability": 0.01131439208984375
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -6.66796875,
            "text": "Spermidine protects",
            "probability": 0.00998687744140625
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -6.87109375,
            "text": "Spermidine",
            "probability": 0.008148193359375
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -7.609375,
            "text": "Spermidine protects against \u03b1",
            "probability": 0.003910064697265625
        },
        {
            "start_logit": -3.845703125,
            "end_logit": -7.875,
            "text": "Spermidine protects against \u03b1-",
            "probability": 0.00299835205078125
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -5.90234375,
            "text": "\u03b1-synuclein",
            "probability": 0.0006742477416992188
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -5.90234375,
            "text": "synuclein",
            "probability": 0.0006537437438964844
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -5.90234375,
            "text": "against \u03b1-synuclein",
            "probability": 0.0004968643188476562
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -5.90234375,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.0004527568817138672
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -5.90234375,
            "text": "-synuclein",
            "probability": 0.0003993511199951172
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -6.54296875,
            "text": "against",
            "probability": 0.0002620220184326172
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -6.54296875,
            "text": "protects against",
            "probability": 0.0002384185791015625
        }
    ],
    "606074ab94d57fd87900003e_1": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.234375,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.9599609375,
            "text": "Rt",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -2.298828125,
            "end_logit": 10.234375,
            "text": "a",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -6.28515625,
            "text": "Rtpc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 10.234375,
            "text": "pca",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.9140625,
            "text": "Rtpca:",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -7.92578125,
            "text": "Rtpca: an R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.140625,
            "text": "Rtpca: an R",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.15625,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.171875,
            "text": "Rtpca: an R package for",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.21875,
            "text": "Rtpca: an R package for differential thermal proximity coaggreg",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.2421875,
            "text": "Rtpca: an R package for differential thermal proximity coag",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.265625,
            "text": "Rtpca: an R package for differential thermal proximity coaggr",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.28125,
            "text": "Rtpca: an R package for differential thermal proximity",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.296875,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis.",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.296875,
            "text": "Rtpca: an",
            "probability": 0.0
        },
        {
            "start_logit": -2.298828125,
            "end_logit": -7.9140625,
            "text": "a:",
            "probability": 0.0
        },
        {
            "start_logit": -2.298828125,
            "end_logit": -7.92578125,
            "text": "a: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.298828125,
            "end_logit": -8.140625,
            "text": "a: an R",
            "probability": 0.0
        },
        {
            "start_logit": -2.298828125,
            "end_logit": -8.15625,
            "text": "a: an R package for differential thermal proximity coaggregation",
            "probability": 0.0
        }
    ],
    "606074ab94d57fd87900003e_2": [
        {
            "start_logit": 9.96875,
            "end_logit": 10.2421875,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -1.9677734375,
            "text": "Rt",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -2.283203125,
            "end_logit": 10.2421875,
            "text": "a",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": 9.96875,
            "end_logit": -6.2421875,
            "text": "Rtpc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 10.2421875,
            "text": "pca",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.69921875,
            "text": "Rtpca is",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -7.76171875,
            "text": "Rtpca is an R package",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.0234375,
            "text": "Rtpca is an R",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.1015625,
            "text": "Rtpca is an R package implementing methods for inferring protein-protein interactions based on thermal proteome profiling experiments of a single condition or",
            "probability": 0.0
        },
        {
            "start_logit": 9.96875,
            "end_logit": -8.140625,
            "text": "Rtpca is an R package implementing methods for inferring protein-protein interactions",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -7.69921875,
            "text": "a is",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -7.76171875,
            "text": "a is an R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -8.0078125,
            "text": "a is an R package implementing methods for inferring protein-protein interactions based on thermal proteome profiling experiments of a single condition or in a differential setting via",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -8.0234375,
            "text": "a is an R",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -8.1015625,
            "text": "a is an R package implementing methods for inferring protein-protein interactions based on thermal proteome profiling experiments of a single condition or",
            "probability": 0.0
        },
        {
            "start_logit": -2.283203125,
            "end_logit": -8.140625,
            "text": "a is an R package implementing methods for inferring protein-protein interactions",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -6.2421875,
            "text": "pc",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.69921875,
            "text": "pca is",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -7.76171875,
            "text": "pca is an R package",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -8.0234375,
            "text": "pca is an R",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_1": [
        {
            "start_logit": 9.109375,
            "end_logit": 10.1484375,
            "text": "polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": 10.1484375,
            "text": "disease",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -3.0078125,
            "text": "polycystic",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 10.1484375,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.66796875,
            "text": "polycystic kidney disease (PKD",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 10.1484375,
            "text": "kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 10.1484375,
            "text": "recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.1484375,
            "text": "of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.171875,
            "end_logit": 10.1484375,
            "text": "development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.296875,
            "text": "polycystic kidney",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.1484375,
            "text": "is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.1484375,
            "text": "in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.1484375,
            "text": ", and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.1484375,
            "text": "kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.54296875,
            "text": "polycystic kidney disease (PKD)",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 10.1484375,
            "text": "this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.1484375,
            "text": "the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.9140625,
            "text": "polycystic kidney disease (PK",
            "probability": 0.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -8.109375,
            "text": "polycystic kidney disease (",
            "probability": 0.0
        },
        {
            "start_logit": -2.33203125,
            "end_logit": -5.66796875,
            "text": "disease (PKD",
            "probability": 0.0
        }
    ],
    "5a885daa61bb38fb24000018_1": [
        {
            "start_logit": 2.98828125,
            "end_logit": 2.37109375,
            "text": "DEAD box proteins are putative RNA helicase",
            "probability": 0.93603515625
        },
        {
            "start_logit": -0.0865478515625,
            "end_logit": 2.37109375,
            "text": "RNA helicase",
            "probability": 0.04327392578125
        },
        {
            "start_logit": -0.0865478515625,
            "end_logit": 1.1435546875,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 0.01264190673828125
        },
        {
            "start_logit": -1.1064453125,
            "end_logit": 1.1435546875,
            "text": "eight",
            "probability": 0.00457763671875
        },
        {
            "start_logit": 2.98828125,
            "end_logit": -3.40625,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.002899169921875
        },
        {
            "start_logit": -0.0865478515625,
            "end_logit": -3.40625,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.00013399124145507812
        },
        {
            "start_logit": 2.98828125,
            "end_logit": -6.90234375,
            "text": "DEAD box proteins are putative RNA helicases",
            "probability": 8.785724639892578e-05
        },
        {
            "start_logit": 2.98828125,
            "end_logit": -6.97265625,
            "text": "DEAD",
            "probability": 8.189678192138672e-05
        },
        {
            "start_logit": 2.98828125,
            "end_logit": -7.2421875,
            "text": "DEAD box",
            "probability": 6.282329559326172e-05
        },
        {
            "start_logit": 2.98828125,
            "end_logit": -7.33203125,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing",
            "probability": 5.716085433959961e-05
        },
        {
            "start_logit": -7.296875,
            "end_logit": 2.37109375,
            "text": "helicase",
            "probability": 3.2067298889160156e-05
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 2.37109375,
            "text": "putative RNA helicase",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 1.1435546875,
            "text": "share eight",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": -1.1064453125,
            "end_logit": -4.73828125,
            "text": "eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp",
            "probability": 1.2755393981933594e-05
        },
        {
            "start_logit": -1.1064453125,
            "end_logit": -4.9765625,
            "text": "eight conserved amino acid motifs",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -7.296875,
            "end_logit": 1.1435546875,
            "text": "helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 1.1435546875,
            "text": "proteins share eight",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 1.1435546875,
            "text": "These proteins share eight",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 1.1435546875,
            "text": "putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -0.0865478515625,
            "end_logit": -6.90234375,
            "text": "RNA helicases",
            "probability": 4.0531158447265625e-06
        }
    ],
    "52b2e409f828ad283c00000e_1": [
        {
            "start_logit": 8.359375,
            "end_logit": 8.8828125,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.8828125,
            "text": "with schizophrenia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 8.8828125,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 8.8828125,
            "text": "adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 8.8828125,
            "text": "antipsychotics for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.484375,
            "end_logit": 8.8828125,
            "text": "describe the frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.515625,
            "end_logit": 8.8828125,
            "text": "for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 8.8828125,
            "text": "use of antipsychotics for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.53125,
            "end_logit": 8.8828125,
            "text": "frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.21875,
            "text": "schizophrenia in Canada from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.234375,
            "text": "schizophrenia in Canada from 2005 to 2009",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.234375,
            "text": "schizophrenia in Canada",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.2421875,
            "text": "schizophrenia in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.2578125,
            "text": "schizophrenia in Canada from 2005",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.359375,
            "end_logit": -8.265625,
            "text": "schizophrenia in Canada from 2005 to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": -8.21875,
            "text": "with schizophrenia in Canada from",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -8.234375,
            "text": "with schizophrenia in Canada from 2005 to 2009",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -8.234375,
            "text": "with schizophrenia in Canada",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -8.2421875,
            "text": "with schizophrenia in",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -8.2578125,
            "text": "with schizophrenia in Canada from 2005",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_2": [
        {
            "start_logit": 8.6015625,
            "end_logit": 8.609375,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -6.8984375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -6.97265625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -7.77734375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -7.84765625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.609375,
            "text": "which schizophrenia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.015625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.2109375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.2109375,
            "text": "schizophrenia was listed as",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.265625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.265625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -8.2734375,
            "text": "schizophrenia was listed as the indication",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -6.8984375,
            "text": "38%",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -6.97265625,
            "text": "38",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -6.8984375,
            "text": "which schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -6.97265625,
            "text": "which schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -6.8984375,
            "text": "by 38%",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": -6.8984375,
            "text": "indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.18359375,
            "text": "38% between 2005 and 2009, from 329 380 to 454 96",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -6.97265625,
            "text": "by 38",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_3": [
        {
            "start_logit": 7.37109375,
            "end_logit": 9.546875,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 9.546875,
            "text": "paranoid schizophrenia",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.546875,
            "text": "oid schizophrenia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": -7.91015625,
            "text": "1980",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.0078125,
            "text": "1980. Its pharmacological profile is close to that",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.171875,
            "text": "1980. Its pharmacological profile",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.1875,
            "text": "1980. Its pharmacological profile is close to",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.1953125,
            "text": "1980. Its pharmacological profile is close to that of clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.2265625,
            "text": "1980. Its pharmacological profile is close to that of clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.3203125,
            "text": "1980. Its pharmacological profile is",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -8.328125,
            "text": "1980. Its pharmacological profile is close to that of clozapine: it has dopamine (D2), histamine (H1)",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -7.91015625,
            "text": "since 1980",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.140625,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2) and adrenergic (alpha 1)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.1484375,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2) and adrenergic (alpha 1",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.15625,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2) and adrenergic (alpha 1)-blocking",
            "probability": 0.0
        },
        {
            "start_logit": -8.1484375,
            "end_logit": -8.0078125,
            "text": "since 1980. Its pharmacological profile is close to that",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.171875,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2) and adrenergic (alpha 1)-blocking activities",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.1953125,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2)",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -8.2265625,
            "text": "clozapine: it has dopamine (D2), histamine (H1), serotonin (5-HT2",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": -7.91015625,
            "text": "France since 1980",
            "probability": 0.0
        }
    ],
    "6252f496e764a53204000020_1": [
        {
            "start_logit": 9.515625,
            "end_logit": 8.34375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter",
            "probability": 0.52734375
        },
        {
            "start_logit": 9.515625,
            "end_logit": 8.2265625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 0.47265625
        },
        {
            "start_logit": 9.515625,
            "end_logit": -1.935546875,
            "text": "ABC",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -2.580078125,
            "end_logit": 8.34375,
            "text": "transporter",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -2.580078125,
            "end_logit": 8.2265625,
            "text": "transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -2.6953125,
            "end_logit": 8.2265625,
            "text": ".",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.34375,
            "text": "ATP binding cassette (ABC) transporter",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 8.2265625,
            "text": "ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 8.34375,
            "text": "an ATP binding cassette (ABC) transporter",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.515625,
            "end_logit": -6.65234375,
            "text": "ABCG1 is an ATP binding cassette",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 8.2265625,
            "text": "an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.515625,
            "end_logit": -6.921875,
            "text": "ABCG1 is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.00390625,
            "text": "ABCG1 is an ATP binding cassette (ABC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.02734375,
            "text": "ABCG1 is an ATP binding cassette (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.29296875,
            "text": "ABCG1 is an ATP binding cassette (ABC)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 8.34375,
            "text": "G1 is an ATP binding cassette (ABC) transporter",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 8.2265625,
            "text": "G1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.65234375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.6796875,
            "text": "ABCG1 is an ATP binding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.515625,
            "end_logit": -7.69140625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_1": [
        {
            "start_logit": 9.53125,
            "end_logit": 10.1953125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.265625,
            "end_logit": 10.1953125,
            "text": "7",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": 9.53125,
            "end_logit": -2.712890625,
            "text": "196",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 10.1953125,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.53125,
            "end_logit": -7.53125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.1953125,
            "text": "transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.1953125,
            "text": "the first human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1953125,
            "text": "human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.1953125,
            "text": "heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.1953125,
            "text": "first human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -7.9765625,
            "text": "1967 was performed",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.03125,
            "text": "1967 was performed using",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.0546875,
            "text": "1967 was performed using a",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.0859375,
            "text": "1967 was",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.15625,
            "text": "1967 was performed using a deceased",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.1640625,
            "text": "1967 was performed using a deceased donor heart",
            "probability": 0.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": -8.2109375,
            "text": "1967 was performed using a deceased donor",
            "probability": 0.0
        },
        {
            "start_logit": -2.265625,
            "end_logit": -7.53125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -2.712890625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -2.265625,
            "end_logit": -7.9765625,
            "text": "7 was performed",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_2": [
        {
            "start_logit": 9.8515625,
            "end_logit": 10.1875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.27734375,
            "end_logit": 10.1875,
            "text": "7",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -2.091796875,
            "text": "196",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -5.171875,
            "end_logit": 10.1875,
            "text": "In 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.7578125,
            "text": "1967, Christian Barnard performed",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.87109375,
            "text": "1967, Christian Barnard",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.91015625,
            "text": "1967, Christian Barnard performed the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -7.921875,
            "text": "1967, Christian",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.0390625,
            "text": "1967, Christ",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.09375,
            "text": "1967, Christian Barnar",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1796875,
            "text": "1967, Christian Bar",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1875,
            "text": "1967, Christian Barnard performed the first successful human-to",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.1953125,
            "text": "1967, Christian Barnard performed the first",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.21875,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.25,
            "text": "1967, Christian Barnard performed the first successful human-",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2734375,
            "text": "1967, Christian Barnard performed the first successful",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2734375,
            "text": "1967, Christian Barnard performed the first successful human",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.2890625,
            "text": "1967, Christian Barnard performed the first successful human-to-",
            "probability": 0.0
        },
        {
            "start_logit": 9.8515625,
            "end_logit": -8.3203125,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant",
            "probability": 0.0
        },
        {
            "start_logit": -5.171875,
            "end_logit": -2.091796875,
            "text": "In 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_3": [
        {
            "start_logit": 10.078125,
            "end_logit": 10.3125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -1.5126953125,
            "text": "196",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -1.9814453125,
            "end_logit": 10.3125,
            "text": "7",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -7.390625,
            "end_logit": 10.3125,
            "text": "Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 10.3125,
            "text": "in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": 10.3125,
            "text": "by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.1640625,
            "end_logit": 10.3125,
            "text": "Since the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.078125,
            "text": "1967, there has been",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.078125,
            "text": "1967,",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.140625,
            "text": "1967, there has been substantial progress in",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.3125,
            "text": "performed by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.2109375,
            "text": "1967, there has been substantial progress",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.2265625,
            "text": "1967, there has been substantial",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.2421875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over",
            "probability": 0.0
        },
        {
            "start_logit": 10.078125,
            "end_logit": -8.25,
            "text": "1967, there has been substantial progress in the",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.3125,
            "text": "human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.3125,
            "text": "successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -1.5126953125,
            "text": "Christiaan Barnard in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -1.5126953125,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.125,
            "end_logit": -1.5126953125,
            "text": "by Christiaan Barnard in 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_4": [
        {
            "start_logit": 5.55078125,
            "end_logit": 9.0625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -3.65625,
            "end_logit": 9.0625,
            "text": "7",
            "probability": 0.00010073184967041016
        },
        {
            "start_logit": -4.8203125,
            "end_logit": 9.0625,
            "text": "December 3rd, 1967",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.0625,
            "text": ", 1967",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.0625,
            "text": "on December 3rd, 1967",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.0625,
            "text": "Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.0625,
            "text": ", Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.55078125,
            "end_logit": -6.078125,
            "text": "196",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -4.5234375,
            "text": "50th anniversary",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -4.703125,
            "text": "50th",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.26171875,
            "text": "50th annivers",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.5078125,
            "text": "50",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.546875,
            "text": "50th anniversary of",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.77734375,
            "text": "50th ann",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.80859375,
            "text": "50th anniversary of the first human heart transplant that had been",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.81640625,
            "text": "50th anniversary of the first human heart transplant that had been carried out by",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.9140625,
            "text": "50th anniversary of the first human heart transplant that had been carried out",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.92578125,
            "text": "50th anniversary of the",
            "probability": 0.0
        },
        {
            "start_logit": 0.88037109375,
            "end_logit": -7.9296875,
            "text": "50th anniversary of the first human heart transplant that had been carried out by the South African surgeon, Christiaan",
            "probability": 0.0
        },
        {
            "start_logit": -3.150390625,
            "end_logit": -4.125,
            "text": "In 2017",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_5": [
        {
            "start_logit": -0.052001953125,
            "end_logit": 9.7734375,
            "text": "December 1967",
            "probability": 0.56982421875
        },
        {
            "start_logit": -0.4189453125,
            "end_logit": 9.7734375,
            "text": "1967",
            "probability": 0.394775390625
        },
        {
            "start_logit": -2.919921875,
            "end_logit": 9.7734375,
            "text": "7",
            "probability": 0.03240966796875
        },
        {
            "start_logit": -6.12890625,
            "end_logit": 9.7734375,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.001312255859375
        },
        {
            "start_logit": -7.828125,
            "end_logit": 9.7734375,
            "text": "years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00023984909057617188
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 9.7734375,
            "text": "Christiaan Barnard in December 1967",
            "probability": 0.00023698806762695312
        },
        {
            "start_logit": -8.0625,
            "end_logit": 9.7734375,
            "text": "been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.7734375,
            "text": "has been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00015723705291748047
        },
        {
            "start_logit": -8.25,
            "end_logit": 9.7734375,
            "text": "in December 1967",
            "probability": 0.00015723705291748047
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.7734375,
            "text": "by Christiaan Barnard in December 1967",
            "probability": 0.00014662742614746094
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 9.7734375,
            "text": "Africa by Christiaan Barnard in December 1967",
            "probability": 0.00014209747314453125
        },
        {
            "start_logit": -8.375,
            "end_logit": 9.7734375,
            "text": "since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00013875961303710938
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.7734375,
            "text": "South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00013768672943115234
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.7734375,
            "text": "first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00012153387069702148
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.7734375,
            "text": "human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 0.00011962652206420898
        },
        {
            "start_logit": -0.052001953125,
            "end_logit": -7.43359375,
            "text": "December",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.052001953125,
            "end_logit": -7.57421875,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -0.4189453125,
            "end_logit": -7.57421875,
            "text": "196",
            "probability": 0.0
        },
        {
            "start_logit": -6.12890625,
            "end_logit": -6.5,
            "text": "40 years",
            "probability": 0.0
        },
        {
            "start_logit": -6.12890625,
            "end_logit": -7.0546875,
            "text": "40",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_6": [
        {
            "start_logit": 10.0625,
            "end_logit": 10.390625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.8056640625,
            "end_logit": 10.390625,
            "text": "7",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 10.0625,
            "end_logit": -1.5244140625,
            "text": "196",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 10.390625,
            "text": "in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 10.390625,
            "text": "Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.0,
            "text": "1967,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.390625,
            "text": "by Christiaan Barnard in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.109375,
            "text": "1967, there has been",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.15625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.15625,
            "text": "1967, there has been substantial progress in",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.2109375,
            "text": "1967, there has been substantial progress",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.21875,
            "text": "1967, there",
            "probability": 0.0
        },
        {
            "start_logit": 10.0625,
            "end_logit": -8.2421875,
            "text": "1967, there has been substantial progress in the",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -1.5244140625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.5244140625,
            "text": "Christiaan Barnard in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.8056640625,
            "end_logit": -8.0,
            "text": "7,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": -1.5244140625,
            "text": "by Christiaan Barnard in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.8056640625,
            "end_logit": -8.109375,
            "text": "7, there has been",
            "probability": 0.0
        },
        {
            "start_logit": -1.8056640625,
            "end_logit": -8.15625,
            "text": "7, there has been substantial progress in the field of heart transplantation, especially over",
            "probability": 0.0
        },
        {
            "start_logit": -1.8056640625,
            "end_logit": -8.15625,
            "text": "7, there has been substantial progress in",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_7": [
        {
            "start_logit": 10.0,
            "end_logit": 10.390625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.7998046875,
            "end_logit": 10.390625,
            "text": "7",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 10.0,
            "end_logit": -1.7099609375,
            "text": "196",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 10.390625,
            "text": "in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -7.27734375,
            "text": "1967, the field of heart transplantation has advanced",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 10.390625,
            "text": "Since the first human heart transplantation was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -7.6953125,
            "text": "1967, the field of heart transplantation has advanced to",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -7.8359375,
            "text": "1967,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3046875,
            "end_logit": 10.390625,
            "text": "human heart transplantation was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.390625,
            "text": "first human heart transplantation was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4296875,
            "end_logit": 10.390625,
            "text": "performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.0703125,
            "text": "1967, the field of",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 10.390625,
            "text": "the first human heart transplantation was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.390625,
            "text": "heart transplantation was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.390625,
            "text": "was performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.125,
            "text": "1967, the field of heart transplantation has advanced to the point where",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.1875,
            "text": "1967, the",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.203125,
            "text": "1967, the field",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.21875,
            "text": "1967, the field of heart transplantation has advanced to the",
            "probability": 0.0
        },
        {
            "start_logit": 10.0,
            "end_logit": -8.21875,
            "text": "1967, the field of heart transplantation has",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_8": [
        {
            "start_logit": 9.671875,
            "end_logit": 10.0625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.544921875,
            "end_logit": 10.0625,
            "text": "7",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.671875,
            "end_logit": -2.453125,
            "text": "196",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 10.0625,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 10.0625,
            "text": "50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0625,
            "text": "years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": 10.0625,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.0625,
            "text": "ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.1953125,
            "end_logit": 10.0625,
            "text": "transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 10.0625,
            "text": "performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.0625,
            "text": "was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 10.0625,
            "text": "heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.46875,
            "end_logit": 10.0625,
            "text": "human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4765625,
            "end_logit": 10.0625,
            "text": "human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4921875,
            "end_logit": 10.0625,
            "text": "first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.5703125,
            "end_logit": 10.0625,
            "text": "to-human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.0625,
            "text": "-human heart transplant was performed 50 years ago in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -2.453125,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -2.453125,
            "text": "50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -2.453125,
            "text": "years ago in 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_9": [
        {
            "start_logit": 9.9765625,
            "end_logit": 10.21875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -1.8671875,
            "text": "196",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -2.259765625,
            "end_logit": 10.21875,
            "text": "7",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 10.21875,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.28125,
            "end_logit": 10.21875,
            "text": "Since the first human-to-human heart transplantation, performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.21875,
            "text": "performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.21875,
            "text": "transplantation, performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.21875,
            "text": "human heart transplantation, performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.25,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.265625,
            "text": "1967, advances in organ donation, surgical techniques",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.265625,
            "text": "1967,",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.21875,
            "text": "heart transplantation, performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.296875,
            "text": "1967, advances in organ donation, surgical techniques,",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3046875,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation,",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3125,
            "text": "1967, advances",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3125,
            "text": "1967, advances in organ donation,",
            "probability": 0.0
        },
        {
            "start_logit": 9.9765625,
            "end_logit": -8.3359375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and surveillance",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.21875,
            "text": ", performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.21875,
            "text": "-human heart transplantation, performed in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 10.21875,
            "text": "human-to-human heart transplantation, performed in 1967",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_10": [
        {
            "start_logit": 9.8046875,
            "end_logit": 10.34375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.951171875,
            "end_logit": 10.34375,
            "text": "7",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -2.15625,
            "text": "196",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 10.34375,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.55859375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.58203125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.625,
            "text": "1967 was",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 10.34375,
            "text": "human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.96484375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.98046875,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.34375,
            "text": "transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 10.34375,
            "text": "the first human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 10.34375,
            "text": "heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 10.34375,
            "text": "first human heart transplant in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.09375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.140625,
            "text": "1967 was performed using a deceased donor heart",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.15625,
            "text": "1967 was performed",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -2.15625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.951171875,
            "end_logit": -7.55859375,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": -1.951171875,
            "end_logit": -7.58203125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_11": [
        {
            "start_logit": -0.2171630859375,
            "end_logit": 9.8125,
            "text": "1967",
            "probability": 0.67041015625
        },
        {
            "start_logit": -1.455078125,
            "end_logit": 9.8125,
            "text": "December 1967",
            "probability": 0.1951904296875
        },
        {
            "start_logit": -2.310546875,
            "end_logit": 9.8125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.0826416015625
        },
        {
            "start_logit": -2.81640625,
            "end_logit": 9.8125,
            "text": "7",
            "probability": 0.0499267578125
        },
        {
            "start_logit": -7.734375,
            "end_logit": 9.8125,
            "text": "Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.00036525726318359375
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.8125,
            "text": "in December 1967",
            "probability": 0.00022494792938232422
        },
        {
            "start_logit": -8.296875,
            "end_logit": 9.8125,
            "text": "by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.00020802021026611328
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.8125,
            "text": "Christiaan Barnard and his team in December 1967",
            "probability": 0.00020325183868408203
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.8125,
            "text": "or Christiaan Barnard and his team in December 1967",
            "probability": 0.00018644332885742188
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 9.8125,
            "text": "successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.0001633167266845703
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.8125,
            "text": "of 1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.00016200542449951172
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.8125,
            "text": "first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.0001608133316040039
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.8125,
            "text": "operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 0.0001595020294189453
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.8125,
            "text": "team in December 1967",
            "probability": 0.00015461444854736328
        },
        {
            "start_logit": -2.310546875,
            "end_logit": -4.10546875,
            "text": "1983",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.2171630859375,
            "end_logit": -7.9453125,
            "text": "196",
            "probability": 0.0
        },
        {
            "start_logit": -1.455078125,
            "end_logit": -7.9453125,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -2.310546875,
            "end_logit": -7.71875,
            "text": "1983 had",
            "probability": 0.0
        },
        {
            "start_logit": -2.310546875,
            "end_logit": -7.73046875,
            "text": "1983 had its origin in",
            "probability": 0.0
        },
        {
            "start_logit": -2.310546875,
            "end_logit": -7.9453125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_12": [
        {
            "start_logit": 7.53125,
            "end_logit": 10.1875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": 10.1875,
            "text": "December 1967",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": 10.1875,
            "text": "7",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 7.53125,
            "end_logit": -4.5390625,
            "text": "196",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 10.1875,
            "text": "50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 10.1875,
            "text": "Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 10.1875,
            "text": "Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 10.1875,
            "text": "years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 10.1875,
            "text": "in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.140625,
            "end_logit": 10.1875,
            "text": "since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.1875,
            "text": "It has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.1875,
            "text": "been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 10.1875,
            "text": ". Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.421875,
            "end_logit": 10.1875,
            "text": "has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.5390625,
            "end_logit": 10.1875,
            "text": "first human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.1875,
            "text": "human-to-human heart transplant in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.53125,
            "end_logit": -7.76953125,
            "text": "1967 in South Africa",
            "probability": 0.0
        },
        {
            "start_logit": 7.53125,
            "end_logit": -8.046875,
            "text": "1967 in South",
            "probability": 0.0
        },
        {
            "start_logit": 7.53125,
            "end_logit": -8.0546875,
            "text": "1967 in",
            "probability": 0.0
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": -4.5390625,
            "text": "December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_13": [
        {
            "start_logit": 6.37109375,
            "end_logit": 10.1328125,
            "text": "3 December 1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.38671875,
            "end_logit": 10.1328125,
            "text": "1967",
            "probability": 0.00015842914581298828
        },
        {
            "start_logit": -2.4140625,
            "end_logit": 10.1328125,
            "text": "7",
            "probability": 0.00015354156494140625
        },
        {
            "start_logit": -7.6875,
            "end_logit": 10.1328125,
            "text": "December 1967",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.1328125,
            "text": "on 3 December 1967",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -8.21875,
            "end_logit": 10.1328125,
            "text": "The first successful human heart transplantation was reported on 3 December 1967",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.234375,
            "end_logit": 10.1328125,
            "text": "reported on 3 December 1967",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -8.265625,
            "end_logit": 10.1328125,
            "text": "was reported on 3 December 1967",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.1328125,
            "text": "human heart transplantation was reported on 3 December 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 10.1328125,
            "text": "successful human heart transplantation was reported on 3 December 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.5625,
            "end_logit": 10.1328125,
            "text": "heart transplantation was reported on 3 December 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -8.609375,
            "end_logit": 10.1328125,
            "text": "first successful human heart transplantation was reported on 3 December 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.875,
            "text": "3",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.3359375,
            "text": "3 December",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.9296875,
            "text": "3 December 196",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.96484375,
            "text": "3 December 1967, by Christiaan Barnard",
            "probability": 0.0
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -8.0625,
            "text": "3 December 1967, by Christiaan Barnard in",
            "probability": 0.0
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -8.09375,
            "text": "3 December 1967, by Christiaan Barnard in South Africa",
            "probability": 0.0
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -8.1015625,
            "text": "3 December 1967, by Christ",
            "probability": 0.0
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -8.125,
            "text": "3 December 1967, by Christiaan",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_14": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.9609375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": 9.9609375,
            "text": "7",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 9.078125,
            "end_logit": -3.36328125,
            "text": "196",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.9609375,
            "text": "December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 9.9609375,
            "text": "Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.09375,
            "end_logit": 9.9609375,
            "text": "world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.9609375,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.2109375,
            "end_logit": 9.9609375,
            "text": "2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 9.9609375,
            "text": "on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.34375,
            "end_logit": 9.9609375,
            "text": "the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 9.9609375,
            "text": "human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.421875,
            "end_logit": 9.9609375,
            "text": "human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.9609375,
            "text": "transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.9609375,
            "text": "heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.9609375,
            "text": "first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.5546875,
            "end_logit": 9.9609375,
            "text": "at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.88671875,
            "text": "1967.",
            "probability": 0.0
        },
        {
            "start_logit": -7.125,
            "end_logit": -3.36328125,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -2.66796875,
            "end_logit": -7.88671875,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -8.0234375,
            "end_logit": -3.36328125,
            "text": "Groote Schuur Hospital on the 2nd December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_15": [
        {
            "start_logit": 9.0703125,
            "end_logit": 10.1015625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": 10.1015625,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 6.300210952758789e-05
        },
        {
            "start_logit": -2.3671875,
            "end_logit": 10.1015625,
            "text": "7",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -3.232421875,
            "text": "196",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 10.1015625,
            "text": "3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 10.1015625,
            "text": "Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -8.328125,
            "end_logit": 10.1015625,
            "text": "by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.1015625,
            "text": "December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 10.1015625,
            "text": "human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.1015625,
            "text": "performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.625,
            "end_logit": 10.1015625,
            "text": "Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.6015625,
            "text": "1967.",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.1015625,
            "text": "to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 10.1015625,
            "text": "human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.640625,
            "end_logit": 10.1015625,
            "text": "since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": -3.232421875,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": -4.203125,
            "text": "50 years",
            "probability": 0.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": -6.37109375,
            "text": "50",
            "probability": 0.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": -7.31640625,
            "text": "50 years have passed since",
            "probability": 0.0
        },
        {
            "start_logit": -0.60009765625,
            "end_logit": -7.6015625,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967.",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_16": [
        {
            "start_logit": 9.8046875,
            "end_logit": 10.21875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.234375,
            "end_logit": 10.21875,
            "text": "7",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -2.205078125,
            "text": "196",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 10.21875,
            "text": "In 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.61328125,
            "text": "1967, he led the team that performed the world'",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.65625,
            "text": "1967, he led the team that performed the world's",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.90625,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant.",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.984375,
            "text": "1967, he led the team that performed the world's first",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.0,
            "text": "1967, he led the team",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.03125,
            "text": "1967, he led the team that performed the world's first human-to",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.0546875,
            "text": "1967, he led the team that performed",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.0703125,
            "text": "1967, he led the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.0859375,
            "text": "1967, he led",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.0859375,
            "text": "1967, he led the team that performed the",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.1171875,
            "text": "1967, he led the team that",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.140625,
            "text": "1967,",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.171875,
            "text": "1967, he led the team that performed the world",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.203125,
            "text": "1967, he led the team that performed the world's first human-",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.2109375,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.21875,
            "text": "1967, he led the team that performed the world's first human",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_17": [
        {
            "start_logit": 8.109375,
            "end_logit": 6.640625,
            "text": "1967",
            "probability": 0.876953125
        },
        {
            "start_logit": 5.68359375,
            "end_logit": 6.640625,
            "text": "1953, followed by the first successful heart transplant in 1967",
            "probability": 0.07781982421875
        },
        {
            "start_logit": 5.68359375,
            "end_logit": 6.109375,
            "text": "1953",
            "probability": 0.045745849609375
        },
        {
            "start_logit": 8.109375,
            "end_logit": -2.3515625,
            "text": "196",
            "probability": 0.00010901689529418945
        },
        {
            "start_logit": 5.68359375,
            "end_logit": -2.3515625,
            "text": "1953, followed by the first successful heart transplant in 196",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -3.76953125,
            "end_logit": 6.640625,
            "text": "7",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 6.640625,
            "text": "3, followed by the first successful heart transplant in 1967",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.69921875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 6.109375,
            "text": "3",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.98046875,
            "text": "1967, and later to the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.03125,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.046875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.0546875,
            "text": "1967, and later to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.09375,
            "text": "1967, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.1875,
            "text": "1967, and later to the first",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -8.1953125,
            "text": "1967, and later to the first infusion of bone marrow",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.68359375,
            "end_logit": -6.015625,
            "text": "195",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.640625,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.640625,
            "text": "successful heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.640625,
            "text": "transplant in 1967",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601ee4c61cb411341a000066_18": [
        {
            "start_logit": 7.23046875,
            "end_logit": 10.078125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": 10.078125,
            "text": "7",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 10.078125,
            "text": "3 December 1967",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 10.078125,
            "text": "December 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 10.078125,
            "text": "on 3 December 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -5.171875,
            "text": "196",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -8.3515625,
            "end_logit": 10.078125,
            "text": "Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.078125,
            "text": "at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.390625,
            "end_logit": 10.078125,
            "text": ", on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.40625,
            "end_logit": 10.078125,
            "text": "Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 10.078125,
            "text": "Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.453125,
            "end_logit": 10.078125,
            "text": "performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.078125,
            "text": "first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.53125,
            "end_logit": 10.078125,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.078125,
            "text": "transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 10.078125,
            "text": "ote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 10.078125,
            "text": "heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -8.0546875,
            "text": "1967.",
            "probability": 0.0
        },
        {
            "start_logit": -5.19921875,
            "end_logit": -5.171875,
            "text": "3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -8.0546875,
            "text": "7.",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_19": [
        {
            "start_logit": 2.662109375,
            "end_logit": 10.0234375,
            "text": "1967",
            "probability": 0.9931640625
        },
        {
            "start_logit": -2.357421875,
            "end_logit": 10.0234375,
            "text": "7",
            "probability": 0.006534576416015625
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 10.0234375,
            "text": "December 3, 1967",
            "probability": 0.0004229545593261719
        },
        {
            "start_logit": -5.84765625,
            "end_logit": 10.0234375,
            "text": "On December 3, 1967",
            "probability": 0.0001989603042602539
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 10.0234375,
            "text": ", 1967",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": -8.3828125,
            "end_logit": 10.0234375,
            "text": "3, 1967",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.55859375,
            "text": "1967, in Cape Town",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.62109375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.6953125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.6953125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolution",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.7890625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnar",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.828125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.85546875,
            "text": "196",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.890625,
            "text": "1967, in Cape Town, South Africa, Dr. Christ",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.921875,
            "text": "1967, in Cape Town, South Africa",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.9453125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant.",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -7.9609375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -8.0234375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -8.0625,
            "text": "1967, in Cape Town,",
            "probability": 0.0
        },
        {
            "start_logit": 2.662109375,
            "end_logit": -8.125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_20": [
        {
            "start_logit": 9.890625,
            "end_logit": 10.2890625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.07421875,
            "end_logit": 10.2890625,
            "text": "7",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.890625,
            "end_logit": -2.017578125,
            "text": "196",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.2734375,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.453125,
            "text": "1967 and",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 10.2890625,
            "text": "in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.109375,
            "end_logit": 10.2890625,
            "text": "Barnard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.71484375,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.74609375,
            "text": "1967 and followed this by",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.828125,
            "text": "1967 and followed this by introducing the technique of",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.8515625,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.91015625,
            "text": "1967 and followed this by introducing the",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.94921875,
            "text": "1967 and followed this by introducing",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.95703125,
            "text": "1967 and followed",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.95703125,
            "text": "1967 and followed this by introducing the technique of heterotopic",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -7.97265625,
            "text": "1967 and followed this by introducing the technique of heterotopic heart",
            "probability": 0.0
        },
        {
            "start_logit": 9.890625,
            "end_logit": -8.046875,
            "text": "1967 and followed this",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 10.2890625,
            "text": "human-to-human orthotopic heart transplantation in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 10.2890625,
            "text": "human orthotopic heart transplantation in 1967",
            "probability": 0.0
        },
        {
            "start_logit": -8.6953125,
            "end_logit": 10.2890625,
            "text": "1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 0.0
        }
    ],
    "5fdb2e23a43ad3127800000a_1": [
        {
            "start_logit": -4.02734375,
            "end_logit": 4.87890625,
            "text": ".",
            "probability": 0.65478515625
        },
        {
            "start_logit": -5.65625,
            "end_logit": 4.87890625,
            "text": "gene transcription.",
            "probability": 0.12841796875
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 4.87890625,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.07696533203125
        },
        {
            "start_logit": -6.609375,
            "end_logit": 4.87890625,
            "text": "central to understanding gene transcription.",
            "probability": 0.04949951171875
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 4.87890625,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.034820556640625
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 4.87890625,
            "text": "understanding gene transcription.",
            "probability": 0.0233001708984375
        },
        {
            "start_logit": -7.578125,
            "end_logit": 4.87890625,
            "text": "identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.018798828125
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 4.87890625,
            "text": "elements is central to understanding gene transcription.",
            "probability": 0.01287078857421875
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -2.416015625,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0004436969757080078
        },
        {
            "start_logit": -5.65625,
            "end_logit": -2.416015625,
            "text": "gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 8.732080459594727e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": -2.416015625,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 6.341934204101562e-05
        },
        {
            "start_logit": -6.22265625,
            "end_logit": -2.416015625,
            "text": "DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 4.941225051879883e-05
        },
        {
            "start_logit": -6.609375,
            "end_logit": -2.416015625,
            "text": "central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -2.416015625,
            "text": "understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -2.416015625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -2.416015625,
            "text": "digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -2.416015625,
            "text": "gold-standard approach to locating such elements.",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": -4.02734375,
            "end_logit": -5.99609375,
            "text": ". Hypersensitivity of cis-regulatory elements to",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -2.416015625,
            "text": "elements.",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -2.416015625,
            "text": "the gold-standard approach to locating such elements.",
            "probability": 1.0848045349121094e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_2": [
        {
            "start_logit": 3.341796875,
            "end_logit": 5.84765625,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.947265625
        },
        {
            "start_logit": 3.341796875,
            "end_logit": 2.5546875,
            "text": "Hypersensitivity of cis-regulatory elements",
            "probability": 0.03533935546875
        },
        {
            "start_logit": -0.73046875,
            "end_logit": 5.84765625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.01617431640625
        },
        {
            "start_logit": -0.73046875,
            "end_logit": 2.5546875,
            "text": "cis-regulatory elements",
            "probability": 0.0006008148193359375
        },
        {
            "start_logit": -4.69921875,
            "end_logit": 5.84765625,
            "text": ".",
            "probability": 0.0003056526184082031
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 5.84765625,
            "text": "elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 5.519390106201172e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 5.84765625,
            "text": "DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.9729137420654297e-05
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 5.84765625,
            "text": "regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 5.84765625,
            "text": "the gold-standard approach to locating such elements.",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -7.6875,
            "end_logit": 5.84765625,
            "text": "elements.",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 5.84765625,
            "text": "locating such elements.",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 5.84765625,
            "text": "remains the gold-standard approach to locating such elements.",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 5.84765625,
            "text": "gold-standard approach to locating such elements.",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 5.84765625,
            "text": "digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.2695789337158203e-05
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 5.84765625,
            "text": "of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 5.84765625,
            "text": "such elements.",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 3.341796875,
            "end_logit": -5.546875,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -8.09375,
            "end_logit": 5.84765625,
            "text": "with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 3.341796875,
            "end_logit": -6.0546875,
            "text": "Hypersensitivity of cis-regulatory elements to",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 3.341796875,
            "end_logit": -6.828125,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 2.9802322387695312e-06
        }
    ],
    "5fdb2e23a43ad3127800000a_3": [
        {
            "start_logit": 1.47265625,
            "end_logit": 5.96875,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.98388671875
        },
        {
            "start_logit": -2.951171875,
            "end_logit": 5.96875,
            "text": "gene transcription.",
            "probability": 0.011810302734375
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 5.96875,
            "text": ".",
            "probability": 0.0013151168823242188
        },
        {
            "start_logit": -5.15625,
            "end_logit": 5.96875,
            "text": "central to understanding gene transcription.",
            "probability": 0.0012998580932617188
        },
        {
            "start_logit": -5.3671875,
            "end_logit": 5.96875,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0010528564453125
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 5.96875,
            "text": "identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0003695487976074219
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 5.96875,
            "text": "understanding gene transcription.",
            "probability": 0.0002913475036621094
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 5.96875,
            "text": "is central to understanding gene transcription.",
            "probability": 0.0001418590545654297
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 5.96875,
            "text": "elements is central to understanding gene transcription.",
            "probability": 0.00013327598571777344
        },
        {
            "start_logit": -7.65625,
            "end_logit": 5.96875,
            "text": "to understanding gene transcription.",
            "probability": 0.00010710954666137695
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 5.96875,
            "text": "of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 7.718801498413086e-05
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 5.96875,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 7.2479248046875e-05
        },
        {
            "start_logit": -8.171875,
            "end_logit": 5.96875,
            "text": "transcription.",
            "probability": 6.395578384399414e-05
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -4.53125,
            "text": "The identification of cis-regulatory elements",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -6.765625,
            "text": "The identification of cis-regulatory",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -6.8359375,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -7.0078125,
            "text": "The identification of cis-regulatory elements is",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -7.05078125,
            "text": "The identification of cis-regulatory elements is central to",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -7.1328125,
            "text": "The identification of",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 1.47265625,
            "end_logit": -7.47265625,
            "text": "The identification of cis-regulatory elements is central",
            "probability": 1.430511474609375e-06
        }
    ],
    "53318685d6d3ac6a3400003d_1": [
        {
            "start_logit": 9.953125,
            "end_logit": 10.2265625,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": -2.25,
            "end_logit": 10.2265625,
            "text": "dominant",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.953125,
            "end_logit": -2.025390625,
            "text": "autosomal",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.2265625,
            "text": "AD has an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.015625,
            "text": "autosomal dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.078125,
            "text": "autosomal dominant mode of inheritance,",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.140625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": 9.953125,
            "end_logit": -8.1484375,
            "text": "autosomal dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 10.2265625,
            "text": "has an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 10.2265625,
            "text": "an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -2.025390625,
            "text": "AD has an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -8.015625,
            "text": "dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -8.078125,
            "text": "dominant mode of inheritance,",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -8.140625,
            "text": "dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -8.1484375,
            "text": "dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": -2.025390625,
            "text": "has an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": -2.025390625,
            "text": "an autosomal",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.015625,
            "text": "AD has an autosomal dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.078125,
            "text": "AD has an autosomal dominant mode of inheritance,",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": -8.140625,
            "text": "AD has an autosomal dominant mode of inheritance",
            "probability": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d_2": [
        {
            "start_logit": 9.71875,
            "end_logit": 10.125,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": -2.361328125,
            "end_logit": 10.125,
            "text": "dominant",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 9.71875,
            "end_logit": -2.5234375,
            "text": "autosomal",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 10.125,
            "text": "an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.0546875,
            "end_logit": 10.125,
            "text": "Finally, WMS is transmitted either by an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.65234375,
            "text": "autosomal dominant or",
            "probability": 0.0
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 10.125,
            "text": "S is transmitted either by an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.0859375,
            "end_logit": 10.125,
            "text": "WMS is transmitted either by an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.1015625,
            "end_logit": 10.125,
            "text": "is transmitted either by an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -7.94921875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.046875,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0703125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.0859375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1328125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1484375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.15625,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.1796875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.234375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.25,
            "text": "autosomal dominant or an autosomal recessive (",
            "probability": 0.0
        },
        {
            "start_logit": 9.71875,
            "end_logit": -8.28125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance,",
            "probability": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d_3": [
        {
            "start_logit": 9.9296875,
            "end_logit": 10.15625,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -2.09765625,
            "text": "autosomal",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -2.396484375,
            "end_logit": 10.15625,
            "text": "dominant",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 10.15625,
            "text": "three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 10.15625,
            "text": "vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": 10.15625,
            "text": "consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 10.15625,
            "text": "an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.59375,
            "text": "autosomal dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -7.6015625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 10.15625,
            "text": "families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": 10.15625,
            "text": "was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 10.15625,
            "text": "transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.2265625,
            "end_logit": 10.15625,
            "text": "The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 10.15625,
            "text": "cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": 9.9296875,
            "end_logit": -8.0625,
            "text": "autosomal dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -8.3125,
            "end_logit": 10.15625,
            "text": "condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.3203125,
            "end_logit": 10.15625,
            "text": "16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.359375,
            "end_logit": 10.15625,
            "text": "observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": 10.15625,
            "text": "sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -2.09765625,
            "text": "three families was consistent with an autosomal",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_1": [
        {
            "start_logit": 9.7421875,
            "end_logit": 9.8671875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -2.42578125,
            "text": "Oh",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -2.943359375,
            "end_logit": 9.8671875,
            "text": "io",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 9.8671875,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.7421875,
            "end_logit": -7.90234375,
            "text": "Ohio,",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.8671875,
            "text": "2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.8671875,
            "text": "measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": 9.8671875,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.8671875,
            "text": "outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.5625,
            "end_logit": 9.8671875,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 9.8671875,
            "text": "in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.8671875,
            "text": "a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 9.8671875,
            "text": "Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.609375,
            "end_logit": 9.8671875,
            "text": "communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.65625,
            "end_logit": 9.8671875,
            "text": "sh communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -2.42578125,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -2.42578125,
            "text": "2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -2.42578125,
            "text": "measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.40625,
            "end_logit": -2.42578125,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -2.943359375,
            "end_logit": -7.90234375,
            "text": "io,",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_2": [
        {
            "start_logit": 9.453125,
            "end_logit": 9.609375,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -2.8515625,
            "text": "Oh",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -3.3359375,
            "end_logit": 9.609375,
            "text": "io",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 9.609375,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": 9.609375,
            "text": "in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": 9.609375,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": 9.609375,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 9.609375,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.5,
            "end_logit": 9.609375,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.53125,
            "end_logit": 9.609375,
            "text": "outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.609375,
            "text": "subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 9.609375,
            "text": "outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 9.609375,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6328125,
            "end_logit": 9.609375,
            "text": ", with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.1328125,
            "end_logit": -2.8515625,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.3359375,
            "end_logit": -2.8515625,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.375,
            "end_logit": -2.8515625,
            "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.390625,
            "end_logit": -2.8515625,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.3984375,
            "end_logit": -2.8515625,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.8515625,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_3": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.953125,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.474609375,
            "text": "Oh",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -2.76171875,
            "end_logit": 9.953125,
            "text": "io",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.953125,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.03125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.0859375,
            "text": "Ohio were",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.09375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1328125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.15625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Ami",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.953125,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.953125,
            "text": "measles outbreak in the Amish community in Ohio",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_4": [
        {
            "start_logit": 9.7578125,
            "end_logit": 9.8671875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -2.3671875,
            "text": "Oh",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -2.939453125,
            "end_logit": 9.8671875,
            "text": "io",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -7.82421875,
            "text": "Ohio pushing the annual cases to",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -7.921875,
            "text": "Ohio pushing the annual cases to the",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.0078125,
            "text": "Ohio pushing the annual cases to the highest national number reported in",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.0234375,
            "text": "Ohio pushing the annual cases to the highest national number reported in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.046875,
            "text": "Ohio push",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.0859375,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.0859375,
            "text": "Ohio pushing the annual cases to the highest",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.1171875,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 0.0
        },
        {
            "start_logit": -8.234375,
            "end_logit": 9.8671875,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.1328125,
            "text": "Ohio pushing the annual cases to the highest national number reported",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.140625,
            "text": "Ohio pushing the annual cases to the highest national number",
            "probability": 0.0
        },
        {
            "start_logit": 9.7578125,
            "end_logit": -8.140625,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last",
            "probability": 0.0
        },
        {
            "start_logit": -8.4140625,
            "end_logit": 9.8671875,
            "text": "in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.546875,
            "end_logit": 9.8671875,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.578125,
            "end_logit": 9.8671875,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6015625,
            "end_logit": 9.8671875,
            "text": "subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6171875,
            "end_logit": 9.8671875,
            "text": "outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_5": [
        {
            "start_logit": 9.8671875,
            "end_logit": 10.0,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -2.185546875,
            "text": "Oh",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -2.724609375,
            "end_logit": 10.0,
            "text": "io",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 10.0,
            "text": "in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.0390625,
            "text": "Ohio, resulting in 36",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.1484375,
            "text": "Ohio, resulting in",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.1640625,
            "text": "Ohio, resulting in 368",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.2265625,
            "text": "Ohio, resulting",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": 10.0,
            "text": "2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": 9.8671875,
            "end_logit": -8.3359375,
            "text": "Ohio,",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": 10.0,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": 10.0,
            "text": "measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.5859375,
            "end_logit": 10.0,
            "text": "outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.0,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 10.0,
            "text": "a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6796875,
            "end_logit": 10.0,
            "text": "in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -2.185546875,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.4375,
            "end_logit": -2.185546875,
            "text": "2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.484375,
            "end_logit": -2.185546875,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -8.515625,
            "end_logit": -2.185546875,
            "text": "measles outbreak in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_6": [
        {
            "start_logit": 9.703125,
            "end_logit": 9.953125,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -2.474609375,
            "text": "Oh",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -2.76171875,
            "end_logit": 9.953125,
            "text": "io",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.953125,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.03125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.0859375,
            "text": "Ohio were",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.09375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.109375,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1328125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.15625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Ami",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily",
            "probability": 0.0
        },
        {
            "start_logit": 9.703125,
            "end_logit": -8.1875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected",
            "probability": 0.0
        },
        {
            "start_logit": -8.5078125,
            "end_logit": 9.953125,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.59375,
            "end_logit": 9.953125,
            "text": "measles outbreak in the Amish community in Ohio",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_7": [
        {
            "start_logit": 9.65625,
            "end_logit": 9.765625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -2.560546875,
            "text": "Oh",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -3.126953125,
            "end_logit": 9.765625,
            "text": "io",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 9.765625,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.8203125,
            "text": "Ohio pushing the annual cases to",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.89453125,
            "text": "Ohio push",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -7.96484375,
            "text": "Ohio pushing the annual cases to the",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.0078125,
            "text": "Ohio pushing the annual cases to the highest national number reported in",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.0703125,
            "text": "Ohio pushing the annual cases to the highest national number reported in the",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.09375,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.1015625,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 0.0
        },
        {
            "start_logit": -8.21875,
            "end_logit": 9.765625,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.1171875,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.140625,
            "text": "Ohio pushing the annual cases to the highest national number reported",
            "probability": 0.0
        },
        {
            "start_logit": 9.65625,
            "end_logit": -8.140625,
            "text": "Ohio pushing the annual cases to the highest",
            "probability": 0.0
        },
        {
            "start_logit": -8.4609375,
            "end_logit": 9.765625,
            "text": "outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6484375,
            "end_logit": 9.765625,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 9.765625,
            "text": "Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.6640625,
            "end_logit": 9.765625,
            "text": "in Amish communities in Ohio",
            "probability": 0.0
        },
        {
            "start_logit": -8.671875,
            "end_logit": 9.765625,
            "text": "continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 0.0
        }
    ],
    "61f95f9f882a024a1000004e_1": [
        {
            "start_logit": 9.8046875,
            "end_logit": 9.71875,
            "text": "Oguchi disease",
            "probability": 1.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -2.267578125,
            "text": "Og",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -3.095703125,
            "end_logit": 9.71875,
            "text": "disease",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -5.390625,
            "text": "Oguchi",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.71875,
            "text": "cause Oguchi disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.125,
            "text": "Oguch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.26953125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.5390625,
            "text": "Oguchi disease, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.796875,
            "text": "Oguchi disease,",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 9.71875,
            "text": "uchi disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -7.8515625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": 9.71875,
            "text": "i disease",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.1171875,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.171875,
            "text": "Oguchi disease, a rare",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.171875,
            "text": "Oguchi disease, a rare subtype",
            "probability": 0.0
        },
        {
            "start_logit": 9.8046875,
            "end_logit": -8.203125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB)",
            "probability": 0.0
        },
        {
            "start_logit": -8.5234375,
            "end_logit": 9.71875,
            "text": ") cause Oguchi disease",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -2.267578125,
            "text": "cause Og",
            "probability": 0.0
        },
        {
            "start_logit": -3.095703125,
            "end_logit": -7.26953125,
            "text": "disease, a rare subtype of congenital stationary night blindness",
            "probability": 0.0
        },
        {
            "start_logit": -3.095703125,
            "end_logit": -7.5390625,
            "text": "disease, a",
            "probability": 0.0
        }
    ]
}
